<SEC-DOCUMENT>0001144204-16-101325.txt : 20160512
<SEC-HEADER>0001144204-16-101325.hdr.sgml : 20160512
<ACCEPTANCE-DATETIME>20160512170954
ACCESSION NUMBER:		0001144204-16-101325
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20160331
FILED AS OF DATE:		20160512
DATE AS OF CHANGE:		20160512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGMA LABS, INC.
		CENTRAL INDEX KEY:			0000788611
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
		IRS NUMBER:				820404220
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-02783-S
		FILM NUMBER:		161644884

	BUSINESS ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507
		BUSINESS PHONE:		(505) 438-2576

	MAIL ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRAMEWAVES INC
		DATE OF NAME CHANGE:	20010130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MESSIDOR LTD
		DATE OF NAME CHANGE:	20010122
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>v438343_10q.htm
<DESCRIPTION>10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE</B><BR>
<B>COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Mark One)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD STYLE="width: 92%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUARTERLY
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.25pt; text-indent: -18.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the quarterly period ended March 31, 2016</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.25pt; text-indent: -18.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 96%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OR</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.25pt; text-indent: -18.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 92%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.25pt; text-indent: -18.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 69.85pt; text-align: center; text-indent: -69.85pt">Commission
file number: 033-02783-S</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 214.55pt; text-align: center; text-indent: -70.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sigma
    Labs, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center; text-indent: -0.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEVADA</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27-1865814</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of
        incorporation or</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">organization)</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
    Paseo del Sol</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
    Fe, NM 87507</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(505)
    438-2576</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
    telephone number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
    Name or Former Address, if Changed Since Last Report</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1)&nbsp;has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to
such filing requirements for the past 90 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> No </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T during the preceding 12&nbsp;months (or for such shorter period that
the registrant was required to submit and post such files).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> No </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer</FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate the number of shares outstanding
of each of the issuer&rsquo;s classes of common stock, as of the latest practicable date: As of May 12, 2016, the issuer had 6,237,436
shares of common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
</FONT><FONT STYLE="font-family: Wingdings">&uml; </FONT>No <FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGMA LABS, INC.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the quarter ended March 31, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_018">PART I</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 5%; text-align: right">1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_019">ITEM 1.&nbsp;&nbsp;FINANCIAL STATEMENTS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_020">ITEM 2. &nbsp;MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_021">ITEM 3.&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_022">ITEM 4.&nbsp;&nbsp;CONTROLS AND PROCEDURES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_023">PART II</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_024">ITEM 1.&nbsp;&nbsp;LEGAL PROCEEDINGS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_025">ITEM 1A. RISK FACTORS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_026">ITEM 2.&nbsp;&nbsp;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_027">ITEM 3.&nbsp;&nbsp;DEFAULTS UPON SENIOR SECURITIES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_028">ITEM 4.&nbsp;&nbsp;MINE SAFETY DISCLOSURES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_029">ITEM 5.&nbsp;&nbsp;OTHER INFORMATION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_030">ITEM 6.&nbsp;&nbsp;EXHIBITS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">17</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_031">SIGNATURES</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_018"></A>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_019"></A>ITEM 1. FINANCIAL STATEMENTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sigma Labs, Inc.<BR>
Unaudited Balance Sheets<BR>
March 31, 2016 and December 31, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-weight: bold; padding-left: 0.25in">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">1,086,363</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">1,539,809</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Accounts Receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">381,309</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">280,222</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 0.25in">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,186</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,129</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Prepaid Assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">38,862</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">55,484</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Total Current Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,600,720</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,895,644</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Other Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Property and Equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">697,316</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">714,754</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Intangible Assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">197,630</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,644</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Investment in Joint Venture</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,222</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,222</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Total Other Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">904,168</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">891,620</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,504,888</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,787,264</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">144,026</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">38,393</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Accrued Expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">82,630</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">71,523</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Total Current Liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">226,656</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">109,916</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">TOTAL LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">226,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,916</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Stockholders' Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 0.25in">Preferred Stock, $0.001 par; 10,000,000 shares authorized;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 27pt">None issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 0.25in">Common Stock, $0.001 par; 7,500,000 shares authorized;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 27pt">6,232,778 issued and 6,210,278 outstanding at March 31, 2016 and 6,239,073
    issued and 6,206,573 outstanding at December 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,233</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,239</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Additional Paid-In Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,579,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,636,979</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in">Less Deferred Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 27pt">22,500 and 32,500 common shares, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(272,750</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(401,750</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Retained Earnings (Deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,034,787</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(7,564,120</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Total Stockholders' Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,278,232</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,677,348</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,504,888</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,787,264</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The accompanying notes are an integral
part of these condensed financial statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>Sigma
Labs, Inc.<BR>
Unaudited Condensed Statements of Operations<BR>
Three Months Ended March 31, 2016 and 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; font-weight: bold; padding-bottom: 1pt; padding-left: 9pt">Services</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: right">358,455</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: right">185,686</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 27pt">Total Revenue</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">358,455</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">185,686</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">COST OF SERVICE REVENUE</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">107,581</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24,867</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 27pt">GROSS PROFIT</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">250,874</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">160,819</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Other General and Administration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">395,488</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,703</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Payroll Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,589</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,660</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Stock-Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71,551</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Research and Development</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,071</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">70,147</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 27pt">Total Expenses</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">721,699</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">533,260</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME (EXPENSE)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Interest Income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">158</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">560</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 27pt">Total Other Income (Expense)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">158</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">560</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(470,667</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(371,881</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Income Tax Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Deferred Income Tax Expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Income (Loss)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(470,667</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(371,881</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Loss per Common Share - Basic and Diluted</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(0.08</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(0.06</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Weighted Average Number of Shares Outstanding - Basic and
    Diluted</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">6,233,729</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">6,206,220</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The accompanying notes are an integral
part of these condensed financial statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sigma Labs, Inc.<BR>
Unaudited Condensed Statements of Cash Flows<BR>
Three Months Ended March 31, 2016 and 2015</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; font-weight: bold; text-align: left; padding-left: 9pt">Net Income (Loss)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">(470,667</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">(371,881</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Adjustments to reconcile Net Income (Loss)&nbsp;&nbsp;to Net Cash provided (used) by operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Noncash Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 27pt">Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,002</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">577</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 27pt">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,868</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,405</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 27pt">Stock Options Awarded</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,540</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 27pt">Stock Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9pt">Change in assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 27pt">(Increase) Decrease in Accounts Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(101,087</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(46,845</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 27pt">Decrease (Increase) in Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,057</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,269</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 27pt">Decrease (Increase) in Prepaid Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,622</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,457</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 27pt">(Decrease) Increase in Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(212,409</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 27pt">Increase In Accrued Expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,107</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,510</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.5in">NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(393,028</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(463,705</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Purchase of Furniture and Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,430</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,357</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt; padding-bottom: 1pt">Purchase of Intangible Assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(34,988</TD><TD STYLE="text-align: left; padding-bottom: 1pt">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(1,347</TD><TD STYLE="text-align: left; padding-bottom: 1pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.5in">NET CASH (USED) BY INVESTING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(60,418</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(8,704</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">NET CASH (DECREASE) INCREASE FOR PERIOD</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(453,446</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(472,409</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">CASH AT BEGINNING OF PERIOD</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,539,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,962,069</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">CASH AT END OF PERIOD</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,086,363</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,489,660</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Supplemental Disclosure for Cash Flow Information Cash paid during the period for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 27pt">Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 27pt">Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Supplemental Schedule of Noncash Investing and Financing Activities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">For the three months ended March 31, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3,080 shares were issued to a consultant at $4.87 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">625 shares were issued to an employee at $4.82 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">10,000 unvested shares of common stock were cancelled,
and deferred compensation was reduced by $129,000, or $12.9 per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">Stock options were
awarded to employees during 2015 and 2016. The expense recognized during the three months ending March 31, 2016 was $53,540.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">For the three months ended March 31, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">36,038 shares issued to an officer, a director and
two consultants at $5.3 per share. Of these, 16,509 vested during the period and 19,528 remain unvested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3,750 shares vested relating to the Company's Equity
Incentive Plan, reducing deferred compensation by $35,250.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>The accompanying notes
are an integral part of these condensed financial statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><B>SIGMA
LABS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MARCH 31, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 1 &ndash; Summary of Significant Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nature of Business &ndash; </B>On September 13, 2010 Sigma
Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging
6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition
has been accounted for as a &ldquo;reverse purchase&rdquo;, and accordingly the operations of Framewaves, Inc. prior to the date
of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &ldquo;B6 Sigma&rdquo;
refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating
company acquired in September 2010; the terms the &ldquo;Company,&rdquo; &ldquo;Sigma,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially
all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result,
B6 Sigma became part of Sigma and no longer exists as a subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">B6 Sigma, Inc., incorporated February 5, 2010, was founded
by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials
technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance
and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and
ultimatley leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele
to combine advanced manufacturing quality assurance and processs control protocols with novel materials to achieve breakthrough
product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical
manufacturing, <FONT STYLE="font-size: 10pt">automotive manufacturing, and other markets such as firearms and recreational equipment</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Basis of Presentation</B> &ndash; The accompanying financial
statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation
S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly
the financial position, results of operations and cash flows at March 31, 2016 and 2015 and for the periods then ended have been
made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S.
generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements
be read in conjunction with the December 31, 2015 audited financial statements and notes thereto included in the Company&rsquo;s
Form 10-K. The results of operations for the periods ended March 31, 2016 and 2015 are not necessarily indicative of the operating
results for the full year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Reclassification</B> &ndash; Certain amounts in prior-period
financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Property and Equipment &ndash; </B>Property and equipment
are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are
capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation
is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined
to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fair Value of Financial Instruments</B> - The Company applies
ASC 820, &ldquo;Fair Value Measurements<I>.</I>&rdquo;<I>&nbsp;</I>This guidance defines fair value, establishes a three-level
valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The
three levels are defined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-left: 0.25in; font-size: 10pt; text-align: justify"></TD>
    <TD STYLE="width: 94%; padding-left: 0.2pt; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-left: 0.25in; text-align: justify"></TD>
    <TD STYLE="width: 94%; padding-left: 0.2pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial
    instrument.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: justify"></TD>
    <TD STYLE="padding-left: 0.2pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level 3 inputs to
    valuation methodology are unobservable and significant to the fair measurement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The carrying amounts reported in the balance sheets for the
cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments
and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and
their expected realization and their current market rate of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Income Taxes</B> <B>&ndash; </B>The Company accounts for
income taxes in accordance with ASC Topic No. 740, &ldquo;Accounting for Income Taxes.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company adopted the provisions of ASC Topic No. 740, &ldquo;Accounting
for Income Taxes,&rdquo; at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740,
the Company recognized no increase in the liability for unrecognized tax benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has no tax positions at March 31, 2016 and December
31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company recognizes interest accrued related to unrecognized
tax benefits in interest expense and penalties in operating expenses. During the three months ended March 31, 2016, the Company
recognized no interest and penalties. The Company had no accruals for interest and penalties at March 31, 2016 and 2015 or December
31, 2015. All tax years starting with 2010 are open for examination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Loss Per Share &ndash; </B>The computation of loss per share
is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &ldquo;Earnings
Per Share.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Accounts Receivable and Allowance for Doubtful Accounts
</B>- Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine
the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations
applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts
receivable previously written off are recorded as income when received. The allowance for doubtful accounts at March 31, 2016
and December 31, 2015 was $0 and $0 respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Long-Lived and Intangible Assets &ndash; </B>Long-lived
assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously
evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value
of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying
amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a
loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market
values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the
lower of carrying value or estimated net realizable value. No impairment was recorded in the three months March 31, 2016 or the
year ended December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recently Enacted Accounting Standards</B> &ndash; The FASB
established the Accounting Standards Codification (&ldquo;Codification&rdquo; or &ldquo;ASC&rdquo;) as the source of authoritative
accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements
in accordance with generally accepted accounting principles in the United States (&ldquo;GAAP&rdquo;). Rules and interpretive
releases of the Securities and Exchange Commission (&ldquo;SEC&rdquo;) issued under authority of federal securities laws are also
sources of GAAP for SEC registrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Accounting Standards Updates (&ldquo;ASU&rdquo;) through
ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations.
The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability
to the Company or their effect on the financial statements would not have been significant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cash Equivalents</B> - The Company considers all highly
liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Concentration of Credit Risk -</B> The Company maintains
its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Organization Expenditures</B> &ndash; Organizational expenditures
are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.9pt"><B>Stock Based Compensation</B> &ndash;
The Company recognizes compensation costs to employees under ASC Topic No. 718, &ldquo;Compensation &ndash; Stock Compensation.&rdquo;
Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based
on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required
to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and
without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective
vesting periods of the option or stock grants. Unvested option or stock grants for compensation are included in the Statement
of Stockholders&rsquo; Equity as a contra-equity account as &ldquo;Deferred Compensation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity instruments issued to non-employees are recorded on
the basis of the fair value of the instruments, as required by ASC Topic No. 505, &ldquo;Equity Based Payments to Non-Employees.&rdquo;
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the
date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related
to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the
FASB Accounting Standards Codification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Amortization</B> - Utility patents are amortized over a
17 year period. Patents which are pending are not amortized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Accounting Estimates</B> - The preparation of financial
statements in conformity with generally accepted accounting principles in the United States requires management to make estimates
and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities
at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimated by management. Significant accounting estimates that may materially change in the near
future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs,
and allowance for bad debts and inventory obsolescence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Revenue Recognition &ndash;</B> The Company&rsquo;s revenue
is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No.
605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed
or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services
under the relevant arrangement have been performed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inventory</B> &ndash; Inventories consist of raw materials
used in the production of customized parts totaling $94,186 and nominal work-in-process components which will be sold to customers.
Inventories are valued at the lower of cost or market, using the first-in, first-out (FIFO) method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Research and Development</B> &ndash; Research and development
costs are expensed as they are incurred. Research and development costs for the three months ended March 31, 2016 and 2015 were
$39,071 and $70,147, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 2 &ndash; Stockholders&rsquo; Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective March 17, 2016, our Amended and Restated Articles
of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &ldquo;Certificate
of Change&rdquo;) filed with the Nevada Secretary of State. &nbsp;The Certificate of Change provided for both a reverse stock
split of the outstanding shares of our common stock on a 1-for-100 basis (the &ldquo;Reverse Stock Split&rdquo;), and a corresponding
decrease in the number of shares of our common stock that we are authorized to issue (the &ldquo;Share Decrease&rdquo;). &nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the Reverse Stock Split, the number of issued
and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse
Stock Split shares (after adjustment for any fractional shares). &nbsp;Pursuant to the Share Decrease, the number of authorized
shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. &nbsp;All amounts shown for common
stock included in these financial statement are presented post-Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016, the Company had 7,500,000 shares of authorized
common stock, $0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 23, 2013, the Company issued 20,000 shares of the Company&rsquo;s
common stock to a consultant as noncash compensation for services to be rendered valued at $45,400 or $2.27 per share. Of these
shares, 10,000 (valued at $22,700) vested immediately and 9,607 (valued at $21,808) vested during the year ended December 31,
2015. The remaining 393 shares (valued at $892) vested and were earned by the consultant during the three months ending March
31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In January 2014, the Company issued 437,500 shares of stock
to an investor for a total purchase price of $3,500,000. In connection with the purchase and sale of the shares, the Company agreed
to issue to the investor a warrant to purchase up to 142,593 shares of the Company&rsquo;s common stock, at an exercise price
of $15 per share. The warrant had a term of nine months from the date of issuance (January 10, 2014) and had a fair value of approximately
$1,212,037. In May 2014, the term of the warrant was extended by nine months to expire in July 2015 and had a fair market value
in excess of the remaining fair market value of the original warrant of approximately $1,283,333. A warrant was also issued as
part of the offering to a consultant to purchase up to 21,875 shares of common stock at $8 per share, valued at approximately
$271,250. That warrant had a term of two years from the date of issuance (January 10, 2014). Offering costs paid from the proceeds
of the offering were approximately $199,089.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the warrant of $1,212,037 was calculated
using a Black-Scholes option pricing model with the following assumptions: expected life of nine months, expected volatility of
202%, a risk-free interest rate of 0.09%, and an expected dividend yield of 0%. The fair value of the warrant of $271,250 was
calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility
of 201%, a risk-free interest rate of 0.39%, and an expected dividend yield of 0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the new warrant related to the extension
of the warrant expiration of $1,283,333 (net) was calculated using a Black-Scholes option pricing model with the following assumptions:
expected life of 14 months, expected volatility of 226%, a risk-free interest rate of 0.1%, and an expected dividend yield of
0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2014, the Company issued 62,500 shares of stock to
an investor for a total purchase price of $500,000. In connection with the purchase and sale of the shares, the Company agreed
to issue to the investor a warrant to purchase up to 20,370 shares of the Company&rsquo;s common stock, at an exercise price of
$15 per share. The warrant had a term of one year from the date of issuance (June 4, 2014) and had a fair value of approximately
$132,407. A warrant was also issued as part of the offering to a consultant to purchase up to 3,125 shares of common stock at
$8 per share, valued at approximately $36,250. That warrant has a term of two years from the date of issuance (June 4, 2014).
Offering costs paid from the proceeds of the offering were approximately $25,035.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the warrant of $132,407 was calculated using
a Black-Scholes option pricing model with the following assumptions: expected life of one year, expected volatility of 163%, a
risk-free interest rate of 0.1%, and an expected dividend yield of 0%. The fair value of the warrant of $36,250 was calculated
using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of
287%, a risk-free interest rate of 0.41%, and an expected dividend yield of 0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During July 2014, the Company issued an aggregate of 60,000
shares of common stock to three employees valued at $12.90 per share or $774,000. Twenty-five percent of each employee&rsquo;s
shares vested immediately upon the grant date, 25% of such shares vested upon the first annual anniversary of each employee&rsquo;s
start date, and 25% of such shares will vest on each of the second and third annual anniversary of each employee's start date,
provided that such employee remains in the Company&rsquo;s continuous employ through such vesting dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In November 2014, the Company issued 15,000 shares of stock
to a director, subject to restrictions, pursuant to the Company's 2013 Equity Incentive Plan (the &ldquo;2013 Plan&rdquo;). The
shares were valued at $9.40 or $141,000. All shares vested during the year ended December 31, 2015. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In March 2015, the Company issued 10,000 shares of stock to
a director. The Company also issued 5,000 shares of stock to an officer, and an aggregate of 21,038 shares of stock to two consultants,
subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $5.30 or $191,000.
33,037 of the shares vested during the year ended December 31, 2015. Another 429 shares (valued at $2,275) vested during the three
months ending March 31, 2016 and the remaining 2,572 shares unvested at March 31, 2016 (valued at $13,630) are reflected as prepaid
assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2015, in conjuction with the hiring of Ron Fisher,
the Company's Vice President of Business Development, the Company issued to Mr. Fisher 2,500 shares of common stock, subject to
performance-based vesting restrictions. The shares, valued at $14,750, remain unvested at March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In November 2015, the Company issued 625 shares of common stock
to an employee valued at $6.50 per share, or $4,063, and issued 2,500 shares of common stock to an employee valued at $6.15 per
share, or $15,375.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In February 2016, the Company issued 625 shares of common stock
to a new employee, valued at $4.82 per share, or $3,013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In March 2016, the Company issued 3,080 shares of common stock
to a consultant, valued at $4.87 per share, or $15,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016, there were 6,232,778 shares of common
stock issued and outstanding. As of December 31, 2015, there were 6,239,073 shares of common stock issued and outstanding, reflecting
22,500 and 32,500 shares, respectively, issued but unvested shares pursuant to the Company's 2011 Equity Incentive Plan (the &ldquo;2011
Plan&rdquo;) and the 2013 Plan. As of March 31, 2016, an aggregate of 1,500 shares and 167,132 shares of common stock were reserved
for issuance under the 2011 Plan and the 2013 Plan, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Deferred Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described under the Common Stock heading above, during July
2014, the Company issued to three employees an aggregate of 60,000 shares of the Company&rsquo;s common stock, subject to restrictions,
pursuant to the 2013 Plan. Such shares were valued at the fair value of $774,000 or $12.90 per share. This compensation is being
expensed over the vesting period. As of March 31, 2016, the balance of unvested compensation cost expected to be recognized is
$258,000 (20,000 shares valued at $12.90) and is recorded as a reduction of stockholders&rsquo; equity. The unvested compensation
is expected to be recognized over the weighted average period of approximately 2 years (through July 2017).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described under the Common Stock heading above, in November
2014, the Company issued 15,000 shares of stock to a director, subject to restrictions, pursuant to the 2013 Plan. The shares
were valued at $9.40 or $141,000. All shares vested during the year ended December 31, 2015. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described under the Common Stock heading above, the Company
issued 10,000 shares of stock to a director in March 2015. The Company also issued 5,000 shares of stock to an officer, and an
aggregate of 21,038 shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the
2013 Plan. The shares were valued at $5.30 or $191,000. 33,037 of the shares vested during the year ended December 31, 2015. Another
429 shares (valued at $2,275) vested during the three months ending March 31, 2016 and the remaining 2,572 shares unvested at
March 31, 2016 (valued at $13,630) are reflected as prepaid assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described under the Common Stock heading above, in August
2015, the Company issued 2,500 shares of stock to an employee, subject to performance-based vesting restrictions, pursuant to
the Company's 2013 Equity Incentive Plan (the &ldquo;2013 Plan&rdquo;). The shares were valued at $5.90 or $14,750. All shares
remained unvested as of March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016, the balance of unvested compensation
cost expected to be recognized is $272,750 and is recorded as a reduction of stockholders&rsquo; equity. The unvested compensation
is expected to be recognized over the weighted average period of approximately 2 years (through July, 2017).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is authorized to issue 10,000,000 shares of preferred
stock, $0.001 par value per share. No shares of preferred stock were issued and outstanding at March 31, 2016 or December 31,
2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Stock Options</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2015, the Company granted a total of 56,875 options
to three employees with vesting periods ranging from one to four years beginning August 10, 2015. As of March 31, 2016, none of
the option grants had vested, and only a nominal amount of compensation cost had been recognized during the year. The weighted
average period over which total compensation cost of the options of $306,796 will be recognized is 3.81 years. The weighted average
exercise price of the options was $5.94 and the weighted average fair value of the options on the dates of grant was $5.91. The
estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left">Expected term:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10 years</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Volatility:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">180-184</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dividend yield:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free interest rate:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.24-2.32</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2016, the Company granted a total of 21,875 options
to three employees with vesting periods ranging from three to four years beginning February 16, 2016. As of March 31, 2016, compensation
cost of $53,540, including options granted during 2015 was recognized during the period, for options vesting. The weighted average
period over which total compensation cost of the options of $116,177 ($306,796 in 2015) will be recognized is 3.91 years. The
weighted average exercise price of the options was $5.75 and the weighted average fair value of the options on the dates of grant
was $5.73. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left">Expected term:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10 years</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Volatility:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">176-184</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dividend yield:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free interest rate:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.24-2.32</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of March 31, 2016, the Company had one outstanding warrant
remaining to purchase a total of 3,125 shares of common stock at an exercise price of $8 per share. Such warrant will expire on
June 4, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the three months ending March 31, 2016, a warrant to
purchase 21,875 shares of common stock at an exercise price of $8 per share expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ending December 31, 2015, a warrant to purchase
20,370 shares of common stock at an exercise price of $15 per share, as well as a warrant to purchase 142,593 shares of common
stock at an exercise price of $15 per share, expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 3 - Continuing Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has sustained losses and has negative cash flows
from operating activities since its inception. However, the Company has had increasing revenues in recent periods. In addition,
the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. The
Company believes it has adequate working capital and cash to fund operations through 2016, and has entered into significant revenue
contracts that are expected to generate cash flow in the near term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 4 &ndash; Loss Per Share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following data show the amounts used in computing loss
per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods
ended March 31, 2016 and 2015:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">3 Months Ended</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">03-31-16</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">03-31-15</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left; padding-bottom: 2.5pt">Loss from continuing Operations available to &nbsp;Common stockholders (numerator)</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">(470,667</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">(371,881</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of &nbsp;common shares Outstanding &nbsp;used in loss per share during &nbsp;the Period (denominator)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,233,729</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,206,220</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dilutive loss per share was not presented as the Company had
no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect
is anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 5 - Joint Venture</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As previously reported in our Form 8-K filed with the SEC on
July 6, 2015, we entered into an Operating Agreement and Statement of Work with Arete Innovative Solutions LLC (&ldquo;Arete&rdquo;).
The Operating Agreement and Statement of Work govern the operations of Arete-Sigma LLC (the &quot;Joint Venture&quot;), a joint
venture formed by us and Arete for the purpose of pursuing business opportunities related to AM utilizing our EOS M290 or like
machines, including enabling and implementing sales and manufacturing transactions. Under the Operating Agreement and Statement
of Work, among other matters reported in our Form 8-K and set forth in the Operating Agreement and Statement of Work, (i) each
of Sigma and Arete hold a 50% ownership interest in the Joint Venture, and (ii) the Joint Venture is managed by William F. Herman,
President of Arete, subject to certain limitations. Based on the Operating Agreement, the Company holds the non-controlling interest
in the Joint Venture. Therefore, the Joint Venture has not been consolidated, but rather is accounted for on the equity method
of recording investments. During the three months ended March 31, 2016, the joint venture had no activity. The Company is evaluating
whether to continue the Joint Venture and is continuing to pursue business opportunities related to AM utilizing the Company's
EOS M290 or like machines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 6</B> <B>&ndash; Subsequent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has evaluated subsequent events from the balance
sheet date through the date the financial statements were issued and determined there are the following items to disclose:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 17, 2016, the Company issued 3,529 shares of common
stock to a consultant for services to be rendered valued at $4.25 per share, or $15,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 28, 2016, at the Annual Meeting of Stockholders of
the Company, the Company's stockholders approved an amendment to the 2013 Plan to increase the number of shares of the Company's
common stock reserved for issuance under the 2013 Plan by 638,538 shares of our common stock to a total of 750,000 shares (on
a post-Reverse Stock Split basis).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 28, 2016, the Company's Amended and Restated Articles
of Incorporation were amended to increase the number of authorized shares of the Company's common stock from 7,500,000 to 15,000,000
shares of common stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_020"></A>ITEM 2. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Throughout this Quarterly Report on Form&nbsp;10-Q,
unless otherwise indicated or the context otherwise requires, the term &ldquo;B6 Sigma&rdquo; refers to B6 Sigma, Inc., a Delaware
corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September
2010; the terms the &ldquo;Company,&rdquo; &ldquo;Sigma,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer
to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations
through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became
part of Sigma and no longer exists as a subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>This Quarterly Report, including
any documents which may be incorporated by reference into this Report, contains &ldquo;Forward-Looking Statements&rdquo; within
the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended</I> <I>(the &ldquo;Exchange Act&rdquo;). All statements other than statements of historical fact are &ldquo;Forward-Looking
Statements&rdquo; for purposes of these provisions, including any projections of revenue or other financial items, any statements
of the plans and objectives of management for future operations, any statements concerning proposed new products or services,
any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing.
All Forward-Looking Statements included in this document are made as of the date hereof and are based on information available
to us as of such date. We assume no obligation to update any Forward-Looking Statement. In some cases, Forward-Looking Statements
can be identified by the use of terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;potential,&rdquo; or
&ldquo;continue,&rdquo; or the negative thereof or other comparable terminology. Although we believe that the expectations reflected
in the Forward-Looking Statements contained herein are reasonable, there can be no assurance that such expectations or any of
the Forward-Looking Statements will prove to be correct, and actual results could differ materially from those projected or assumed
in the Forward-Looking Statements. Future financial condition and results of operations, as well as any Forward-Looking Statements
are subject to inherent risks and uncertainties, including any other factors referred to in our press releases and reports filed
with the Securities and Exchange Commission (&quot;SEC&quot;). All subsequent Forward-Looking Statements attributable to the Company
or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that
may have a direct bearing on our operating results are described under the caption &ldquo;Risk Factors&rdquo; in our Annual Report
on Form 10-K for the year ended December 31, 2015 and elsewhere in this report.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview of Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a technology company that specializes
in the development and commercialization of novel and unique manufacturing and materials technologies. It is the Company's belief
that some of these technologies will fundamentally redefine conventional quality assurance and control practices by embedding
quality assurance and process control into the manufacturing process in real time. In addition, the Company anticipates that its
core technologies will enable its clientele to combine advanced manufacturing quality assurance and control protocols with novel
materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical
and power generation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain members of our team are uniquely
qualified scientists and engineers with broad backgrounds in manufacturing and materials technologies. In the past, these members
have worked with some of the largest defense contractors in the world, in such varied projects as next-generation manufacturing
systems, advanced reactive munitions, nuclear weapons stewardship programs, and naval nuclear reactor programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our current business plan and principal
business activities include the continued development of our In-Process Quality Assurance&trade; (IPQA&reg;) suite of technologies
and the commercialization of both our IPQA&reg; and materials-related suite of technologies, with our main focus currently on
the 3D Printing (&quot;3DP&quot;) industry and making operational the contract manufacturing business for metal 3DP, which technologies
are described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Our strategy is to leverage our manufacturing
and materials knowledge, experience and capabilities through the following means: (i) identify, develop and commercialize manufacturing
and materials technologies designed to improve manufacturing and quality control practices, and create innovative products in
a variety of industries; (ii) provide engineering consulting services in respect of our manufacturing and materials technology
expertise to third parties that have needs in developing next-generation technologies for materials and manufacturing projects;
and (iii) build and run a contract manufacturing division for metal 3DP beginning with our Electro Optical Systems (EOS) GmbH
M290 DMLS&reg; (Direct Metal Laser Sintering) (&quot;EOS M290&quot;) state-of-the-art metal printer. We are presently engaged
in a variety of activities in which we seek to commercialize technologies and products in the following industry sectors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aerospace and defense manufacturing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oil and gas and energy manufacturing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bio-medical manufacturing;
    </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automotive manufacturing;
    and </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&middot;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other markets such as firearms and recreational
    equipment. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect to generate
revenue primarily by direct sales and software licensing of our manufacturing and materials technologies to businesses that
seek to improve their manufacturing production processes and/or manipulate and improve the most functional characteristics of
the materials and other input components used in their business operations. Additionally, we expect to generate more revenue
from our contract manufacturing activities in metal 3DP. We also expect that our continued development of our &ldquo;In
Process Quality Assurance&trade;&rdquo; or &ldquo;IPQA&reg;-enabled PrintRite3D&reg; technology will enable us to finalize
our commercialization of this technology for the additive manufacturing (&quot;AM&quot;) metal market in the remainder of
2016 and 2017. We plan to assist our commercialization partners with marketing-related activities for those advanced
material-related technologies, including our dental implant biomedical prosthetics technology, for which we seek possible
commercialization in the future. However, we presently make no sales of our dental implant biomedical prosthetics
technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In late 2015, we launched two programs
&mdash; an Early Adopter Program (&quot;EAP&quot;) and an Original Equipment Manufacturer (&quot;OEM&quot;) Partner Program &mdash;
designed to broaden our market presence and ease the adoption of our PrintRite3D&reg; technology. The EAP was designed to attract
early adopter customers who have an existing, installed base of 3D printers and to offer them incentivized pricing in return for
feedback on initial and beta releases of our PrintRite3D&reg; software modules. Our OEM Partner Program was specifically designed
for AM machine manufacturers seeking to embed our PrintRite3D&reg; quality assurance technology directly in to their machines
for customers purchasing a turnkey solution for their new AM machine purchases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors, management and
business advisors comprise scientists and business professionals with extensive experience in the energy and advanced manufacturing
and materials technology markets, as well as business operations. These individuals collectively possess over 100 years of experience
working in the advanced manufacturing, materials technology and commercial industry space. As such, we believe we possess the
resident expertise to provide engineering services and support to companies using our IPQA&reg; software solutions for metal AM.
Accordingly, in addition to our primary business focus, we intend to generate revenue by providing such engineering services and
support to businesses licensing our IPQA&reg; software technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, our President and Chief Executive
Officer has worked at or with the Edison Welding Institute, the United States Department of Energy (&ldquo;DOE&rdquo;) national
laboratories (including the Knolls Atomic Power Laboratory, Bettis Atomic Power Laboratory, Los Alamos National Laboratory and
Sandia National Laboratory) over the last 30 years. Due to his work with the DOE, our President and Chief Executive Officer has
developed extensive relationships with the DOE and its network of national laboratories. Accordingly, we expect to leverage these
relationships in connection with licensing and developing technologies created at such national laboratories for commercialization
in the private sector.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our principal executive offices are located
at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, and our current telephone number at that address is (505) 438-2576. Our website
address is www.sigmalabsinc.com. The Company&rsquo;s annual reports, quarterly reports, current reports on Form 8-K and amendments
to such reports filed or furnished pursuant to section 13(a) or 15(d) of the Exchange Act, and other information related to the
Company, are available, free of charge, on that website as soon as we electronically file those documents with, or otherwise furnish
them to, the SEC. The Company&rsquo;s website and the information contained therein, or connected thereto, are not and are not
intended to be incorporated into this Quarterly Report on Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporated as Messidor Limited in
Nevada on December 23, 1985 and changed our name to Framewaves Inc. in 2001. On September 27, 2010, we changed our name from Framewaves
Inc. to Sigma Labs, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective March 17, 2016, we effected a
reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis, and a corresponding decrease in the number
of shares of our common stock that we are authorized to issue. &nbsp;Accordingly, the number of shares of our common stock outstanding
at the effective date of the reverse stock split was reduced from 622,969,835 to 6,229,710 shares, after the adjustment for any
fractional shares, and the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments (in reverse chronological order)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Sigma Labs Signed Agreements with Creatz3D and Spartacus3D</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 4 and 18, 2016, respectively,
we announced that we entered into agreements with Creatz3D Pte Ltd. and Spartacus3D, a unit of France&rsquo;s Farinia Group, to
expand our presence in Europe and Asia, respectively. Under our agreement with Creatz3D, Creatz3D serves as our non-exclusive
sales and service agent in Singapore, Indonesia and Vietnam. Creatz3D is an authorized reseller of 3D printing systems and materials,
AM solutions for metal components, and rapid prototyping software. As part of our agreement with Spartacus3D, Spartacus3D will
serve as a demonstration, test and evaluation site for our PrintRite3D&reg; commercialization and market adoption activities in
Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Sigma Labs Announced Participation in Industry Events</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 22, 2016, we announced that we
would participate in The Additive Manufacturing Users Group (AMUG) Conference and Exhibition on April 3-7 in St. Louis, and The
Rapid 2016 Conference on May 17-19 in Orlando to showcase our contract 3D metal printing business as well as display our patented
PrintRite3D&reg; software applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Sigma Labs Entered into Contracts with Aerojet Rocketdyne
for Air Force Program and &ldquo;America Makes&rdquo; Initiative</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 7, 2016, we announced that we
received a contract from Aerojet Rocketdyne, a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD), for a non-exclusive
license of the Company's PrintRite3D&reg; software applications. Our technology will be utilized on Aerojet Rocketdyne&rsquo;s
contract with the U.S. Air Force to define more efficient processes for qualifying AM components, and be evaluated for liquid-fueled
rocket engine applications. The broader Air Force initiative is part of a plan to transition away from the Russian-made RD-180
engines currently used on the Atlas V launch vehicle. Separately, we received an order from Aerojet Rocketdyne under the previously-announced
&ldquo;America Makes&rdquo; additive manufacturing research project with GE Aviation. The program, funded by the National Additive
Manufacturing Innovation Institute (NAMII), uses our proprietary In-Process Quality Assurance&trade; (IPQA&reg;) software for
advanced AM monitoring. This is the second PrintRite3D&reg; system being deployed under America Makes, the first being with GE
Aviation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><I><U>Sigma Labs and 3DSIM
Signed Technology Development Agreement for Metal AM</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January 27, 2016, we announced that
we entered into a technology development agreement with 3DSIM, LLC to pursue commercial metal AM software opportunities for rapid
qualification and part certification. 3DSIM, based in Park City, Utah, is a provider of simulation software for metal AM processes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported assets, liabilities, sales and expenses in the accompanying financial statements. Critical accounting
policies are those that require the most subjective and complex judgments, often employing the use of estimates about the effect
of matters that are inherently uncertain. Such critical accounting policies, including the assumptions and judgments underlying
them, are disclosed in Note 1 to the Consolidated Financial Statements included in this Quarterly Report. However, we do not believe
that there are any alternative methods of accounting for our operations that would have a material effect on our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect to generate revenue primarily
by selling and licensing our manufacturing and materials technologies to businesses that seek to improve their manufacturing production
processes and/or manipulate and improve the most functional characteristics of the materials and other input components used in
their business operations. We also expect to generate revenue though contract AM manufacturing using our in-house metal 3D printing
capability. However, we presently make limited sales of these technologies and services, which include limited sales of non-exclusive
licenses to use our PrintRite3D&reg; technologies and related hardware, including under our recently established Early
Adopter Program and OEM Partner Program. Our ability to generate revenue in the future will depend on our ability to further commercialize
and market our PrintRite3D&reg; technologies. During the three months ended March 31, 2016, we recognized revenue of $358,455,
as compared to $185,686 in revenue that we generated during the same period in 2015. The increase in revenue was primarily due
to our ongoing work under additional contracts as compared to the prior year. Our revenue during the three months ended March
31, 2016 was primarily generated from engineering consulting services we provided to third parties during this period. We expect
that our revenue will increase in future periods as we seek to further commercialize and expand our market presence for our PrintRite3D&reg;-related
technologies, and obtain new contract manufacturing orders in connection with our EOS M290, as well as further perform on our
engineering consulting contracts for the GE Aviation lead National Additive Manufacturing Innovation Institute program, and continue
to provide our similar services under our contract with Honeywell Aerospace for the DARPA Period 2 program. Our costs of service
revenue for the three months ended March 31, 2016 were $107,581, as compared to $24,867 for the same period in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our general and administrative expenses
for the three months ended March 31, 2016 were $395,488, as compared to $267,703 for the same period in 2015. Our payroll expenses
for the three months ended March 31, 2016 were $215,589, as compared to $72,660 for the same period in 2015. Our expenses relating
stock-based compensation for the three months ended March 31, 2016 were $71,551, as compared to $122,750 for the same period
in 2015. Our research and development expenses for the three months ended March 31, 2016 were $39,071, as compared to $70,147
for the same period in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">General and administrative expenses
principally include operating expenses and outside service fees, the largest component of which consists of services in
connection with our obligations as an SEC reporting company, in addition to other legal, accounting, marketing and investor
relations fees. The net increase in general and administrative expenses for the three months ended March 31, 2016 as compared
to the same period in 2015 is principally the result of increased investor relations expenditures and consultant services
provided to us due to an increase in our overall business activities, including our continued development of our
IPQA&reg;-enabled PrintRite3D&reg; technologies and our related efforts to expand our services. The net increase in payroll
expenses for the three months ended March 31, 2016 as compared to the same period in 2015 is principally the result of our
hiring of six employees since June 2015. The net decrease in research and development expenses for the three months
ended March 31, 2016 as compared to the same period in 2015 is principally the result of the shift in operations from
research and development to more of a production company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of our increased operating
activities, including as we seek further commercialization of our IPQA&reg;-enabled PrintRite3D&reg; technologies, and our increased
marketing and sales efforts associated with such technologies, including with respect to our EAP and OEM Partner Program, and
our contract manufacturing activities, our general and administrative expenses in the future are expected to continue to increase.
Similarly, we anticipate that our payroll and non-cash compensation expenses will continue to increase as we engage more employees
and consultants to support our efforts to grow our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net loss for the three months ended
March 31, 2016 increased slightly over the prior year and totaled $470,667 as compared to $371,881 for the same period in 2015.
The increase in our revenue was offset by a larger net increase in expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 31, 2016, we had $1,086,363
in cash and had a working capital surplus of $1,374,064, as compared with $1,539,809 in cash and a working capital surplus of
$1,785,728 as of December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect to generate revenue primarily
by selling and licensing our manufacturing and materials technologies to businesses that seek to improve their manufacturing production
processes and/or manipulate and improve the most functional characteristics of the materials and other input components used in
their business operations. We also expect to generate revenues by providing contract AM services using our EOS M290 metal AM system.
However, for the period from our inception through March 31, 2016, we generated revenue and financed our operations primarily
from PrintRite3D&reg;-enabled engineering consulting services we provided during this period and through private sales of Sigma
common stock. During 2016, we expect to further ramp up our operations and our commercialization and marketing efforts, which
will increase the amount of cash we will use in our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect that our continued
development of our IPQA&reg;-enabled PrintRite3D&reg; technology will enable us to finalize our commercialize of this
technology for the AM metal market in the remainder of 2016 and 2017. However, until commercialization of our full suite of
PrintRite3D&reg; technologies, we plan to continue funding our development activities and operating expenses by selling and
licensing our PrintRite3D&reg; systems and supporting field services, as applicable, and providing PrintRite3D&reg;-enabled
engineering consulting services concerning our areas of expertise (materials and manufacturing quality assurance and process
control technologies) and contract manufacturing for metal AM, and through the use of proceeds from sales of our
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cash flows used in operating activities
during the three months ended March 31, 2016 decreased to $393,028 from $463,705 during the same period in 2015, primarily due
to increases in accounts receivable and inventory, which were offset by increases in accounts payable during the quarter. Also,
there was a larger net loss during the three months ended March 31, 2016 with fewer non-cash expenses during the quarter, as compared
to the same period in 2015. The Company anticipates less loss during the remainder of 2016 due to an expected increase in revenue,
offset by the increased cost of growth in salaries and related expenses in connection with our additional employees. Cash flows
used in investing activities increased during the three months ended March 31, 2016 to $60,418, as compared to $8,704 during the
same period in 2015, due primarily to the purchase of furniture and equipment as well as the purchase of intangible assets. Purchases
during the remainder of 2016 are not expected to increase dramatically over 2015. There were no cash flows used or provided by
financing during the three months ended March 31, 2016 or 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of May 12, 2016, Sigma has four
active contracts with respect to which we expect to perform and generate up to approximately $160,000 in revenue during the
remainder of 2016 (such amount is approximately $170,000 less than expected due to a reduction in scope of a contract through
no fault of Sigma), subject to the achievement by us of certain performance milestones, as well as our contracts not being
terminated by our clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Some of our engineering
consulting contracts, including the contracts from Honeywell Aerospace, GE Aviation and Aerojet Rocketdyne, are fixed price
contracts, for which we will receive a specified fee regardless of our cost to perform under such contract. In connection
with entering into these fixed-contract consulting arrangements, we are required to estimate our costs of performance. To
actually earn a profit on these contracts, we must accurately estimate costs involved and assess the probability of meeting
the specified objectives, realizing the expected units of work or completing individual transactions, within the contracted
time period. Accordingly, if we under-estimate the cost to complete a contract, we remain obligated to complete the work
based on our initial cost estimate, which would reduce the amount of profit actually earned under the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have no credit lines or facilities as
of May 12, 2016, nor have we ever had a credit facility since our inception. We are continuing to evaluate potential future sources
of capital, as we do not currently have commitments from any third parties to provide us with additional capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the funds we have as of May 12,
2016, and the proceeds we expect to receive under our PrintRite3D&reg;-enabled engineering consulting agreements, from selling
or licensing our PrintRite3D&reg; systems and software, sales of contract AM manufacturing for metal AM parts, and from offerings
of the Company's common stock, we believe that we will have sufficient funds to pay our administrative and other operating expenses
through 2016. Until we are able to generate significant revenues and royalties from selling or licensing our PrintRite3D&reg;-enabled
technologies and our contact AM manufacturing services, our ability to continue to fund our liquidity and working capital needs
will be dependent upon revenues from existing and future PrintRite3D&reg;-enabled engineering consulting contracts, possible strategic
partnerships, contract manufacturing orders in connection with our EOS M290, and proceeds received from sales of our securities.
Accordingly, we will have to obtain additional capital from the sale of additional securities or by borrowing funds from lenders
to fulfill our business plans. If we issue additional equity or debt securities, stockholders may experience additional dilution
or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock.
There is no assurance that we will be successful in obtaining additional funding. If we fail to obtain sufficient funding when
needed, we may be forced to delay, scale back or eliminate all or a portion of our commercialization efforts and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Inflation and changing prices have had
no effect on our continuing operations over our two most recent fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have no off-balance sheet arrangements
as defined in Item 303(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_021"></A>ITEM 3. QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><A NAME="a_022"></A><B>ITEM 4. CONTROLS AND PROCEDURES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management, including our President
and Chief Executive Officer, and Principal Financial and Accounting Officer, evaluated the effectiveness of our &ldquo;disclosure
controls and procedures&rdquo; (as defined in the Exchange Act Rules 13a-15(e) or 15d-15(e)) as of the end of the period covered
by this quarterly report, as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on that evaluation, we have concluded
that as of the end of the period covered by this quarterly report, our disclosure controls and procedures are effective at a reasonable
assurance level in ensuring that information required to be disclosed by us in our reports is recorded, processed, summarized
and reported within the required time periods. The foregoing conclusion is based, in part, on the fact that we are a small public
company in the early stage of our business, with limited revenue and employees. Based upon our evaluation, we also concluded that
there was no change in our internal control over financial reporting during our most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_023"></A>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_024"></A>ITEM 1. LEGAL PROCEEDINGS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_025"></A>ITEM 1A. RISK FACTORS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_026"></A>ITEM 2. UNREGISTERED SALES OF EQUITY
SECURITIES AND USE OF PROCEEDS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 17, 2016, the Company issued 3,080
shares of common stock to a consultant as compensation for services to be rendered valued at $15,000 or $4.87 per share.&nbsp;
The foregoing shares were issued in reliance upon an exemption from the registration requirements pursuant to Section 4(2) of
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_027"></A>ITEM 3. DEFAULTS UPON SENIOR SECURITIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_028"></A>ITEM 4. MINE SAFETY DISCLOSURES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_029"></A>ITEM 5. OTHER INFORMATION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"><B><A NAME="a_030"></A>ITEM 6. EXHIBITS.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 88%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Change Pursuant to NRS 78.209.(1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Amended and Restated
    Articles of Incorporation of Sigma Labs, Inc.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment to Consulting Agreement, effective January 1, 2016,
    between Sigma Labs, Inc. and Monica Yaple.*(2)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Sigma Labs, Inc.'s 2013 Equity
    Incentive Plan.* **</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1 &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a) Certification of Principal Executive
    Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2 &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a) Certification of Principal Financial
    Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Executive Officer
    and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
    Act of 2002.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Schema Document.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Calculation Linkbase Document.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Definition Linkbase Document.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Labels Linkbase Document.**</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Presentation Linkbase Document.**</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) Previously filed as Exhibit 3.1 to the Company&rsquo;s
Form 8-K, filed March 21, 2016 (033-02783-S), and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) Previously filed as Exhibit 10.13 to the Company&rsquo;s
Form 10-K, filed March 16, 2016 (033-02783-S), for the fiscal year ended December 31, 2015, and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*&nbsp;&nbsp;&nbsp;Indicates a management contract or compensatory
plan or arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">** Filed herewith.</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_031"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGMA LABS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2016</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: &nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark
    J. Cola</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark J. Cola</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer (Principal
    Executive Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2016</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Monica
    Yaple</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica Yaple</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasurer (Principal Financial and Accounting
    Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>v438343_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tex3-2pg1.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tex3-2pg2.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>v438343_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amendment to Sigma Labs, Inc. 2013 Equity
Incentive Plan</B><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reference in Section&nbsp;3 to the 2013
Equity Incentive Plan of Sigma Labs, Inc. (the &ldquo;Plan&rdquo;) to the total number of shares of Common Stock which may be offered,
or issued as restricted stock or unrestricted stock on the exercise of Options or SARs, under the Plan shall be 750,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>v438343_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Certification of Principal Executive
Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Mark J. Cola, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this Quarterly Report on Form 10-Q of Sigma Labs, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Mark J. Cola</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;Mark J. Cola</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:&nbsp;&nbsp;&nbsp;&nbsp;President and
    Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>v438343_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial
Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Monica Yaple, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this Quarterly Report on Form 10-Q of Sigma Labs, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Monica Yaple</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;Monica Yaple</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:&nbsp;&nbsp;&nbsp;&nbsp;Treasurer (Principal
    Financial and Accounting Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>v438343_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification Pursuant to 18 U.S.C.
Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Mark J. Cola, the President and Chief Executive Officer, and
Monica Yaple, the Principal Financial Officer, of Sigma Labs, Inc. (the &quot;Company&quot;), hereby certify, that, to their knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Quarterly Report on Form 10-Q for the period ended March 31, 2016 (the &quot;Report&quot;) of the Company fully complies with
the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Mark J. Cola</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Monica Yaple</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mark J. Cola</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Monica Yaple</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief
    Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Treasurer (Principal
    Financial and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Executive
    Officer)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounting Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">May 12, 2016</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">May 12, 2016</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tex3-2pg1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex3-2pg1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$_0,T P$1  (1 0,1 ?_$ )T  0 " @(# 0$
M       ("08'!0H! P0""P$!                     !    8#  $# P(#
M @<+!P(7 @,$!08'  $("1$2$R$4%18*,2(702-1,B0U594887&14]/4)7:V
MUI>!H4(S=;6W&?!2-#9X.;'!T44HX7*B0V.T)B=WN'D:.A$!
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M&L2G[L<*P3M<"M-=<4#L*'BKNN+#BMJPR;.5?5FO4L$J0SX1($Y[42>F-0F
M-]INAEEA&;R9>5:!>/9=0%2,%=.G0?7'6U@-5:<W\[L$D21$<F>79\:8Y^II
MS,U+6_A@T#;WE\2IQK=-RY0>>9L)) BR51R8-:]T^3*]?&!#:;O7K^AZXF',
M\UGD<K*Z+$YVG\O=I=SW)I6G6',S\.!S>"-&[6KP1[><G/7IEK&Y%FZ*T!N,
M,/+)V&K_ "S^:>2>-YNXXFU:T;7/3=7]HR%/&Z]E0;J?*[-;MN+?$'=CD^P(
MJHL% _Q-]:I@2H).(.)/" &O[L?OUL(3:%T7W!#.@J(K2S^:^='&J+7F#G"9
MS9M+]-SF:RZF',==3R<0USEE73#G2OC%D9FSC!AM*=<0[:T2J.U\@-:T'Y T
M[YC/(_>/B^HF+]#UKRZQ=20Y;+38A,HR3:$BK^<1?XXC+YTHER%"U538Z!ZA
M[)&H0O/=CS#41C<67H[>C"=&C*#BZ^\N$;Z>\;;3Y!.,XA"[.4DK8DPV!2]D
M6*XU\[5[-G:3QB)RV"2&2L$)G9B)]B:R3E+4Y@VO[9X:]DJ2! +4E"P-,^4#
MS#W3XX>B^%>>BN:*ON)P[EEB.NXW)AWE*Z_10&:ZEU:PES$^-X:8FJAWBX':
MRTQY"D@92L:9.9H:8(_;[@FY"^E^R =01&B;7YTH))7,Y@UIKFN\Z6Z-F5G(
M(K:M;)HHXE558\(DU!UHY1I=(663"7)E1*U8#:=&9K8 F;  00V\?OF(LKK+
MR&]<>.F].<(+S5;O)J->Y*2D=T/=D++99$+ZF:!RF#(%U4U^2EC@FY^8W8L:
M@\Q2<W/1(PDZ]ANPA9-!+RNJ9==732.JTKH-&TU$X(N<[E06'(U,O66-82-T
M?4-5&5RHKY*S)76-0U.VO3HN#(3BP(I VA+)$,TWX0T+RGY2Z+ZS[C[FX<@?
MQ@FW%3A"T2U\T[$K$UC%N*3\;9:ED0%IBQH2ZEL78(\Y>XTWWJCBQA]NAZU@
M1I\TWE[L#Q(M//,K:^=X=?<7OZQ%E7I2U]O/59/T5D*5O2.1;@H3IZNGR!Y9
ME*=0/6_:<F/*&7K7M'H?J ,CO3RY._#O6//?-W?E&1ZIJ^ZN6J(Y1W4]36JX
MV74^Y\C<FMJ6P>V&265K6$EK52G4/[;O3@4)Y0;*<"S1C*)*6&)0M)Z(O2!<
MQT3;O0UHN0&FOZ9KZ4V+*E@A@ 8)KB[2I<QH46A[UH]T=32 )4A.O41ZHXLL
M.MB%K6!I#QW]KP3R'<;T=UW7Z$MC;+9BXEC[$?RA;RI@LX9'!9'IQ"5KB!,A
M$L.CDG:U)!9XTZ?:I-HI1HL 30ZP)J8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M-RUW#;3@ISLR/BJ&3Z/-DKBB]UCCDG>6)6YQYZ3K&ESVUNR0I22!02:6$\H
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MUS.VNC9-U*W2:&ML09K''&CJQ2R0([ ;%[@I(< .L?;U;F-S Q-X3U0C-*C
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M_%+'!&.72W/,3$HVR.099:U+,BP30V2="BWLQUD$5 2G5%M#EM,'>CRRB1;
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MASV4EFRY\0QEK)-;%DG-_3RHQ$O='UF*5?9QN/\ SIS-"5JE@ I]A $[XQF
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MRVI0RDY8-6T,21&LDRY].&E+0%/$69&Y)I9)BV1N2@2$%#+)):O_ %BL0-"
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MJ# V"/P!A!^1D4C<'M+&V9&(O9Z[1AZ8HX,P?NDK;A-A4/!YORY+"T%]SLZ
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MNX1^(F&2?\J4[QZ&JTIS@)W2M:,D:XC0#S ",&6$66[RH1(GD^L>Y)OS#TO
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MIO;6DAR,NO%38U3!FAEKRV5QJ425LLMO5H$YB 9 R0'Z,.+,+^/83WP& P&
MP&!T_P"3.MBR#EGSB>6R)=5.O/[?9=S6G$*Q4)F^"CB5Q<\<',:_G^N8(BFZ
MEB%9T0-OJ>M$I;6YPB+TVNZ-<]$JD&]KM_SA;?#I1(8=Q'R3REPY0:.AK7LS
MF6M)F32^Y@=&_P#8_IV0LK(OL1ZD$T>&"8N7]2TSR]KV.,*'- K6/LPT>X+
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M&+NP2HY5D,@D:0L:NSIJJV%S/0!5+QJ24NSC@H0A(";V P& P& P& P& P&
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M? KCG*O'[0=E[?H6<4L)U&GT9._C$M1Z*5#*_NQ#V#^7 WWKZ?3_  8# 8#
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M&:L"_P =23Y"[$!WKV&S$Y1Z#V4+2CY"EC+\>Q@/V'8?;[->[7IZ_7 K'?\
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MC[0_I>+MQJUOT[%O#VZJS"&P"(YF0DR=:X21J_&N*4X"HXO9!(/=O80%%^@
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M)%$QQWH-D;8/.%,BC29^.1[,7@*:'-!M>G=$",HW[D19N])1F&&';$+>A&%
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M$<4,!@1^[TW[=[U@83<+7!($A51\N*SESF84RETCB:/(K $:O3 <C%#L]O\
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MO6_;Z>H<]:5*2]/%XZ]2B+K&E!-6XQRAZYQ*^U(D:$OU^8Q-K9I2H.DYN_\
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MKX5Z!-+6.1*0[7O1:]H7V8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MH P!TQ.TO'CT[PJ[JG6X6(V;T\E.^-CZSJ:.N(H1I%Z""1_6J#(ORCM3+P
M@Z.4FB61LXWU&4L*'OX@!&J 6$5%'9ID[\R%S5C 7]^S.D?=B=)#EVR1;:7H
MA6E3N*%>6W*PEJ=$>@BU'L]IA@?7UT&\'VX8O,JHK>+H%"H^8,87MFE+DK-U
MHM='$<C7O\20$&:^IQX'5Z6FGC]VPZV41Z?X<"3#RJDD'BE8-$;:9&[/=8UB
MCE[L4+1+M5X$,P52>4SHZ3B&0J:QK6Y$N;4(0&&#"$SU #030ZP-'UY%FFP*
MMGC2)BC(9'"I3"YF.0J6)M4.Y<!7*EK1,B52X1&SQ-3.N.0*Q%B]=>P8P>N@
M_3 ]-6L57S*TWE\E\28&2M2-'$JVE%]LS)V5%(U6HXUKTAJP\&A*XZ6NVYB+
M$9O9PD8@_P -^F!D-/QEVK_HDVHW/20@Y\7R6KG \*5*<4(V1M2YJC[^W'")
M'LKWK5B):E4D" /98PB"/TW@<%-G,_5'L;'/B#B;(C5EO:%D5NXA@D!D(,9"
M]/J!Q,6^U>:W-TM3 ^Q^?>PA$<>$OTUZZP/@D?1D1:8\Y5V- WVE%'6*QA4E
M9$B5R8C(U9B)A:6HZ5ML@& YT$H2!;A)S_@T0A<"!A+,#]-#T$0E"QW>7EEB
MNTKXX225J HHA64&9'*7V5,UQ@]%%(HY#V).J?W0P01;]Y@2_A(]VAB.+ '>
M]!V!^%/ W,[.$SV1WTW#K^L0[3N+/R)&W_2B53,.CBE:-1T38L=5EE(&HT =
M;.B#"?H!GNV6X+S0?(CV';"C$7CD+C[+$X@PL\6B\<;$;+'XW'FU$S,+$SMQ
M $R!J9VEN(3H6YN1)RP@*)* $L =:UK6M8'/8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M:W>G&25W4=8P*1/#<0T.S_"X%%8L].C2E-">E:W%U8VE"N6MR8\.AED&F"*
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M$P7]YL0Q!FU']8="UU^XW7<(<V=!6AU=P^_46=.;[BL_L1QOA!RU/0Q&4NI
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M+V:469L&]Z%L&Q@T+8-BU]!;#O?IZZ_C@>W 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M=MN>J$=H>BER%VKJ%3OI>!2DJLWHF8*%I<@:X>^O*C;:L"I(,,3G:3C( $L
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MXS'F.+M+@SFN(%^ZZ2M6Q&N*;21*:(W6CAAT7L,U[DXP.[1J6KFO4U1U-?5
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M# 8# 8#T_M_M_AZX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8&#V5*7>$0.6S%CCI,L7Q:/N\A#'C7H$?$[$,S>I<E")*ZG-[DF3KE)2;8"/
MF  G9HM?(86#U'H*TO$GY78;Y<J@L"]*LI>9U-7T!L155IP[#DD<<)&\RU!'
M(U*5VT#-&-."4AE3-<J2Z^X/5EFC/V((2=AUL>@MC'L>@"V6$(AZ"+8 C%L
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M_P"CTA3R<-( K9B-2+ ^RW>!:8X&ZUX/Z+\:#050<@Z ZB@]%]!\]5:]./\
M1+H[G>7166R"?3M;5_Y%=&FR34='6(4E1/S4F2@*(*, >(7SE[P([=C\HS/R
M"=7^0F[N/W6-T9?/%2>M.:;#@$O4OFZT\CB!)7<-OR0UAV%#6Q[8TJFDEL5D
MK?%XPLUH:I8 +AM:>8W:2$) [!7"/0C=U?QIS)T>U0,=7H+DI>!S@BN]E *3
MPS\LQI1&QYK^-,C+.86TXL1;<<$DD)Z'1)FBP:%H.@EC@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,")70O$M ]+R9BG\^99*Q6?&X--*N9[7K&:R:L[*35C8H$X)
MQ7IDNB+BVN*R)R$:0LT28[9GVJD/SI1$'B&8(/%5<(<ATKRR?Q37-"P1DY><
M(U((F^5&J0J'UAE+3+"SBY0.7*W]4YO4J=Y!\XA*G!P5*%QH]!%\OJ 'M# >
M?/&KR5S38<5M:OX;*WNPJYJ=%0M2RFT[,L"VG.G*1;3SCT-6U498,B?PPN,%
M:/V4,:;6G!0ET%.>I,("$O0:F6^&?@)0"Y$;?64UC3'TI*7B7].1>)75;\:C
M/2#J]S9\L%25<K.TS1,FE+<1(I*N"20#[<(&Y48W_5 +:; LRC4:CT,CK!$(
MBQM,9BL596N.1F-L*!*U,; P,B(AM9V5G:T11*-N:VMO3%D)R"@ +** $(=:
M#K6L#150\JU11]AVS:4#.LC]87D_)93:2B5V]9\\:)/)6]D9HPV/@(U,Y6^Q
MU@7MD6CR%L(VV)40"T"0DGV^PL.M!F#;0E2,UYR?I-IA;8V73-JZCM53&;H/
MF2KI3"(B]N<@BS8_)R30(7-1'W!Z5:2JS2A*RDY^R-&?"$  A6+)/V_OBCF"
M&X&22\UKW2)7?:6KIF$##<MWM4!;;.,&<)?+X+#62PVQ@@#P[@4"(5FM)"49
MR+04?KI&$*?02>L'QD\>VI;G-=[SZ#3*1VUR$RL##SQ,U%QV^F75ZACQJ<Y.
M8!&WS=(TR1Q<_M"@.2IW3KU#H46$"H9H->W UZC\.G +>GZS2I*IF)1/=.S!
M]9ZW>EYF#NDTZ3.,L//D)IEB#-;%"AV>5NC!M>T AI%IZ7>_MS1%;#D'[Q">
M/^4T;0?-TEI5P?:8Y>=I&_4)#W2T;85CK5[DB-P1C=F*2&3;<L$O8-.AQS,8
M>O.$SJ=@.1_":22,L-]4=Q)SY0<SM>SXO&WN6V]>:-D:;<N&V9=(K5LR<QR,
MMH&:-Q!RE,U<'90BA3(UEA*)9T(4K:(6OE,)&=L1FPCES)X;O'IQ[;;U<G/=
M)N,$?G:2+YFBB0;0M-[J.)S!R2'-ZJ60RFWZ8N59QN2E-R@Q*C7D->E38D,$
MG0C3$"$7L-R<U>.WE+D6VKOO&AX5*8M9W23N9(KVDCM:UIS?5FR4;RZOX9)(
MFJ;S&0LVGY.Z/R\92E,G3F%!6G%AWHL>PX'*,G /*,=[5F/D*:*O*2]8SVMT
M%4R>ROU%)S2E\1;DS&WD@!%#G<<32.YC3&6Y$8N*1 5#2(P%^_TV9[PF3@,!
M@,!@,!@,!@819%:5Y<4%E%86Q!XI9-<S5J/8Y=!INPMLGBDD:%.PB-;WIB>$
MRMN<$VQ@"/03"Q>TP 1A]!!UO01NIC@#DSG]9'E=75>N;"H:/1D&9Y+9=LV/
M%J^-  12<VNX?94ZET5K\U$0/9283,C0B3$BV65L -[#@:7N;PW^,3HBS9?<
MUX<;5-:%ISUR"[2^<2\J1NC\]KBDB9 G&I4F/^@ED)$",H@@DH)9!!)80%@"
M'6M8$FR^.^8B* BG+26EX8@H*!EL.H+7#:D4MC7"5D5> R&,OD/<6]6F?HQ*
M(]( :7HG="K(<TJ[_*"U 3=['@;$J:E:MHR+*X95$.;8<Q.;\\RM\"C-7K7B
M3RZ1&@/D$PE\F=U;A)IA+WLPH'W;JZ+%;@HT6#1APM !H(8;4/*]#4-,;0L"
MIH&&(3&ZW\,KME])DLP=E-@RD!($Q<EE!3]('5*Z2 I(6$@"T9>U($X=%!'H
MO7MP,3E7#7)TULB1VQ)J4C#E,YLYQ)\GX]*G]#%K+?H#LC<(D-HUZW/"2OK.
MD42TD("W.#^UN*Q&!,0$HP(2"M #8-S<XTMT"&*CMF$)Y&Y05:[KX5)$#S(X
MA,XB=(FH;%)28U.(4\1V8,C?*&0S:-U2IEQ:5S2Z"4J+- $(=!L"!0&$59#(
MU75;1*/02!0UH2,$4A\3:43%'(\S("]%)&UI:6XDA&B2DA_@$ ->HM[WOUWO
M>]AK!9RY0"Y?T*['5BPE.W5S2R,71+JA-=&QSM=ICD--KUC125P;G!*L^-LA
M1XVTO:<9 M)1;#O>_7UP(7UWX2/$_4T^AEHUUPK1<5G]>2=EF<*DR!E=#%T=
ME,<7D.C$]H +'=4E^^:G),6>0(98] -+"+6O4.MZ"5-H\5\Q7+.76RI_5B)?
M.I'$DD F,E89',X,X6#!$!RI0WPJS?T)(XT19L2;AKU&D[:_@<D9 %)X"RP@
M.-",)(,;&R1AD9XU&F=KCT<CS4WL; P,;>D:65C9&E(2@:F=G:T!1"%M:VQ"
MG+)3IR2P%$E "  =!UK6! GHSQ1>.SKFS5MR]+<GUE<]G+VAH8%$QFY;\Y.8
M61A(&G:&A*$#V0D0-R()I@@DD%%E[--,,%K9A@Q"#<U;<5\PTU1B3FJH*H:Z
MJHQ&O>7(-=5N]2J$,ZI5(E2I8_Z<U,:?FUW=DSTH6#VJ(5*3B3P^T P;  (=
M!N!%456-E7#I%KKN%M=/&1%P@(JP:XVTML$U"75O4M+G%01="E(9RV%>VK#2
M3DP2M%&%FBT+6_=OU#1/-7!W(W( /;SI24;KHTIK-86]:!QDTI<V&-GJ@+CX
MK%G:;/DD<XG$CEI19PVEL-2-PC2@"V3L0 ;"')V?Q/R_<<Y?+)G]4H'";2V*
MH(+.GYDD4RA1UE0EJ,4C:XA:J2$2..M]J1AM"M/+3H)$2YI22%!I0 :*-, (
M)*LS,T1UH:H_'VIM8F%B;4+,R,C,A2MC0S-#8E*1-K4U-J(HA$WMK>B( 200
M2 !110 @ '0=:U@<E@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"HGS$>4Q?XD*#B
M'2+O0!=[U[(K)9*J<T#5:P:]EC)))&QRJ0-*TAO75Y+&MW8QHXD>6<9I8G4%
M'& ]"1@]PPAJOH_S.*.&[%Y-:.V>9A5E2W83DVQR!=!U1<R.X(K")8Y)F)4%
MFM6+/M<5-*8\C1)I$G..7("W4G:8!YA83-D& T%XXS"RP^XP8"P[$ &A#%H
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ME2VVI='*1-UDR>QXE'HX76(JV;S6M[0NE7N!C@88]&)"DQB<1)AY@QEE!+7
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M#\U]07]9M^I:<H+R7)G"GJ\K.WY; 6B&/<&MZ[SV=40!O5J$J]L0QU@3,Z%
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M/1RBKJ,42!R+9C@?S2::'E'I0B2-*8US"N;MGD)S\G?<7:8>?9*BY<Z=\?\
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M']V79T#NGH7G9HE=M5JTIH_$+%C$ULVIY>ACR(Q2:BCS@^5%-8(OD#"B^^4
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M03^;L3 !&6TM<CDB=,!Q<DB4MM2A]HQ[^321/H?N^ GV!N[ 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M^[11X=(/*&.6-S5*6$X*=\C;DM85R],A?V50/1:M&:("A,/>@F #OZ8&:8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MHPMYTJ*@NXYN+@D1J(.BA+-)=*-@UZ>_ WJPU[ XO"$59QR&19CKIN8QQA!
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MYUE94_K.-OR:O;EC]GPV_8_6L<DMAP[3Q7RES0LRY$TK7%#(#T1@DPT EA@
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M94Z6?(M*^1:?F)$*F[;%V:%+V]/(W5 E0J9"X*',@Q(:V%)C5*D*@^:+0BL
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MN;'=Q,9_9(:HH-K;7%4FULB1H([P^[PN4M; XJDI6I.@99X=MI5%)-G!+=#
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M'_?/-?4705801K/?99**+K=5*4\J<F5@2!,4OZV".[\W/Y:;0!%EC;0JS-@
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M:6L=X4QZO)X_HXDMGZQCADH>$D$;0E#<9JI;&-<M(B3> XH\D2V2&D:1E:&
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MJ,D"(YP;T$I:F5V.;1JR# %*?@T0HT#8R1&%[",0;NP& P& P& P& P& P&
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MDA*,)BG2@)C8#TUZ^OI]=?PW_;KU_C_P^F ]-?3?I_#^'^Y_9]/_ "8# 8#
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MQ],#]X'CTU_@U_'>_P"']N_X[_W]^N!YP'IKU]?3Z[_CO^W?I_#_ (/7 8#
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MJ%<\QMVL.9H:9&:6U&6^J4Q@T">.Q%2N5Z3M"P2LM8]+@C)9R5JDDTLL(*^
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M>&</DBE[NG*+(C(3!&L!9JYP^S&6G3'!7,\V79CCX:N7^ 'OCWL!@ZTXTO\
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MKI2%2PJFYXMK.45+/.=ZGCL,<XG8:9F'&IM)9%(X^J0$,#&>Y/H5)0M&)
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MA$8,)F8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MZ4(7B1*DCJ6'XG(I84,PL8658# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M]?=L.A;UKU_AZ[P/(A@!L.AC"#8Q: #0A:#L8]ZWO0 ^N]>X6]:W]-?7Z8
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MWEI:[F)212<9M$0YOA0!HCRQGAW\0C0NIP& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P*2O.KQ=#NX^9:II-R<]0&>3CI&KX) ;G:&\!TNK9?
M+ 2!,>>@5DFHUZB.NXR"R'5OT> I6EWL6O:>60:6'7$Y)[RGK+RUW%X&_+HS
MI2^H>=J/M))S1+[ 5#6;M&/PZ#NCW$(VQ3!5M.L<Y='V(HEV@[ZF-*5/$>V$
MD(P*T@=*P[./1WD=A/"'8WCT\?#=SL!3%^RAJH36<PA<L:(PP5A^D5;6U.#>
MOKT,4$$UL1DO:$:;:5>7\VC#=;"7LK6S UOS[YH";]A_E:>4/-#E&I5XJGN;
ML4[C2VVFYQ:[84UZEM1?(C(G)D\$3F,!9B*IU@D?WC>;LX:DD)GP?W@@!"LK
M]S(%)2/$_5TF\?=ML'+78EM/5'(9Z1<$"?)\R6(U2)]80$P^JTC*G7SZ.GB8
MC?1<K7Q\9BHE00408$L@Y4$_.7?*0IZ;[UZG\8/0O):ZA;8J&GVVURVYULZ'
M75%K%J.7D0Y,>DDNXVQ(F-@D(FRRFO[IL+4O*(7S*2M*QZ("-0'6<\'_ ))K
M@\>7B-Z&Z-=^6Y9T'SA6'><R3738J.ZX]'9C!8Y+VJE8<B_IY7;TS/ZV>!CC
MFY(AKBE;C'4Q>G$KX#3@Z5F)0[1-G>6VO3+AYGYUY8A;9T%<W4',+MV9%2)'
M/RJEKV)\ZIHHIDD6E$RENXO.7I-(;,7D::F-L3,ZC05&S#UYZ-,6$9H0UM_]
MR#1E<\6<3]VQBAYE/:=Z[M952+ZT:F21CL&DK)9%CDBE3.]QI+$Y(3,DC*./
MN(R34"DHY<66F$43Z*@^P+9N.^GKVZ->>A$-S\6VQR$W519:2(UDNM221E_4
M7="W!D+>4L^:"8J$]J9=$@.*+5HR%SL2E/.^WVL$J(5D$!'J^?)\")=K.GC]
MYRI]'??1L'YOE/4EMII%8PZK@T @+)IN!'(EJ1IH-8;@\6;/E3PBTB0_8)T"
M1*N(4J5@0BV7H*-/-1Y77'K[]O@+K'B@4MAE?7K.(U5-T.ZF9$PNSJ?/1S1M
M:I55C@T-"-P,DA<N6IQH59R%R1E&LAY9V]')UHR0A?3XLN/ZXYVI]SNF,5VO
MJ6Q^OV.I[6NFND=CGSRO6&7,5>H(T@60)(0S1UB82Y&T:"XN.DR(!AJM3\0S
M#"DR?0 ZO"]%R5$/W1/D2@73D>A9/,8>,RW8RNG*-KG:+[F#[5_,[JX.$+@\
M;0K%I=B.H7!U/2'LJ4+P-:H-&F%]P9ZB"1_B5['ZO\7WB>Z%Z4\AL)Z?DE*H
MNE(]%.*:TM%NDKA>Y<#GS@DC;64_?JTI=+H?5WY=2G.2C<BC#"0D+!-R13M4
MA3J@N>I+S$PN3=6]Z\?= 5@33MB<#TZ5T5.IA"ITJMBM99288=%YP\O[8N6P
M6N9<R2F,M,R0 6,ZIG$9\PC0@-V(O8,"$Y7[C)T641RGU&V<2+CJ-[DZ-EG-
M/-:IVZ'C\=G9DOC\L4PQC>;>8UM:GQ.OF&9O+:N"2-&^O>D 4(AJ1?&869@2
M>Z)\W<8J&;=FQBNJ'56ZV>.&M*PL?M9V_J@TPY5%U=DK"=G5M2R)1&'M!;,_
MA<=+6.+GI8MCK4$:/[$"O:HW6BP^:Q_.?68^A&[G+FFMV*\I^]<<PWLF"L,N
MMQ+2LAOI@L9@U,(/47.;:[PB5(+#N!TA)A;L-O6K&<KXQZ3DF'G 5?:A=]#G
MU1*(C%I,K:E3$JD4<9'U2R+M&Z6LRAW;$K@<U*]'ITAVE3>8HV29[RBA>\&_
M4 =_309'@,!@,!@,!@,!@,!@==C]RCP_U?Y%^+(#S+R74?Z_F2>^X=:[X_O,
M]KF"1-CC\4B5B,!Z Y3+Y2U.[@^+UTJ3B)*3(S"-$A&(9P1:T 0:J[W\<G:/
ME@H[B?B.<0!)R!R_2CE5D\Z9L&9V#7\\M*P'^O*].@R>!TQ#*J>IPQ ;P >G
M0S;R_.[;K1IB8X*$W[<1!X;.G_CIMCE;R]5/Y'N::@=;LI#_ &)U?(LTI:#2
MB"L-A5PYP5B:VZIWV-)[/ET%C+]!G9KBS4SK @=?OFTT)BL1)Q(M[+"I5W_;
MG]KQKQ"5I!ZZD4'3^0FNN\73R*)8 5+$>H21*'I@8XB14K3.5ND4=/DT;9HF
MTN0' T2=J-="E232G:<92S O0NB">0SR2^+WKND;YY=KWCNZ+<Y]<H% *Y77
M@PVNLD=G@0B<ESP]2:%(5$1@<!?7A"F1M:8:MV<R@'&G+1D:* $X*6*E\:GE
M%>;._;_3>><>-M>0SQAL9E>7.D.Z$I:1SMQ3E/$:1+9RVLC7)PQXR/+&EH+5
MH4B5V6N@]EJ2U!)&])ON0G4T\%=I,/F0\K79HJ"5.%$=5\22#GZFGI%9E0A?
MWV?,T!IY@:-N,963I,XL#%+'2 K@)52SXA)P#)&J+(T,?QA5G)?"SY,G'P1<
MO^/9'SFW&]#5!WN[] 2A&*Z*5)B(ZV*;K(6(UZ"3CG?VZAS<UUA$I"TFB_E+
M&C/,-]A>R1&A8GU7X^>PJY\QAODQJ#AZMN]Z-ZCY\AE3=!\W61-:,C,SJ.7Q
M^.0R/H9 TK+=5N$#5_B2($U"$J;#UOS &Z)MZ+ 8F5&!G'D \>G7]R=%^$"Q
M:9Y;JV/PGA:_7.\;YA=+R^L('7%>LLHMBJI>.!UBRR1T@JN8/D?9H:M,<%Y#
M4V(W5:+[DHHD:D28@//&/C;[ B?:_GBL2TJP2UK5WDA8)(S4%-W"=U[)])?D
M)M2.HCYI&X;*GR1L0G%'/DS@67I.;H!))I1HP':  82S_;[<K];\,\&1CD/J
MJH(Y7+O3LPL\;+*F.THS81%FD3JR9/-R'UF;8N4>&,L#>@>@$!"YJ"W)0=ZB
M$D3A#_.$Z+&3W0/O/GR7L%!RR24Q#J,Z KJ:6XCFE5-Z%DDUP2_G61QK:2%O
M,W;YR],[6FI]<6YJ"4(3"#%)'VY2H/R; %9W4'A58'?R_P#%GE9YS:66/22,
MV>X%=?0L@Q$SHY@SK:TF4;8KK92QB(3FS1N7K4C>^I@>ICLF,)6!U]RG4[5A
M'?I[Q_\ >D<\S_4?9E#4+';QJ'L#QVRKEY!)%=P0BN&^G[)5Q2'QQ*KL-MD1
MIDN<V$T<"*-+VQ-KF,[\@$(A$_$:( 1 1>(;R&%_MIW/QAFT,B+ZL57Z2_DL
M.[9J$42%$/ZX(+B'*13($WVS@2%M:83?M+[MK]N'IO1&T^_GT$NW[Q^=N/?E
M%\*_6)//JI+4O%G'$8I+H)6JL^G=O,=G;E6MCPQZ)C[.GGIZN6M,7<I2E,/5
M)->BDCW[3!-$'V[#1_.'BQ[VA7+7[A:KIG1!,>EWD6F%O6!S(C%:-2.Y#Z"P
M7"T_Q<;E*QEFR]/$GQ*3+D)APU6](M V;Z'[$7H(@^ER\17871O('B&\;]N5
M*"JX9PA=S;:'45['3VOY%7TUC%=&RI-&8[0J:/R598TD>;.:)8=H9CU'X^4P
MC!O:C9@@E@.#*FCQM]@<C>5ONBXHMX_Z&\B_)'D'E*&S43S9DYI.+.O/5FJG
M)Y?'<4I1VTS2-^'#@/,K=2UI<?;',]8VA0'$A&J3C0C"0G1O /6\I\TWBPZY
MA%"Q95SEQK0Q]5VH^P&1U?!XVV/THC%H,9P:HJQ[F:63DP*&'3-%H! B2E!:
M0LPM,6?LD&S0Y?RKTT]5AY<O#3Y(U10MTY7=AS;DFZY 8$?XVO%/03!)X93$
MH?U&O4EHC3Q.+!5MBEQ4;+2I5AJ(LP>A*"]8&B/-5XI;4\A5BVE+(1RE)8UU
M#6CY3NN%.XZ@MBLH$D7,Q39$'29Q?IYK=INSSQM9*LF8WI<Q/S2UN+V7K91:
M#0-E;3N(;&\N?/L_ZLZ,\'/"Z:0'V'9M>WBR]9](39&D$';)4?-S'$6B:6?)
M=!]I4?(LZ8NQ[8S:.V'[QW.^$K0ME&>T.SU@,!@,#J[_ +ASQ_\ :/?EE>/M
M3RM11D\9N4KAD%K6$_OEEU/!&UU0NSE52Y"P10B531"^+W<)4+6:/&H1)4I8
MA%:":9H0M@#87<_C0Z,\OO9O'\NZ.@S9S9POQF_NM@J*YDDSB4\O/HJ?OCE%
MG)6T+VFMG&4P" 5X!+#4: Q09(ESF8G/6>Q* 1Y1B<(X3;QP]>\P^8GJWK&N
M^#:5\C_)G>C+&5DCCE@SFEXC)J&LIH1MQ)[FX;NE"ZA-C&W(EQ&?^&0.!JEL
M<"@Z!M2B F4!R/EK\3M@=Q0Q=!#^(&)+;=,T+5:3B'ISD>9U753)7MPE@?%<
MVHFPH?.IK#G<CFF.RHM&XM;JF;E+BWE+E@T"=*J]2U8<-='CO\HW*/?W!_DN
MYNB;%WG8L-XSK3D?M^N'*V(W5TML9\C$/!')79<:F5G+&=G4(I.["2.@#31#
M6%N;3HU0F,*6&B)#=/FGXS\@OD%J3QY!AG.<2.L:G.L&+I&X8;'+D@0XW7\,
MCWSIFV!)IE/W2"F6%/#6Q:'[I2A;$K3]T4: L>ROB--"37[A/C_I7R >-]TY
MKY?J\R96G-K,JV4F-KY,X!"VV*LT/<AR!V,?WB2RA"WGJ_<$*0HEO&M]YXMB
M]VB@^_84Z='.5OUA^XV\-2IFI-UF=IPWQBN+5(*4+F\$8Y0<>SPCJ5CF;0P2
MU:]G5JODC4A(5*6\"EX1-CB82 DQ>DT;LTL) 4?X=NO;$H;STVA;,5C-'=">
M6QTFO]&:5D$W8I3JLH>V+I_(("AM*6P(^2Q-+))2Y30"99^,5.9#>4FT;L8A
M&")+#4O4GC+\EO0/[?CF;QQ-_+;''^@J<F54M*QJ-OJHG!J/C%5H9G^6F[K(
MMR%!'D!$F4R!&4U-J%2Z+-:+/,5[3:T6$83E<^$NGZ#\K*#RD5M1TGN..7EX
M^0<V6[2;#,ZG:[1J2ZHXQ5XGBJWYI=8,<@$D@;\76K<VJE38\JC4"LP]4(HQ
M+[1Z"L&T/ 1V]#? /#N JUB$;M/J^SNR$G6=QMK78,+C4 KL9\;6,9T82RR9
MOK&2_J6QD:F=*(2 DXHYQ&K$ 6TQ99QP6?PKAWL,7GTJ;R /%$+8_P VLW#,
M=YS?Y NL>I%DB9)]J)JUR\X^)L\Y<7E<PMKVM_%F*$I9PC#P".* --[31!V6
M<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,""7<C+<C^7S(&G
MZ2D=QBAW5%2VC/OP<PK*(!B]?096X&R)Q*%8DRBNWZ0&%.8-H&Y+H05.RC-'
M*$WH#9@5H>=GPM1_R=UQ7MXU0R-\7[6H!9'WB .+@H;6@-F09&^I'Q^I><.Y
M9QR LY.(2A6P+AG&$-SKLPKY )5RDT(<;YB>(^M+=[L\2_</,5/%7\V\86Q,
ME5LU4BL*!UQ+#([+U\%7-\A8WBQGEAC"M(W_ *=6%K"ON=J0C$1LLH8!&#*"
M+?$7CH\@-+1']P<5<7/S&BEWD<56Y*^?D,!N&M91&GIYL5MOUD2QU4]/+]%G
M1B*0*+80*-K'9O;@F(R% MEEGA+3&!"^8>'CR3N/B;\3?(C?S>D573Q?V7+K
MOMYMU<]*$Q\4&3V#-9>S'1R1'SLM([.4C03DLHI/H(1IST2C1_QAV0,X+>*1
MXHZSC/[B+J+R$R.F#V;EFY^4&2B8M,U$_K%6_IY5'62BU G%WA#3,7&2I6)R
M<*S7HR!@)-.T882,PLLH8A@"J?G_ ,3'DFKKPW=4>*I]YX:4-I=C]'LEGMMR
MEVS6+G3%35M)9!3+M+MV:<FDY<]U-X:EJD\O;:P,CZG7C<4^TJLS0%/PA(KJ
M/Q ],<O=M^/KKGD/FJNO(-4'/G&5<\,WCS?9<DJ^&R%\BM9QMQBC%94:/N!0
M&"DN"Y.Y)EV]?,><E7-H@;+$G6&'$AL7RR>.3L'JWG#@""\\\:TY73S4?8C=
MU)9]/T_+J@@E?UC$FXI:05"M.SHY0-HL*T'),Y!&Y.#8UIFHY84<$)@B@DGG
MAVJD2@Q4C2*CD:EN.4IB%!K>M$E$L0F'% ,&C5B0JEJ$2E*(6P&;)..*V,._
M8,8?06PZ[-N\)=(<^^8F^?)A1]4/'1]?=6<1/=!2R!1&65Y&9U75VQY!7K=!
MG(]-9\Q@S"XUE+FRM&Y.H6)5RA8V+3SS#4OVP0F""LNPO!)V;7'[>)C\:]81
M1CM[JJT.AFCH.U"VJ>0N,5W7[@)Z;')<PDRB;/L?V]Z:HY'&Q![T1!P5+G]R
M:'VIM%F&!W!.?6V1,E%4ZPRZ.+XC*8]64(CTBC3FM8W):SO3!'&]G<D9CA&G
M5[8EP JT0MEFIE1Q9A>PB]=;WL.@Z\-%\/\ :<1_<6](>2F2<YO#5RU=E&H:
M1CST*S:46S-I<&^*46Q@EC_"F^QE3@3&U3C5RS?L3C4KRR#RA[3^[WEA"R+S
M-U[Y#;5XBDD \:#TD8[]DTXAS;)E)<T:JWEBFG3Q.0)V@KVP'HY(AALO5G;0
MATX!4I%B=N^[VC. L^#U"H'D3QM]3\H>3/MKL&Q.1>>87R'>OCS3U\HKY@Z*
MCK_"XF^1BNZO%(*SFCY-XK&GV9K)4Y5FM#)Y0[-R%J/VZJ'$]<K'HS1P4T\D
M=.<[4;1?(E@=:^*GRJK^9^6;*D_4%?";XDEE_!=!SBRY9^?W;57K5\:8YW/:
MKC"E0!='!RR;2-"5M08H3B4F*=&&A;\W>/;JWG/RL=<=3UEP;1WDIXR\CR6)
MV2C46/-*<A+_ $-.EI'YL2^0(;L:'IU+BABY^<]JRV5K<%2IK/1"T7M8CVA-
M#G?+AXE;*[D9GB.I>+&QFOBDJLI%GX6ZQY3G-7U/&(O+VYG2'3JGK6A<OG$;
MDC-0<$FY)[G'7)"WK75M3*S ("R3RQ%.(=H*C8K.H+2E/PBT9D.Q;,AU70"+
M6)8 Q'B'.9S'XHTM,LF AJBR50Q25^2*%F]F@"9OYO46M"]=8&TL!@,!@,!@
M,!@,!@,#!K&M"M*>BJV=6W8D%JV$-IJ<EQF-C2U@A$50'*S/B2E+9#)G!L:$
MIJDW^4L)AP=C%]->N\#F8K+(K.XZT3"$2:/S*)2%&6XL$HBKRW2&.OC>;L6B
ME[0]M"E8V.2,W8=^TTDT8!>F_3>!CD(MRJ+-6R5MK>SJ\L%QACA^)F""$32-
MRM;%'7Y%)/XR2I6%R7GL3A\R,X'PJ@E&>XH>O3U"+T#)%<LBR"1-$/725@12
MV0(7-T88NK>6Y/(GMM9-I=/+BT,ARD#FY(6C:TG2HXDH9:?9P/?L/O#ZARZM
M6D;TBI>O5)T2%$G.5K5JLXM,D2)$Q8CE"I4H.$ E.G3D@V,8Q[T$ =;WO>M:
MP,-C5H5I,XJNG4/L.#RJ$-FG';C,HY+&%[BJ#3.1]R["62%L7J6A,%K3?WBC
M8SM:(!]1^W6![(!9=<6Q'PRRK9_";*BHEBEN#)H!*F*91\3@B^/[Q"%YCJ]Q
M;MK$GRA^4KY/>7[M>[6O76!RZ65Q9=(W:'HI(P+):PM[8[OD62O#<HD;*U/8
MUA3,YNS(4I&YMS>[FMR@*4XXH!:@1!F@;%L O0,0F=VTS7$AC<1L.W*Q@<LF
M)J=/$8Q,Y[%8O(94>K6:;DI,;97QV0N3X:I<-Z(+"E*-V,[?LUK8OI@??95K
MU;3$6/G%PV5 *HA254F1*IA94QCL%BR9:MV(*-(?()0XM;22J5B +118CM#,
MWK?MUOTP,@8)7%Y7'&V8Q>2,$DB+PW%O#1*6!X;GB..K0:7LXIT;7QN4*&Q<
MW&%:]P3RC1%;#]="],#%*ZN>GK@"]CJ6UZUM$$95D()&.NIU%YL&/KU18SDR
M)[%&G5STU*U!)8AEEG_&,80[WK6]:W@96?*XLEDK?#%,D8$\P=FIP?6J*'O#
M<5)7-C:5"1(Z/+>Q&*0NBUJ;53@04H4%E")),/+",6MC#K8<PJ5)4*52N7*4
MZ-$C3G*EBQ4<6G2I4J<L1RA2I4'" 40G(*!L0QBWH(0ZWO>]:U@<5&)1&IM'
M627PV1,4MB<F:T3Y&Y1&'9 _1V0,KDG K;GAD>VI0K;75K7I30F$*"#3"C2Q
M:$$6];UO _<AD<>B+*XR65OK-&(ZSIA+'=_D+HA965K2!$$(E3BZN1Z9"A3!
M$/6MC-,"'6]Z^N!P,'LRN+-1KG&MK A%@M[8K"@<ET'E;#+$;>N&2!2!&N5,
M*]>0D5C3F!,T68((]@%H7IZ;UO X9AN^EY5*CH+&+>J^1S=,:Y$*(<PS^*/$
MJ(.9A# \$G1YO=E#N4:TC+%I2$1.MD;#O0_;Z;P-H8# 8&-S"'1.PHL_P>=Q
MIBF4-E36K9)+%I.U(GN/OS0O*V2L;79I<25"%>B4E"WH99H!!W_@P/KCK V1
M1A9XRREJBF=@;4;0UDKG)S>59*! 0!,D)/='E6O=5PRB"PA^10<::+6OYA;W
M@8Q&JKKV(2^=6#'HHV()U9BAH/GDQ&$Y=)I*5'D8T$=;%[VX'*W'4?CB4XT+
M<VEF ;T&U!PB"2Q'G;&&P,!@,!@,#BF9]9)&A_*1YX:GYL^]=&W\BS."1T0_
MD6-T6,;V@^[0G'I_O6=Z;E"-45[OD3JB#"C-!, (.@Y7 8# 8# K'D_(_C[N
M;R*,72"V7%R'R"\_0%M_$HXST/*RIC5E5K_SL>+1N5.L,T PL\,E)DH="#_R
M#/['$U>?O8ABWZA"SC 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8'K..)3$FJ%!I1"<@HPX\\XP)1)))0=C----'L("RBP!WL0M[U
MK6M>N\#B(W)8Y,6)LE$0D#)*HT]I0KF:11MU0/C$[HA[$$"ML=VP]4WKTHQ!
MWK1A1@P;WK?UP,4G-PU)6!B0FRK2KFO#G DQ0@*G,WC,2,6IRMB":>D _N;>
M)226(&]"$#0@ZWK?KOZ8'-0V>P:Q6<,AKZ9Q.=L CC$P7R&R)GD[.)03Z?*0
M%S9%BY%LXKUU[@>_W!]?KK RS 8# 8'!2>3QV%1M_F,O?&N,Q2*LSE(9)(GQ
M:G;69B8F=&<X.KNZN"H929$WMZ).,TXTP00 +#O>]^FL#U+YA$VE?&6EVD\?
M:G::J5"*'-3F\-[>YRM:C;%#TL11QO6*"5CVL2,Z0U6:4F 886F*&8+6@!%O
M09%@:XL:XJCIY$W.5MVG7%6MSPJ,0M"^QIO&80B=5I0 F&HVY5)G-L(7*BRQ
MZ$(LH0AZ#O6]Z]-X'/Q:<0J<H$[I"9?%YBV*V]&[I'&+2!ID"!2U.)Z],WN:
M=8TJU:<YO7J6M462<$6RS1IC0A%O98]:#*,!@:AG4RHQ_D@.9K%E%;.DNN&O
M9JK*H^5/# HD-C5@E)(CL_4E01P4"<)'$"$[^!(Y#"G-3: I]AF_3>]8$;&7
MQM\L,L)9ZGVT6H_49'D+&T,G/LQZ O&9T4A88RH1JH]%CZPE%@.L9>H4RFMY
M&DS$XDK&8DH@LH*71198 A/#6M!UH(=:UK6M:UK6O36M:^FM:UKZ:UK6!YP&
M P& P& P& P& P& P(R7?R#SMTC,81,>B*SA]V-M9,\E2PR 6O'8_.JO8GB5
M;0%O<YW!I.V.+ MFVF=N"WI7)44:<W(#U12;9.E:G9H=5:QD4OX-\.'F%L_E
M%P>*IYUZ+[+-C7"[,PN*] VUQ2]TS^G^>Y_:%4:T:%3$(3/9.ZR9RB($.R"2
MVP*!S1^T"HL6PM"[*CT<XH[4\&*FAF-O@K:[65.^")/'(JA*:FZ5\_2RG#7M
MCBS\E1:)TY-->SZ"-S^VZ.T/:)=\YH-A^Y4:-#,[=@\/8?W!/$\Q98TS-<KF
MW /91,OD2)"00[R8J.6)0@(^6]K@!T>X!92W=2!-\FQ?"6<((?0/IK0:3[4M
M6W>NO*,'A"(4R[WOSCQOS[%>GK]I0BP8O6<.Z"O*QGXXBCJXNM^DYII;Q3\-
M8FLV0 8@(W!"^/\ M.%T3&(DFMA#3_6'>T/[SJ?QN4G7\+EE10^Z_+/"N0NU
M:!G"!J;WZ%&\S =;#M#F2:%QI>X1=SC\C>(^R;-TC./0.[$/10PA >>0$)I:
MDBNF?W!336$' 6T0'K7QJ.%B6K$VTH*1H7VMSS=)44@5FGH4_L3!D6ZYE2B.
MJ%/L^12@2(BABV%(3H(<1Q/!H? _.+YA$,,C3-&$;Y0OCKE#RF94)" ETDCN
MPWR!V?EP" @"I=W7[,L2E0/U-4##[S!"'O8MA$N&6ASP3)_//SKY)U43C%KV
M3<MK2>-I;:2DI7>U^%CJ0C33SB.DC7E+HV9,%8 C[J>!/'A*C6&2*#U1H2%Q
MQAFPD_XMJ,@'=GC4\=O1W?T"CG0T[C7+FV%G:^@F-BL>$-Z YZ<F?5NJHS-F
MYS9E]CSRN(RS?>2%: ];I#\NB3"@K%NU 5HKZ(MBA/#1Y WCF:&SM;R5:/D*
M<+KI*C866\.+\3XU#+JJM'<*.MF0!@GU%7%OQ>+2AZ1-9 =?/!W;:@(1:6CV
M()>6MTSSG+O+SX8IEP58->S4^]Z\ZEJ:[@4L<A/C,FY;BU.L]BP!HG@8^22@
M0#J:=H2UC0W+/B6LIYZA.(@C1XBQ!(B40:'1O]QO1\H8(TS-$BG'BIZ$4S%[
M;T!"9SDZEGZ6IM.TJ7Q86#1SDH;4JTPD@9NQ"*(WHL.] "$.@W=Y(9.Y7U7'
M27+$->E;3 (!SK9<^ZWEK*]&,KEII6U?)WVM><V%V0&EN"*1VH)&%XDXB!%G
MH(0G^#>RQR!$H*#F/$I84!A'B5\:JJ:SB'1!.X<:<])$1\GDC)'DZQ8FJN-&
M*DJ0QT6HRCU"8 O4PL&]B!K?UUK6!Q_E*ICI;KBB*K8>2XGR1T56J>QDUB75
M371LUF;?6O14)B;6X&1.MVYXKUI?F-S1F3PU,\&A=C2VH2YD1EJ-&D"4 P-+
M>/R31"SN .H8!X]^5*O\<'6L)EEJ4W9_/TG9$D>B=)]@I(>R-Y4IDCS7$>5&
M6!%/P:]G=V5\1(1@=VT"<(  #H6@!'3Q90ZK^6.PR>4NF?'!S5R5WJMI"0RV
MINI>>"_UO7O7M6QU=&FNVG)CLN3LK99K/9C:\*T"V1M+Z(YQ7E';7F&: 8#1
MH=EW 8# 8# 8# 8# 8$3.W+Z7<[\ZR^81A:P);/E2^-U'2),F<$#:QJ[KMM]
M10.MANZAR-)2:8&.0O1;L[>X0= :&]49ZZT#>]!37X0Y(7ROT=WCXEWJV3KB
M;J=F3?U[S+9;I)&:2O-AT7T<84Z6+]ZO9E!B8UUA-VJ%>W,7L (U>^F&:]0[
MUO82=G'D,[,>.E?(/R[0'*](R"8<5UY15FL4MLF_I,PQ&>1FW(A/IJ)*Z$,5
M4.+\SS58FAFF]N:RDYK84HV<>L>"R@DEG!K.#^7^]9?%/&MTLOY6A,5XZ\A%
MFT]S^G<UMS+W;H. 6[=<??SXO(QP=N@08(Y5(5,XRI:@G?G0OBE(,IP-1(O=
MM)H,FZ<\O;W %?41O.->PFWS^/9ZJKF95D^&VV39M[S6*,,:D]F0RE3X!6\T
MC;$\Q9!*"6YN-=MJ]O+^G5)!)D*8HI<H#-W/R.=+S[L!KY*YWY;@C@NL'@2$
M=N5K.;QMF35L0RM\XGR*#_@;LAC=6#_+X.LC"P1Q)K:U)WY>L6;*"8- 5H\T
MH.#K+R\.$ZY,HRPE])MS9US>_64VX0BW/Q$[-404'1]:3J;Q*PGU999<=/=$
M]+1".5\Y298Y 9SW#2$L"(I.<K.*V,(KP&97]6WFD[]GL_K>GG2T8#XC:@EK
M"U0*8R&,0:VFZ/W?;K\B=W1U=XA(9# W=6H(4LYQ1Z=\V#;<6>$_9)X2R SR
M+>8?J]76?C0Z+D?&=<CH7R)/5?5"QMT7OE4?=$:O:VX1)Y;7AVV!Z@S? 2:B
M<W",FH#5I[\)X)3;VN.1D#T% ,)#0'RERZN'CR00[NVK(!5$G\=U85[T#)7B
MAI](;3A%@TS;$0F4IB*6.+)O"ZSD!5B-[A!U;,I3*D25*K7FDC($ @?NP.(K
M'RCVS)>I*,HIYI&*S.(]*06=ND9G=0CNQ:V<^6E#XV7*VBLNC7^45"B8BXS.
MT!AB1NES2$)8'1(:0)J&7LI0,(T,7FJZK7<8UOY!W_CFI8YS.EZ-44;?J7_:
M!?GBTFEM6]4+>7$<OIQB1U:4P2QLBLC&C-7B?%S&K<C1'@3(DZ<LM6:$K*9Z
M![ F?F3[(H&1'5,=S[2G/W,;Y%H^WR&:HWEG8+3>[G<#I<:B-C2MJDMFR%PC
M!*9>6,YN;FYK2IBTQB@W[@TX+G<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,"/\ U9"(?8W-5[P^>1IFE\5=ZDL(IUCT@0D.30XE@B3N86!8
MA4@,3GZ*-#H8/<'?L,"$8?000[T$*O!Q_P#8@_'7_P#6K5=_[E!@0R_<-)8I
MIB\2+M+F A_:&[S1<6@=DGZ54S)>KCJE%9YC\T)(XVM;R\OY;JF2A"8W)4R@
MU;L 2]%&"]H<# *?KJ9I/-1=78W('.MO5=QA&^&W.,]'IRJ>E5&L/7G3;(]O
M3_"D=3U3.V."+9Y/H]'OM6\4HTVDI?F3G(OO-_<>IX2WI;R<7&Z];\<\O] U
M%4\#D_;%'V?;3774,L=V=[OY2E%9PR,V2HJ;I2&/C*W^]W=89)MDZ<DH&K1+
MVW*DH41Q(0J\# +%\P%FL'(T^\@U>T/!)KS)!>GWWG/<*D%A2.%W ZLC)?NN
M8!7"J=DD+ES#'TQULF 4:C(FI6NU'!:5;6Z5[^PT&V>A/)O+8).[7HZMHS3R
M6^N?JCK>?VS&;$D%MO\ #U]D6=&7:81RB8#)JVJQ<YJ5Q[ RB/.DSDW(R4X7
M%N^-J5"/4@1!@S-Y@3K-<N(X)&X-#N8+4['H">7@SQWN%UEE7($TKKF:LE=O
M/.$:&G86]R?K3<),XJ512@PE.($?2E."=M7[5@3%!)JZI-8-ZU3QW1%G01'6
MUF=3S6#/=^5@G>#I(C@]<TZA2W+>D8 _@1-NW^/.;S'&J$C6B3)PJRI06/91
M?R>P(1,\@L(B"/S#^"RPDL;9T\Y>+,[AB[K+"D) 7YPCB'CV3N")B5N6@_='
MM*)>7\Y*<0ME%'"&,.M"&/8@OBP.NIX*'HKMDSLOR6W8A23&[+,ZYN*D*L52
M).6[#H?F>G#F9H@5.5T0X_<AA;>I5."MQ?MH I1OSB:%4MT::$ @A/>\R.8/
M%U'^T_(ON+?IQLGD%J4^TH% FIN;1V39\(?)7$*X4,2/[A&TE3^SWFU6]@/.
M$ DDXTE.I4F;WHXS Q66]S] \W7]RK5'7=05.Q0SM:0N-5U18-23^4O2.K>C
MP1M1*HQ1UM%26)H=OS9/D*%6D:):R@+"-R1&%'LY))A:C @T?YB>[W/FF^NO
MX7X_ZMD-,\>WWT36_2S*#I5T_J*YP?GB>+(I-9'03=JIRFR8GQ9@:5;RYJ'\
M<<":$O[9$D4;"8>$)LH^T87/O(3QE!(_1M7R"(='<+VATW4?5CBO3'VPR5\6
MJJ=Q60-"TJH60KB,<E*69-B];LF0*2%FTY7R$ &3K>!&%7YMG%U14A=U65"W
MW!S?;]S-E<*XA!&RXWCIF*U=(96Z0YBZ2$TMU;+JU>HL!4V!<W&.DN 5:)C5
MD'?D3%7RHB@D;67D5LF_.@;JK&CXM1,@3<Z=:D<TW%3,EL=\C_4D=@C3+F&+
MR[II+#?PI[4NKP13J<Y,B'1>B71E3;5Z=@J?>V@"WO 8# 8# 8# 8# 8# 8#
M K6\B4&\@-IL<(KGCR+<L/U:/9SF;T,DZ'N"XZO=9O'2RRRFRL(\HJ.J)ZN1
MQ&2FC&*2*!*TRE>W VVEA 2J4'8&FI%QYU_W)QWU1R=Y#$?*=/Q2U*_C5?T>
MP\;.5CS1IK1PB^QR%BLE[>+-B%;K%+G&)PUL1S8R-Z)*A)1M @"/$)3ZDAE+
M9R%T=?W1_$-Z]A!J)B2<(Q*?/$=CU3S&5S<NY.D[%A396B^V784E@L%U"(+$
M8H0YJF9F_P"E%YCJ]>Y0I"!N+$L#+K3YBOF6>4GF#L%@;:T'2=)\XWS2,H(<
MYX_H+*<7BZ)'6\@2/C!%4]>N,<4M$>U =E'A4OJ50=M5[@ _N_0P/BF_(]S5
MCY#7COGFLBOIFGNZ@6"@>F*8L.7/%=C=%-9OBY_IVX:_FC-")\4;(V1,\+6)
MW:7%&2F4-9I*A.I H3B)4!&%Q\0\L442[2-!,X&V]L*?)7ORQM,@*T_BIELZ
M#*?D:4NF1+1-7ZQ45(OIE%^C5COM!IQ.//,>M-^C/:W:"8--<FV,\=V6'Y!^
MADL'C\_.YUBG*-'5; I,ZSIKKJK4<T<;0LB3R6:O,1@^WJ;V3/5:0L!*-L)3
M-;.S$%_.I-5'Z)#@:%Y:OJO?)OW#US+&^LP4WTY5/,E>0E.QSI_=+$9%_/;=
M8:->XRN-+*_:(\F0RHR=:VFTC>EAJ<*;^\#O8_Y SCM?FRXNU(NNYH4/K%3W
M,\[]K-?T]CSTL=+QLRJE)A8I32E=HRV1&SUDUV8C)_'/TB/<'!:4S''I4:#1
MZ@*U(&G^XZ6[B7PJF>>.#*AY!/YBBT60QZT(->%N6S50))$8L@(88/24>05;
M5TW&CJDEL0$[?@&*RS'M" +4(!:(Q;]T&]^7EWD*00RR'KKNO^6&V3HCXVS4
MK3W*LRFSA$TT<;&\87=UE=A6I$XDK)=W1Q7!))1)&H")O;VPO8-GG*!Z"&.T
M/Q@_I.IIOW7TD[QF27^]085-4U H/I<?5/+E%C>MR)WA\&7NZ%I<YI8UDR/0
M7*6RU2WMABX0"$"-$D0IMZ4A@\QYDZ >?+?3_:3:P5\.B:_X^LSF)Y"JGKBF
MLE2_6-:,'L8J7-<3!"U#"='68F'?:&EFO1"PPP_8P%;"#6AAQW8?AQX%ZN_K
MM9DMY3IN4]*VM")$A26M+$KV!Q'.M0/<0A#\[JT"XP( L.D#>#Y2TI@P$I0[
MT >PZUL,"XX\,''-5<$\S\I='\K<V6S(ZQC$>E-F%ND/36'"WGHMR@$3B%JV
M?'S9NT%*]KIB**IP&*OLT0STZ<KW$E^GMT$GYI$.EN9PT'67C_YJY,<^8HLT
M2F/3BK)+8LLYY>8$)2M0KX<X50HAU6V?#1QDA4K=#7A I:BU1QIA(DQ@?4WU
M#&(YSYTO051=06G2)%!S[NCI:UFJ\9BDL-7-XG0*M\;&"N:Q;:X;7F.-[C.$
M;%#Z3KU,V-SN>C$>XOP1N*M*G)5#1D!SM<49=5O=!U/UGU=#JNK28T56MDP2
MFJ?JV=O=M)HR\74.%!M2>2RU'R U<)X<EK/ D+4TM2)D*2($ARP\]4K.4D@1
M!8'@,!@,!@,!@,!@,"ON[J%L^^>OZ37656%1SGC&GX98#T6Q2B4&/<DD'0LR
M1-,;CTU?:I>8(OAKI%:ZK\Z0MR#9CMM;^0D)BK1(=)BMX$.^J/'A;3)WIP=V
M7X_:HYPK<[GLJTX7T<R+GO=-HKII"U4C2A60)"SP&JI2C<9'%ER(YY:UK@)(
M02X[)T+8P:%L ;'@G*/3<1[A\G72ZF)UFL@W85&<]5Y4+.GLQS!*F^34/ ["
MB2@5@I3(#II8665+9_\ ,0H;UCL<E(1[^0@0S-!"$26'QK]D1_Q^>(KEH+-2
M2VR?']U?S=>EL.0;6D9$,E<2YZ=)8J4-]>N@ZM$\KI!,4DKU]N6XM[:G2&IA
MA-.$$0![#:+1ROY/^/>L^HY#Q&/E&U>5NV;=5=$/\=Z/E]E0^8\RWU+F)B8K
M0DS(F@L;D!-H0.5"CZ=Q"SEJ&M28K %.%0A#HY:I"2L9Y-Z(8?*<D[*=UU>2
MRI4?CP8N/EKJ?*G9JM>1V,TW$9<"^?JX.F@AD.;(T\*#1(OA*?A*"#!?)HK9
M>M!P*W"?$7VJT<^5L\0J5<_Q+L+EWR<7WW[092^:3J44C/X;?$]FL@D]-6@]
ME5E&Y?%UKC$IH-O/7-S8O"6>EULH?L4",("3K'R-Y )=VGT;V%9L(Y5B26]/
M',S\E-E90Z];.EKC%+ 8IM8TK:U:^8NO/\60O\:6'338EJTMN0GI2QA*(2*Q
M$".4AKUM\:_7C9Q?X9>=PIZ&4SCQS]&\ZV_<CE_5*:$Q>6QJAHM-(DH05FNW
M3ICHYO<H(EP510'1$TD)1)Q%#-'H6C-!LRVO&!9G1G17E@7VFX0:-<_^0WDF
MD.=(:^Q65O3Y:4$DE.L=CH2YC(86OA++&1(#7F>$+4I"=]5#'IM^([0-'[V6
M&Y>,8IY>X\W0&O>T'KC]?$Z;CYS>LM*CI79[O:'3CC'V@QEA)<KC<UKR.Q2H
M4;I_=N4D6I%+RH6+B=$(TJ0@PPS000WXJ.R1^%9[\<PS.>PWBY])J+9)DP;1
MG>ZK!$E'<!77VRS'K=,ZEFGX#65^"^VTS;(VJW]Q]S\?\F!/^*<O=30+RCVQ
MUU&$U'+J)Z9YYYWK:TT\AFDU*M.L9/0KE9BXY'"(LUP(R+3]KER>? (+<%CX
MR#0#+&<)(HT6%.>%K& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P&!JZ[F>52.G[.C<(:FU[ELE@LHC<?;7EY%'F@YT?V98T)1NCT6W/!S>WIS
M%FC#C"TJDW18-^PL8O0.PBYXPZ M7E#@SF+F.Z4D1*L.A:KC=8/CC Y(OE,1
MD!D82:2%OS&Y.T=BCL!*X%^@MDJ4!)I0];#_ #:]!;"/WE:Y&Z.Z[6\(%4*S
M5B>DY8[SH'LR;K+)L!YAWYYCI4R4@4P*+)V*!S4P]_?RY'[RU*O:5(1\6M"$
M+8M^T+#+YB5G67SS<,&JN:CIVXY[3T\BU>6$4+:XRL;'DT-=&J+RPLU*6,:@
M<0DBTA5HPH&Q;VG]P [WZ:P*$**X&[[A5I>):W9M5/&M5MG"+%T1!;Y;(?<5
M@2=XGX;HJ6)P2:],N,Q=*N93I--Y<X1 UU/97'1ZXQ:L$>OD!NSC?M@C11L,
MZJFU5SKJ*O>>_&?T1RO9/2]G=K,$BD';W1U#5C+%[?:#I):WLV5\ZF5E-Z K
MV;-++'&IP4Z<!G['($H7EVUIZT<86$Y#J<\C4;Z?.\D7 \0HA]B7D"H'GI9U
M+R7U?.IA7+M6UF0&"$M<!L"(6# H?-B#SV.'.X6=\1[;=B5:2?(46<,PG:(-
M\=3<GW[T5%XS4/4/-O+O?5(2*GU']2&>02D^G)=7O2CG*9&Y&2FC')SA<M=(
M[7+?%GDAE(7EOB*4H$K<F/!]Z>:K 8&Q?'IQ==O-#9537T%9G]87N@^3J_YR
MK^<*7]S?G%P6NLM?I]<K@<<\HDKF)L( WPJ+M:I5Z+5[=#P*SRB!J?@+#]=C
M<Q7_ ''W-XV.AZV8*_6UQQC.[[E]C D\]<(]*Y*ENNE76H4B&$,J.%O[<K5Q
MLYSVX*-N"]O+/+!HHL7N%L00M,P*0*3XVZS\;MZ](+^-H?5/0O&W5%O/G0KA
M0DYM-WI:T.<[MFQ2$FPU57R,Z#3Z$3JJID:WE*?Q*S;$L9S"RP)AJ A,V<&^
M.RN*+6\B?&71?/EZRV-TZ^W+&8H76++7ZU=/8[2\VKF5-5D029/LH<66%NU@
MOAL^84(W0M.C:T1;6GTD2A$;LU<>&"N?,/5/8DKX,<^TH14]9IN)+A:.DIDI
MK.R'&QB;SZ%@E>R>"5ZYP0A9"H<I@M7)7R8+).K"[!&[_<IDC: C96CE^PK5
MX"A'5=Z<2^2CF"KH56+9#NA/(!Y.*H#?D@GZ\"BK(K8USR^&V,\/%4AB!JV6
MRQD:W-<ICJ=$Z@0.*D9!2\YO 288>%D8."K'A'>7"UE5I'X09RAR-PY8G&QZ
M9]GCFGLU4WRXJL4,:<&J-)8:>RN+3'66KDZ9:8<\(E)XU@ADD^A6M&!HCA[D
MORO\4-;?PM'97RS+N%H#,WD-,=-N[]/".G*]Y^=Y*ODA-3GU*&+*81*;'8"'
M(UJ:7M2\$M:!+[%)I*WX2V_8>GHGQTWOU1?4 M*8TC0]2=!TQU^U654GD-J*
MS7-EMDGE2)W"?)&NJ["@S1 XV\3>9/U+!_1Q[.Y.3G& :5#</O BT:B.#L"X
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# A*V>-7QXLL[.L]HX;Y-:[ 4/HI2?+6_G^KD;R;*!+/R I*
M-2GC!?ND.W#_ "C[[>ONOG_O/?[_ .; FU@,!@,!@,!@>LTH!Q1A)FM[+-+&
M4/01C+%L!@=A%H(RQ!&#?MW]-AWK>O[-X&JZCHBFJ#:7YAI6LX;5K)*90\3>
M1M$'8T4>;7R9R$[2F02QT1-Y9*=9)'Y3K1BU<,.U*LS6A&C&+6MX&V,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@8Z5&&O[YY7K2"G0UW<"5P=.29,JTW%DM#6U:0H-FE"$2B$)MVHV
M#U]/G4&"_P#2P/J_3S!_H-G_ -6(O^0P'Z>8/]!L_P#JQ%_R& _3S!_H-G_U
M8B_Y# ?IY@_T&S_ZL1?\A@/T\P?Z#9_]6(O^0P'Z>8/]!L_^K$7_ "&!XW'X
M_K_\!L_T_P #8B_Y' ^58V11O3'+5[9'T*-.#Y3U:Q&VI4I)?]HS5!X"R2PA
M_MV+>M8$<I3UAP[!S32)GTARO%%! M@.32&W:F:%)8M;V$01IET@)/"((M;U
MO6P^OKKTP-?E>0;QJ'':(*['XS$;L7L]O]<*?#_-_@T(4AT'?_#@;MA5Y\JV
M482375O\_3T]1Z? 1"[ KF4''>N@[_NBF1W6F#W_ #:_AKU^N!NC3#'O[6)H
M#K^S8FQ%H._]X7P[U@?O]/1__0;/_JQ%_P A@/T\P?Z#9_\ 5B+_ )# ?IY@
M_P!!L_\ JQ%_R& _3S!_H-G_ -6(O^0P'Z>8/]!L_P#JQ%_R& _3S!_H-G_U
M8B_Y# ?IY@_T&S_ZL1?\A@>U$U)&]2I.1%@2DJ2$A6T*<HHA&68F,6#$J+)*
M  .E*D*H(#!?Q$$D&O[,#D\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>-
M[]-;W]=^FM[]-:]=[]/\&O[=X%<P_*OQP!PZ.;@/EV+C.1'I0P=*J&7E3I^1
MH*A<4K88^JOU&OCM1NJ56B3,!0G$Q4WB6)@-^ONMF:(_O,":U2VU6=\5M#+A
MIN;QVR*PL)C2R.%S>*.)3HP2%F5^\):M"K)W_C%'%C*.*'H!R<\L91H &@&
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MP@']3VB.-OMV'U /6\"LN9.%B7DNT"SI!<O0+JX&IP 4WA;MB66E4+S58ME
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M@+#[E)R6(/PR]RQM3[UZ"<&(YT;_ /\ ;_7 L)T+6_7TWZ^G\?\ RX'G 8#
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M+%)-%)X8U;85*!J^ Q0<V-*)I1)BD28@I8XIOMB1B^%.6H]?E]-8&:3NLV&
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M=TY)G]QUY,*YBR&*HW-/&5$* RQP"%2><.)JH@:6A5H733D)4 G0A&Z$,[Y
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MN%D DJKJ![-6-YS&A+$C"O;292OVJ2.R5R5-Q.S"47VX%28O0M?(/>QB"Y2
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MA88<F4(@I@($RXHW2\"7[H\+U)7-*02(X*J0O4@."E1$:!L\&DOR"UK7TV'
M28D@"HPE6 A*GV#0D;<-06I6-99 1;1%O!P-Z*2*-:-]VDXC @+V,0A;4'#W
ML(19N2OX?;$*E$!L)A1RB(RAN4MCXT*2PC*4)3];ULTDS8-FI5J;?H8G.#_>
M$FAT(.!TM>B^;Z;X+L^]81?-8RRTX_/X<-1S5-T;V:@1L;@)U*&D<GI& +?M
M8MBH$X=*BOR1?REDC3>S8!A-T&F>;WY*JD35";?-D,/;C%"-)(E86WYGA$!0
MB H;9"B9W'2("\"D(@#'K1@0[_O!!&'7LUL)VN%AU<0SR> LE>#9X>X,:](<
MX.9Z1VLR4R5)L08VZOTE4%E((NU,J[?W8T#4F*+'[?B&(S8MCT$9J9NJ5\J7
M1670T2,-,D/.TW33I2D*#[C934;B7^(NF"Z!H01'$R:N%"W9&M:]@%B-(;K^
M<&O0/Z1</ED>G<4B\UB3HG>XK,8XR2N,O2,>C$;Q'I"V)7=E=$ANOY34R]M6
M%&@%KZ;"/6!DF P& P& P& P& P& P& P& P& P& P& P& P& P/G5HTB].:
MC7)4ZU(>'03DJL@I2G.#H6A:":0<$91@="#K?IO6_KK Z+G[Q*2'R26>-'D6
M-Z:FQCE=C2ZQ7=A4L[V"*N3XZ2BN:NA@GK<7",XE&03)G[9VR4^UFRC1A(V(
MPW0-AWB8@PIXK$XO&$B9*B2QN.LC"F1H3%1R)(G9VU,WDID9JX9BTU*06GT
ML1PA&B!K6Q[V+UW@<@\LS5(F=UC[ZW(W=C?6U<S/+2X$%JD#FU.:4U$XMRY,
M;H12A&M1GC+-+%K81@%O6_IO _F,]*=1=JH*A\B/A;XGE*8GE_@";=?7;8]C
M,LFW^K7GC",V9&?M>?V5R("Y')&F%R6;.&G3290$;D@+VF-V4D(5$*0[$_*S
M1S97?F?\=49X6B];T[&)YXC'N==+P2M&5A8-2J#OP8>^T>KL,IB:P-3[.D\B
M&!7MPWLMY.)T(1QXTQFBS [+].=*T9T"]7#'J;L9EGSQ0-FNU-V^C9R'0O\
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MQ5L4)E"%0YNZY8[ <8X>8%<D_'((OH+LXFNGQDGEI->AFC=[#K6Q>OJ&9C(
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M:CW:W*=W<HRF722 QF\84?!GN60X#>.0LS6J6H5:H3:2Z$*&XW[HE%M.:6:
M0!D&C#Z?7 S3F>C6?F7GFD^=X\_.TI8J1J^%5<T21^2LZ)\?FZ$L"%@2.[PF
MC[>ULX'1P)0Z-4;((+",T0A;]1;V+80DIK@26\W^2GH+K*EI9%V?G+L6N&I?
MT32*L#NF=$G34(6(TD7N2! 2)SF'2>7112O3R$@\2<XU<9I2'9FQ;" )\5S1
MM*T^LE+C4U0UC6#A.78Y_FBZOH'%X:LEKVH,,./=Y*ICS6W'/CD:<:,8CE(C
M3-B&+?KZ[WZA /OWQ0T_W'-*SO=BLJT>4^NZ7V816?5O/CB@8+-0,!^E'W,)
MEI:Q*<@F\(.,5&&!0J_880(PT))Q92A24<$/7#P(ZZ,&UH_)QY!^M?(;"(^:
M<L8J<D+@T<^TN6\Z*.3MLD>H33:A M?Y*S)U1NDRTUQ : 0]_P#H;$6(,M2_
MMNO%<Q4*BI&#U!**]>F^90JPT?0T2GK\1TLCFU?GJU,9>FRWG0QT?6 A"<M,
M&% VZ1-X#- ,+( 846,(4H^8?C6AO"FA\>_8?&D?;WGJM#VA(6M\M/HBR7J:
MVI<SQ:]2S*-"=K%G4E5*5KE%8JO/).5EEE$IDX5&AC]##C#1A!RX?!]Y=.2>
M<^UHS7%21?HDVYK#YEZHFG1\4L5K>.@E;Y3ZE99$\@4)I$EK)<;#>TMK258Y
M?$<OT2X%M9.T9*A4<'6@WSV),JFK;Q"P=FY\Y/\ (@1#)GY"^4)[U7?O1E([
M0W!U[9AR]YGT[F*R*S*2.C[+5CO-X6U( #/1M\;,>%:)"D/6&#68%J/-'AJ?
M/('+['\FGEIK% 7UY;IRT7.G,LY)72.J^/X!$R7UGJ-BG$"^^;&NU'@!QQ#R
MZ-CN$2$\>]_<$!4*%!9(1K[KJ7]SSTG0SQXW'"F.,W^MK 9U,2FW75;OS?#$
M$]K2//+)LE(OB;V[)D54K'9*:E J0H(]]TH3E* -H @)-&$/MJ[]LKTS,S+$
MO?J[LN&)NWFQ#R^KY%NZD8J_C0\S./-#*!A8(R)E?OT^BD\'7L"- @4)B"4J
MDTUN+6"4B&,XHX+ K%\=/FAZVCCI2/7OD]I.)\V3)D<XC;$>Y3YI11FR;2A;
MVA-;'Q@62^?&.Q,/_,H#1E'&-Y8P: >8'XQ>@,#3] >/ORX^'\MZI3QL.7*?
M7G$;K*I#-HO5W3RE945^5VYOI^ESFUG6I &% QSL"X6@DDKW,E08'XP!"G1D
M T 02.WV-^X0$IV0'PU<ZEEB.V2!:9Y#*Z&E+"(>P!5F +CNEAB<O6]#$$)6
MC1 UZ:#H7TP/1#^)?)GW'>U2VSY2[&ING: Y\L.'W%5W%G($HFSDU3BXZXD;
M5**_G%^6:_$-JN3M$.?VD"Y&RI?E1'*0EC&$@18M&!V"<!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,#QO_P"[K_[?^_K _F>2)<9,KHL)<N5"VJG_ %?T
MS(SC3?=L9ZEYZ(GI:0D8M:T8/?VBH(0ZWZ:$$OTWK>!+@521$F8I2CW:6)Z^
M<)BX05*Z&(VL4^)>6_8 &NZR%C G"2P>\\H?KH_W:*']![,T(&@KN;D?/SY>
MX4_34@E,5JH$;L'?Y:"M1+H^F/Z1,)M9O:B'L:DTY4Z$%'%!+ <$1Q>M#!\6
MQBP-S<HM)+;&EZ^*!&)H%*'H]H-^X$J.<V,ES4EMVUON2(3=A/;O0P6ME!]I
M@MB$ O>]!P.R7X]920_PJ:LAI8_<V/K8X% -'H!9)"Y'LH18/9HL>Q!,1>@P
M_38@^O\ #^P+<JFGQ;6\J8;)&I@(B$E3C:0*6UMTA_RIP$:F"G<QE_*<J)<2
MU.R?E,,W\?TWZ_7>\#'(O7$=I^?$0J4-[$XK$#"8XUE.W)*44Y/T(9UA+>='
M7)4<(8DLIAP7%.4H&F$ "Y*>2JT$ ]G%@#8=AWE%#X[*(5&6YR>'-'^-8'<N
M&_A) YQ<E])$<B=36O3DG&XA+2Z"?H 1Z$85K>A""/6]8$"I9/RJ]2R%OT1-
MZQ6&M; M5*Y+'8P\P23OJ5M"UI'9W7B<7#47+$KVC0&?;&GJ%(=>X?\ /OW:
M#YT%L\[M+U'W.15$X-$G(1-CDJVNVM4MZ%Y<S31+EC7%7E^- YMX5Y(E)*H!
M.PB]H1:#H0 ^H;?G2CC:VOQ\FE;I#3'5VD44B.G]N<UD;>E[\_'Z+86-;\6D
MZ@?WXP"+$885L)80[ULP&M?0(PW8Y59SETA1)AYL/%6TP5A:@D''HCV&%M!!
M7XU4L>UZMP,+6? I :K+,,"::8>HT'XQ[T#6@V$??O'EC.0VZN"H-'90]MPV
M1QLV:5LIAS)$HJ%:%4N>6]#*61N/E\B2'%:.:4*=&8(:H0##S"4VC-B#+7:;
M5FL;T$4K-XC:"%Q*,J6"NFH*U,G6;;0 &>:XNA0S=&*G5]>1&J51IGL&:>;[
MAZT/>\"I)Q8U(7E:ZO'L.0 6*P* 'C%^1 H$<,L83T8]@&F-3#]-^_6_3>O;
M[O77IZ!4ETNS<V_[8<47=+NDN0U4XU\+:\Z'(AJ7O\ZA,0IV(LP)*,\*QM5&
M:W]Z+9I&R4Q.QA,$/0"QAKKAN7-43?9(LCL\>J];1L4]BK#*E;9^47I=*5RA
MU8#'E(S)EOQGKC$1"8T:4D7P ,V,&OY<"6EEW4JL> 3)IE$JFJQU,88\SQR/
M#=WF2Q9X=V!62:IF3R:_KR -:Y8E*&$HA*A]!#,W[M%ZWO6PDMX#WU8T>1.*
M(-DA(U+./[MC;CK0O7?RQ&QZ<?DA?T]-;$$Q2<+>M^OIO>\#N]Z_AK_>U@><
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@:WN"W*ZH2K9]=%N2IJA%:5C%G>9365/2DM*W,S"R)#%:Q08,P0?F
M4&:!HH@@'N-4J!@*+"(P80[#J%7_ ,@7EY8^-/(/Y+NSZQ=J_7+.7I\/Q;\Y
M2!(4ID5#5-"6AON=ANY8 E\V4VV]T(Y1U$0YC5(TKDW-B<1!0M(CB0;#LQ>-
MB\1=*>/_ (VO,XYV4K[(YRJA]>53\Z(GI[5R$$1;&Z1K'=T0*59"QR5OJ%08
M<(0M'Z,%O1P"SM#+"$V1 "/7H,(1Z]="]!:T+7J'>A!WZ;UO7J'>O77^#>!^
ML!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?D6O7T_W!!W_
M .?_ ._@?S*QHS$MFKD_W):-?'^C[Z3Z/,U[_@>&+H2<I0;$'TV+82U6O46O
M06_0&_IO L^)=>AFIQT?*^QX>UH!R)0TJAF6@XRPHU=O?S*D9C2U-+DE ,Q,
M9K^X-&2 L ]:$(&M;] J$C5@U%5]TN3S=M/BNZ.;@5CLA$."Y&MQ)3RK-&-E
M=1&E%* A(3>[1HU/\4X-;,U[MX$A>2$?ZJ@B4EF+5->EDH>4I;<$E.D.T4-:
M8)M1IB=A*2%#"4,L@0/4).@B%]0A#ZX%E?$W3<.A=HO* IGE!K(^Z21=UE"%
M0SF,0=Z=RDC?(4S']R.0K&TES]Y(U@2 @" \(A!"2()NPOJ*5 "83\:@LW1X
M/F ::>62G$$ 1J-G[/-$647\) -F#V+80EA#O?KK6M^@<E>#'8/0//K_ !VN
MUZY#T?318IS5CFG<1(E\E($2J:W>-Z=]$& +$^,9PT@/KO9B@"87NUK0AZ"@
M]?;G8#>Z/.C)V_-CZK<VU%)&<V23!%*"E;<I&E1-CRP'Q(Q4UN*%I"<3H!Q'
MJ'7N%OU#KWZ#=ZSKSJ6+0Z/5(<AC<\ :U$J)PMGT'D#M+SGYO? .*QFBLKCJ
M9I1FHD@T28E%MQ0JW!6:(P.O\70"PU_9_075\LEK;)58WY[AZU\&M96*40*F
ME#NR(6E<A<D3<\29N.A$@51.4:</M%*164C4[#O6Q%>N_D &1T9>$Z;7LARO
MN0/;$T;W0S6S#<(?&4[*T+ZODAKV=.9AJ)/#]MA**B*\W[Q8$@LE6(L0=AV(
MK6\#BO)1:*&96#7HSAJ$;=$B:U?4<<<8Z6@D$>)=YK%ERIMF2Q0$2Q7)BW96
M:$O1@2P)VXI+ZZV<,P8@]4;H6_+'CL=L-LC4=+CSZ,8F+3M+F!O<BAE["?H(
MB7#2891F]F%'$A]?<+1NM_7TW@;.<^1N@62._K)WCK+HC0]'+#D,\BQ@]EF^
MNM!/*"J+"/Y3 ^T6@"WOZ:W_ !P-(:7*2U#G'7-,J0O!B0IQ)">8G5Z$E-$(
MHS:9=I2>4KT2I& (] WL1>C ['K6A!W@5>]!3J!5EU'54FM6HR+RB".(*M.E
M;_,$.U*U>\$DM3EHPM*K4A$W'%_.G*!HL2DXO1(QZ+&/6PC]S*PD3=PD![*G
M:X<RN$AD;R60[O"P3-$XX6J4^]2L=%0%#B<C;_\ $"/0#3C#!!* $0Q:UL)<
MSVM4,3CBR61FR8)9S(V@)&\CBA[XC=&(P81[2B=&24M#&Y_CUBD.R0*B0'$A
M-] F?&(0=;"6O@IT8Y^2:K5I91N@D<S]+/QWIH7M+3N,IIQ$0$S?\/YC56O;
MOTUZ^F!WE-?PU_O:_P#M8'G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M P& P& P& P& P& P& P& P& P& P/YO76L.45CUSV#"S4PDP(CVK>3FD!H
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M-TSC$:*-1%*D8ECN7"SP'[$( 24NC3@^HM!!L+#N;^LVZX6:OVT:-J8)=+F
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ME)U%KTYR8R)O6ED2BNUI$8G=S0^&S1O=E+"[-R-:V+HV\J BVJ"/[<>@F@$
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M=G@-A]X5C$K$:B F?*:TFR!I3JG6.KA>@?:ZQAYVH;E@/3U J2F!_LP*KOW
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M!7,?)A>;%V=TC1M"-1"Z-]_6@_V('I.P8<S.IIQM*AMI6WK-(9-I0H>64QI
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MXYXZ+)B<[KDEVM7HF1RGDFU6%T9+Z9&U,$AU11LQM3:2*T.U6RB3EHM>WW&
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MIO?K@:?HOJ2D.DG"WT-,SICG)5)6N^4O,W-C<F]P;-SN+1Z)/LJ0M*E&J/\
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MJ25J%<C4%A-3JD:M,,Q.I3'E"T( P"$$0=ZWK>]8'V8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# P6(_Y_M#_KTW__  SKO SK \;UK?\
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M#6<./$(8AC" ][=!&KU(=;$020%LV P. 3?_ %4O'_L"-_\ O&5X'/X# 8#
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M/4>S9@=>F@X''U-?47@+E*Q+VI4ZHI+"'6/F-ZT.F]-MSTK;GF+.^CU82@K
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M@RU!IH0@%H>]#$+6M>N]ZP.5P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MDZM.TVFRH'6%G]$DMT$[/KFQ T^?Q7?3!#) [U58RRVT[@B<*\6S0_2YC0.
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M%0D5JF5R\:57Z8^K>7X@ZKC?>G<6UXONTV:$G$:WOX 138->T'\@0[E> P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M,-7<\.!#LXR?ESF+<)O3J=P86%2PQ4NW72=&22-U*RC5&EO+REB@E*AP<TX
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M8#"C2QZV PLP&]Z$'>MZWK?IO ]2-$C;DB9 WI$R!"C)+3)$2,@I*D2IR0Z
M40F3$  2024#6M! '6@AUKTUK U^]%5#3S;/K=D!-<U@TI&A?*K0LQU)C<-0
MD,;"D.<'.13N8*0-Q(&MG0DF''JUZCXDY01#$((=;W@8ZR//.T^L"5MT=<J:
MF5I)81#G2;HV=1"I!/"*YFP5BZ +Y22D$K?P0N6!9%!S08KU]DMTD,$GV/XA
M;"&XU21(M2J$*U*G5H51!B54C5$EJ$JE,<7LHY,H3FA&2<0:4+81 %K81!WZ
M;UZ8'S;:&G9C8;MK;MFLH# ,QNT2;9C2 U/I(:!L'\7N0 ,2:^(6BM@ULO\
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MQF=FYEF4TY\BU?MRZ5+":Q15U*CVY4\!")82][(4^I98E0AA#,6CRP^8NI^
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ME4?IX<"P+CM*/CV$)998=!INMO%17=;3?RGS=#:LU<E7E/)"182)4TL1)%6
M# K"@?K##"0[,=A?:V&H4?Y=K>OD3EA]/38M[")$]\ L*>N3?'GSQ6?6URTY
M9'C8E\FF5#=$1V+0IXDQKC,'U0_OHWV'.H-,!I^E>DOV@P&Z 3I-Z&%GA,&#
M X;I3PW2V/6IVKV_2G45YN-A="\2S:J;PYU0Q"$O#'U).(?RU)*@@)ZYRTA
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M+%SB"PN@I-/2XT9M7LX6PAVZ+?38M&AT6$=>BO!3);^.O:M#?)/ULR\=]+6
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MR1&!=:4%,7Z15-)[V:$T<LN,.R533L,<U;1*;',=D2\UH11-C7MZD)ZH\\H
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MZ8.<5JN*W!=JMRD-<SJ4QZ,'_AT)+04UL[R\$Z7 .]3BT6PNH_<XT3=O3WC
MDE%<[5%8UTVO*[@J=X:8A742=I&K"SQ1\-=GUT<UB1/ML:$:-*'6@[4GEC.,
M'H)01[]WM#0O:_'5^>5'H/Q/5\P4U9=2<R<1RF,7UTC<URQY16"U[DK(W5V:
MRTM5D&D?VT_DDB4CB2M,Y.VFXEB0A6 ,+6'FD_"8&&\X>-V8]1__ .Q9S[T/
M4-AUC NX>FWF;<_3NPH(\L+0]E)/U<IKRTXJI=&_VJ/TE/6]K<_@%HI48G]G
M\GL-%Z!^!<L]TRO]OAT4Q])5G,IMWY;?+48YE9JQB\>='^=$0"CGY7 J>CJ]
M&0%48>_R0D]TESVX[, G.-?=F&;#\6M8$9;,XK[";'+AOH;CJO>DJL["K7F7
MQT<QWK2MFU.]2/E'KRKV>)PQNL./VB:[H!Q*L7OFUU+<?S8Y)LA,H3(DRN/G
MZ=0@-$'&]A>/'M?I.V?W,#!5%/VC&Q]:QSAMXYODS['5\4BM^D\QA8U-L5]&
M)6\_CF@*J0B:S$3?]R>G(<QC!L(Q)1&FA#>-@\K=0W3<WD^Z@A5&75%:GF_@
MM0\-U]74GKJ21*>7)TI(H %80QQJM7AO02Q8FJU<8)D4.YR,MM&K5CTB4J$I
M:@XL,;X-Y$Z7KCLSP 2>0<T7#"(=S=XWK=J'H*0+ZU>F2/5G:\K8[+()C<Q6
M_9DIR'1ZD9FU SO[PHPU>2>,S_*-#V'<GP& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M<U;=H7RD& /UHW03-P/6<<2G)-4*#2R"""QG'GG#"42224'8S#33![" LLL
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M'M@6K$:UL7)E(!E['HD\._4(RP[UK>PL(P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MS(8H&)&T)3"6U((>]E$ WO>!O# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M2=JE%9C>8E*70FP(S]DP+FR0MS4649[ $M@=D? 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7 \X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
38# 8# 8# 8# 8# 8# 8# 8'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tex3-2pg2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex3-2pg2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$@ ,T P$1  (1 0,1 ?_$ +$  0 !! ,! 0$
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M!P' <!P' <!P' <!P' <!P' <!P' \T^GUHO#C\P)Y@J8YM$Z]@4=7\ 34!
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M_,^;-PKJZ7",CVV7LRKL2Q=\DH(6JS''4FY8-6ZJRJS8S4JQ #Y#L]I4O\,
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M>^>X1"G$1,8Y29#1(!A4Z=%1$0]1X'HF^/ <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <"U4:/2VEOD,A-JE6V]\
MEH1K6I2ZH0<:E:Y&NLG(O&<$^L*;8LLZAVCLPJIMCJF134^T4H#Z\#%L[JMK
M+9X>%KUDUYPG/0%:>R,G7H27QA2Y*)A)&7=N7\L]B8YW"JM(]U*/7:JSDZ1"
MF754,8XF,(CP.Y::\X#8VR$OS'">*&EYK3*.C:[<6V/:HA:8&/AXLT%$L8>>
M3BBRD8TBX50S1NFBJ0B+813( $$0X'R9:Y:_1R,:VC\'8C8MH:)MD#$-VF.J
MBW1BH.^G44O$1')HQ!",XRXG5,,H@F!4GXF$5@/U'@=E/8+PK9Z'$XNLN(L9
MV'&L V9,H/'TU1JU*4J&9QR)6T>TBJN]C5X6/;,FY0(D1)$I4R!T* !Z<"V'
MNJFL4DPJ\5(:[8/>QE*CTXFG1KO%E(<,:I%(R)Y=.-KK16$,WA6*4LJ9R5)L
M5,@+F%0 [AZ\#OY/ &"IMW*OIC#6+)9].34;99MY)4&KO'4M88=(J$1.R2[B
M*45>R\8@0I&[E03+(E  (8 #IP*5# &"\?6N2OE#PQBNEW>73?I2EPJM JU?
ML\FG*.2/))-_.Q,4UDWA)!VD558%%3 JH4#&ZCT$ Z*5U6UEGTI%&=UYPE,H
MS%C4N,LC*8MI3].2MJZ9DE[,_3=PRQ'4^LF82F=G RX@(@)AX':NM==?W\8O
M"/L(XE>0[NKP-&=1+K'=3<1SFF5-4B]8J:S-6),V5K=<73*=BR,46S4Q0%(A
M1#@=?&R&M4&OEN%B7F%8E=!D>=SI&1Z]*8G28'A?N=:6RDV;F3[6P5^-!J=:
M4#M!FB"9A]LH!P(L14CXIZ/C""M4,VTLJN(=@;?%0T)*,H3%412\I72#>BI%
MM2@FP0CIZ6K[Q#WBF5*86';[IA3*'?P,L-9S1&KVNPXD8K:T5ZWX+QE,FL5%
M08X_B9#%V)+"U^^[&V=Q)6[<*W2I1B\!W(-R@DV.DN558G:H43!:R\[XV\A4
M+'VPKQ?4.XX[8'K5*QGEQZRQ;,UZ(/7G2;RIU>K6MRW70AOPXY0*X:-$54OD
M>P%2E3*7N )!6XVO4U;82.O!,2S%UN5!L\? -[*C5I*?L>+_ )=.1N#1B,@1
M9W(451OV+/R )F!R]#*=?3@6I XMU"S#(0N4*UCW7S)<M2W)JU7\@0U6H%L?
MUAS3_=K7W%$V5HR>N8H:\5H=F1NDL0&Y$_;*4"ATX%\PNO\ @JMS-<L==PWB
M^"GZ>:;/4YR(HM9CI>MGLQU#V$8*1:1B3N*&=46,+L4#D^8$P]_7KP/@.NN
MS9&=YB/A3$Y\MR#)S'/\G'Q[5!OSUB[;F:.FCNVC%??J[=RU,*2A#+F*9,>P
M0$OIP+'0TJT^:5^R59EJUKY'URXEA"6J$CL04*/C+(6M2BLW7 G6;.!00E"P
M4RX.[9@L4X-G)S*I]IQ$>!W9=3M8BS+ZP?Z?L.FG9+(L'F"0ESX\JRDB[RO6
MH@T!7LE+.CQAEC7F%A3BU:RG7YU!#[!% #TX'!RGIYJAG'(%5RMF;6W!V5,F
M49)DA3;]D+%]-MUNK*$9(GEHY&#GYV'?24:DPE#F<HE24*":P]Y>AO7@<.VZ
M5:?7V/F8B\ZNX!N$58+K(9*GHZS8DHTXRF\ARR"#:3O4LVDH1PC(6Z0:M4TE
MI!4#NU$B 0R@E  X%Y4'7'7W%<\SM&-,(XIQ_9HZE,L;L+!3:#6*Y--,?QKK
MY^.I*$G$QC1XG5V+P/=18@?Y9(_J4@#P+%MND.FU_A1KMZU6U[N$!^+++>QA
M;-B&B3D4-VN1BFMEN%A(P3AJ:R64Y0%\][/F'(A_$.8>!RU=+M0E[_5,JKZO
M8"7R;14:JWI>05L2T52Y51"BLQC:6E7K(>#-+Q!:G'F%&.!!4GR:0 5+L  Z
M!ES'F+<:XFAWU>Q=0J?CN!DIZ7L\E#4NNQ5:C)"RS[D7D]8'K*(:M&[N;F79
MA5=.CE%=PH/<<QAX%^AZA^GZ=.!7@. X#@. X#@. X#@. X#@. X#@?!RY;L
MT%'+MP@U;HE$ZSAPJF@BD0/B9154Q4TRA](B/ U4[#><3Q2:N3DC5\N[JXF:
M6>(<%9R5>I2T]E.48O3MA= S>IXSA+:@R=$* $4*LHF**ANQ3L-U  UV6[\V
M[X=ZXLY2A\A9BO ("T!)>LX>L#5L[*Y4C"K&;C:5*ZN7Y)-\J90%4TQ'Y14"
M=PBC[H9KQE^9[\,&2G#-@;:E6@R,A(HQJ+/(6,LF020*.C%(BZ<2S2JR<(T9
M'.;H=55TF5+XJ=@>O W,85V3U]V/KR5JP'FG&.8*^KW_ /C''EU@;2FB9($Q
M43=HQ3URY8K)E5()B+$3.!3E$0Z&#J&;> X#@. X#@. X#@. X#@. X#@.OT
M_1P*=?T#U']7] \"O IU .OZN!4/7UX#@. ^K]8_[!'_ &<"@CZ@'U]?ZN!7
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@.!Y9-XO!I'4F2\C^[N";_FW)F2]H*SCAY:]=FB\.E$S%.JF;,1Y,S3
M7(3V2I?B]S:Z)C9PUC(I=L10_NJLO<<@[$O U_93T;SAF=KMIMQJ!A*58Q6U
MMZN>MNLNH>PFKTJTI3'&>5:?6:Q>MC:75[--X\'4.PMIAN"CZ8E6#19U&1KE
M%!%R9=%-8+APOIID77V-I-"V%PAEW,F4=2MO]M,^;;9H1Q;;KQ(;7:NOZ=%%
MQQ#1=J:1ZJN9FV6&(Q,2A3S+/5FBL*J1TQ0;IE$P6SB;&U%F7;;:AGK'GUC@
M#)TGN\GF35!OJ9DJFXUQALEL'@*@5/7Z QC@Z5I[1[+M(VE8[>QLU;4(]I ,
M[%806(Y00.=4@7;JCHIY/(#?#QV0>XF.8:9H3C1_9/6>TY(IE[N4W%X]P)/T
MF4CH6CVQN6BR=?Q[G-%.306([),2C*P.$"I&7:&3[1#T2^);Q9X\\3F +=@K
M'^2[QE5"[9/L>3)NQW;Y=%5-Y)@A&14?%1C0ZC>,;LZY&M".NTQ@=R(.'71/
MWO:(&TX/A_N^'_#@5X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!^1
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MJZ@>TJN()=>\0X&[3@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M]FW3]8_'K_P_9P*\!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M_F-Y=?\ U:=,O_3UD/\ \A>!0<C^7,"B8=:], *4!$PCGO(8  !ZB(C^!>@
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M<*4; 13&'8)B8QC&$C1@@W0*)CF$1$"_$?U\#O\ @. X#@. X%!#K\>!7@.
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MU]#%E;QPPA"(Q\!3Y&QVJSV&PN2D%R^F)6;KU995V,B3D$K9)J#]1X4_<J9
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MT"K2@B(G4B"D* !]8AP.@\;'_P KYTH_^1=PB/Z_7'L#]'T>G FSP' <!P'
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M.-?R*[+R1:K3/NQO_*E=Q5?2CSNB.TP%(J"NM0&8.E&_4X* 11(0 2" =>O
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M\B]A'_XWL#P)L\!P' <!P' <#RU?G %#$\/\@8B)U1#9K"(]Q4RJ%;^VC<U
M74$?^S3ZD @B'KU, ? 1X'HOUS5,MKY@A8W3N6PUB]4XEZ 7N4I$&8>T $0Z
M=1^@>G S+T].GK_M_;^W@.@?T>GI^S@5Z=/Z1Z\!P*=/3I^GQZC^_@ #I]?[
M_P"O]O KT_3]P_[.!3H']O\ 7\>!7]_QX#@.!00Z_'K^SZ_V\!T^'J/I_P!'
M7]O "'7I\?3@5Z!^_@.!3IZ=/7_?Z=/7@.GIT]?W^OZ=> Z?1Z_3_3U^/]/
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M(FJT*3V#E*7J3J #P/O7\ X5JMH?72O8RI\3:9.C0V,9&<:Q* /G^/:ZW!G
MTMX<X'(YKD0U 4V[0X&11(8P%  ,;J%G4G4'6/'$%=:S2<'8^@Z_D2,6A+G#
M)0:3F,GH)Q[AEJ^X:2!G:3>O'.L8WR"(),P./<"?=Z\#]2.KFL,FQ"GR>'<:
MNF;F2IUL/!+PK'O>3&-8]O!TBR.&_4%WLE5(Y!)LT>*=ZJ)"%+W^@<"ZYO7[
M"5EM+V[V'%M*F;A*+4]U(6.0@VCB7>/<>RI)ND2#AXJ0RRDE5I1,%F3D1]]
MWH4X%$0X':Y*PUBO,:-;;Y1H5=O:-/L#2V54EC8%?%K]F8& S"?B^\0%E+L1
M !1<$Z*I#ZE$!X%G6#5G72U9$ELN6'#M&E,H3M2E*',WYS#I_BN4IDU"N:U*
M5=]-I&(^=0CR%>*MSMS'%,"J&$  P]>!=$I(8FUOQ(+J2<U_&F(L85MNT3^9
M6*R@J[78M(C5G'H N<YCD G:B@B G45.8I"@8P@' A#AB2\;5>IV0MPL9U*D
M8QAZE>+K"9'GI>IV'',K4,DP5E7@+7"2V.;(VB5ZW<3V<10(W)&(.G#A4OM
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MLEM1W"\PNF.(*EDQW,UC4CQRY-V'D<@Q2:*CR/R7L=!,<-XDRG&(/^TIYU.
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M&*,\@(X0S" !U$<7WP #ZQ&KRG0/W\"/WC8_^5]:4_\ R+V$?_C?0/ FSP'
M<!P' <!P/+C^;Z>_*>'N=3$A3"^V/PJR 3>[]D3)VYSW%]LAR]W:VZ?;[2>O
MQ[N@<#T-ZPF*IK5KRHF @0V#,2G3 PF$>TU!@!*!A./>(@7IZF]>!G/@. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@:-OS("0*^&O=$#*I)=E(B%0%0AC <4[+$F!$O84P@JI_
MU1'H "/J(?'@9@\$Q 3\0N@Y4SMU _D1%'[VR*J274\Y.*'(*:R:!_>(8PE4
M-TZ'4 QBB8! PAMH >H?H/\ 7]/ KP-9GDH_]Z] /3K_ /9$,0>G0!_^I)GK
MZ_J^/[>!<^>L_P"HU9R99D<AX6<98GL'1]?L>6LBU[!['*">!V,^V4DJJ]M#
MY..?6Y1V_8-E':2$"SEG;5ND*ZR:)  _ E8ZIV";IDV%N4C4,5VC,]!@&[JN
MVJ1KE3F,HT>M64[L6QHB==LG-JK$1-G(OV@BJ@DN(']#>O _,ACS 5-LUCR1
M)T3$57N>4$HZB6Z]NZK38BTY$1E%48Z)I]CLZS!O+6Y%^J":*#!TNX*H(%*4
M@].G YUDP;A2XTAIC2VX?Q;:<<,731ZRQ_9,?5.<I#-Y'K_,L'32IR<2Y@FS
MIDY_B(J$;@=-3[11 ?7@7:M3*>Y<1[EQ5*TX<Q,,\KL4X7@HM9:+KT@@BV?P
M4>L=H8[*&?-FY"+-4Q*BJ0A0,40   (>[-9<U<UHKL57[KA<F07]@@)6:A\.
M8IPU$9$N<S1\3MS3\_/15!8L"&EX;';60%P1LV*L[]]P5%BW6=+D1.&(K?>\
M/TG>? SS->P5^9MMA8 &NF6#K?CMI5<.Q&08BG-D[8RBKJ,(E(N<K3D)T=,X
M&=7:.6RAS@Q1.K]DH305RICF]Y6O>L<O69>;G(?'T);[C&6*GF>T&3HMZ>3L
M'$ O)2*2T%-H3CZN2;4[,04. LU?=3*02"<+J;88P^SJ3.@-,4XW;42-<E>Q
MU*0HU82J;!X0P&([95TD6$.V<D'X'(B4X?0/ O%_7*])PQJY)P4-)5\[4C(\
M"^BF#N&49)D!--H>+<-U&(M2)AV@02=@!Z '3@1\RJOKMJ7KSE[(,WBVN5_"
MU)JL[><FUC'>+&4LE)P,8T]Z=?.J/6(4XV$&T:F8[CO;J 1JD8YQ*DF(@&4:
M_6L7V^+@KW&4FI.4[- 4Z6C)5>J0I9)6%8-VLU3B*K'8F<D+ ^ZFJR3$W1FJ
M "D!1#KP.19<18FNT#:JO<<88[ME8O;HCZ[UVRTJM3T!<WJ::"*;RU1$I&NX
M^Q.2(M4BE4>)K' B9  >A0  O"#@H6LP\97ZY$15?@85BWC(:#@XYI$P\3&L
MTBH,X^,C&"2#-@Q:(D B:21")D*  4   #@=KP' U;YQNN/]?<:9WS[;JED"
MZM([96*J\C"TR^R5<> ?(5AQMCN+D46KFP0\(#*,E9]LLZ #$5^7*H8H*G I
M#!F$A<)UQG(.LT2ZV$DT55SQ#R[;$E:1-IC&$8TD9>7@WSJY,U5&U?%U[,@"
MR*)FRQ!$0%,2G,'3S-OU5:3MEJ%?OKJT7BJ+8D++U=+.#RNF^4S3)$;49XPG
M;;<H&M2YIB)!9^U;M'BSE\@D5-LFJLJBDH':T"RZ<90,=*CYF0F'A'%U0")-
MF*T1LZNGCIZ$=>)!O 2L^RFG$16'H^T\>%0%J@80[E ZAP,<[.Y-U^U:I^*<
MKV^)RQ:\*9#O-:IMARK0;];+/ 8OBK@D8]>R9;F<;85I%?%XKB4C^68INDH]
M-9-94H(F%0H9&K888EKE:*U..)VIQ+*1K\?CNU2N='AXW,)9ZE.[Z=>B-T;8
M9W(A&UI@J[.0"B=1HD=RF!T"'4 .\35U"53ACI9VJRI+ G"+0"B>Q@G";3LZ
MQFM<6B#%NHC)$GW)#)LC(]X.CE$J7<(=.!A2X9BU5IV1L0UY_;R'Q/EVK94F
MXW8PVRD8VQ'$6/%DW4X&1HCR:<9!("UDDY"U FD!0%(B[95 Q@6**90D?-U3
M7*LN!:6/) 0#@L&[LPISF:YJ*#\/,6:D@_G!4D+0@3[I91Z1G"SCK[22!14,
M($ 1 .YJ^,,)7=BZDZ9<9.W1C&3?P;V0K&7[#/L6DU%+>S)Q#MU$V5VV;RD:
MO]A=N8P*HF^R<H#Z<"Y!U_Q^/Q7NWT?_ %0KI] __GOZ>G ?Z?\ '_\ G78/
M7_\ J%=/_?WP'^G_ !_T_P"WNW7Z_P"85TZ_O^^^ _T_8_\ \ZZ_^D*Z?^_O
M@/\ 3_C_ /SKK_Z0KI_[^^!7_3_C_P#S[M_Z0KI_[^^!3_3_ (__ ,^[?^D*
MZ?K$/_RW] \!_I_Q_P#Y]V_](5T^C_\ 3?U<"H:_X_ >OO77K_\ %"NG_O[X
M%!U^Q^/_ +NNOJ/P#(5T /B ]/\ [M_JX -?\?\ ^==1_;D*Z?\ O[X#_3_C
M_P#SKK_Z0KI_MF^!B_-^!Z$TPMEYPFI<3G3QA?1*"M^N2A.HU:4]1(::$AA+
M\0Z@(=>!T7C8_P#E?6E'_@AJ[A$  ?4>@8^@0 1'Z?3@3:X#@. X#@. X'EQ
M_-^-S./#W-&*JJG\ML?A5R<$A$ 5*"=O2!)8/^LD)E@'_P"V*'U<#T/ZS=_^
MF_7WW$DT%/Y(8H]Q!+K[2)_P' =R277U]M,>H!U]>@<#-_ <!P' <!P-56_?
MFC\>OC8EXFI;-YI3C\C3"31XABVBP[V]Y#91+\BBC.<FJW!^XX@X5V5(WLKN
MC) L(?PP-P+3T+\ZOC@\C5Z7Q7KOF5XGE4C1V_98XR-692@VF?9L$E7+Y:KM
M9HA&]C%BS2,LNFT44512 3&* %$0#< !NH?T].GU#UZ" C\. [@_6'Q_HZ"
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M@>@[6,BB6MFO::G3W$\'XG(I_$%;[9*% %-_%$I!5^T']X0 1^/3@9QX#@.
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M$9*IXYE[<R>OX!=O;*A*3$%+FB7S,T?)13IO\R!S <KH.SN6#4;FV[^5QO\
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M/Z>H"'T=.@]>G0?3T]!Z>G3X\#]<!P' <!P-'GYCIL5UX:]U ,X1;^Q1(UR
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M41*(%$!$!^ @' S7P' <!P' ^#E!)TW7:KE[T'**K=8@@ @=)8ADU"B @("
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M >G<'S_-)H2K_P 8GAP0:,7+F4<0&/TV[!JP4%55]_I^@@1;I1G:HN94Y@Z
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M?J9'YTPG13156#J(=_03?1P.N:#0+>Y&28_@ZTO(\Z7_ (P:#"S;EBKT!1N
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MZ]!X'Y_U2>07_P!JYF?_ &9&OG^#@/\ 5)Y!?_:N9G_V9&OG^#@/]4GD%_\
M:N9G_P!F1KY_@X#_ %2>07_VKF9_]F1KY_@X#_5)Y!?_ &KF9_\ 9D:^?X.
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MIX:M"3J&$Q_Y2RY1$Q>T>U/(]W(0O0!'^Z0H!U^GIUX&Y( Z>@<!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M<G50"]1+UZD$>@@ @( &YK@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <"G3] ].!7@.
MX#@. X&GWS\!_P#8<_(#_P#$"G_B0#_!_&CZ=1#M_;\0^/ MO\NW_P#*7-"O
M7K_\+.V?]8QO_JMY#].IP ?3ZO@'P#TZ<#=-P' <!P' <!P' <!P' <!P' <
M!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' \
MS'YMD@G\.>0S =$@)YHPZ8057*B)_P#QA,D[$2F$!<+")P'L+U$0 1^!1X&]
MW4%)5'4[6%)<#%62UZPPFH4_M]Q3DQS6P,!O:$4^X.G3T'IP)%<!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M !0 #KT$2\#[.-Z_S8O<JU2\9>M)#N7J;]%X1P^519,8],B3B&'OS1T.$NH
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MAP/U^GZOZ. X#]_ ?OX#@. X#@. X#I\?CZ_K'^KZN _3X\!P' < 'I]?]/
M=/V_I_;P*=/3IZ_O]?W\!T]>O4?ATZ?1^WZ^O KP' ?TC^G[. X#@. X#@.
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M\<:[A9'E]G,29$B#6"XLH&QR^7*U0(H%$3R-/F5#1Y*S,G*+-R#==4#G3$0
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M.: RJG7$;HO,6/(5BL[Q"H2K.;K",3=9^X2=PK"4++,$5T2Q;YF7O2+W 8
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MJ-I")EF:3^.?-S]/M(.VBY%"#Z=2F#@=J(] $?7T]>G3U_X].!!;=?R1Z?\
MCT0Q(XVMRD3'(9ONI*)CPA:_8; >4EBJ,"2+Y[]P1LB6%K\($FW,]?NQ1;-R
MK$[C?:#@3A:/&K]JV>LUDW+-XW1=M7*1@,DNV<)%6072-_UDU4C@8!^ @/ Q
M!E78C"&#YO%U:RQDZI4:S9LNK7'6)JW.R[=M8,@W)T@9U]S5:$[C2DNJU;E
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ME<_EI.56B7"0O%%G QS)PV42.HQ*HHDDX 13$"^G ]5H#UX%> X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M/3+*]QC=3F[S"(?&2_+]>2AQJ#8-%D+)XPS:W3&3Y++:-/''VTR$A'Y <N'
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M84W9"F>+ CC"MS;6[%]YQKD':*E7*L^^E$M[!#(2)XR73/%V%.!;?-"*0.2
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M^Q*M462PG2(8"M2*E1+U HF$(@;![BL\';U;*[G>*K.\HT'>^N0%&SYC#/\
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M@. X#@. ZA^G]'^_@.O <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M_!/@KS9N@F4A$VGLD*4A0 /LEZ!?>.\78SQ% +57%&/*-C*KK2K^=6KF/:G
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M41*8I@$!$/7@??KT^/7]W^[T_LX%>O3XCT#^H/UB/ =>H?'U'X? ?H_KZ#P
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MOK(D(]3;G*@4J8 *1E.X#A>&^'D.\H.D<-C/$^==UO&IK_D1CBJQY&MF7YN
MG;O;\W7=!U9',)B[&^MD8F>Q52IDC8UFV<6=\F5):0=%(GV@ @(1XL>YV_V^
M.9?R]>RV,Y?"^,ASA'YYE)_'UD;W*5H;S)5#J\FCD&?EJZSEA<.ZO+TIBL:"
M$%OGXMZH BH80Z\#+FLWD.VYN^"]5=2] <*ZQ80V-V[S%O[;I2Z.XN8=X;P;
MC?!VQ]BKUPR82GHJKO+O;;389$YC%6,=%11;W!2,)NA [^[>9/R3T*E2>J:]
M&UND?(YC'R'8'T;L\Z\)/M,+91J^Q&.,@6W'>:*_!I.&DO7B>]5$U9%N)_91
M3(H5,@G 4P"<FKFSGE.LV8MY?'GG"S:NR.W.#\+XPS%@G92HT>VQN%IUAE1P
MJ@TB[YCU5Z>;*O77C)9!0&IDA5 O<'<':<0W[0A)A.&AT[ NP=3R<7'DG',4
MBJWC',P5JB637C4'!U7"#!5X50R1%#&.5,2@(B("/ [7@. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@
M. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!^#G
M*0ICF,4A2 )C&.(%*4H=>HF,(@4I0 /CP(.;3:J8ZV@R9IUE&=R6K5);3[/Q
M<_U9I%.8-=G;G84FT4EU7YH[L_S+>,6:6,ZONMSE,!T>@@8!'H&;JK5IV.S)
MDO)#_.\K:*1<XBGPU4PTNG4$ZACB1@6)D)J:AY5DS"SR,O<')O<<$=/#MD@*
M )(E'N.8,'Y U'QE>-X,&;S/<C/HR[8&P_E?$#.I)/83\,3<%DN5JTJ^DI-8
MX%DFKZ%=5HH%Z*BB8JWVB 8H"(0.LG@[T^G=M-P=I("^6"BL]Y-:\AZ]9NQK
M3)&!CX5T\RC&DC;7DNK3JQ'DM7K-)M4BKJ-VX@R.Z**@I]AU4CAC/"'@[0Q[
MF74/-F5/(/ES-I])XJTU37NAN*-@3&N.8#&M@@9BL+UEW#XXID XFWI8N02%
MU*+N5'#MPAWJ!VF!,H2SH'BPQ10=6],]7XC+TZ\B=.-DVFR=4M3N/JKF3N<Z
MXN65;@> GXXR)HY*/>%R@\;(KMRD73*T143-WE$>!B_+WA@P?FFY[=9'DL_9
M+K=\V(SIAC93'MUICZJQ5EUGS;@JN_<-0M]!? P<MI43-R 5RWE$5R*-Q,F(
MB(^X 2-TFTIR7KI?<J9MV#WSSANID_(,5 55M)Y#>UVB8OQ[4ZT9TL5A4</X
M[+%X[B9Z5D'9SR$I\H+M<J21 [.BIE0L/=#QIQ&RF>JEM7@?;7)^EVS33'#G
M"EGREAPE!L"N3\-.9YE9B4NS0%ZAYR/6<0<RS%>,?M/97:&75[O=*8"E#'^(
MO#OK!A&#T#K%*RS:0=Z(9NR?GEC*3<U!2]BS+E',4&_87R:R([< 1<S^64D3
MN2"@!3)$*1,O1,I0 )6[]:38UWVQG3ZXXRI9,-98PQD2(RW@?/>+Y:*2O>'L
MF0[99BA,QY'H.(^4B96+D3M)&-<E^7?ME0(?TZ#P-:4CX(<8Y5Q;>G>PN\6;
MLP[=SF?<=;'1VZ#"3HU2N>+\AXFCGL1C=K0:&RCI/'%.K#!G(.BNV#=BD1Z=
M3O 4U$R' *I>"7#=KQSLU_J8W3RQL+L#ML7"C?(>S-P4QI!V:,A,"V!A/5&L
M4.MQ<2G6*Y6CNV1$73=--0RJ7:4QQ$H#P+*\D>@&P^UWEATJR7A3.=VU6A\'
MZQ96*.TU#8T:PO(?("]PI\?"8XDZS:GJD=-%M];G9%<C9RR6:?P>_H8Q0* 9
M-LG@?P$YUDPYB2H;/Y0H.T>",XVC::J[IQ,C57&7G^?[R\6=W"[V^&?)*1,U
M!SJAB)C%F%-%!-$I$3IE$X&"VJGX!L;N\?'>V+;_ "5FO8.W;IX*W$S9LI=6
MU:FIB^R.$$%PK.-8^L5Y:)KM;JJC)Z!VYCB[7;'6.9(00%)!,+RWG\,&5MBM
MOKIMKKIN) :]S.:L3UC!>=(2ZZTXFV >K8^KSB8*[>XELF0D%W>+[-(QDRHW
M46;I*=5!(N)@.DF4 L=KX+LMXUUR\>&*]>=Y0QUESQ[9"RK8J/EF?PE"VN+N
ME4RTT?Q=FJTI0U;<TCF<FC"/SMR2 K.CB4QA$A3"4Q [UMX'Y6AX:USA\ [G
MW7">T>K&7=CLBX?V3A,?P,X0U-V3R%8,@6_%UUQ?.3+NMV^LE>R;</XRA4E%
M6QE/9#O I NJ@>#"N5RO428R)M%=\L[-K;[80W[S[L3::I6VM@S->,(-)6-J
MU CZI'N$8FC4)G$2KALQ;HF=BR*LH8G=_#*F$P;'H1;";=;:;FXCV+<8URUL
M5K1C/7NKE6HT1<8;%CS&\V\EFV0 C9:8(VLT@\.\.B5DJ1LV3#[1O<-UZALC
MA@7:PT:A(RQ)A\QCF;63F!*V;A(/FS9-%[(*HMQ*V;"[<)F4%,H 4@CT .@<
M#M2G*8"B!BB!_P"X)1 P'#XAVB B!NI?7@4 P&$Q0. F3$ .4! 1*(@!@ W;
MU$O4I@'U .H< 50IQ.!#$/[9Q34$IRF[#@4#=A@ 1$#@!@Z@/0>@@/  <#>I
M3%$!^ ]0$.G7H(@(#T$.O]?IP*@<H]OJ7J8.H!W!Z@/P$OJ/7KP*B8H" "8H
M";X%$0 P].@>@"/KZB' "(_MZ!Z_1_MZAP/P"@"43 9,>WU.(& 2D#M _J/4
M/^H(#Z]/3UX%3JID)WG43(01( '.8I2"*ABE( &,(%$3"8 #U]1X'Z WKT].
MOQ .O0>GU]!Z#^W@.H^O3H/KT#]X_'H(_#X?MX%/<+T,/<7H41 P]P="]/B!
MA^!1+]/U<#]>OZ?3\/7@?GO#N[>H=WQ$.H ;H/7H/:/KZ]!_</ J)O7MZE[N
MG4 ^D0^'7MZ]1 !X%>OZOHZ_\/3KP'4>GP_K_MX%1Z_1\?U\"G4?J^G@.H_5
M\?H_MZC\.!3J/U?T^O\ 1]'Q_LX%?7].O^[@ Z_3Z?JX%>!3K^K@.OZA]/T]
M/I'@/7_=\0_?\>!3J/U#^GZOZ.!4!'ZO[?A^[X\!]KI] #Z>GQ_;Z^G  (CT
M]/V_1]? K_1^G^_@4ZCT^'U?V^H?T<!Z_5T_:/\ NZ\!U'^O]?Z?T\"@"/KU
M#X?M]?[/7@5]?T_;P'4?J^GI^G4 X#U^GI^KIUX#J/U?[^ Z_H/[^ $>GT"/
M[/T]?Z. ZC] =/V]?Z> Z_J']/Z^ ZCZ_P!7Q_=]/]7 ?I^G3KP "/T@(?JX
M#UZ_J^@?U_T?1^[@.H_5\?V_U_IZ<!U'T]!Z^GZ^GK^W@.H_5]/]7]'7UX 1
M_4(\ (_1T_I^CXA_3P'KZ_#X^G[/W^O]7 >OZ?\ 2'QX#K^KZ.OI_P!' =?A
M^O\ 4/\ 9]' >OZ=0^C^WKP'4>H^G_'^GX<  C](=/WC^KT'Z?4/W<  _M_=
M\/[>O KP*=?]OZOA^_@5X%.H_I]7[/Z> 'K]' KP' <!P' <!P' <!P' <!P
M' LC(CB):U&35G$7"\4*\0@[2;)/EU3E<S4:W2#VHU-5Z<GOJE[NPHAV=>[H
M7N$ ^1\:T$[T7QZI$"[-&?= K&;^H1H'.8&@$[^P$A,H8?0.OK\>!\XC%N/8
M!LJTAJE$Q[9;VP62024Z']I$K=,W4ZAC 8B)0+W /4 #Z^!Q'>'L9/V"$:[I
ML0NQ;.5GB+=0BXD*Y<=WO*F$JX'5]WO'N PB4>OPX'U5Q'C99-%%2GQ!DF\>
MA%HI@FL4J;!J?W&[<@%6+VE2/\!_O?1UZ<#K%L%XD7,F9:BPYQ2,L=(/^< J
M8KNUWRP$(5T!"E4=.3G$.G01-\.GIP.W-BS'IFSIK^%8[Y=\Y:/'290<E!1R
MR0,U9J]Q5P,F+9 XE(!1 H (_6(\#XEQ'C<HAV5&+)T<KO/L_-%ZN7)1*LJ<
M 7+W&4+_ .%U#ZN!]$,3XZ:))HMJG&HI)$3(1(GS/M]B?O\ :!D_F.U3I\R?
MX@(B)OIX'RD<28VEGD;(/ZA%.7D0LV<1BY@<I'9JLS$%N= $ETR@*8E#H AT
M$0]>!^#8<Q>=V#\U*A3/"B!@=>RK[W<" -^\#@MU[@0^P _'IP.2GBO'B311
MDE4HM)HL0B:J)"K)E4(0Y3E _18IQ, E+Z]>HB ?0 <#KR87Q61%=NE1X0B#
MD'17*1$5B$7*]0.V=>\4JX"N*B"AB@(]>G7[/0?7@<5W@7#SZ,80SO'T XBX
MPK8C!FHBL*34C0B:;<J?1?OZ)D2*'J(]>GKU'@=PMB7'#AXV?KU")6>,U$UV
MSA1-8RB2Z0"5)4HBL)>](HCVB("(>G3IT#@?5QBO';M%%%Q4HA5-!8JZ7<B<
M#@J0PG*8RH* JH &'KVF$2_JX'1L\$XDBT5D8VCQ<>BM\I[J+%:0:)*?(M4V
M+,3IMWJ9#"W:)%3*/3KVE#ZN!]'&#\5O';)^XJ+91XQ4%=HM]X3)3)*"5J43
M=I)$I%.H-$O0P&#['[>H?!]@3$<FX1=OJ8T7<MP$$51D)I,R0#U >P$I,A0$
M0'U'IU'@?1'!6*$%D%TJ@W(LV33204^\YPQDDDESN4TR":3'H0BZAC 'P]?J
MX'-_DWC03N5!JK8RCPADW)S/94YU"&%0PE YGXF('54W]T0Z=P].!\"81Q:1
MZK($J34KM8YU%50?2WVU%%S.3J"3Y_V^\RQA'KT^GZN!]$\+8P18EC4JDT38
MD>/) &Q7DJ"8O)!)R@\6-T?]3BND[4 0$1*'>(@ #TX'Z/AK&JBP.!K*952K
M)."G3DIE,$UT6PLTE$R$D2IIF(V'L#H !T$?3UX','%=!,]<2)JZF9\Z;(,W
M#@7TEWJM6JIEFZ)@!^!>B*AA[1Z=P!Z=>G ^*^),>.7(.UJ\ KE6!P4Q)"81
M ''V^Y;M0?IE,H<#]#"/7J !]0<#Y!A_&O>_5_"Z 'D 5*]'Y^7_ (X+JD75
M[B_/]I/<63 P]H!ZAP.<UQ;0V;H[UM7T4G2AXY0ZGSLF<!/$M4V4>($.],F4
M&S5(I    #=.INH]1X'W>XWI<C[8/8--T*2OO)>Z]D>B2G>NIWD[7@"3J=R<
M?3T]?J .@<<<64(SMX^&!+\W(-&K%VK]XRP&5:,DP2;)=H/P*G[9 Z=Q0 P_
M2(\#\2&*,?RC/[O>UU%5G[(M_9*]E$>J(IF1,F8Z+Y,YBBD<2^H]>G Y#?&5
M&:?+_+P")/E.@-BF>2*A4NC8K,.A57ARCVMB@4.H#TZ=0]?7@=:7#V.2)L4_
MPZ!@CU'"S4YY*9,=-5T8YW!U#FD.Y3WCJ"(@;J'4?3IP.N98&Q/'*I*LJ@BW
M42[!(H27GQ, IE<E()A/*F[Q ':GQZ]1-U'X!T#MR8CQZD1\FG7RD3DOE_G2
M!)2_8N+58CA$YBB_$ ."J91,(=!, =#=0].!RTL84=!DZCD(3VF+U^>3=-R2
M$J!%GJCE5VHL)A?"H0#N%3&$I1 GT=.GIP.L>X:QI(.U';RKH+.E3D6.N,C,
M$.)TT5FQ!**<B0" 5%<X !>@?:$>G7UX V&\<"@Y;FKA5$'311BJD>4FA &B
MIRJ*()&^\/<2*HH4!$2B!NOT\#]2&(Z7(HG;"VE63595LX7;Q\Y*M4UUVB@*
M(**B#HRO<40Z#T, &#T$!X'626#*#,&3-()3[@J(J^VD%FFT4B^Z@];&#M0>
M)"8 *^.(=1'H<"C_ -4.!S$,,4%LHJ=-A)"5;Y\JJ)Y^:.B=.3;?*/4>PSX1
M*FJEZ@ " E-ZE$!X',+B>EHJHK-F<@T,A'FC2$;S,J5,6IA?'/W)G=G*=8YY
M%0PG'[77M]?LAP.(AARC)2"<K\K+*/$T ; HM/S"A3)@4I!$Z7S@)&.<I0 1
MZ=>!S?Y54\'*[XK>3!^X.U.H]+-RGS ?)*BJS(0!=>R4C<YA[0[/4/0W7@?*
M>Q'1K.1FG-QSYY\D\+(HG":EVQQ>IF7,FNJ9H^0]TR?S!P ! 2]!^ ] Z!]W
MV+*:_?1\DJS?IO(LIRLE&\S*HE2!5/VE>Y(KOVEO<)\>\#?JX'QB\34N)4?K
M-VLDH>1240="ZG)9P IG555'VP4>=$1!14W02]!#KT^' ^*&(*2@U>,_EI55
M%^83.??GI=10W5LNTZ%4!V I%*T<F( %$/0>O]X '@?9YB:FOVX-7*,J=N"X
M.!3).2J?<N5P1P4YS)NBG'L.F  '7IV^G3IP.M;X1H;7H#=*=3*0J::) LDR
M8K=)%,B2:2('=FZ$*4H_'J(B81$?7@=P^Q939)F>.=-'QF1RIA\NG,RB14SH
MAT353.F[*J50IOM=>[IW?1P.N/ABCJ+_ #*B,T=3Y!O&AUL,P!"M&RHJD(4A
M792@<YQ^T?\ O&#TZ\#Y$PE0B(R2 MIE0DJ=@=V*EBFC'[HY,J2/LG!X H H
MF0 4 O0#]/7U]>!6:PI0IUHDQ>M)<C=!H=FW!G89MJH@FHLDL)TU$G@'%;N1
M .XPB(%ZA](\#[Q^&Z%'"<48^04[EUW0%<SLRY*FX<*'5.JG[KT>TP**")0^
M!?H#TX' 6P70%G$<Z.A.BO&'74;'+9ILO<*Z7MG(N4'@$7)W")R@8![5/7]7
M Y?\EZ"?[V]]A)NAG!>C)&<6":,94DBA\L];IB1\F""*Z?T$[1*(=2B \"@8
M7H169F!&<HFW$RPF M@FBG'YA,J:H"H+P3=!(4.@ /I\0Z<#@2.!,9R1V2KN
M)E#G8$[$!3LE@1 P_)F8@HL5*1*550$!#H(A_>* _'@?ESK_ (S=RH32L9+?
M>/R 1RBJ=EGTR+-B(?+(@J@61! 54$?0AP*!@^(B(\#E2F$J9)QZD2FXL\1&
MK'*JHTAK/+,B&7(N9<KGW176< J(FZ#T.!>T #IP/HRPW7F+)!D6>N[CY52/
M5:.W5I>K/FPQWS_LE2<=I>J:II PJ@8#>X)$^O\ <#@?H</5_P"5%J2=NR1#
MHIHK*)VE\5=?V4BI)*JJB4PBL0"]0,'3J8>H]>!\#X6@#B^ ++?TT7[9-HHV
M3MKTJ"*"160)D;%%,3H"51@0_<!NX3F.(CT,(<#X.,)03I=)=2V9' Z#ALN0
M27%X0IOEBB ('(5$ ,V5/T.H7_K'* ]>!]F&%:U'OEY-.=O2[]>-;QGS3JV2
M#@R*;<"=KINF(>RF^4[/MJ=@]W4?3@?M'#, @9THA8[ZBL[<%<*+EMCT5"]%
MSK*HH]Y#D3;N@/[:A0#[28  =.G7@<&+P57HA!TU;6S)*C9V\?/E$75S>N2%
M6D7:3QP5(5$N]-(#I 4A0'H1,1*'H/ ZJ-URJ47%C$-[;E!1F#AVX0^9O<FX
M7:?-B411;.%""J5NV[ !(IA-V 'T\#FR6 :U*%5%>V9+2742;H_-M;L_;N4R
M-W$8Y#VSD3["F6-&%*H/;U,154/3O] Y),%UQ,53I6G(J2SARS<NERW)\*KH
M68!VI+"=,Q/87.7N5*4"]YN!PUL 5Y4\@*=SRDT3DURN'*#2\/DT"N ,<ZCA
M IVYS(*+BH8#]H]H]WH >G ^DC@2OR<<TC7-SR@5)FW(V360NSQ%VH5)<KAN
MHNX(W RJS90@ 0P_]7T'J' ^;S ,$]08-QO65VY8]H@S3,TO+M%19-NL=<IW
M1_EC"NL<QQ QAZ")>@<#XPVNU4@E'BC"V9/_ .=05153<WF1=)$.X(T(NZ1*
MNF<4G:@LB&$P#T PF$ #N'@?5KK]769NB-TRG\O]WNF!F1[R^4:J"] Z;E^<
MAT!4&1404,G[G< %(8>@ /0>!S8_!L'',?NY.Y9,<-.PR8)O+F[<&*07*3D"
M@J9N"OV3) 4/7J!.H?3P*NL'PCR59RZURR9\RQFQG&R1+F[3:%5%&91"/,V*
MW BD40LXJ((FZ@!DTAZ_PPX'-?X;A'ZK5P>T7]LY9L!CD7#.V.FZ@HF04;G4
M4Z)&34<&25$!.)>O7U^/ _;3#T,U9SK0]HO[TU@%/YMZ]M;I9\U*BX<.4TXU
M<J*8,B%5<B/V2]1 I0$>@<"D)A^,@HLL2WN.1G:12N"BZDK:X>OU/F2.TU3*
M.CM@,8P@\$0'H'02$$/[O Z-W@&#=E9?_1YEALM'_)"T=-+RZ1<)J,3]Q%A-
M\H8BBJ_P5$Q3 </3H' J;!* &0,VRMFEF"#]=^0C>\D%,QUD10!NH1>(6!1H
M@F/\-,?0H@ ^O [*:P^K,+%<)Y6R_$'30!(A(FW-F[?O $.BZB"D.L553N0Z
MB _9$3&].@\"I,0*@NW7/E3+ISMX]W' 'XL:D(L1TN=<KMRF6' BT@T$_8DK
MT#M(  (#TZ\#YGPZJ8G8&6,QE#M< 826]H"AS+H,T"G.I]R]PF;@T$Q.G0 .
MJ<1Z]?0/VPQ K'IJ)$RIEUY[Q%$E3R-L;.U@(JF) %%3[H2,@JB(]R9P_NC]
M? ^YL3#[,HW1R5E1HWDC-022;VE OW.DT0%%-"#5/%'69IJ ;N4$YE3'. #U
M#ITX'"1PVLFM'K#ES,JIF"HJ"52WLQ3?%%NU:^Q(D"$[7*) :=Y>G:8%E5#]
M1[N@!S,-'>%J\K'/[3,W-Q7KG;('\0SRT>YDWJ<9**(I LI%]K8Q6Z8@F4!*
M53M+]HH&X&70_P!_]O KP' <!P' <!P' <!P' <"V;<0%(!V052(E^8C!.H<
M!,4"$E6)CE,  /45" ( '0?CP/.+Y%]M[KC7R.PF!]F]M\Z: Z8W?!-8<:[9
MRQ##5UA3+SL"XLJI[K'96RC*U.RA4#UR-:LVT9&O!0C'_P Z8RXF 0+P);0^
MWV?M=+7XM-5\NY@UXSCE+91W>*_EK)JCV1BK/D:LU*O"^I^0\305601J<A*6
M10A3RPF$K-$1$R"0%'KP,WCYA_'\.3H?$K?-@O[3:<M2&#:4ZCJC:GU7O>4X
M5_&1=CJ5+M;:)4@K \K$A*D1?G16%%%1)8 .84C] M!MYR_%ZZL"D"7:" 12
M2R3+8A6LKJLW1M3DLCQ*;HYJF:SK5\D6,M('9JIM$RG,+A0O:7XEZADJ%\LV
MBEBPG8L]PF859*EU3+Z.O\_%MJ=;S7MAFUVU%^QQ>>C&ABV-2W/X_HX1;D0,
M!T3 ;N#UZ!)/779C"FYF'$\M:^W\;32)A[9*BM-QS=Q%3U7MD"LI$V* F(J5
M;$>0-LK+\W:NU<H]Z*H%$Q1*(=0U:^"^_;'Y=QMMI?MA]E,AY\6JFX^<L T%
ME<V%28-:K3L+68\ Q=H!6X2*6=R\\1P4[I1<QB]R8 0 ZCP)L97\G>F^$<\Q
M^NV3,F.JS>'ESI&-'<RO6)]?'L#D_)<4RG:!C:QWQLQ5K\+=K;"235VS9+*@
M8Z#E,PB7J( &N+3?S'UPNP^Y>O.[&5&$#9\;[USNN^([ VQH^JF,8&M2<;74
ML9U.UWELR4B6=JM=CD7#%J:3=&5=.R@7N(4Y $-E.-_)5I_E_/2VNN-LE.+A
M=D;%;:42=AZS/N<;O,@4-@,I<L?L,A_(%K3JY5N/**KAH18?0.A#&-]G@38L
M48\FJ_.PT?,OZY(2L/)QK&PQA6ZLE O'S-=NTF6";M-9HH]C%U"KI%5(=,QR
M !P,41 0\P'BF\J<1B/1Z\[ ^3O<Z:GI2T;M9LUQQA+WRM-P6=ABJ3(PC8"L
M1=#K(+NI&48JJ/')5@,;^$!$Q$0 #!MB@/+[H78L#W[8EKEQTQI.,,JM<%7&
M#F*C9(K(D?F:3]C[EQ@A0G3 D^_N4X1P0[1HBF<RI.INH 4W:$H-6=ML)[CT
M";R+@^<EY2+JEZLF,KG#66M3-1ME)R#4C-#3E3M%=G6C1]&2S=G(M710^VFH
MU=HJ$,('X$F/T_3IP' <!T]>OT_#@. X#@. X#@. X#@. X#@. X#@. X#@.
M X#@. X#@. X#@. X#@. Z=?CP' <!P' <!P' <!P' <!P' <!P' <!P' <!
MP' <!P' <!P' <!P' <!P' <!P' _/IU^GKUZ?V?[/ZN!BW%DDE(,;J"16I2
M1F3KQ$B5FBFBF46$J*8@J5!)$AUO7[9N@B(_$1'@94#X?I^G7@. X#@. X#@
M. X#@. X#@67D BYJI)@U+W+ O$* 4#NDS&*G,QJBI0.S(HY*(I$'^Z _K#I
MUX&J[=B^;+O[IEO US\8A]_=2<EXZJR>/'-5N&'XHC:YR2,Q%7>JYCA,MV>!
M=5^$14<LG3"Q0A'[YBB"QR-#+$3'@:>\/^/#>75:N>&/'-XQ<?*=4TLS'L?F
M[-F2(C)5:=4?!&%LL0=EC(3##&<N<G7+S;5<<P:Q >+,X@C,S1-,C4B@E*D0
M(%:3Y"RUCQ'QX7;<_$6P%4\=6&MWLBW'2^^X_IF-#X\<Y V)RUE*'P1)72RS
MN2G>;[;B9)I>%_N8R=,BWS@\B#IPL=JFB98)R+Z%[QLM.97';O4"VH7$?.JC
MNBWJM:N&%IMZTU\;Y5@<@2%W9/7E_AH.3=N(>OJ(I1YODW:B[DB1D!#W% #O
M<DZM^4ZAYLWJN>$-?L@U['6;_*-5LWV.RXXNN!'>?;=K+ XMK].=3NKSC($U
M)5/'.1+-,Q+@SY_+IQDJUCUD4FJI%2',(;'O MKSL!J3J7L+1,]X-R7B^PS>
MWF?,XTFNWBYT*_7JV4/)@0<U6"RMFKELE8^3O121IFLFL_=-P6DA,<%/:,!R
MA%C0&Y^1?2?&&X-4D/%'GFY6/)>V>PNP^)U(3+6M,97)6*RW/?>]<A;"F]S
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MO <!P' <!P'7]OQZ? > X#@.!3K^WTZ?U\!U^/H/H/U?']G KP'7@. X#@.
MZA]?Z?H/ <!P' <"G7]0_M]/]_ K_1T_3]7 IUZ?I_L^/  /7]/T'@5X#J'U
M\!P' => X#@4ZA\.H=?CP*]> X#J'U_ITZ_V<!U_W\!P' =?I^C@.!01]>G3
MZ?KZ?[>OT\"O =0^OX?']7 <!P' <!U#Z_A\?T_IX#KP*"/3^D>GT?'^D0X
M!_4/]7^P1X%> ZAUZ=?7ZOIX#@. X'YZ]!].H_N_6/I^O@8JQ:L50V1$D6*;
M1NAD^VD!5-=1<SUPHY24>.5>[J"*@KF$!*!A .GP+\.!E?@. X#@. X#@. X
M#@. X#@=//0,19HA_!3S%"2BI- S9ZS<$[DEDA.50O4/H.FJ0IRF#[13E 0]
M0#@8]+ABBI1:$.FVF$FB#EJZ*<D]*E=&48 H#,%70.?>52;"L)B%$>A3>OQ
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M@ )AZB;KU'@7,&.JL"9DC-':R1TD4_;6DGRI/X"XN4U0 RPB5?W1ZB</40
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MFP?5U"%2&PY&]@"$(9J6_P!C!LJ0HK=Y54P> 10%BKF(I_X1.@#Z!P.:PP[
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MCM0QC>HGZ\#L4Z#%ID*F$K:13)[)2)FLLH)"E1:*,S)_]MU$CA,_<J ]?<4
M##Z@' Z9+$\$A(MI%.=O7O-)!M(I(C=9TS,QFI2E(T5:"Y%%2/.4.AT1 2G
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MRSU\B1%=!DNB85 Z'Z#P+FU:\JWC_P!U<GV+#>LFR=0RCD:LUQ.W.ZVQC+7
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M D3+6^IP$I"PDY::["S-D7.UKL1+3<;&RD^Z1#N4;0D>\<H.I1PF3U,1 IQ
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M-!W?QZ:Z1="M40=O5:AE;(^'\ZWZ]SF&)2928&3=RL[7)9(B)5BK()J)H>Z
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M2.RNREC+F1QKYDC4%6J9YB?PZSL$JL7&]B),VF2A8>OQD:<\M&V1D\>&*(&
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M07+U^D0$>GKT]/7U]>G4W0!'KT]>!^N X#@. X#@. X#X<!P' <!P' <!P'
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M>GIP*/++=4739-KCI=ZW6;JJJ.@L\0W^6531%4&RJ"R0G$RJWV"F*(A]/H'
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MK8IN\P% >H /3@=+_-M8R\@@7%^6.K$%3(*FJ1DV\B"2JB/1JJ+OT.K[1C%
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M]S.ZJ7D]R$S8U;+VN59FU6*\ANM/U*9>UNU1LZA9$;!(SRJLXS,<_MM 5*T
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M%[8YSM4[+9KC+3M-RI58.^/G6!DH AED6+=1.9(_:E Y%!5* 97\/C',]?\
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MCB.+KE)R)?L,Y#I-!H%VPTU91>.Y^*KJJC*/>/Y6(=NRNUBJ/5%I8I#^VHW
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M>_EQS+8_)C"1D(^^6:.OKNH!'$A5VA\@-9%.UE?/8DHH*O"N@='(8W4_4>O
MQM):.8+F-*U]!)=&[R.O"^)VV$E(YU?;.K<S8Z8M&\:SA37PT@-I441C&A&W
MOF<F6.@7M,80$0X$=<>^'_4O%^8-><Y5"7V(;9 U>QTAB'$+N2V.R[-PL'BY
M YCFH;JN2UJ=PLC6W91(5PV51,FX*W;@H!OED.P)#85T5U^UXRSLMF##<5:*
M'/[93+2TY?K\)<[(C1GEX08J1[N]UVGC(&@ZM<)=$_5V^8)(**F* ^G M?5/
MQU8 TSK^:*Q@^6S1'16?;%8;MD8+1FW)5S?.L@6Y%4MJR! 2=DL4@_JMQL+E
M<SET_CU$%U70%5$W>0@@&,\2^(323$>N.:]1F](MN1=<<]3<A:;YB_,N1+CE
M:'"V3*YG\W;:\]N<M*RU=L\G,D1DCOV:Z3HDHV1=D.5<@* '=X7\7>O6%W4$
M\;W#8C*"E!@G5>PV&;M@,GY<# K=S#GKYY/"@7>Q2W\N[26 4^2)+Q_M2)6P
M 0%NG PY7O"-J%3Z98\;T[(.Y52QO<K%9+/=<>US=#8V(I=MDKI._B6ZC.UU
MCD!",=IW"5.<\E_# SHJJA3B('-U#O;EX:]6+1GJR[,P%_VQQ3F2X5"OXYG+
M5B/:S-M ,MCBI-8EM5,>LV<#;VS6-IM?5A&[ANP0*1#YHIE3%,<YS"$S\#:I
M8OUQPU-X4QP]R"$'9YF]6>S6VTY%N%NRC8K?DB1?2]NMTMDB?EGMN<V-_)R"
MBJ;D77N-A @(B0I"@ 8XT;T#P=X]Z->,=8#E,I.:ED"_2^3YN/R7DRW9+53N
MUB*D-DG(][;9*2=LG=D70(XD#%/U=N@%903*&,80NC5S1[6[3:6SQ,Z_4!I1
M7>Q^5I',F4/E5UG!).Y2:9DE!9>^90\?#-C+K';LDQ!LV.X5%,I?<-U"FVND
MV#=SH7';/+3&U1UHPY>&V2\,Y-QU<;%CS)F*;\T;F:IV:EW&K2$;*QKE9J/M
M.$1,=LY3 "JIF  Z!$>Y^%/2J[X4?X6D6V7VQ+'G*M[+WS*K?,=\7SCDC.].
M0=(U'(M]RQ(S#VX6*2J9GACQ;=9R+*.$B8-TDP3( !L#S1K]C?8+ -^UIRTR
MD[9C')^.I'&-W:.)F0;S<W6I:*^YY!16P-ETI1.770_B"[(H"WO?;Z]WKP($
M8_\ $!@+'%]H>08C*.P\S+8RU+LNE](0N&4)&W)PF&K4F8LFS([G4GDDYE6Z
MA@.R556,1B5-,B!")I)E*&-:;X-M<\3#K_-X,S1LYA7)>OV([)@2,RY1LGF"
M\7O"]DF)RS!CN^K3$;)Q<I"5VU3RDG$F1;(+Q[PA3HG+T$!"?6P6HE-V&U7G
M-1[!>LH5C'EIJ\12;+8:O:W"60IJJ1QVWWI%/+?)IR,I[MF;-Q1?.BF!T<BA
M^U0HCUX%O;1Z+XGVVU%<:9Y-GKZAC9S!42#4L4#8C,\@&4QRI$NZU-!9G"#I
MP,ZA*0;9VHZ$HJ*.$Q,(_:'J$7W7AXPM+3.Q-GL&;-BY^U;0ZK5K3[*MH?7I
MDG.R.):RV59,BLI!G#-UVMA=-'"R3EYU,HLDNJ0?LJJ 8+6EO!KJ-:7U!_'E
MDS!>:W1-'FWC^3I\W<$4X2;P8V3;"1615C8YC*,[D$BT3>DDF*[55)X7W"=H
MB/4.TO'ANQQE?7*_ZP9;VLW'R?CF^P6/:2=.WY>%^XKN.\:S+2PP-/@F18E.
M$(JZGHE@X?3*[5:=>!'MTU'@I)]@AW.8_"UIMG^V9WM>66E_MAM@\!89P#<H
MI:VNF3:/A\!O6,IC"[UUZP(WEXW(-?EXU)T5_P#,'[U0-W$$IS%,&/X?P6:P
MJ2&P\CD_*^RF=7FTV'J;AW,;S+64%[')RS'&KYM)XQME>FB,6LQ3+5CB1:D6
MB%8M=L@T/W=J70Y@,&2E_$+AZVX0E<2YHSWM;GFVN+EBZ_UO/&3,U6!YEC&]
MPP>\EW>(Y[&+B*^[*O0Y2I#.N2KN(V.;K3@J">3.\4Z& ,IZ=>.:E:<9;SAF
MN"S;GK+U]V-8U ,MRN:;@PMZUCL5)0580MK27+$,W44\;Q"QF:;-J=*-0;CV
MI-T^@= B;F'P,:PY;RCE*_IY?V1H%9S'GNK;5WG$E'R$@RH4ELA3G,:X@<MI
M%D8F0G&LNR,R/V,R.PCR&7,8B)3)HBF%\VCPJZ]V_&F<,;S&7MBS!GS:JE[C
M7*V-,AIL[,WS/0",C5J4B5F\61BW8MI"(8/5$SHG,L\CVZIS"=(H@&/\G^ S
M5G(]TN4PQRWLECG&E_S?4-E[3@#'N14(/#[O8&H.FK]#*K""-#N'T)/2D@T*
MY<I,W*+,7(BJFD0_00"?.^^CV//(3K_*:UY:NV2J?C:Q3L#,V9'&-A3K4M8P
MKCY*6B8J5D5&;Q16);S#9!V*(  &<-TCCU,0H@&&+SXI]?KSG#7G8UU:,FPN
M9,%8T;X2G;C 3[..<[ 86*S3CWN,,]-"1@LKU7))D4Z:HG(FX JRG8H43=>!
MBS&GA7P-B>EV/%M)V W'B<2(5^Q5W"6,6FQ=[9576Y&SNB2$F]QDW8/VB\H_
M;2! /'GL1YDL8GU1:E22$2\"TYSP3ZW7>%S;+9/S'L5DG8+.%DP5;)C:6P7*
M&9Y>J<YK>^:R>)7M'0@:[%4>!6@9$CA98Q8DYGAW9Q6$PIH^V%J7W\OOJ[>[
M/>9YUG;;6+B,F9AI>QV0:4RS"Z=52W;%T<R"L;FB992L<^<.;8NN@"BB8J_)
M$4Z"FB3L)VAEFW^$G5._!LW'VRVYLE*KLSFN$V@=5@E_<1Z&)-HH=RH]/GW$
M,W'MFUEJ]WD78IBJD=VXCB)(D13;D2#LX'>7#P^8BR/BVI53)6P^W%]S'0,R
M1>?*%M/8<WSR^<*+DN$KS^IQKRE.DBI4^J5<*[)+(.H%A%(0T@H<R[INLN(J
M<#.FC'CRQ;H0USBCC+(68[X\V#R*?+.2)K+]W<WJ=DLC/8_Y&?M:4J_0*[3D
M+(IT7>=3&(HL4!    #@7KJ1IC1M0X7-L)5KOD+(Q,\YGNV<[G(94DX^S2WX
MMOR3-.?8MY$L8S<.*^(,2@W:N3+%;IB*:8@GT* :N:%^7PQ+CD<3QM<W VI:
MTO"6Y#[=W&U!25Q&WK57RS+2$DYF8Z*!OC9.48TZ4C9A=DM'HN"(F14,<0%4
MYCB$F=DO$90]@\I[=Y.8;"YLQ*.\6 ZQ@#8*H4IMCJ6K%E@ZA$?AV#M<<E=*
M;8GD%;VU< &(N&BJ29VX=!3$PB(ACU+PKURI/<(6_"6Y6T6"<NXGU@@=/K9E
MFB*XR<SN;<'4\[HU%BLAP=BHLM5T;91&SCY:)GHUHSEFC4.PJW40, <>^^"[
M7_+V9-A\K9HS3G/,$3LOK=7M7\A8^OSZG3,>WQ]3E8V:I\C 70U73R3'V^M7
MR(;S[>2/+JN#O4^Q45$!]O@7?6_%+E*LT6I5U+R@;WRETQ:^HO\ )B_2=AQD
M*-&KM#079-JM9,=LZ"UQUF)E8HU?V9EU;8Z6?R()IB=<.PH $E]%O'UB[1?'
M>7:36[9<,IS.?,K6_,N8[MD%.OMG]QN=S8L(J4%.NU*(@*C7H9.)CD6Z3)@R
M01 H"(@(B/ AC0?!9@^E2F,*?(9]S_==2L%YO5V+PAIQ:92IN,7T+*A)5>>A
MW;NY-ZVCE>YU"LSSDSR/K\M-.HA%<>HHG#J A+W1[0&.TCMFU%KBL\93RX?;
M/.MCV*N\+?XW'\="US)ER.!K3)U)"F52O.&+*8(B@F9NJHJB0C9,2E XG.<,
M!Y7\1Z.3-U,G;O,-S]F,?9!RI@Z9UNF:G5FF'G%,BL+2[!R4M/@F<_C:6=MS
MQ]E<C,(/UU'#XKWKU5%,>T Q[2?!+KY5X?16L3N9,T9$IFAE.RW0*+4+@%!4
M@LB53,97[6Q16148RH1ZCH&,9(J-6BS(S1<$^@J'4$.!VU1\)>,HS"%JU.R#
MM'L[F'3I[BF;Q+CC6B[6*IM*=B:(DY2+F8:;AK+6JO"WJWV.A/X5J>NN+!(R
M80PIF]@I?</U"W9WP<5#)59R6QSMN'LOF:\W'5E?2^E9.GT,5PE@Q1KS*R$4
MZMU;K<37:%'UN;M5\8PR+":L$NT?2[QH'3WBG$3\"#_E$TNR4RLG@OU:P_9=
MIIV&UISNB%HV@Q[4(&QY#Q936%18TRH7><E$ZZ:DL9HLBR(0ZJT:9N1ND=04
M3#VD.$VXKP*X I$#AFQ8ASEF_%>U&',TY6V!+N+$A0+!E_(^3,ZEC$\NO<H0
M]JJ$M0+?7[>A"-$PBEXSY)B5N46Y"&$XF#JJ!X"L)8[OVMN8(O938N2S)@;8
MB\;1VO(T\YH4S)Y^RUD1PDC8Y?)T9(5%S$-VOX>!6*9)Q*3 [%DX.")RCT$
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MM5BI/.B;=VX3*HJ0+HE/)?E>C[J4 ^4J_GVKPQ?%KDS:BZ:M1E?P1)TBT3-
M6K=ED[I3<J%S$9V-E80X/D B7"+5 K1PD=1;W@,D =O0/S!>/+SARCY,<ZA;
M$4>R[!W"%J>G6/L@R&*Z8&RB,S5OQ2M;8C(EDO49C.F4^NLR&"4=24J51L(
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M,BH)>I>!D[@. X#@4Z?I^T>!7@. X%.@>GZ@Z?O^/ZO7@5X%.@=>OZ>H>O\
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MHEIMNO\ 2[M27FU=YN;9TTQID/9?&/ML,=#(X_5.D\6^[#.5G;DIBE.0HE$
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MT9BW.YC#&<E[Q$ITI5DH@3[!TC?QUB%)Z"']X?V<"XN!&_:['>;,L86L&/L
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MJGN,AV.Y5:OT%I$)3[N[SE@B8FI-8-=!-RA,.+%(.V\2A%K-U2J%7,L"1B&
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ME,A2>R8O3@;&L:Z1;4;-8S\WU&R/K]*:QSN]<C7K1KW:+Y+XZD4T7 Z[4C&
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M$"7.HN=-<ZX%"4UHP=DK9A#Q\1&+]#<VX:8Z->._:[$NZL79==;73&\G)WC
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MBQR]#E.8-0N,X6TZ^>2F/R%J1@7:"U82O&?=A[_MKK)G#4_)TI(:N6QI7):
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MG.U5CN%G.0(NB0+.XJK.%%ESN5E+"@X$Z@F$5#=3?3TX&=> X%/AT#TZB/\
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MC&BRA5GHLT%2'5!,INPI@$>@#P(I;"[LXKUKS;JI@>]PE^>6O;S($QCG&TO
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M5Y3'Z=ORT5HQE).R87KI"O9>'1>HM3^U[[Y%<HFZAP,*[IYKR,S\&V8LRVZ
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MN&HB5:@1S;+XE"O94\7"F3;*I(2(0S%00.<R?4  @&ZF*40SJN*!$Q,Y%$"
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M(B @3W5#&$.HB/ NANU;M"G(V;H-2JJG75*W132*HJIT[U3E2(4#K& H=3"
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M=2;)BB^7]TB90,)CCW 4 'T .!V2U3JS@9GYBM0"_P"(Q0_$/O0T:K]_?*]
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M%M-U7'F7L07&"@;+76$]7X"X4:<@9".0D*W,1L;)LW\2X9K1;LBK14A.@)'
M2" "' O5M4*FSK2-)9UBO-J8WBPA$:DWAHU&LHPH)>P6)2@DVQ8LD:"/V?8]
MKVNST[>GIP,<V?7'7Z[0E9K-NPCBFRUJF22LO4J[,T&KOZ_6Y59P@Y6D(6%<
M1AXR/>*.&R9S*))%,8Q0$1'UX'FXR?\ E^<EW^2VPI3LVE=TK^U.<)K)O^L+
M)M"OLSNIABL6-NT;I5Z@QD8U:8]>S>,T&7L51\,O'D9@L*JR9U$R%$-^N/\
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M'&4S6+? 8PD[Y4\+YI@K"G:ZC>+C&Q))):*MEBKRDA#.%$FJA&SL6R)S(HI
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MRI4HN2F#KR):TS=G$[4W7N%%?KV$-]D TM9XWX\@6PVIN-=BKQ2$X/*&(_.
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MJ3&;09*L.4\4W_$&/[!1X:/;$O\ D#'MCNM>A8BX5"'E15Z.8TZZ)TRC[1E
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M#$:>C9J/JEY7=4-_82CU#!N<,[[&[88-SVSR17YJ?GEIYS_,:$FX#&R*A;C
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MGK6; V*(/%=EL]=PYGI;:]:18T#(D:XLL1:+91:U57D.^^^&K@T@LH5L (+
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MQA"Z2N-<$6#%EIK#+'+/ +=I#Y%ITS*N(5E"1[J$?=?E3G4 TH0WO%$QS'
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MRE5E*JQ1=UX>\0BPZ^Z)BK]% $H!/</A_P .G]7 <!P' <!P' <!P' <!P'
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M!H1\I:R*?DV\"X=[+YPVR6S!$D7+X6K@6RN%80KE1J@4@J.SE[2]2B<I/7U
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M&JT\M#A-1<4H5<+Y7<G*,7;.8E73F_U$ADZO:GTQ*R[V9?2M?3'HT,LX4*@
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M5/)%ARKC&&8Y8NC:F8<MML*Y/9%<3U1&03BJ<PFY)XJ^<()%.4[U05.H="E
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MXC;OTZ@O;WK=5;W%S(BD<SA4QDQ,<>!BJC>"SQS8VS/5LZ4S%ELA;;0LI/\
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MWP$O ^+?,6-W;U&.0LI#O'" .$$!C)M,54A_O=AE(TB8JI@/4Y -[B90$Q@
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M]XL<P*OU,?W09MP4[S")C'[P3 W<8PB(C\1$>!4(Y@ F$&#(#" %$?E6X")
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MF1$#@(&! I$P]L# /0>G3J' ^ P,$94JYX2),X(0"%5&.9BH4I>XQ2%4%'O
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MHB<>GK[8<#K$]:,"HN9)ZEBRJE=RX!]YK U5]QX!56[@ONF%?H( LT3,'3H
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M!E/>KR?8LU/USS]?*7(T_(FQ6%M=T]B5=='L\=M9FE35EZ=$%=7A.'!\>HH
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M14(3N >!CS,GEPPMKI5=B,K9MBX""P;B#(F!L?8RR73,P8XR$?/*V<5(YO\
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M.!]8N\TF<GIBJPEPJTQ9ZZ1,U@K<788F1GX(BP@"1YF'9NUI&-(J80 HK)D
MPCZ=>!=?]7 <!P' <!P' <!P' <!P' <#\^HB/7X?#Z/7_?_ +.!XKO,1LYA
M#:M#*F%LSZ<;?8W\I&J5]>I^/1ICVD9-R-7\A6A>:B)S%.5:G/U&&D,4RU8F
M9>&26DB3"'O-6B"R*"QS"<H!ZM,#YP<6V35PC?V<HUS_ (NQ?BJQ9D%I4+/&
M8[/8+O6FS]RG2+?*1[>$LB39^18BZ31=55F8.Q4I!].!&/S00$S:?%-OM7ZY
M"/K'.2VME_:1<'%P\E8)&2>'8D,DV80\.DO(OG9NWJF5(ANA@ Q@[0'@:WO(
MOC27MW@XT[QK+4*:L:CR]>,Z'M]$>5N6FGBT*EEK$:5FCK#",6Z;M-@DP!4K
MT%4R)I) ;W.@<"%?E]T9N-JVUV[QYICA9.N3>5O"VE%KP6*Z*VK4%;%ZAL18
M?O&B,%(.*:5YS<9^D0C=K'1AE62CU-HF@4PE, <#"/BKHD;F?R.Z.W:"S7NA
MG*TZG8LR)#WM"V^.RC:@XEURC[%B-O2E<'97N#5]5YRSW D@@U^100:3J9EF
MQG!52E.HH4-_GFTQ%?'NON,MSL*02MGSSXX<O0NV= J39"1<K9 K58:K1V6<
M:IMX=%66>J77'[ITW220*8RBY2!T$>@@&@%U@/(>)-9?&5Y$,]ZX9"S-4[WO
MWG_?7?[%U.I<U?;U%R>Q;=XA@6?L.*A8.W]KCL%51HR:+-%T$ C5" 4$@.;H
M(8DW%BZOMIBCRY[OZNX8R##:<RUM\;L'7:RAK]8JBYRUDO"6?(VRYUS=5,>3
M%3:3J,I3J++J0CYP9@U5<H/'!5Q,CU!0,39UDH1YM7N;G.2SUM]K]KUO11\6
M6/4ZT8=\=\9L;7=@<-.,?,*^VPI#JW^I%L.(+359(IV80(HPS=-$ 4,N0_:4
M0]J7BZQ!*8'\=VIV(W[;)K%Y3,.1+%K#YM:Q+7)L#'/UI"8@JO>(V FIZ+CY
M.L1$DWCQ:(/%@;(MBHF$IR"4H>*S"\M5\AZ=8Z\7E!TQS;">2>;\C">3VV59
M' MMJ*6*ZRQV82R$]V>1S#*QC5=I6H_'T.XCVYOF"@0"= 2,@4#B&Q'/&OF0
MJQYB8;Q:0]?9RNG&[6R%&\K%K8B\=F<ULF,BN7>:L?)1Y&J,:%,OF8Z^,HHE
M[G:V]](A2&[NG ]'WE2U?>[B^/O:7 <$13\:6?&;^?QLY;('5DF.4,>/&60,
M=NH=1#JY:RHVVLM$454OXA14'X@(E$/"#CS4KR.9?#%^>W]+S RR+YK<@Y,T
MUW5;SM0FD7^(L/UFYT%N-DF4TX*.<UMK.4>GR+AQ(/V961D$C"!A.;H8-^T!
MI?@.W;8?F$4KSK32IIK4M?<*8TQ,%DH+*338TJK:60ZL(%":RK=ZJW<&EF:0
MF?1BC<7"R":8E*9$"@&INJX;V+R[AFS4?%U5R#)Y#M?Y8S6R"01;Q4XVMEVC
MZAN$K,Y1QO"R+Q$71KM-8M:R<6WBRJ&<"L]13!,2F3#@9PV1SQXU]P];LM5'
MQZZ"Y*G<UXL\8N<*==LRX[Q)=L/N-70&C?)J8(R)7C1$%!Y(O-U<IJLCD;IS
M2W:H845Q$Q^@; 936?'6%-P/RT]@PQ@R$QI'#B?,E:R#,T>@_A]TJ>2UMQA-
M14=D>Q-63<SI8\TI(KII2CI5ZL\56.4BA@5,4)6_F%XO%,'BG1#/&:<?(VW$
MVOGD3UVR#EZQGQ\]R$E1\2%7GX^X2D]$1<5+OW-0=*.6B+YK\NNB[,9(@I**
M>T7@:P,5:TX$V!UG_,FY8)ANHW&4R1L#G[^4]_?8Y;NK"YH[/'$?.4;^7BDO
M$I34,W0DW1EVQ67RZH.S /0JA2@4-7%KA+)@3.MPN&XN<[=J! [3>/S1ZN82
M=W/Q^-=VJ[EO'=2U$HU*O>(*S)/U%K'B#+<9;4))NXBP9-CE</".EUT2^VL(
M>SWPJXKD\1>+S5G'TJ[S!(,V%"?K03+.E-CL=92C:G*S<J^@(:?IT7=;XVK@
MH1C@HM6XRJITFZB8&!,0[0#QOZAW>MX.W3U9UWUDKCC8QG#[LRZK[1C;_1M_
M5-RM0*W*VZ70MF9$ME*6PE:F]KB;>0571D)2:D@^2,4%V:(=Y"AE*+)A"G8Z
MCVF0<*62_P",-#/-]LID[R$84J.+I(UC1PUDNS9>)JUENS4XU=CHW).(:?.H
M$>>RDI))Q[$_:F0I'*:1@OC--0;;O,?+-LCXV==\D)Z3VZ-T;/=ZM6<<6?%*
M&X!L6Y=@[?L &,\=.D:C/JQ;G%L>\;OC-&(JS@%%N8A#K%(H%_>0W:SQT;C:
MT[51_C?TYL9KS :K8U@;?L_4,%6K#,#C**0SI6T*UB)U35X.L2%UM\)((KNB
M*-XYV@V(B9(CL>T"E#']KQ]9-*M!O,CX[LP5:S97VARGKU%;?8]V_C\>6=]9
MMJ</VM[C2)G(BWV%X26>P]IPG8RG;!"J/?;1CU@6123,!BB$Z]V-17-3VET*
MK6DN,(K%>4KEXH-Y\7UF1I54:U-C,61;7M!>CP5OEXEDBT/+JSZYC-E'JOND
M<'$Q5.O C%K);=3=BTO!WK+IKK)<,<;SZ;9>Q3:MM57^"+GA^UX&H./\6RD%
ML(ZRO?9FMQ#:RH99O3ENY9H ]DE7ZZ9@421[CDX&)=<7&%M;Y;1W;C>G&L[;
MM&Z!G#RU46W6^S8@E\C4##^?<HYSAST3(60Z#&U^UO'T'=*O#R$9&RQ8LS5F
M]4*('(8 $0BC9**.1=.LFYIP76,C8+T<HGGAR#G.\,V. )'(:F*]?):C0A,7
M9/E=<+ G +7*D4&85]Y2'72%!@FKU5#J3M$,@3V,(//&I?E5SSA78?-VX-!R
MT.C&,[39XS12)U/P'FJT1>P]6:I*8EK-<G4IF1FZ)53/4)ARE MTC)RZ1E%A
MZDZ!L%\V&-]8M1LPZUY/K+R-T^MBNHMKQU'O[_I?#9\T1S3!)!#KN]?[S$TB
M.E;UC[,DXJB QSUC$I'<(AT%ZB< [@]%WAKMF1[MXU-4I_*>N\#JM:5L>)M$
ML)56)EZY6JO6XZ0?,:FZ@JO/R$K/56*L-=0;2",6^<*.F!' (J")B#P/*M(Z
MQ8I_[D;R59;<X"A'F>F?EJNSUGD?\"NBY>8H16]&)XV*D8B?3BBV@C1E3[ \
M1239J)MC(.E#%_BF,;@7AD',.G>J^9?,AC'R0:TS%]VKW!MZ\KJH\3PA;LMO
M=D<177&\=!XZHV#K&C6'J=4<TR67#YQ(7T<JDOU4,H"R($*$4,M:_P"Y-:P)
MLCBBUU7*=ARO2_#]XI9#.])B4Y>0OUHPW2LJ9!D<PXI57*V;2RTQ'5P2Q\@V
M0]QRB,>J!Q5*DHKP,W(9L\:N=O(MCF\^,3%[>/IE5\2N]%3S>%#Q3/X\J03,
M;KP\=TJGE7<UR"=V*^UMNX=1LJ_:-'2ZSATC_%<"8! )">,#7K"&QVUF@D+G
M_"E+R?"TO\O;@B0KL/D&!0GH1E.3ER7K%@DFM7E8UU#HRC:*<J,DES%*L@)A
M52,54>!"W [;"V'X/QZ9"V\I$_+>+;73=CRD8OL$:_K5@R%A?#F5WF;)&'P9
M*Y?J+&.L19"FM:Q\U%Q@N6;END^*H<A"F!<Y@W5_EJ9C7>PW3RYS^I$&%;UH
MEMVHMUAN'",>0Z3.JC1CE4^[XE^4CV+A'$R5TLQ:JE*HBV4* @ =  -)_F\D
M<382\A^Z-X^_,03UKL3?"5WN>G&\>%+M*.]DDH"#K;"#G-(]@,>-Y^5C5Q$@
M($BUI>NF:2":I 05(F).!LZPMKC@_:?=[S9Y%V#UIK<[+L=#-)4Z;4,G5,EO
M/B0+WJ-8+-:Z1#3$NW5*TL]=EX./:J.4.R3(=F"@*D$Y@X&HJ^[%PU,PCXNZ
M!E> U8Q'*-O%.\- ;>[PX1RWL>I8V<W<9>)E<,:_XMK",G"IY4KS8B!5'S]L
ML_'YE%,!*7L P9!\;&/:?FO7_P#+C8GRE76>2:E4MW/)37KO0<A5,\_%$>5H
M[F:@Z_8*C,LW9&\3&MGS=91L^3%HU5,5)4G4"E ,-[JT+'5$V?\ *#@S;K9_
M ^I#.S9%1_DOB"_:.7'/=VO.#9#'T/#8W#6"^55%"-I,6R?_ /+L8B'52!E-
MD5<N"E**O O'?2I8CU]D,07&ZY_BD\[6'QCX2JMGH?E-U4MMJQEM7CZKP K,
MF.*+E3%;;=<,9UC2-D6;V#.=@Z!XHF87QU#&X'M>U.N+[+/BTPW;!PNZP&K:
M]-H;[IP@HZD7IL?1IL5#'P%78NY@ZLVK'-HM) K,7HB]^6,G\QT6[P /*CXI
M]?,>YFV%\*U4V$PI 9)KM8\8VXR\96,A4D+#58"?@-KYB,92KR'GV"L6K)(L
M; \0!9<JZ0F=$]LI#]#<#>9X"ZXCCFE^1##T#6#4G'>*?)IM/5\95!BU?L*Q
M6Z@I:BO6434(UX4Z#" :&5$J9$%%4_3KU ?0 \\7D:AM3J+L]^8/P?:Z70X3
M.V;7WCZO."H5.@N2V>QTJ9LV#DL^R5-EXJ,!!HTF)655<3:;9\V>22ZRRITS
M&3,< S=Y2-5[C@K9"[XO\:F'&>.)G,_A6S&VM-*P/75*?+W2%IM^QHC(*QT/
M!@HYN-O4A'RS5 I4QE/^8,!#JK'+U"-OB.I.!\B;V>-Q?7W<>*OE^P559=U;
M\9:[^/ZVX3E:72!KRC"YTC;K++ZU$9/59200^73<'"4!9\D8XD3!1,PAZ)?/
MY^%H2"T!R;L93WM]\?\ BS<R&LFZ=<2CY&9A&=>D\?7.JXGN5[A8A07\GC^G
M9+GFSJ13%-9L93V"JD$1(0X:%ME+[XU,HOX#,6I>K^0XKQ58]\C>"LC>0K+-
M;Q]=B:RYFA8>CV&NQD[5,5D(SF75%H5G?)?B--E#$0$ZA%@2.82$5##NSRVL
MV5:KYKLK^.^BH-O'Y:J3H+C:;EJ'#2=2PU?LX*Y9:N,C2E K[UO7_DG4= S#
M5E(K,D@."YC*D 2JE$ V ;^T?Q*:4^4/QL?ZK<%8NQ?JQ!:4Y;391C/$KJ>H
M3#(OXAQNQJ4UDBO5*$EI2;3B(QY*)#(/FSX_SKI$RQA-VF (!1%)QS6HG &T
M67<59 1\#*/E)V"RGCK&[REVI_1:'B2T0,FWQEDRXXD""=65EAF3O_\ S+5-
MTDNF5N<2E0#W [@L;8=_@;->)?)I(::5Q]!^+7*'D"\7L3C%@C2;)3\:7/*T
MS+2-2V5E<1L)]C"OHN&D_EVP22+=N8RBITU2$324)T"1/F6H>E&J6Z8ZM8MU
M]T/UMK-?TA3E5,D;;U#*F0Z%*0=LM;N&/!:QX:Q5#R:KW/J;J. 5GJAQ?NU#
MIG,!44E%A#!_CSK6J+_ OY>7*NT$51W\)#9Z\A&$K9><MINR5R*?0S^PV+"-
M%FI.<<)0D4RAK2Y!Q"-'BA?845* (C\ #O,5S^O2<;XF''D"AXEYXZ8#9/RI
MQELDK.V6?X@8[+3&QMK5I!LX-2HJ)C$-*LL4T>=XD"15EP4#H1-R) QK9L58
M)S#DZLXLQ%$R,[X>;SY^]9JE@AM6DK/(4>2E;'B.[16:8##:@)OY7^7\W-2"
M#58[8H)%753,0X="=0]*OCOPKB?5#SH^1W7+7*DQ>(,&J:@ZM923Q94/FV-*
M2O\ .2\PSFK8T@UW3Q!M+R350$U5$00*)"]HICT W U:^>:'FI'S'8R0S7>-
M,,:X/EM*$(K"5O\ (/C#(E]UN5NJN1)U/*M?KCFEN464%E9U&N8A19V^,F@2
M)*  JDK[0*A&G6W5;$>?XSP8ZT9KOT+MUKU,[8;V#$,H*D9<H>*G5)J];E;'
M&TRA/+\WC;3;,.1D]'E^06(4C51D)TR.#(B8>!;V^&L>MN*,)>4_'=>QK5*Y
M@C5[S"Z6350HXLIV3AL.T#*.,,:J9RD&";0TDS@J)<VA.U=-,JQDD6YTE$DQ
M% .!T&SU%T\NF(O.;8<<5?&EAUOPWOCXF<GXTE:R*,_C^L8ZGXYACRTSU8-!
MNU'S2OR-,LLRP>$+WI"@[5133!4G4@??8.W:^*T'RX-=4/P,K@J4WC\04GB-
M;%BJ[FF,X./EJH5&4B$V1%D&T>NN4R($$Y2E<#V$3[_7@9ISKI7K#E76+\S?
MMW?\1Q%BV'Q!O5G:*Q7E:?-)J3F.FE(#&]BC34J2*\:I,'7WC97BJHH#[RB*
MZ2 @($2 0PU?%_'X\EO)I*>:*42EMC;GJQ@&TZ$3UN89&*_?8M=:T-6U2E-<
M@22+#M9T^3_ERN6[DY3JN$5#KD%J#HXAZT/#]6&5Q\'.F-2O,6C,P5ETOKD/
M)1#HH@WDJW)U%R@FS5^5<*JB1S&*%*(@8BGKU[2#Z 'C0U<U^T2RW@_Q3:].
M:ICV3E[UY:=AZ5M=CV#M3E>Y6&LU,N27&(X_)\#\^67AXPM=8-&;'O\ ER.6
M":W:*AU5^T,A^4+#,[J1'^6O6[4.'B\.:G5[:'QZWG+N.HT;4:E5'&%]JMG8
MRLNZBHV0/-ML:S-X+'ISC=@4Y7*'V/[O3M"/C*D)4ZG>4Q+ ^SFA]IIA?%_8
M?YW8G\?..-BOY"320VJMMZ-9++:,@P[VC1.5(\KY?JHTE054*H**I!6*N0 V
MKQ'B?T!/Y"O"/B6,UNIR6(\VZ%7_ "SG"JK3-B<0&<K?6,<4"7K\[>F23@4[
M%+1MBO#B0,=1<B"YCIAV$3021.&[G\N5 ,*EHUF?'<*)$Z=CC?G<S']'ADG+
MIXRKE*KV33-86M,#O%%5B1\8@<Q$R"/V2CT]?B(>7;=+#.NN$<J>9>"IE4)0
MIJ(W_P!47^<6-/DK4RRC'^/7)5>K%OV1E8:NLI7[\>XQF;[+IN)1\5N+4@/$
M@25 IR$ -LNCB6@<9YT,+)>&!2-<Z_2&G&2D=Y&V#5)QWK]'^V>OO<!O91Q*
M%/%ER"[G0%-V"2QY$J@%!4I#&=]P8E_,@L[[??)CHYC'(UUUEQ[K.]P5D>7I
MTOO07(9=-I+,Y)1^E)?CA7'\DD!K\E @W2C32(MVS=,Q3"'V^\P0AQ1#T;$?
MB0SS)Q6V..+WEW#ODGB+#XP'VI$5EIW5F.S5@@,;R$S@G \'DAM%3F0<231Y
M]=L_135?1:*:AU%71G BF(8-R5=)_)^G&,%;CE:#5VZVQ\E3&K^7)OM))77#
M5'HMKI<':GN"]=,QN8<S>2QMKHH_C"G3<1Z2+!TZ[2K.D2(#P.DR-1[OAS5[
MRU8NB<W:IJX:F0TNLLKKOH_FO)N8\2XVME[RVVCI65I=LLC-2,KR\[!@))%D
MC,O5S*' %DNA"FX&V?+VF_C/QSY*]=-"MKHAOA;QS1FALGG/ %1R5F*T43$=
M[VANF0&J.7K+?;Q-V=@V=9!+2X*,$C5210:(@D)R)E.X(50(]5"RZM(9-@J+
MJAN'LO7M38CQ0>4:HU[8_*,'D.Q3^,:O7+9"KKVG&K*N0K6TS.-: W256B'K
M))P^7;(#[)P5%,3!#'1V_.]7K@\B,)XTQ-:=GLZ^.//C+ .P&B.QUFRFWR38
M8V""7<9(V=P):)=_:JKF-6,;.78/)%6&=1CSJ Q_O@8J(<CQ]8WNU+SWXKLS
M8PV0\?.,,Q9,RG21M%JQ]LQGK,^S6T,5:XA5;+=0V,QF$9/QT!8&D0[?M &<
M3B6;"=13336/_"4X'],C@. X#@. X#@. X#@. X#@.!^/V#_ -;Z.GZ^H?L#
MI^WJ' XYV3)5PF\.S:*.DP*";H[=(S@A2]W0"+"052=O</3H/TCP+0C\AX^E
M+W8\;1=MK3_(]5AH:>M-.9R3-:S0<'/&6+!2<O&)',]9,904#@V.H4"J=H]O
M7@6[<,Y8?I&3,884NE]KD#D[-C>X+8LHTLY*E,WU"ALXZ0N(0+0Q#%>_<,?*
MH*N"]0$J:G7UZ#P,JG1143!)5%)1(HD$J9TR'3*)! 2="B E_A"4! ?HZ<"H
M)$]WWO:3!7V_:%7L+[@I@83 3W.G?V <PCTZ].H_7P/F@T;-C+J-FK=N=RH"
MK@Z*":1UU.@A[JQDRE,LH #TZF$1X%K1]]HTW;;/CJ-M$!*76GL(=_;JBWD&
MSJ;K\=8T3N(1Q-1A#F79-YALF8[<52@"Q $2]0X%U^RE[0M_:2%'L[?8!,HH
M@0  H$!,0[ +Z?#IT].!\4F#!)N=HFR:I-5!,!VA&J)&Q^\0$XBW*0$S=X^I
MO0>OT\"GW;'BDW1&/9"@U[1:HBT0]MMT_N^P04^Q'M#U^R >O YOT#T#U^GZ
M/W#T^(<#BE8L2+_-%9M2N@(*8.BMDBN/;]?L>]V IV?:'TZ]/4>!JIT\UDUA
MF=Q-KMZ<?YORAL-EN3M]OUPD!R?/R-AA-;V]&N$@ZNN%\.MYAD@O6ZBA:U%#
M&2;G4;F*4I2',0/4-K_J'3X_2'IZA]?K]/0.@].!&VU[8:Z4#)5SQ)<<C0%5
MN>,L/O<_WIM,I.(V)IN(V;X(Q[=YN?7;IPD=&I.S]A^J_N^HCV]O4>!GJ'?0
M<_&,[%!JL)*+L4<QDF4LT!)5O,1;UJ1=@[*X*7JZ:+LU2F3$1$!(8.GIP.P1
M9M&YB*(-&J!TT0;$.D@DD<K8I@."!!(0HD0 P=W8'V>OKP.*S@X6/%X9A$1;
M$9%059 6<>T:_/J" A[CT442"Y/VCTZGZCP(UVG<;52F;*8]T_LN7J/'[*WZ
M!>6FC8B,M\Q;7$&R;N#_ 'C\HV;+)PR+MJS<?+"N9'Y@C97LZ]O SA9KCCV)
MF:K1+A8*NTG<C.9:/I]3G7K )"X.8&(=V*::0T0\,968/$PD:N[7!,A_:01,
M<W0 Z\#HL/Y0Q!FZ@1^1<+6NI7_'-B6D48ZS5%1J\@)1>*>+14FD19!,B2RK
M)\T405 P=2G3$H_#@9 ?0D+* V"2B(N2!DH"C('[!J[!FJ4@I@=J#A%3Y8X)
MB)>I.@@ ]/AP.R I2]I2% I2@!2E#[)2@'0  I>G0 *'PZ?0' ZU*"@T)-::
M1AHI&8<)@BO+)1S0DHNEWF.":SXB(.E4^\1'M$PAU$1X#[EB ,_/]U1AAE2@
M23-]WM -)$*42E)(&]KJ]*4IA /<[@ !'@8BM.>L 8N:,T;)D6AU9FZR55<+
MM6A'[,J?\T[N\0C:IC\S6-*L#>R33UTFFDV4*0P=X=W:'KP,M-:_!1Z*[9C!
MQ#-NY-W.4&D8R;HN#=_>!UDD4")K' _VOM /KZ\#F+,&+@W>X9-'!Q0,V,99
MJBH86YA*8S<3*$,/L',4!$GP$0 >G ^AF[<RJ*PMT#+MRG*@J*28JHD.7L,"
M*G;W)%,7T,!>G4.!QT8J,;.UY!K&L&[]T7L<O4639)XY*4QC%(NY33*LL0#&
M$0 QA]1Z_7P/FO#0[Q@K%NXF,=1;CO\ ?CG#!JLQ6!4PF5]YFJD=NI[AQ'N[
MBCW"/7@?0D5&$:+,21L>1BX()%V1&;8K5<IB 4Q%FX)@DHF8OH(" ]0X'R90
ML+',BQD?#1C&-(8IRL&4>U:L2')V]IRM$$2-P.7VB=.A>H= ^K@?J2AXF:0(
MVF(J-EFZ:A5DV\FQ;OD2*ICW)JD2>)*D(J0P=0$ ZAP.Q*4" 4A"%(4A0*!2
MEZ$*4/0"D    #H'P^@.!Q?N]@**K;Y)I\LLJ*R[<6J'L*K&.57WU$O;[%%?
M=*!NX0$>X.OQ#@<=W!PL@X9/'\/%O7D<83Q[MY'M'3I@<0Z=[)==%19J82_2
M00'Z.!]#148=XM(GC6)I!PT+'.'IFB!G;B/*=10K%=R*8K*LRJ+'$$S") $P
MB >O Z2$HU)K21$:Y3JO!))G>G*E#0$5&)E4D1$7ZA09M$0 SX3#[P_%3K]K
MKP.V:0D*Q4;N&$/%,UFS$L6V7:,&C=5O%E5%8L<@HBB0Z3$%1[P1*()@;UZ=
M>!K<WW\>-AVP98?L> ]F<E:69AP7/728I=XQ''PSNO3C/(J\&YN<'?J%)I?A
MVUL)-]7V[M,SA,YTG8'4]14-P.ET,U:P3XP*K'8,M6??YB[&[>Y>O62K/D/)
M"T/7[SL)EHT&M.V,U=K<45"-;-:Y4H115)BT*((-TE3B(@/0 V-63&N.[C*P
ML];J+4+/-UQ9%S S%@KD3+24,N@J9=%:,>OVB[A@JDJ<3E%,Q>AQ$0]>!=A8
M]B11ZH1BS*I(]H2"A6R(*/@(D*)/G3 0#.@(C]@O>)NA/0/3@6W*X_HDZG"I
MS5)JDL2MNRO:\E)UZ)?)P;PAP4*ZARN6BA8U<IPZ@=$"#W>O [-M6:VR4369
MUZ#:*HO7$BBHVBF2*B4D\3(F[?I&3;E,D\=$*!5%2]%%  .X1X'!FZ+2;.^B
MY2QT^KV&2A'!74/(S4#%RCZ*<E!1,KB/=/6BZ[14I3CT,F8H@(]>!;MSC<06
MF>K=/R!'8\L5F<$=SM2K%L9UZ5FE$H@"F?2T#%2J2[PR4>4P>ZNB3M3ZAU$.
M!DCVR 0$02)[0$!+VNTH) GV]OM@3H! 3 GI\.G3TX'$1BXULJ@NVCF#=5LW
M4:-E46:"2K=JJH591J@<B93HMU%2@<Q"B!3& !Z=>!]6[%FT,N=JR;-3NG!W
M3LS9!)$SAR<  [AP*9"BNN</B<W4P_7P+;D:!1):P(VN4I=5D[0W8&C$;$_K
M\4\FTHXZZ3HS!.4<-5'A6@KMR']L#]O>4H].H<"X1CHXS].4^[V0R:#-1@E(
MBT0^?28K*)+JL$GGM^^FT560(<Z0&[!,0HB'4 X%OUV@T:HO)B1JM-K%:D+
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MFW.7]+JKYQD"/815X7>0,:Y6M\7%-UV<='V4ZS8YIEDP:NE4T4W'N$3*<P%
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M5<>5^*MSM[*"M]Y.22S9F#EFI(&<'%;V13!43B)NHCP)B\!P' <!P' <!P'
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M?']F'7/":&NM9R?@Y2+E7]IQ*@[DI4(&\Q,P9DUGI!><F';Y9X94BBCA?NZ
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M[1VDN;=?L$-X91_C+..29ZM2-9RY)1UA6KL[$5R,B6Z,@S&.61,LBY5$Z#M
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MX;0M8V6)<C7C$%GK.+LZR%53?J24;B"WN040MLB[48&2CT/;25?JG*1(HF,
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M6[5G,-@I%0L>YNXN4\_83LL>JI:(1BU6FHRPX]E;%'D:QJ\6#V4B4P<)(_\
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M0PB*"Q.\"G$2@$KWCV*069LW[N.06>+ 5BV>N&R:SMPC_&(5F@N8%%UDNSN
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M:KR(_FXY_+/Y R;;(C%EIF;#:";,SN7*XVRQ83M26%Z]K.2(!-.0<)H$!%5
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M(Q. ;M<*\LXLAEVX*F(FW2;N$#F3[ [C0#5VN[$[:>5GQ^5V(UUUW@LR^/\
MJ,Q3L>:9; 77.6 X'-55ME7L=-O:-IL<V_//Y$A'8IA*$;&*@U3%9(@!WG$0
MS>ZWOVQWIQ5G;:O' Y8QOE;Q->+QYBNR04<TDAL"'D#R%9R4W.%I:LU3O'LR
MI0\=41=RD=<5UH]PO[Q!%7J8 O#%.+]6M)M@?#?FCQK;-6+*F=MQY20CMP,?
MH9\L^7G>>*E<,*3-AR'FW)=;=6*7:0$MC2UH&,0#(,3@].3J0RS<QRALL_+
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M[]#-=D=7&7=2$M4G-^.4&DC.)"1XV:KE,58AP*;@6%B3 &?=.'&V;6@2^LF
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MG7@=2XGH9G,Q===2C!O/3C25D(B(7=HIR4HP@C1I)EXQ9F,"SIO%'F&I5SD
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MXJ)I%<A(^)JL=&/EW+EZP:P;-NE'(M'KA\LHJF"?:H=4XF 1,/4+&I.M>O\
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MX%>GJ _5U_I] #_9P*\!P' H #T]1Z_U?V< (=?V=/J_X\!T] _5_NZ<"AA
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M.OP^CIU^'[1^'3KP*^O7]7[?]GP'@/I'T^KH/^_Z> #X?7^[_9Z<"O <!P'
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M!<1#,P)MD%SID<O'"95#$3$ZA0WCI#W))F$HE$R9!$HCU$O4H#VB/TB' ^G
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M)-0K0')!3!TN_>OW)5^HC]D5/0/^J4?3@94#].G <!P' <!P' <!P' <!P'
MZ6Q6"%J4!/6JR23>'KM9A9.P3\L\,8C2*A8=DXD922<G*4YBMV+%JHJ<0 1
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M(*]2I$$I" 8P;9K/.XIN=7M-5L%MI\A7)N'EH"S-0M<4B0(N38+M)-LY<MY
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M-6>JY,U7)%7EJNNB+C)<[,HKUDDJ83R]<,23[4WB"9&JRI5/:%0@ J</0O\
MO^(_1^[@8PQI\^4U_(^^1[0R3:3LODQ>>Y\FLLB9'YWYI58OS7J(#[7:ETZ=
M"EX&4. X#@. X#@. X#@. X#@. X#I\!^K@.!3I]'T>O]?7T_9Z\!T^CZ/\
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MI?D+N-,I".!L=PK'$]_T,R]2J E98D8:&3>W"<M%7"7DY1D\$S%%)3W ;C[
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M%M,D<BT#'?RTBC YU=SXQY\C*7&'8$3L;ETL<(-PP6(V('4!( 9?U1F[E_\
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M!U_;^GZ_AP' <"G7] ]?V<"O <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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MH@M*L!,\>V61@I>=K*E):OFDE*5@7GW#(+N)!1T_!W&%D%BIG*L4PD/VCU*
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M\FX>L!)!3O=1%@@7P2$$N"0*D$#(K"   \#>OP' <!P' <!P' <!P' <!P'
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M[EL5EN*=L%F;NG8LK>"(BB3"=B31(0D4-CM9C1J*:IDRJN4!(4JA@[0#T_\
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M!#J ]>!)Q0Y$R'.<Y2$(0QSG.8"$(0H")CG,(@!2% .HB/P .!H]RKMCL5Y
M<K7G5/QK6J/QWB#',_(X^VM\AIVC>=84:<*S.G,8MU.9J^_!Y"S)$E5 KZ95
M]V(KZAB]1,X]O@9'QUXW_'CXX<49/V%F,9Q&0;M2J39LBY8V4V#<#EK,]Q/
MQ3J:EW\U>+K]Z/T0D7+<XI,F@H-4CJ FDF =H<#N_"5C6S8[\<^&I.V,"0DI
MFFP98V49UA%B2/;5.K;#93MV6:-76[,G0&Y6-*M$>8Z?:3V5E#)].A.HAMCX
M#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X
M#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X
M#@. X#@.!C#,V8<>:_8GR)F[+5C9U'&N+*C/7BZV-Z;^!%UZN1Z\G(N0)W=[
MAQ\N@)4D"=5%E1*0@"8P!P/A@[+]:S_A[&6;Z;'V2*J65Z7 7NM,+A$?<-H;
M0=FCT92+3G(7YEW]V2 M'!#'1%13L$>G7@94] #^@/V_N'ZNG TR[D;VYDE=
MS]?_ !RZ'K5&;SS8Y>,RKM;D678?BFLZQ:UUR29.)E:QQZ"A6:60<G%-]VP;
M-RH0_<K[G: F3-P-S?Q^'U?J_3UX&BGSD>2&:U#PM6-8M<E3S^_6[<@3"VL5
M/CP<@]@75P?-*I-93?/TA20AVM.3FBBS745+V2!T51**"*YBAMBUAQM;\/:[
MX5Q=D&\6#)=[H>-:E6KE?[5)JS5BMUHC8ALC/3LO++"*L@\?28*F%4?[P=/0
M ].!G7@. X%.H=.O7T^D>OIT^GUX&!<2;0Z\9YN.5:!A;,=!RA;<'RL)"98A
MZ1/-; :C3%C:OW<-&3#V/%6.!ZZ0C' F3254.B9(Q50(;TX&>^!JOV;\AUEB
M\HO=2]$\5M]I=Q&SE)"YQLRXLU2U^UUAW#!%\6U9XRTSK[Z+(^43=HBRJ\2L
MK-R'<83BS3*"IPN#QM[3; 9]A]B,8;7P6*HS8O5O-\GB/(<I@TEI2Q/:&CF+
M:V"K3U60NKEU9&AW$2Z['2+A0_MJE#M'H/H&R\/AT_Z?Z_7@!^/3Z>@^O[N!
MKDV&\@4!4\H2>J>L-54V4W(3BFDC(8RJSMD-3PU&2ZQ&T?==@;6+]NC1ZP4Z
MG>#5+YB6=@7M30 # H 8\JGC$@\OV>*S'Y%+].[EY*;KLYB%P]<')6NGN(I%
M$O>1C0]>XQK&T^[N6"INI)F[HV66]T!405;%[4RALZJU.J-%AFU=I%5KE.K[
M,3BS@ZK!QE>AV@J=GN"VC(AJS8H"IV%Z]J8=>T.OP] T]>/]M5Y/R6>8VV8M
M;MFN-S9:UYIMH7A#HDKD[GJK80@D,JO4VZ#1!(+-"R*Q8^8."BQQ>IG]P2GZ
ME +4VYRQG'R&YFN_CETOM]CQ-BF@NF$3O[N7",V*R-;@)IJDL_U9P7)&<E5=
MYDNM<=J_?DLU,0:DS41ZF,X<@F ;=<$8&Q'K/BJG83P;1*]CK&M%BD(J K5<
MC&<:T(5-,A',F_!H@@,E.2ZQ1</GJP&<O')SJJG,<XB(:K/)/=IC;/+^,?$]
MAMPE*.\HK5_*.\=HC44)9/"6JD!,MY9G!SH%D&J,1<<ZST02.B6SCO.=@FNL
M9N=%9,PANG81[&*8L8N+9-(V,C&C=A'1S!NBS81[!FB1LT9,F;8B;=JT:MTR
MD233*4A" !0  #@<S@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M47JGJML'L=, 51OAS$]SN[)JHE[OWE/14*Y&LPI$0,05U9NR*-&:9 'N,=<
M#U'U")_AFP)9=>?''KI5[Y &K.3[M 2N9LIPYRLP4:9#S!-/[W/E6!DBBE[Q
M!F$R&Z@)P,40,(B \"X_(9N);\#0V/L!ZW1L)>MW]HI*0I^O./Y-8ZC"!9LT
MTRW3-][30[C1>-\6Q[LKMRX7 B+MX*+8O<)S@4,B:*Z14;2?%;BO,)5_D?,N
M0)#\9[!Y^M8$>Y"S3DZ1 Z\U8)V76*+Y* 8O%U48:* _RD4P$J")"_;$P3?
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M^' KUZ^H>O[/ZOW\!U^/T=/KX%>O IU_4/\ 1Z_\?IX#J \!U#]/]H?1P'<
M_ >OKT_I^H?J'@ $!#J'Z?T?7P*@(#\.!0!Z_#K\>GZ?3P'7]/V\!U#]/T^G
M@.H?I_7^[@ $!#K_ +OH^/P]/3@ 'K^GZ?5P'4/W?IU]?HX#J'[1_3_?P'7]
M/Z^ Z]/CZ<"O IU#Z_CU_J^/]/ =?^CT^/U?'X\!UZ?U?5]/P^GZ1X%!, ?$
M?^'[?JX'ZX#K_M_J^G@4Z_M_3T']W KP']7 H(]/T_MX#N#]8_T#^X.O3J/
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M^8[P1@N7PA6&->PK;-::GDNRXBLK>X1S-&;M 2[NC),9EI)JJ)*E=^Z3U)U
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M,(X(S?B.^C,)9XSM8\S$C7C^S8KL#-ZWC:ZYK3.3 D/'N$E?OA9(_P!DX (
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M'9#Q7CS EHRQ1U8;%6/LDR91GIFI1L30XBTRQVSEN"#1U,N)-!L)13*'0 (
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M+&Z&E!)=WGMA:<V3);O:*R]L432<<8XNM;S'ER<<PL=#S4;/K-/ET5TW':5
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MAFZT"Q9+QUC7*2$ RH-^36NEUL)8BGER1'HN5FR)6DFV,J=:3,46R;=10/\
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M!.ON(]1]6*7KU$NA6PQAO%YJ@X?7UZA()N*9$1"Y9EW:7;X/DU&*L<"QG(&
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MY(R9<HV[L6K=9^D]B$H>)=NU1224%0WMAC+'WBRWFB=;=K,85K2+:R'PV=;
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M0I6WPT=E@M,>N%$F,2E))+/7+)$""=1-0!$/,YB>5DZGK]&Q^=+%Y*JZR@]
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M*"'J _5U_KX%> X%.GKU^CI_7]?[N!7^CKZ_H/ <!P' <!P*=/B ^O7].G
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MULC2+QA%'$V\^#<14]"AR3&TQU$W3LT-=Y9Q=)LLX#65DJY88KVS BDD"[4
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MZ#9%1PY62;H)$$ZJZRB:2*9 ]1.=502D(4 ^(B(!P.$SF8B2550C9:,?KMP
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M)=U5\>)%NH\2.W,)U@5*F!>A#!L%T"\K^U^R6W^.]=]CM8<28<IVP6G3/=O
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M4C5UZ5C?6G5_8>W[>V#"D33%9.9R;LC,+KO8&T+7"3F%P@*ZSEWRSV08HMS
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MT']O "(A\ $?T].!\".FRBRK<BZ)W#<""X0*JF99#W2@=/WTBF$Z7N$'J7N
M.H>H<#[]?U#^@?H'[>!QS/&I$@7,X;@@*A4O>%=(J7NG4!(B?N"8"=YU# 4
MZ]1,(!\>!]^X.OQ^H0]!^GX#^P>!7K_M_3^G@4'T]?\ ?\/ATZ]?CZ\#]?\
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MWX7<Q*OMPUFQVVD(5J0"*+&7/W$$-BGCSS1?</>%W<KR%90SE?,RN<RNMO\
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M")ID*FFF4I$TR% A"$( %*0A2@!2E*4.@ 'H <#]<!P' <!P' <!P' <!P'
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M<I>P5PU'O7; <A3=_P##,8#=# ':(<D.O3U^/Z=?C^O@5X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MN)_CXWJ<+9@^\4O\M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\
M'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG
M"V8/O%+_ "U?W$_Q\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U.%LP
M?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_P ?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4
MO\M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\ +5_<3_'QO4X6S!]XI?Y:
MO[B?X^-ZG"V8/O%+_+5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5_<3_
M !\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U.%LP?>*7^6K^XG^/C>
MIPMF#[Q2_P M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\?&]3A;
M,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\ 'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O
M%+_+5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_ "U?W$_Q\;U.%LP?>*7^
M6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$
M_P ?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\?&]3A;,'WBE_EJ_N)_CX
MWJ<+9@^\4O\ +5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5_<3_'QO4X
M6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5_<3_ !\;U.%LP?>*7^6K^XG^/C>IPMF#
M[Q2_RU?W$_Q\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_P M7]Q/\?&]3A;,'WBE
M_EJ_N)_CXWJ<+9@^\4O\M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]
MQ/\ 'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5_<3_'QO4X6S!]XI?Y:O[B?X
M^-ZG"V8/O%+_ "U?W$_Q\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U
M.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_P ?&]3A;,'WBE_EJ_N)_CXWJ<+9
M@^\4O\M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\ +5_<3_'QO4X6S!]X
MI?Y:O[B?X^-ZG"V8/O%+_+5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_+5
M_<3_ !\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U.%LP?>*7^6K^XG
M^/C>IPMF#[Q2_P M7]Q/\?&]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\?&
M]3A;,'WBE_EJ_N)_CXWJ<+9@^\4O\M7]Q/\ 'QO4X6S!]XI?Y:O[B?X^-ZG"
MV8/O%+_+5_<3_'QO4X6S!]XI?Y:O[B?X^-ZG"V8/O%+_ "U?W$_Q\;U.%LP?
M>*7^6K^XG^/C>IPMF#[Q2_RU?W$_Q\;U.%LP?>*7^6K^XG^/C>IPMF#[Q2_R
;U?W$_P ?&]3A;,'WBE_EJ_N)_CXWJ<+9A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>sglb-20160331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<!-- Based on XBRL 2.1 -->
<xbrli:xbrl xmlns:sglb="http://www.sigmalabsinc.com/20160331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
  <link:schemaRef xlink:type="simple" xlink:href="sglb-20160331.xsd" />

<!--Context Section-->
  <xbrli:context id="P01_01_2015To03_31_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2016To03_17_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-03-01</xbrli:startDate>

      <xbrli:endDate>2016-03-17</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P05_01_2014To05_31_2014">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-05-01</xbrli:startDate>

      <xbrli:endDate>2014-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn05_12_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-05-12</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P09_01_2010To09_13_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2010-09-01</xbrli:startDate>

      <xbrli:endDate>2010-09-13</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2014">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

<!--Dimension Section-->
  <xbrli:context id="P01_01_2016To03_31_2016_PatentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P05_01_2013To05_23_2013_ConsultantOneMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2013-05-01</xbrli:startDate>

      <xbrli:endDate>2013-05-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn05_23_2013_ConsultantOneMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2013-05-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_ConsultantOneMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P05_01_2014To05_31_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-05-01</xbrli:startDate>

      <xbrli:endDate>2014-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To01_31_2014_WarrantExpiryLifeNineMonthsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeNineMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P05_01_2014To05_31_2014_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-05-01</xbrli:startDate>

      <xbrli:endDate>2014-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_ConsultantTwoMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P06_01_2014To06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-06-01</xbrli:startDate>

      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P06_01_2014To06_30_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-06-01</xbrli:startDate>

      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeOneYearMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P06_01_2014To06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-06-01</xbrli:startDate>

      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To01_31_2014_WarrantExpiryLifeFourteenMonthsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeFourteenMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To01_31_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeTwoYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P06_01_2014To06_30_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeTwoYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-06-01</xbrli:startDate>

      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_DirectorMemberusgaapTitleOfIndividualAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis_OfficerMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_ConsultantTwoMembersglbThirdPartyAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantTwoMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P11_01_2014To11_30_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-11-01</xbrli:startDate>

      <xbrli:endDate>2014-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-07-01</xbrli:startDate>

      <xbrli:endDate>2014-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2014-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis_FirstAnnualAnniversaryMemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:FirstAnnualAnniversaryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-07-01</xbrli:startDate>

      <xbrli:endDate>2014-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis_SecondAnnualAnniversaryMemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:SecondAnnualAnniversaryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-07-01</xbrli:startDate>

      <xbrli:endDate>2014-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn11_30_2015_CommonStockShareIssedToEmployeeOneMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:CommonStockShareIssedToEmployeeOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn11_30_2015_CommonStockShareIssedToEmployeeTwoMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:CommonStockShareIssedToEmployeeTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P08_01_2015To08_31_2015_VicePresidentMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:VicePresidentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-08-01</xbrli:startDate>

      <xbrli:endDate>2015-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2014To07_31_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-07-01</xbrli:startDate>

      <xbrli:endDate>2014-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P11_01_2014To11_30_2014_DirectorMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-11-01</xbrli:startDate>

      <xbrli:endDate>2014-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_DirectorMemberusgaapTitleOfIndividualAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_DirectorMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_OfficerMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2015To03_31_2015_TwoConsultantsMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:TwoConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-03-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P08_01_2015To08_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2013Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-08-01</xbrli:startDate>

      <xbrli:endDate>2015-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_WarrantMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_WarrantsOneMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantsOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To12_31_2015_WarrantsOneMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantsOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_WarrantsTwoMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantsTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_CorporateJointVentureMemberdeiLegalEntityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_EmployeeMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_EmployeeMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:EmployeeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To03_31_2015_StockCompensationPlanMemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2014To07_31_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantExpiryLifeOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-07-01</xbrli:startDate>

      <xbrli:endDate>2014-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_VicePresidentMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:VicePresidentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn02_28_2016_CommonStockShareIssedToEmployeeNewMemberusgaapTitleOfIndividualAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">sglb:CommonStockShareIssedToEmployeeNewMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_EquityIncentivePlan2011MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2011Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_EquityIncentivePlan2011MemberusgaapAwardTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sglb:EquityIncentivePlan2011Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_WarrantsOneMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantsOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_WarrantsOneMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">sglb:WarrantsOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_ConsultantOneMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To12_31_2015_ConsultantOneMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_MinimumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_MaximumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_CosultantMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:CosultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_CosultantMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:CosultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P04_01_2016To04_17_2016_CosultantMembersglbThirdPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:CosultantMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>

      <xbrli:endDate>2016-04-17</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn04_17_2016_CosultantMembersglbThirdPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:CosultantMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-04-17</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016_ConsultantMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2016_ConsultantMembersglbThirdPartyAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="sglb:ThirdPartyAxis">sglb:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To03_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn04_28_2016_SubsequentEventMemberusgaapSubsequentEventTypeAxis_TwoThousandAndThirteenStockOptionPlanMemberusgaapPlanNameAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sglb:TwoThousandAndThirteenStockOptionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-04-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn04_28_2016_MinimumMemberusgaapRangeAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-04-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn04_28_2016_MaximumMemberusgaapRangeAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-04-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>

  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>

  <xbrli:unit id="USD_per_Share">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>

      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>

  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>

<!--Element Section-->
  <dei:DocumentType contextRef="P01_01_2016To03_31_2016" id="Factid_1">10-Q</dei:DocumentType>

  <dei:AmendmentFlag contextRef="P01_01_2016To03_31_2016" id="Factid_2">false</dei:AmendmentFlag>

  <dei:DocumentPeriodEndDate contextRef="P01_01_2016To03_31_2016" id="Factid_3">2016-03-31</dei:DocumentPeriodEndDate>

  <dei:DocumentFiscalYearFocus contextRef="P01_01_2016To03_31_2016" id="Factid_4">2016</dei:DocumentFiscalYearFocus>

  <dei:DocumentFiscalPeriodFocus contextRef="P01_01_2016To03_31_2016" id="Factid_5">Q1</dei:DocumentFiscalPeriodFocus>

  <dei:EntityRegistrantName contextRef="P01_01_2016To03_31_2016" id="Factid_6">SIGMA LABS, INC.</dei:EntityRegistrantName>

  <dei:EntityCentralIndexKey contextRef="P01_01_2016To03_31_2016" id="Factid_7">0000788611</dei:EntityCentralIndexKey>

  <dei:CurrentFiscalYearEndDate contextRef="P01_01_2016To03_31_2016" id="Factid_8">--12-31</dei:CurrentFiscalYearEndDate>

  <dei:EntityFilerCategory contextRef="P01_01_2016To03_31_2016" id="Factid_9">Smaller Reporting Company</dei:EntityFilerCategory>

  <dei:TradingSymbol contextRef="P01_01_2016To03_31_2016" id="Factid_10">SGLB</dei:TradingSymbol>

  <dei:EntityCommonStockSharesOutstanding contextRef="PAsOn05_12_2016" id="Factid_11" unitRef="shares" decimals="INF">6237436</dei:EntityCommonStockSharesOutstanding>

  <us-gaap:TechnologyServicesRevenue contextRef="P01_01_2016To03_31_2016" id="Factid_12" unitRef="USD" decimals="0">358455</us-gaap:TechnologyServicesRevenue>

  <us-gaap:TechnologyServicesRevenue contextRef="P01_01_2015To03_31_2015" id="Factid_13" unitRef="USD" decimals="0">185686</us-gaap:TechnologyServicesRevenue>

  <us-gaap:SalesRevenueServicesNet contextRef="P01_01_2016To03_31_2016" id="Factid_14" unitRef="USD" decimals="0">358455</us-gaap:SalesRevenueServicesNet>

  <us-gaap:SalesRevenueServicesNet contextRef="P01_01_2015To03_31_2015" id="Factid_15" unitRef="USD" decimals="0">185686</us-gaap:SalesRevenueServicesNet>

  <us-gaap:CostOfServices contextRef="P01_01_2016To03_31_2016" id="Factid_16" unitRef="USD" decimals="0">107581</us-gaap:CostOfServices>

  <us-gaap:CostOfServices contextRef="P01_01_2015To03_31_2015" id="Factid_17" unitRef="USD" decimals="0">24867</us-gaap:CostOfServices>

  <us-gaap:GrossProfit contextRef="P01_01_2016To03_31_2016" id="Factid_18" unitRef="USD" decimals="0">250874</us-gaap:GrossProfit>

  <us-gaap:GrossProfit contextRef="P01_01_2015To03_31_2015" id="Factid_19" unitRef="USD" decimals="0">160819</us-gaap:GrossProfit>

  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="P01_01_2016To03_31_2016" id="Factid_20" unitRef="USD" decimals="0">395488</us-gaap:OtherGeneralAndAdministrativeExpense>

  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="P01_01_2015To03_31_2015" id="Factid_21" unitRef="USD" decimals="0">267703</us-gaap:OtherGeneralAndAdministrativeExpense>

  <us-gaap:SalariesAndWages contextRef="P01_01_2016To03_31_2016" id="Factid_22" unitRef="USD" decimals="0">215589</us-gaap:SalariesAndWages>

  <us-gaap:SalariesAndWages contextRef="P01_01_2015To03_31_2015" id="Factid_23" unitRef="USD" decimals="0">72660</us-gaap:SalariesAndWages>

  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="P01_01_2016To03_31_2016" id="Factid_24" unitRef="USD" decimals="0">71551</us-gaap:AllocatedShareBasedCompensationExpense>

  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="P01_01_2015To03_31_2015" id="Factid_25" unitRef="USD" decimals="0">122750</us-gaap:AllocatedShareBasedCompensationExpense>

  <us-gaap:ResearchAndDevelopmentExpense contextRef="P01_01_2016To03_31_2016" id="Factid_26" unitRef="USD" decimals="0">39071</us-gaap:ResearchAndDevelopmentExpense>

  <us-gaap:ResearchAndDevelopmentExpense contextRef="P01_01_2015To03_31_2015" id="Factid_27" unitRef="USD" decimals="0">70147</us-gaap:ResearchAndDevelopmentExpense>

  <us-gaap:OperatingExpenses contextRef="P01_01_2016To03_31_2016" id="Factid_28" unitRef="USD" decimals="0">721699</us-gaap:OperatingExpenses>

  <us-gaap:OperatingExpenses contextRef="P01_01_2015To03_31_2015" id="Factid_29" unitRef="USD" decimals="0">533260</us-gaap:OperatingExpenses>

  <us-gaap:InvestmentIncomeInterest contextRef="P01_01_2016To03_31_2016" id="Factid_30" unitRef="USD" decimals="0">158</us-gaap:InvestmentIncomeInterest>

  <us-gaap:InvestmentIncomeInterest contextRef="P01_01_2015To03_31_2015" id="Factid_31" unitRef="USD" decimals="0">560</us-gaap:InvestmentIncomeInterest>

  <us-gaap:NonoperatingIncomeExpense contextRef="P01_01_2016To03_31_2016" id="Factid_32" unitRef="USD" decimals="0">158</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:NonoperatingIncomeExpense contextRef="P01_01_2015To03_31_2015" id="Factid_33" unitRef="USD" decimals="0">560</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P01_01_2016To03_31_2016" id="Factid_34" unitRef="USD" decimals="0">-470667</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P01_01_2015To03_31_2015" id="Factid_35" unitRef="USD" decimals="0">-371881</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="P01_01_2016To03_31_2016" id="Factid_36" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>

  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="P01_01_2015To03_31_2015" id="Factid_37" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>

  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="P01_01_2016To03_31_2016" id="Factid_38" unitRef="USD" decimals="0">0</us-gaap:DeferredIncomeTaxExpenseBenefit>

  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="P01_01_2015To03_31_2015" id="Factid_39" unitRef="USD" decimals="0">0</us-gaap:DeferredIncomeTaxExpenseBenefit>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2016To03_31_2016" id="Factid_40" unitRef="USD" decimals="0">-470667</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2015To03_31_2015" id="Factid_41" unitRef="USD" decimals="0">-371881</us-gaap:NetIncomeLoss>

  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="P01_01_2016To03_31_2016" id="Factid_42" unitRef="USD_per_Share" decimals="2">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>

  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="P01_01_2015To03_31_2015" id="Factid_43" unitRef="USD_per_Share" decimals="2">-0.06</us-gaap:EarningsPerShareBasicAndDiluted>

  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="P01_01_2016To03_31_2016" id="Factid_44" unitRef="shares" decimals="INF">6233729</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>

  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="P01_01_2015To03_31_2015" id="Factid_45" unitRef="shares" decimals="INF">6206220</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>

  <us-gaap:AdjustmentForAmortization contextRef="P01_01_2016To03_31_2016" id="Factid_46" unitRef="USD" decimals="0">5002</us-gaap:AdjustmentForAmortization>

  <us-gaap:AdjustmentForAmortization contextRef="P01_01_2015To03_31_2015" id="Factid_47" unitRef="USD" decimals="0">577</us-gaap:AdjustmentForAmortization>

  <us-gaap:Depreciation contextRef="P01_01_2016To03_31_2016" id="Factid_48" unitRef="USD" decimals="0">42868</us-gaap:Depreciation>

  <us-gaap:Depreciation contextRef="P01_01_2015To03_31_2015" id="Factid_49" unitRef="USD" decimals="0">40405</us-gaap:Depreciation>

  <us-gaap:ShareBasedCompensation contextRef="P01_01_2016To03_31_2016" id="Factid_50" unitRef="USD" decimals="0">18011</us-gaap:ShareBasedCompensation>

  <us-gaap:ShareBasedCompensation contextRef="P01_01_2015To03_31_2015" id="Factid_51" unitRef="USD" decimals="0">122750</us-gaap:ShareBasedCompensation>

  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="P01_01_2016To03_31_2016" id="Factid_52" unitRef="USD" decimals="0">101087</us-gaap:IncreaseDecreaseInAccountsReceivable>

  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="P01_01_2015To03_31_2015" id="Factid_53" unitRef="USD" decimals="0">46845</us-gaap:IncreaseDecreaseInAccountsReceivable>

  <us-gaap:IncreaseDecreaseInInventories contextRef="P01_01_2016To03_31_2016" id="Factid_54" unitRef="USD" decimals="0">74057</us-gaap:IncreaseDecreaseInInventories>

  <us-gaap:IncreaseDecreaseInInventories contextRef="P01_01_2015To03_31_2015" id="Factid_55" unitRef="USD" decimals="0">6269</us-gaap:IncreaseDecreaseInInventories>

  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="P01_01_2016To03_31_2016" id="Factid_56" unitRef="USD" decimals="0">-16622</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>

  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="P01_01_2015To03_31_2015" id="Factid_57" unitRef="USD" decimals="0">-8457</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>

  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="P01_01_2016To03_31_2016" id="Factid_58" unitRef="USD" decimals="0">105633</us-gaap:IncreaseDecreaseInAccountsPayable>

  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="P01_01_2015To03_31_2015" id="Factid_59" unitRef="USD" decimals="0">-212409</us-gaap:IncreaseDecreaseInAccountsPayable>

  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="P01_01_2016To03_31_2016" id="Factid_60" unitRef="USD" decimals="0">11107</us-gaap:IncreaseDecreaseInAccruedLiabilities>

  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="P01_01_2015To03_31_2015" id="Factid_61" unitRef="USD" decimals="0">1510</us-gaap:IncreaseDecreaseInAccruedLiabilities>

  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="P01_01_2016To03_31_2016" id="Factid_62" unitRef="USD" decimals="0">-393028</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>

  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="P01_01_2015To03_31_2015" id="Factid_63" unitRef="USD" decimals="0">-463705</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>

  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="P01_01_2016To03_31_2016" id="Factid_64" unitRef="USD" decimals="0">25430</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>

  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="P01_01_2015To03_31_2015" id="Factid_65" unitRef="USD" decimals="0">7357</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>

  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="P01_01_2016To03_31_2016" id="Factid_66" unitRef="USD" decimals="0">34988</us-gaap:PaymentsToAcquireIntangibleAssets>

  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="P01_01_2015To03_31_2015" id="Factid_67" unitRef="USD" decimals="0">1347</us-gaap:PaymentsToAcquireIntangibleAssets>

  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="P01_01_2016To03_31_2016" id="Factid_68" unitRef="USD" decimals="0">-60418</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>

  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="P01_01_2015To03_31_2015" id="Factid_69" unitRef="USD" decimals="0">-8704</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>

  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="P01_01_2016To03_31_2016" id="Factid_70" unitRef="USD" decimals="0">-453446</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>

  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="P01_01_2015To03_31_2015" id="Factid_71" unitRef="USD" decimals="0">-472409</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>

  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="PAsOn12_31_2015" id="Factid_72" unitRef="USD" decimals="0">1539809</us-gaap:CashAndCashEquivalentsAtCarryingValue>

  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="PAsOn12_31_2014" id="Factid_73" unitRef="USD" decimals="0">2962069</us-gaap:CashAndCashEquivalentsAtCarryingValue>

  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="PAsOn03_31_2016" id="Factid_74" unitRef="USD" decimals="0">1086363</us-gaap:CashAndCashEquivalentsAtCarryingValue>

  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="PAsOn03_31_2015" id="Factid_75" unitRef="USD" decimals="0">2489660</us-gaap:CashAndCashEquivalentsAtCarryingValue>

  <us-gaap:InterestPaid contextRef="P01_01_2016To03_31_2016" id="Factid_76" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>

  <us-gaap:InterestPaid contextRef="P01_01_2015To03_31_2015" id="Factid_77" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>

  <us-gaap:IncomeTaxesPaid contextRef="P01_01_2016To03_31_2016" id="Factid_78" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>

  <us-gaap:IncomeTaxesPaid contextRef="P01_01_2015To03_31_2015" id="Factid_79" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>

  <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="P09_01_2010To09_13_2010" id="Factid_80" unitRef="shares" decimals="INF">6.67</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>

  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="PAsOn12_31_2015" id="Factid_81" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>

  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="P01_01_2016To03_31_2016_PatentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" id="Factid_82">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>

  <sglb:StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations contextRef="P05_01_2013To05_23_2013_ConsultantOneMembersglbThirdPartyAxis" id="Factid_83" unitRef="shares" decimals="INF">20000</sglb:StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations>

  <sglb:StockIssuedDuringPeriodValueIssuedForNoncashConsideration contextRef="P05_01_2013To05_23_2013_ConsultantOneMembersglbThirdPartyAxis" id="Factid_84" unitRef="USD" decimals="0">45400</sglb:StockIssuedDuringPeriodValueIssuedForNoncashConsideration>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn05_23_2013_ConsultantOneMembersglbThirdPartyAxis" id="Factid_85" unitRef="USD_per_Share" decimals="2">2.27</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="PAsOn12_31_2015_ConsultantOneMembersglbThirdPartyAxis" id="Factid_86" unitRef="shares" decimals="INF">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="PAsOn12_31_2015_ConsultantOneMembersglbThirdPartyAxis" id="Factid_87" unitRef="USD" decimals="0">21808</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P05_01_2014To05_31_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_88" unitRef="shares" decimals="INF">21875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_89" unitRef="shares" decimals="INF">437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_90" unitRef="USD" decimals="0">3500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_91" unitRef="shares" decimals="INF">142593</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2014To01_31_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_92" unitRef="USD_per_Share" decimals="0">15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeNineMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_93" unitRef="USD" decimals="0">1212037</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P05_01_2014To05_31_2014" id="Factid_94" unitRef="USD" decimals="0">1283333</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P05_01_2014To05_31_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_95" unitRef="USD_per_Share" decimals="0">8</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="P05_01_2014To05_31_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_96" unitRef="USD" decimals="0">271250</us-gaap:StockIssuedDuringPeriodValueNewIssues>

  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="P05_01_2014To05_31_2014_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" id="Factid_97" unitRef="USD" decimals="0">199089</us-gaap:PaymentsOfStockIssuanceCosts>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="P01_01_2016To03_31_2016_ConsultantTwoMembersglbThirdPartyAxis" id="Factid_98" unitRef="USD" decimals="0">892</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2016To03_31_2016_ConsultantTwoMembersglbThirdPartyAxis" id="Factid_99" unitRef="shares" decimals="INF">393</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P06_01_2014To06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_100" unitRef="shares" decimals="INF">62500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="P06_01_2014To06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_101" unitRef="USD" decimals="0">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>

  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="PAsOn06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_102" unitRef="shares" decimals="INF">20370</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>

  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="PAsOn06_30_2014_InvestorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" id="Factid_103" unitRef="USD_per_Share" decimals="0">15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_104" unitRef="USD" decimals="0">132407</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="PAsOn06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_105" unitRef="shares" decimals="INF">3125</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>

  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="PAsOn06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_106" unitRef="USD_per_Share" decimals="0">8</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>

  <us-gaap:WarrantsAndRightsOutstanding contextRef="PAsOn06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_107" unitRef="USD" decimals="0">36250</us-gaap:WarrantsAndRightsOutstanding>

  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="P06_01_2014To06_30_2014_ConsultantOneMembersglbThirdPartyAxis_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_108" unitRef="USD" decimals="0">25035</us-gaap:ProceedsFromIssuanceOfWarrants>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeFourteenMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_109" unitRef="pure" decimals="2">2.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeFourteenMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_110" unitRef="pure" decimals="3">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeFourteenMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_111" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeNineMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_112" unitRef="pure" decimals="2">2.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeNineMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_113" unitRef="pure" decimals="4">0.0009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeNineMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_114" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_115" unitRef="pure" decimals="2">2.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_116" unitRef="pure" decimals="4">0.0039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_117" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P01_01_2014To01_31_2014_WarrantExpiryLifeFourteenMonthsMemberusgaapStatementEquityComponentsAxis" id="Factid_118" unitRef="USD" decimals="0">1283333</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_119" unitRef="pure" decimals="2">1.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_120" unitRef="pure" decimals="3">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_121" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_122" unitRef="USD" decimals="0">36250</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_123" unitRef="pure" decimals="2">2.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_124" unitRef="pure" decimals="4">0.0041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P06_01_2014To06_30_2014_WarrantExpiryLifeTwoYearMemberusgaapStatementEquityComponentsAxis" id="Factid_125" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_DirectorMemberusgaapTitleOfIndividualAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_126" unitRef="shares" decimals="INF">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis_OfficerMemberusgaapTitleOfIndividualAxis" id="Factid_127" unitRef="shares" decimals="INF">5000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_ConsultantTwoMembersglbThirdPartyAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_128" unitRef="shares" decimals="INF">21038</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2016To03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_129" unitRef="shares" decimals="INF">33037</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="P01_01_2016To03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_130" unitRef="USD" decimals="0">191000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross contextRef="P11_01_2014To11_30_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_131" unitRef="shares" decimals="INF">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>

  <sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue contextRef="P11_01_2014To11_30_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_132" unitRef="USD_per_Share" decimals="2">9.40</sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue>

  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="P11_01_2014To11_30_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_133" unitRef="USD" decimals="0">141000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="PAsOn12_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_134" unitRef="USD" decimals="0">13630</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis" id="Factid_135" unitRef="shares" decimals="INF">60000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis" id="Factid_136" unitRef="USD_per_Share" decimals="2">12.90</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis" id="Factid_137" unitRef="USD" decimals="0">774000</us-gaap:StockIssuedDuringPeriodValueNewIssues>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis_FirstAnnualAnniversaryMemberusgaapAwardTypeAxis" id="Factid_138" unitRef="pure" decimals="2">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="P07_01_2014To07_31_2014_EmployeeMemberusgaapTitleOfIndividualAxis_SecondAnnualAnniversaryMemberusgaapAwardTypeAxis" id="Factid_139" unitRef="pure" decimals="2">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeOneMemberusgaapTitleOfIndividualAxis" id="Factid_140" unitRef="shares" decimals="INF">625</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeOneMemberusgaapTitleOfIndividualAxis" id="Factid_141" unitRef="USD_per_Share" decimals="2">6.50</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:CommonStockValue contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeOneMemberusgaapTitleOfIndividualAxis" id="Factid_142" unitRef="USD" decimals="0">4063</us-gaap:CommonStockValue>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeTwoMemberusgaapTitleOfIndividualAxis" id="Factid_143" unitRef="shares" decimals="INF">2500</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeTwoMemberusgaapTitleOfIndividualAxis" id="Factid_144" unitRef="USD_per_Share" decimals="2">6.15</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:CommonStockValue contextRef="PAsOn11_30_2015_CommonStockShareIssedToEmployeeTwoMemberusgaapTitleOfIndividualAxis" id="Factid_145" unitRef="USD" decimals="0">15375</us-gaap:CommonStockValue>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn12_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_146" unitRef="USD_per_Share" decimals="2">5.30</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="P08_01_2015To08_31_2015_VicePresidentMemberusgaapTitleOfIndividualAxis" id="Factid_147" unitRef="shares" decimals="INF">2500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>

  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross contextRef="P07_01_2014To07_31_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_148" unitRef="shares" decimals="INF">60000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>

  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="P07_01_2014To07_31_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_149" unitRef="USD" decimals="0">774000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>

  <sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue contextRef="P07_01_2014To07_31_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_150" unitRef="USD_per_Share" decimals="2">12.90</sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="PAsOn03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_151" unitRef="USD" decimals="0">258000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="PAsOn03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_152" unitRef="shares" decimals="INF">20000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P07_01_2014To07_31_2014_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_153">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>

  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross contextRef="P11_01_2014To11_30_2014_DirectorMemberusgaapTitleOfIndividualAxis" id="Factid_154" unitRef="shares" decimals="INF">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>

  <sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue contextRef="P01_01_2016To03_31_2016_DirectorMemberusgaapTitleOfIndividualAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_155" unitRef="USD_per_Share" decimals="2">9.40</sglb:StockIssuedDuringPeriodShareBasedCompensationPerShareValue>

  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="P01_01_2016To03_31_2016_DirectorMemberusgaapTitleOfIndividualAxis_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_156" unitRef="USD" decimals="0">141000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>

  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="P01_01_2016To03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_157" unitRef="USD" decimals="0">191000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_DirectorMemberusgaapTitleOfIndividualAxis" id="Factid_158" unitRef="shares" decimals="INF">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_OfficerMemberusgaapTitleOfIndividualAxis" id="Factid_159" unitRef="shares" decimals="INF">5000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P03_01_2015To03_31_2015_TwoConsultantsMembersglbThirdPartyAxis" id="Factid_160" unitRef="shares" decimals="INF">21038</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="PAsOn03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_161" unitRef="USD" decimals="0">13630</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2016To03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_162" unitRef="shares" decimals="INF">33037</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="PAsOn03_31_2016" id="Factid_163" unitRef="USD" decimals="0">272750</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2016To03_31_2016" id="Factid_164">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_165" unitRef="USD_per_Share" decimals="2">12.90</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn12_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_166" unitRef="USD_per_Share" decimals="2">5.30</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued contextRef="P08_01_2015To08_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_167" unitRef="shares" decimals="INF">2500</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>

  <us-gaap:DeferredCompensationArrangementWithIndividualExercisePrice contextRef="P08_01_2015To08_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_168" unitRef="USD_per_Share" decimals="2">5.90</us-gaap:DeferredCompensationArrangementWithIndividualExercisePrice>

  <us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="P08_01_2015To08_31_2015_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_169" unitRef="USD" decimals="0">14750</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>

  <us-gaap:PreferredStockSharesAuthorized contextRef="PAsOn03_31_2016" id="Factid_170" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_171" unitRef="USD_per_Share" decimals="2">5.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="PAsOn03_31_2016_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_172" unitRef="shares" decimals="INF">3125</us-gaap:ClassOfWarrantOrRightOutstanding>

  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="PAsOn03_31_2016_WarrantMemberusgaapStatementEquityComponentsAxis" id="Factid_173" unitRef="USD_per_Share" decimals="0">8</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>

  <sglb:ClassOfWarrantOrRightsExercisable contextRef="PAsOn12_31_2015_WarrantsOneMemberusgaapStatementEquityComponentsAxis" id="Factid_174" unitRef="shares" decimals="INF">20370</sglb:ClassOfWarrantOrRightsExercisable>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2015To12_31_2015_WarrantsOneMemberusgaapStatementEquityComponentsAxis" id="Factid_175" unitRef="USD_per_Share" decimals="0">15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="PAsOn12_31_2015_WarrantsTwoMemberusgaapStatementEquityComponentsAxis" id="Factid_176" unitRef="shares" decimals="INF">142593</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>

  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="PAsOn12_31_2015_WarrantsTwoMemberusgaapStatementEquityComponentsAxis" id="Factid_177" unitRef="USD_per_Share" decimals="0">15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>

  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="PAsOn03_31_2016_CorporateJointVentureMemberdeiLegalEntityAxis" id="Factid_178" unitRef="pure" decimals="1">0.5</us-gaap:EquityMethodInvestmentOwnershipPercentage>

  <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions contextRef="P09_01_2010To09_13_2010" id="Factid_179" unitRef="pure" decimals="0">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>

  <us-gaap:InventoryRawMaterials contextRef="PAsOn03_31_2016" id="Factid_180" unitRef="USD" decimals="0">132010</us-gaap:InventoryRawMaterials>

  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_181">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;NOTE 2 &amp;#150; Stockholders&amp;#8217; Equity&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; &amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;Common Stock&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &amp;#8220;Certificate of Change&amp;#8221;) filed with the Nevada Secretary of State.&amp;#160;The &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &amp;#8220;Reverse Stock Split&amp;#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#8220;Share Decrease&amp;#8221;).&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &amp;#160; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). &amp;#160;Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. &amp;#160;All amounts shown for common stock included in these financial statement are presented post-Reverse Stock Split.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As of March 31, 2016, the Company had &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 7,500,000&lt;/font&gt; shares of authorized common stock, $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0.001&lt;/font&gt; par value per share.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;On May 23, 2013, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 20,000&lt;/font&gt; shares of the Company&amp;#8217;s common stock to a consultant as noncash compensation for services to be rendered valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;45,400&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.27&lt;/font&gt; per share. Of these shares, &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10,000&lt;/font&gt; (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;22,700&lt;/font&gt;) vested immediately and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 9,607&lt;/font&gt; (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;21,808&lt;/font&gt;) vested during the year ended December 31, 2015. The remaining &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 393&lt;/font&gt; shares (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;892&lt;/font&gt;) vested and were earned by the consultant during the three months ending March 31, 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In January 2014, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 437,500&lt;/font&gt; shares of stock to an investor for a total purchase price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;3,500,000&lt;/font&gt;. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 142,593&lt;/font&gt; shares of the Company&amp;#8217;s common stock, at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt; per share. The warrant had a term of nine months from the date of issuance (January 10, 2014) and had a fair value of approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;1,212,037&lt;/font&gt;. In May 2014, the term of the warrant was extended by nine months to expire in July 2015 and had a fair market value in excess of the remaining fair market value of the original warrant of approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;1,283,333&lt;/font&gt;. A warrant was also issued as part of the offering to a consultant to purchase up to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 21,875&lt;/font&gt; shares of common stock at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;8&lt;/font&gt; per share, valued at approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;271,250&lt;/font&gt;. That warrant had a term of two years from the date of issuance (January 10, 2014). Offering costs paid from the proceeds of the offering were approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;199,089&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;font style="BACKGROUND-COLOR: transparent"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;The fair value of the warrant of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;1,212,037&lt;/font&gt; was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of nine months, expected volatility of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 202&lt;/font&gt;%, a risk-free interest rate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.09&lt;/font&gt;%, and an expected dividend yield of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0&lt;/font&gt;%. The fair value of the warrant of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;271,250&lt;/font&gt; was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 201&lt;/font&gt;%, a risk-free interest rate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.39&lt;/font&gt;%, and an expected dividend yield of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0&lt;/font&gt;%.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;The fair value of the new warrant related to the extension of the warrant expiration of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;1,283,333&lt;/font&gt; (net) was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of 14 months, expected volatility of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 226&lt;/font&gt;%, a risk-free interest rate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.1&lt;/font&gt;%, and an expected dividend yield of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0&lt;/font&gt;%.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In June 2014, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 62,500&lt;/font&gt; shares of stock to an investor for a total purchase price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;500,000&lt;/font&gt;. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 20,370&lt;/font&gt; shares of the Company&amp;#8217;s common stock, at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt; per share. The warrant had a term of one year from the date of issuance (June 4, 2014) and had a fair value of approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;132,407&lt;/font&gt;. A warrant was also issued as part of the offering to a consultant to purchase up to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3,125&lt;/font&gt; shares of common stock at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;8&lt;/font&gt; per share, valued at approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;36,250&lt;/font&gt;. That warrant has a term of two years from the date of issuance (June 4, 2014). Offering costs paid from the proceeds of the offering were approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;25,035&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; The fair value of the warrant of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;132,407&lt;/font&gt; was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of one year, expected volatility of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 163&lt;/font&gt;%, a risk-free interest rate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.1&lt;/font&gt;%, and an expected dividend yield of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0&lt;/font&gt;%. The fair value of the warrant of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;36,250&lt;/font&gt; was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 287&lt;/font&gt;%, a risk-free interest rate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.41&lt;/font&gt;%, and an expected dividend yield of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0&lt;/font&gt;%.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;During July 2014, the Company issued an aggregate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 60,000&lt;/font&gt; shares of common stock to three employees valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;12.90&lt;/font&gt; per share or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;774,000&lt;/font&gt;. Twenty-five percent of each employee&amp;#8217;s shares vested immediately upon the grant date, &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 25&lt;/font&gt;% of such shares vested upon the first annual anniversary of each employee&amp;#8217;s start date, and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 25&lt;/font&gt;% of such shares will vest on each of the second and third annual anniversary of each employee's start date, provided that such employee remains in the Company&amp;#8217;s continuous employ through such vesting dates.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In November 2014, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 15,000&lt;/font&gt; shares of stock to a director, subject to restrictions, pursuant to the Company's 2013 Equity Incentive Plan (the &amp;#8220;2013 Plan&amp;#8221;). The shares were valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;9.40&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;141,000&lt;/font&gt;. All shares vested during the year ended December 31, 2015.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In March 2015, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10,000&lt;/font&gt; shares of stock to a director. The Company also issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 5,000&lt;/font&gt; shares of stock to an officer, and an aggregate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 21,038&lt;/font&gt; shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.30&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;191,000&lt;/font&gt;. &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 33,037&lt;/font&gt; of the shares vested during the year ended December 31, 2015. Another&amp;#160;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 429&lt;/font&gt; shares (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2,275&lt;/font&gt;) vested during the three months ending March 31, 2016 and the remaining&amp;#160;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,572&lt;/font&gt; shares unvested at March 31, 2016 (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;13,630&lt;/font&gt;) are reflected as prepaid assets.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In August 2015, in conjuction with the hiring of Ron Fisher, the Company's Vice President of Business Development, the Company issued to Mr. Fisher &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,500&lt;/font&gt; shares of common stock, subject to performance-based vesting restrictions. The shares, valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;14,750&lt;/font&gt;, remain unvested at March 31, 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In November 2015, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 625&lt;/font&gt; shares of common stock to an employee valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;6.50&lt;/font&gt; per share, or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;4,063&lt;/font&gt;, and issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,500&lt;/font&gt; shares of common stock to an employee valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;6.15&lt;/font&gt; per share, or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15,375&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;In February 2016, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 625&lt;/font&gt; shares of common stock to a new employee, valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;4.82&lt;/font&gt; per share, or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;3,013&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; In March 2016, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3,080&lt;/font&gt; shares of common stock to a consultant, valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;4.87&lt;/font&gt; per share, or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15,000&lt;/font&gt;.&lt;/div&gt; &amp;#160; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As of&amp;#160;March 31, 2016, there were &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 6,232,778&lt;/font&gt; shares of common stock issued and outstanding. As of December 31, 2015, there were &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 6,239,073&lt;/font&gt; shares of common stock issued and outstanding, reflecting &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 22,500&lt;/font&gt; and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 32,500&lt;/font&gt; shares, respectively, issued but unvested shares pursuant to the Company's 2011 Equity Incentive Plan (the &amp;#8220;2011 Plan&amp;#8221;) and the 2013 Plan. As of March 31, 2016, an aggregate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 1,500&lt;/font&gt; shares and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 167,132&lt;/font&gt; shares of common stock were reserved for issuance under the 2011 Plan and the 2013 Plan, respectively.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;Deferred Compensation&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As described under the Common Stock heading above, during July 2014, the Company issued to three employees an aggregate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 60,000&lt;/font&gt; shares of the Company&amp;#8217;s common stock, subject to restrictions, pursuant to the 2013 Plan. Such shares were valued at the fair value of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;774,000&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;12.90&lt;/font&gt; per share. This compensation is being expensed over the vesting period. As of March 31, 2016, the balance of unvested compensation cost expected to be recognized is $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;258,000&lt;/font&gt; (&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;20,000&lt;/font&gt; shares valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;12.90&lt;/font&gt;) and is recorded as a reduction of stockholders&amp;#8217; equity. The unvested compensation is expected to be recognized over the weighted average period of approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2&lt;/font&gt; years (through July 2017).&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As described under the Common Stock heading above, in November 2014, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 15,000&lt;/font&gt; shares of stock to a director, subject to restrictions, pursuant to the 2013 Plan. The shares were valued&amp;#160;at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;9.40&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;141,000&lt;/font&gt;. All shares vested during the year ended December 31, 2015.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As described under the Common Stock heading above, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10,000&lt;/font&gt; shares of stock to a director in March 2015. The Company also issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 5,000&lt;/font&gt; shares of stock to an officer, and an aggregate of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 21,038&lt;/font&gt; shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.30&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;191,000&lt;/font&gt;. &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 33,037&lt;/font&gt; of the shares vested during the year ended December 31, 2015. Another&amp;#160;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 429&lt;/font&gt; shares (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2,275&lt;/font&gt;) vested during the three months ending March 31, 2016 and the remaining&amp;#160;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,572&lt;/font&gt; shares unvested at March 31, 2016 (valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;13,630&lt;/font&gt;) are reflected as prepaid assets.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As described under the Common Stock heading above, in August 2015, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,500&lt;/font&gt; shares of stock to an employee, subject to performance-based vesting restrictions, pursuant to the Company's 2013 Equity Incentive Plan (the &amp;#8220;2013 Plan&amp;#8221;). The shares were valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.90&lt;/font&gt; or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;14,750&lt;/font&gt;. All shares remained unvested as of March 31, 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As of March 31, 2016, the balance of unvested compensation cost expected to be recognized is $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;272,750&lt;/font&gt; and is recorded as a reduction of stockholders&amp;#8217; equity. The unvested compensation is expected to be recognized over the weighted average period of approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2&lt;/font&gt; years (through July, 2017).&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;Preferred Stock&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; &amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;The Company is authorized to issue &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10,000,000&lt;/font&gt; shares of preferred stock, $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0.001&lt;/font&gt; par value per share. No shares of preferred stock were issued and outstanding at March 31, 2016 or December 31, 2015.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;Stock Options&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; During 2015, the Company granted a total of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 56,875&lt;/font&gt; options to three employees with vesting periods ranging from one to four years beginning August 10, 2015. As of March 31, 2016, none of the option grants had vested, and only a nominal amount of compensation cost had been recognized during the year. The weighted average period over which total compensation cost of the options of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;306,796&lt;/font&gt; will be recognized is &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3.81&lt;/font&gt; years. The weighted average exercise price of the options was $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.94&lt;/font&gt; and the weighted average fair value of the options on the dates of grant was $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.91&lt;/font&gt;. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 82%"&gt; &lt;div&gt;Expected term:&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10&lt;/font&gt; years&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;Volatility:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 180&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;184&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Dividend yield:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.00&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Risk-free interest rate:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2.24&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.32&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;During 2016, the Company granted a total of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 21,875&lt;/font&gt; options to &lt;font style="BACKGROUND-COLOR: transparent"&gt;three employees with vesting periods&amp;#160;ranging from &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; three&lt;/font&gt; to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; four&lt;/font&gt;&amp;#160;years beginning February 16, 2016. As of March 31, 2016, compensation cost of $53,540, including options granted during 2015 was recognized during the period, for options vesting. The weighted average period over which total compensation cost of the options of &lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;116,177&lt;/font&gt;&lt;/font&gt; ($306,796 in 2015)&amp;#160;will be recognized is &lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3.91&lt;/font&gt;&lt;/font&gt; years. The weighted average exercise price of the options &lt;font style="BACKGROUND-COLOR: transparent"&gt;was &lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; $&lt;/font&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.75&lt;/font&gt;&lt;/font&gt; and the weighted average fair value of the options on the dates of grant was &lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; $&lt;/font&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5.73&lt;/font&gt;&lt;/font&gt;. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 82%"&gt; &lt;div&gt;Expected term:&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10&lt;/font&gt; years&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;Volatility:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 176&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;184&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Dividend yield:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.00&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Risk-free interest rate:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2.24&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.32&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/b&gt;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Warrants&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; &amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As of March 31, 2016, the Company had one outstanding warrant remaining to purchase a total of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3,125&lt;/font&gt; shares of common stock at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;8&lt;/font&gt; per share. Such warrant will expire on June 4, 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;During the three months ending March 31, 2016, a warrant to purchase &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 21,875&lt;/font&gt; shares of common stock at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;8&lt;/font&gt; per share expired.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;During the year ending December 31, 2015, a warrant to purchase &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 20,370&lt;/font&gt; shares of common stock at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt; per share, as well as a warrant to purchase &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 142,593&lt;/font&gt; shares of common stock at an exercise price of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt; per share, expired.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>

  <sglb:ContinuingOperationsDisclosureTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_182">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;NOTE&amp;#160;3&amp;#160;- Continuing Operations&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has had increasing revenues in recent periods. In addition, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. The Company believes it has adequate working capital and cash to fund operations through 2016, and has entered into significant revenue contracts that are expected to generate cash flow in the near term.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sglb:ContinuingOperationsDisclosureTextBlock>

  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="P01_01_2016To03_31_2016" id="Factid_183">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>

  <sglb:JointVentureDisclosureTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_184">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;NOTE&amp;#160;5 - Joint Venture&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; &amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;As previously reported in our Form 8-K filed with the SEC on July 6, 2015, we entered into an Operating Agreement and Statement of Work with Arete Innovative Solutions LLC (&amp;#8220;Arete&amp;#8221;). The Operating Agreement and Statement of Work govern the operations of Arete-Sigma LLC (the "Joint Venture"), a joint venture formed by us and Arete for the purpose of pursuing business opportunities related to AM utilizing our EOS M290 or like machines, including enabling and implementing sales and manufacturing transactions. Under the Operating Agreement and Statement of Work, among other matters reported in our Form 8-K and set forth in the Operating Agreement and Statement of Work, (i) each of Sigma and Arete hold a &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 50&lt;/font&gt;% ownership interest in the Joint Venture, and (ii) the Joint Venture is managed by William F. Herman, President of Arete, subject to certain limitations. Based on the Operating Agreement, the Company holds the non-controlling interest in the Joint Venture. Therefore, the Joint Venture has not been consolidated, but rather is accounted for on the equity method of recording investments. During the three months ended March 31, 2016, the joint venture had no activity. The Company is evaluating whether to continue the Joint Venture and is continuing to pursue business opportunities related to AM utilizing the Company's EOS M290 or like machines.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sglb:JointVentureDisclosureTextBlock>

  <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_185">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; NOTE&amp;#160;6&lt;/font&gt;&lt;/b&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt; &lt;b&gt;&amp;#150; Subsequent Events&lt;/b&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are the following items to disclose:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; On April 17, 2016, the Company issued &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3,529&lt;/font&gt; shares of common stock to a consultant for services to be rendered valued at $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;4.25&lt;/font&gt; per share, or $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15,000&lt;/font&gt;.&lt;/div&gt; &amp;#160; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; On April 28, 2016, at the Annual Meeting of Stockholders of the Company, the Company's stockholders approved an amendment to the 2013 Plan to increase the number of shares of the Company's common stock reserved for issuance under the 2013 Plan by 638,538 shares of our common stock to a total of 750,000 shares (on a post-Reverse Stock Split basis).&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; On April 28, 2016, the Company's Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company's common stock from 7,500,000 to 15,000,000 shares of common stock&amp;#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>

  <us-gaap:AccountsReceivableNetCurrent contextRef="PAsOn03_31_2016" id="Factid_186" unitRef="USD" decimals="0">381309</us-gaap:AccountsReceivableNetCurrent>

  <us-gaap:AccountsReceivableNetCurrent contextRef="PAsOn12_31_2015" id="Factid_187" unitRef="USD" decimals="0">280222</us-gaap:AccountsReceivableNetCurrent>

  <us-gaap:InventoryNet contextRef="PAsOn03_31_2016" id="Factid_188" unitRef="USD" decimals="0">94186</us-gaap:InventoryNet>

  <us-gaap:InventoryNet contextRef="PAsOn12_31_2015" id="Factid_189" unitRef="USD" decimals="0">20129</us-gaap:InventoryNet>

  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="PAsOn03_31_2016" id="Factid_190" unitRef="USD" decimals="0">38862</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>

  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="PAsOn12_31_2015" id="Factid_191" unitRef="USD" decimals="0">55484</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>

  <us-gaap:AssetsCurrent contextRef="PAsOn03_31_2016" id="Factid_192" unitRef="USD" decimals="0">1600720</us-gaap:AssetsCurrent>

  <us-gaap:AssetsCurrent contextRef="PAsOn12_31_2015" id="Factid_193" unitRef="USD" decimals="0">1895644</us-gaap:AssetsCurrent>

  <us-gaap:PropertyPlantAndEquipmentNet contextRef="PAsOn03_31_2016" id="Factid_194" unitRef="USD" decimals="0">697316</us-gaap:PropertyPlantAndEquipmentNet>

  <us-gaap:PropertyPlantAndEquipmentNet contextRef="PAsOn12_31_2015" id="Factid_195" unitRef="USD" decimals="0">714754</us-gaap:PropertyPlantAndEquipmentNet>

  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="PAsOn03_31_2016" id="Factid_196" unitRef="USD" decimals="0">197630</us-gaap:IntangibleAssetsNetExcludingGoodwill>

  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="PAsOn12_31_2015" id="Factid_197" unitRef="USD" decimals="0">167644</us-gaap:IntangibleAssetsNetExcludingGoodwill>

  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="PAsOn03_31_2016" id="Factid_198" unitRef="USD" decimals="0">9222</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>

  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="PAsOn12_31_2015" id="Factid_199" unitRef="USD" decimals="0">9222</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>

  <us-gaap:AssetsNoncurrent contextRef="PAsOn03_31_2016" id="Factid_200" unitRef="USD" decimals="0">904168</us-gaap:AssetsNoncurrent>

  <us-gaap:AssetsNoncurrent contextRef="PAsOn12_31_2015" id="Factid_201" unitRef="USD" decimals="0">891620</us-gaap:AssetsNoncurrent>

  <us-gaap:Assets contextRef="PAsOn03_31_2016" id="Factid_202" unitRef="USD" decimals="0">2504888</us-gaap:Assets>

  <us-gaap:Assets contextRef="PAsOn12_31_2015" id="Factid_203" unitRef="USD" decimals="0">2787264</us-gaap:Assets>

  <us-gaap:AccountsPayableCurrent contextRef="PAsOn03_31_2016" id="Factid_204" unitRef="USD" decimals="0">144026</us-gaap:AccountsPayableCurrent>

  <us-gaap:AccountsPayableCurrent contextRef="PAsOn12_31_2015" id="Factid_205" unitRef="USD" decimals="0">38393</us-gaap:AccountsPayableCurrent>

  <us-gaap:AccruedLiabilitiesCurrent contextRef="PAsOn03_31_2016" id="Factid_206" unitRef="USD" decimals="0">82630</us-gaap:AccruedLiabilitiesCurrent>

  <us-gaap:AccruedLiabilitiesCurrent contextRef="PAsOn12_31_2015" id="Factid_207" unitRef="USD" decimals="0">71523</us-gaap:AccruedLiabilitiesCurrent>

  <us-gaap:LiabilitiesCurrent contextRef="PAsOn03_31_2016" id="Factid_208" unitRef="USD" decimals="0">226656</us-gaap:LiabilitiesCurrent>

  <us-gaap:LiabilitiesCurrent contextRef="PAsOn12_31_2015" id="Factid_209" unitRef="USD" decimals="0">109916</us-gaap:LiabilitiesCurrent>

  <us-gaap:Liabilities contextRef="PAsOn03_31_2016" id="Factid_210" unitRef="USD" decimals="0">226656</us-gaap:Liabilities>

  <us-gaap:Liabilities contextRef="PAsOn12_31_2015" id="Factid_211" unitRef="USD" decimals="0">109916</us-gaap:Liabilities>

  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="PAsOn03_31_2016" id="Factid_212" unitRef="USD" decimals="0">2504888</us-gaap:LiabilitiesAndStockholdersEquity>

  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="PAsOn12_31_2015" id="Factid_213" unitRef="USD" decimals="0">2787264</us-gaap:LiabilitiesAndStockholdersEquity>

  <us-gaap:StockholdersEquity contextRef="PAsOn03_31_2016" id="Factid_214" unitRef="USD" decimals="0">2278232</us-gaap:StockholdersEquity>

  <us-gaap:StockholdersEquity contextRef="PAsOn12_31_2015" id="Factid_215" unitRef="USD" decimals="0">2677348</us-gaap:StockholdersEquity>

  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="PAsOn03_31_2016" id="Factid_216" unitRef="USD" decimals="0">-8034787</us-gaap:RetainedEarningsAccumulatedDeficit>

  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="PAsOn12_31_2015" id="Factid_217" unitRef="USD" decimals="0">-7564120</us-gaap:RetainedEarningsAccumulatedDeficit>

  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="PAsOn03_31_2016" id="Factid_218" unitRef="USD" decimals="0">10579536</us-gaap:AdditionalPaidInCapitalCommonStock>

  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="PAsOn12_31_2015" id="Factid_219" unitRef="USD" decimals="0">10636979</us-gaap:AdditionalPaidInCapitalCommonStock>

  <us-gaap:DeferredCompensationEquity contextRef="PAsOn03_31_2016" id="Factid_220" unitRef="USD" decimals="0">272750</us-gaap:DeferredCompensationEquity>

  <us-gaap:DeferredCompensationEquity contextRef="PAsOn12_31_2015" id="Factid_221" unitRef="USD" decimals="0">401750</us-gaap:DeferredCompensationEquity>

  <us-gaap:PreferredStockValue contextRef="PAsOn03_31_2016" id="Factid_222" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>

  <us-gaap:PreferredStockValue contextRef="PAsOn12_31_2015" id="Factid_223" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>

  <us-gaap:CommonStockValue contextRef="PAsOn03_31_2016" id="Factid_224" unitRef="USD" decimals="0">6233</us-gaap:CommonStockValue>

  <us-gaap:CommonStockValue contextRef="PAsOn12_31_2015" id="Factid_225" unitRef="USD" decimals="0">6239</us-gaap:CommonStockValue>

  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_226">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;NOTE 1 &amp;#150; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Nature of Business &amp;#150;&lt;/b&gt; On &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;September 13, 2010&lt;/font&gt; Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 100&lt;/font&gt;% of the shares of B6 Sigma, Inc. by exchanging &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 6.67&lt;/font&gt; shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#8220;reverse purchase&amp;#8221;, and accordingly the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#8220;B6 Sigma&amp;#8221; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#8220;Company,&amp;#8221; &amp;#8220;Sigma,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us&amp;#8221; and &amp;#8220;our&amp;#8221; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimatley leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and processs control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, &lt;font style="FONT-SIZE: 10pt"&gt;automotive manufacturing, and other markets such as firearms and recreational equipment&lt;/font&gt;.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Basis of Presentation&lt;/strong&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2016 and 2015 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2015 audited financial statements and notes thereto included in the Company&amp;#8217;s Form 10-K. The results of operations for the periods ended March 31, 2016 and 2015 are not necessarily indicative of the operating results for the full year.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;font style="BACKGROUND-COLOR: transparent"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Property and Equipment &amp;#150;&lt;/b&gt; Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Fair Value of Financial Instruments&lt;/b&gt; - The Company applies ASC 820, &amp;#8220;Fair Value Measurements&lt;i&gt;.&lt;/i&gt;&amp;#8221;&lt;i&gt;&amp;#160;&lt;/i&gt; This guidance defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; BORDER-TOP-COLOR: #000000; WIDTH: 5%; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; WIDTH: 94%; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Income Taxes&lt;/b&gt; &lt;b&gt;&amp;#150;&lt;/b&gt; The Company accounts for income taxes in accordance with ASC Topic No. 740, &amp;#8220;Accounting for Income Taxes.&amp;#8221;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company adopted the provisions of ASC Topic No. 740, &amp;#8220;Accounting for Income Taxes,&amp;#8221; at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company has no tax positions at March 31, 2016 and December 31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the three months ended March 31, 2016, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at March 31, 2016 and 2015 or December 31, 2015. All tax years starting with 2010 are open for examination.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Loss Per Share &amp;#150;&lt;/b&gt; The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#8220;Earnings Per Share.&amp;#8221;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/b&gt; - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at March 31, 2016 and December 31, 2015 was $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0&lt;/font&gt; respectively.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Long-Lived and Intangible Assets &amp;#150;&lt;/b&gt; Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the three months March 31, 2016 or the year ended December 31, 2015.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#8220;Codification&amp;#8221; or &amp;#8220;ASC&amp;#8221;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#8220;GAAP&amp;#8221;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Recent Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Cash Equivalents&lt;/b&gt; - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Concentration of Credit Risk -&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Organization Expenditures&lt;/b&gt; &amp;#150; Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Stock Based Compensation&lt;/b&gt; &amp;#150; The Company recognizes compensation costs to employees under ASC Topic No. 718, &amp;#8220;Compensation &amp;#150; Stock Compensation.&amp;#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grants for compensation are included in the Statement of Stockholders&amp;#8217; Equity as a contra-equity account as &amp;#8220;Deferred Compensation.&amp;#8221;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, &amp;#8220;Equity Based Payments to Non-Employees.&amp;#8221; In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Amortization&lt;/b&gt; - Utility patents are amortized over a &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;17&lt;/font&gt; year period. Patents which are pending are not amortized.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Revenue Recognition &amp;#150;&lt;/b&gt; The Company&amp;#8217;s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Inventory&lt;/b&gt; &amp;#150; Inventories consist of raw materials used in the production of customized parts totaling $94,186 and nominal work-in-process components which will be sold to customers. Inventories are valued at the lower of cost or market, using the first-in, first-out (FIFO) method.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Research and Development&lt;/b&gt; &amp;#150; Research and development costs are expensed as they are incurred. Research and development costs for the three months ended March 31, 2016 and 2015 were $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;39,071&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;70,147&lt;/font&gt;, respectively.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P01_01_2016To03_31_2016_EmployeeMemberusgaapTitleOfIndividualAxis" id="Factid_227" unitRef="shares" decimals="INF">625</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn03_31_2016_EmployeeMemberusgaapTitleOfIndividualAxis" id="Factid_228" unitRef="USD_per_Share" decimals="2">4.82</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="PAsOn03_31_2016" id="Factid_229" unitRef="shares" decimals="INF">10000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>

  <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="P01_01_2016To03_31_2016" id="Factid_230" unitRef="USD" decimals="0">129000</us-gaap:IncreaseDecreaseInDeferredCompensation>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P01_01_2015To03_31_2015" id="Factid_231" unitRef="shares" decimals="INF">36038</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn03_31_2015" id="Factid_232" unitRef="USD_per_Share" decimals="2">5.30</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="PAsOn03_31_2016" id="Factid_233" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>

  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="PAsOn12_31_2015" id="Factid_234" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>

  <us-gaap:PreferredStockSharesAuthorized contextRef="PAsOn12_31_2015" id="Factid_235" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>

  <us-gaap:PreferredStockSharesIssued contextRef="PAsOn03_31_2016" id="Factid_236" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>

  <us-gaap:PreferredStockSharesIssued contextRef="PAsOn12_31_2015" id="Factid_237" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>

  <us-gaap:PreferredStockSharesOutstanding contextRef="PAsOn03_31_2016" id="Factid_238" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>

  <us-gaap:PreferredStockSharesOutstanding contextRef="PAsOn12_31_2015" id="Factid_239" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2015To03_31_2015_StockCompensationPlanMemberusgaapAwardTypeAxis" id="Factid_240" unitRef="shares" decimals="INF">3750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn03_31_2016" id="Factid_241" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn12_31_2015" id="Factid_242" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="P01_01_2015To03_31_2015_StockCompensationPlanMemberusgaapAwardTypeAxis" id="Factid_243" unitRef="USD" decimals="0">35250</us-gaap:IncreaseDecreaseInDeferredCompensation>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn03_31_2016" id="Factid_244" unitRef="shares" decimals="INF">7500000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn12_31_2015" id="Factid_245" unitRef="shares" decimals="INF">7500000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn03_31_2016" id="Factid_246" unitRef="shares" decimals="INF">6232778</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockSharesOutstanding contextRef="PAsOn03_31_2016" id="Factid_247" unitRef="shares" decimals="INF">6210278</us-gaap:CommonStockSharesOutstanding>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn12_31_2015" id="Factid_248" unitRef="shares" decimals="INF">6239073</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockSharesOutstanding contextRef="PAsOn12_31_2015" id="Factid_249" unitRef="shares" decimals="INF">6206573</us-gaap:CommonStockSharesOutstanding>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="PAsOn03_31_2015" id="Factid_250" unitRef="shares" decimals="INF">19528</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>

  <us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance contextRef="PAsOn03_31_2016" id="Factid_251" unitRef="shares" decimals="INF">22500</us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance>

  <us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance contextRef="PAsOn12_31_2015" id="Factid_252" unitRef="shares" decimals="INF">32500</us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_253">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>

  <us-gaap:FairValueAdjustmentOfWarrants contextRef="P07_01_2014To07_31_2014_WarrantExpiryLifeOneYearMemberusgaapStatementEquityComponentsAxis" id="Factid_254" unitRef="USD" decimals="0">271250</us-gaap:FairValueAdjustmentOfWarrants>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="PAsOn03_31_2016_VicePresidentMemberusgaapTitleOfIndividualAxis" id="Factid_255" unitRef="USD" decimals="0">14750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn02_28_2016_CommonStockShareIssedToEmployeeNewMemberusgaapTitleOfIndividualAxis" id="Factid_256" unitRef="shares" decimals="INF">625</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockValue contextRef="PAsOn02_28_2016_CommonStockShareIssedToEmployeeNewMemberusgaapTitleOfIndividualAxis" id="Factid_257" unitRef="USD" decimals="0">3013</us-gaap:CommonStockValue>

  <us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance contextRef="PAsOn03_31_2016_EquityIncentivePlan2011MemberusgaapAwardTypeAxis" id="Factid_258" unitRef="shares" decimals="INF">22500</us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance>

  <us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance contextRef="PAsOn12_31_2015_EquityIncentivePlan2011MemberusgaapAwardTypeAxis" id="Factid_259" unitRef="shares" decimals="INF">32500</us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance>

  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="PAsOn03_31_2016_EquityIncentivePlan2011MemberusgaapAwardTypeAxis" id="Factid_260" unitRef="shares" decimals="INF">1500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>

  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="PAsOn03_31_2016_EquityIncentivePlan2013MemberusgaapAwardTypeAxis" id="Factid_261" unitRef="shares" decimals="INF">167132</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_262" unitRef="shares" decimals="INF">56875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="PAsOn12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_263" unitRef="USD" decimals="0">306796</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_264">P3Y9M22D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_265" unitRef="USD_per_Share" decimals="2">5.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_266" unitRef="USD_per_Share" decimals="2">5.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_267" unitRef="shares" decimals="INF">21875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="PAsOn03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_268" unitRef="USD" decimals="0">116177</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_269">P3Y10M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapOptionIndexedToIssuersEquityEquityAxis" id="Factid_270" unitRef="USD_per_Share" decimals="2">5.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>

  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="PAsOn03_31_2016_WarrantsOneMemberusgaapStatementEquityComponentsAxis" id="Factid_271" unitRef="shares" decimals="INF">21875</us-gaap:ClassOfWarrantOrRightOutstanding>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2016To03_31_2016_WarrantsOneMemberusgaapStatementEquityComponentsAxis" id="Factid_272" unitRef="USD_per_Share" decimals="0">8</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="PAsOn03_31_2016" id="Factid_273" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2015To03_31_2015" id="Factid_274" unitRef="shares" decimals="INF">16509</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <sglb:IncreaseDecreaseInDeferredCompensationperShare contextRef="P01_01_2016To03_31_2016" id="Factid_275" unitRef="USD_per_Share" decimals="2">12.90</sglb:IncreaseDecreaseInDeferredCompensationperShare>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="P01_01_2016To03_31_2016_ConsultantOneMembersglbThirdPartyAxis" id="Factid_276" unitRef="USD" decimals="0">22700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="P01_01_2015To12_31_2015_ConsultantOneMembersglbThirdPartyAxis" id="Factid_277" unitRef="USD" decimals="0">9607</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="P01_01_2016To03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_278" unitRef="USD" decimals="0">2275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="PAsOn03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_279" unitRef="shares" decimals="INF">2572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="P01_01_2016To03_31_2016_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_280" unitRef="shares" decimals="INF">429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>

  <us-gaap:StockOptionPlanExpense contextRef="P01_01_2016To03_31_2016" id="Factid_281" unitRef="USD" decimals="0">53540</us-gaap:StockOptionPlanExpense>

  <us-gaap:StockOptionPlanExpense contextRef="P01_01_2015To03_31_2015" id="Factid_282" unitRef="USD" decimals="0">0</us-gaap:StockOptionPlanExpense>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="P01_01_2016To03_31_2016_MinimumMemberusgaapRangeAxis" id="Factid_283">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="P01_01_2016To03_31_2016_MaximumMemberusgaapRangeAxis" id="Factid_284">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P01_01_2016To03_31_2016_CosultantMembersglbThirdPartyAxis" id="Factid_285" unitRef="shares" decimals="INF">3080</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn03_31_2016_CosultantMembersglbThirdPartyAxis" id="Factid_286" unitRef="USD_per_Share" decimals="2">4.87</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="P01_01_2016To03_31_2016_CosultantMembersglbThirdPartyAxis" id="Factid_287" unitRef="USD" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P04_01_2016To04_17_2016_CosultantMembersglbThirdPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" id="Factid_288" unitRef="shares" decimals="INF">3529</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn04_17_2016_CosultantMembersglbThirdPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" id="Factid_289" unitRef="USD_per_Share" decimals="2">4.25</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="P04_01_2016To04_17_2016_CosultantMembersglbThirdPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" id="Factid_290" unitRef="USD" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>

  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="P01_01_2016To03_31_2016_ConsultantMembersglbThirdPartyAxis" id="Factid_291" unitRef="shares" decimals="INF">3080</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>

  <us-gaap:SharesIssuedPricePerShare contextRef="PAsOn03_31_2016_ConsultantMembersglbThirdPartyAxis" id="Factid_292" unitRef="USD_per_Share" decimals="2">4.87</us-gaap:SharesIssuedPricePerShare>

  <us-gaap:StockholdersEquityReverseStockSplit contextRef="P01_01_2016To03_31_2016" id="Factid_293">As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statement are presented post-Reverse Stock Split.</us-gaap:StockholdersEquityReverseStockSplit>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="P01_01_2015To03_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_294" unitRef="shares" decimals="INF">429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="P01_01_2015To03_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_295" unitRef="USD" decimals="0">2275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="PAsOn03_31_2015_DeferredCompensationShareBasedPaymentsMemberusgaapStatementEquityComponentsAxis" id="Factid_296" unitRef="shares" decimals="INF">2572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_297">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_298" unitRef="pure" decimals="1">1.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_299" unitRef="pure" decimals="2">1.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_300" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_301" unitRef="pure" decimals="4">0.0224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="P01_01_2015To12_31_2015_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_302" unitRef="pure" decimals="4">0.0232</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_303" unitRef="pure" decimals="2">1.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_304" unitRef="pure" decimals="2">1.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_305" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_306" unitRef="pure" decimals="4">0.0224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="P01_01_2016To03_31_2016_EmployeeStockOptionMemberusgaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" id="Factid_307" unitRef="pure" decimals="4">0.0232</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>

  <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_308">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;NOTE&amp;#160;4 &amp;#150; Loss Per Share&lt;/strong&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2016 and 2015:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="21%" colspan="5"&gt; &lt;div&gt;3&amp;#160;Months&amp;#160;Ended&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"&gt; &lt;div&gt;03-31-16&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"&gt; &lt;div&gt;03-31-15&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Loss from continuing Operations available to Common stockholders (numerator)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;(470,667)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;(371,881)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;6,233,729&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;6,206,220&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&amp;#160;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>

  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="PAsOn04_28_2016_SubsequentEventMemberusgaapSubsequentEventTypeAxis_TwoThousandAndThirteenStockOptionPlanMemberusgaapPlanNameAxis" id="Factid_309" unitRef="shares" decimals="INF">638538</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>

  <sglb:CommonStockSharesAuthorisedPostReverseStockSplit contextRef="PAsOn04_28_2016_SubsequentEventMemberusgaapSubsequentEventTypeAxis_TwoThousandAndThirteenStockOptionPlanMemberusgaapPlanNameAxis" id="Factid_310" unitRef="shares" decimals="INF">750000</sglb:CommonStockSharesAuthorisedPostReverseStockSplit>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn04_28_2016_MinimumMemberusgaapRangeAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" id="Factid_311" unitRef="shares" decimals="INF">7500000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn04_28_2016_MaximumMemberusgaapRangeAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" id="Factid_312" unitRef="shares" decimals="INF">15000000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_313">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"&gt; &amp;#160;&lt;/div&gt; &lt;table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 82%"&gt; &lt;div&gt;Expected term:&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10&lt;/font&gt; years&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;Volatility:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 180&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;184&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Dividend yield:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.00&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Risk-free interest rate:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2.24&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.32&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt;&amp;#160;&lt;/div&gt;&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;font style="BACKGROUND-COLOR: transparent"&gt;&lt;font style="BACKGROUND-COLOR: transparent"&gt;The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"&gt; &lt;font style="COLOR: black; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 82%"&gt; &lt;div&gt;Expected term:&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10&lt;/font&gt; years&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;Volatility:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 176&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;184&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Dividend yield:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 0.00&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;Risk-free interest rate:&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: right"&gt; &lt;div&gt;&lt;font style="FONT-FAMILY:Times New Roman, Times, Serif"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2.24&lt;/font&gt;-&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.32&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>

  <sglb:NatureOfBusinessPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_314">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Nature of Business &amp;#150;&lt;/b&gt; On &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;September 13, 2010&lt;/font&gt; Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 100&lt;/font&gt;% of the shares of B6 Sigma, Inc. by exchanging &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 6.67&lt;/font&gt; shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#8220;reverse purchase&amp;#8221;, and accordingly the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#8220;B6 Sigma&amp;#8221; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#8220;Company,&amp;#8221; &amp;#8220;Sigma,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us&amp;#8221; and &amp;#8220;our&amp;#8221; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimatley leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and processs control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, &lt;font style="FONT-SIZE: 10pt"&gt;automotive manufacturing, and other markets such as firearms and recreational equipment&lt;/font&gt;.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sglb:NatureOfBusinessPolicyTextBlock>

  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_315">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Basis of Presentation&lt;/strong&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2016 and 2015 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2015 audited financial statements and notes thereto included in the Company&amp;#8217;s Form 10-K. The results of operations for the periods ended March 31, 2016 and 2015 are not necessarily indicative of the operating results for the full year.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>

  <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="P01_01_2016To03_31_2016" id="Factid_316">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>

  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_317">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Property and Equipment &amp;#150;&lt;/b&gt; Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>

  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="P01_01_2016To03_31_2016" id="Factid_318">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt; - The Company applies ASC 820, &amp;#8220;Fair Value Measurements&lt;i&gt;.&lt;/i&gt;&amp;#8221;&lt;i&gt;&amp;#160;&lt;/i&gt; This guidance defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; BORDER-TOP-COLOR: #000000; WIDTH: 5%; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; WIDTH: 94%; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"&gt; &lt;div style="CLEAR:both;CLEAR: both"&gt;&lt;font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"&gt;Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>

  <us-gaap:StockholdersEquityReverseStockSplit contextRef="P03_01_2016To03_17_2016" id="Factid_319">The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &amp;#8220;Reverse Stock Split&amp;#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#8220;Share Decrease&amp;#8221;).</us-gaap:StockholdersEquityReverseStockSplit>

  <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_320">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Income Taxes&lt;/b&gt; &lt;b&gt;&amp;#150;&lt;/b&gt; The Company accounts for income taxes in accordance with ASC Topic No. 740, &amp;#8220;Accounting for Income Taxes.&amp;#8221;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company adopted the provisions of ASC Topic No. 740, &amp;#8220;Accounting for Income Taxes,&amp;#8221; at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company has no tax positions at March 31, 2016 and December 31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the three months ended March 31, 2016, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at March 31, 2016 and 2015 or December 31, 2015. All tax years starting with 2010 are open for examination.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxPolicyTextBlock>

  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_321">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Loss Per Share &amp;#150;&lt;/b&gt; The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#8220;Earnings Per Share.&amp;#8221;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>

  <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="P01_01_2016To03_31_2016" id="Factid_322">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/b&gt; - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at March 31, 2016 and December 31, 2015 was $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0&lt;/font&gt; respectively.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>

  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_323">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Long-Lived and Intangible Assets &amp;#150;&lt;/b&gt; Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the three months March 31, 2016 or the year ended December 31, 2015.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>

  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_324">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#8220;Codification&amp;#8221; or &amp;#8220;ASC&amp;#8221;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#8220;GAAP&amp;#8221;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Recent Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>

  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_325">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Cash Equivalents&lt;/b&gt; - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>

  <us-gaap:ConcentrationRiskCreditRisk contextRef="P01_01_2016To03_31_2016" id="Factid_326">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Concentration of Credit Risk -&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ConcentrationRiskCreditRisk>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn02_28_2016_CommonStockShareIssedToEmployeeNewMemberusgaapTitleOfIndividualAxis" id="Factid_327" unitRef="USD_per_Share" decimals="2">4.82</us-gaap:CommonStockParOrStatedValuePerShare>

  <sglb:OrganizationExpenditurePolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_328">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Organization Expenditures&lt;/b&gt; &amp;#150; Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sglb:OrganizationExpenditurePolicyTextBlock>

  <us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_329">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Amortization&lt;/b&gt; - Utility patents are amortized over a &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 17&lt;/font&gt; year period. Patents which are pending are not amortized.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock>

  <us-gaap:UseOfEstimates contextRef="P01_01_2016To03_31_2016" id="Factid_330">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UseOfEstimates>

  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_331">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Revenue Recognition &amp;#150;&lt;/b&gt; The Company&amp;#8217;s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>

  <us-gaap:InventoryPolicyTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_332">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Inventory&lt;/b&gt; &amp;#150; Inventories consist of raw materials used in the production of customized parts totaling $94,186 and nominal work-in-process components which will be sold to customers. Inventories are valued at the lower of cost or market, using the first-in, first-out (FIFO) method.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryPolicyTextBlock>

  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="P01_01_2016To03_31_2016" id="Factid_333">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;Research and Development&lt;/b&gt; &amp;#150; Research and development costs are expensed as they are incurred. Research and development costs for the three months ended March 31, 2016 and 2015 were $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;39,071&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;70,147&lt;/font&gt;, respectively.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>

  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2016To03_31_2016" id="Factid_334">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2016 and 2015:&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="21%" colspan="5"&gt; &lt;div&gt;3&amp;#160;Months&amp;#160;Ended&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"&gt; &lt;div&gt;03-31-16&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"&gt; &lt;div&gt;03-31-15&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Loss from continuing Operations available to Common stockholders (numerator)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;(470,667)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;(371,881)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;6,233,729&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"&gt; &lt;div&gt;6,206,220&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>

  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="P01_01_2016To03_31_2016" id="Factid_335">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Stock Based Compensation&lt;/b&gt; &amp;#150; The Company recognizes compensation costs to employees under ASC Topic No. 718, &amp;#8220;Compensation &amp;#150; Stock Compensation.&amp;#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grants for compensation are included in the Statement of Stockholders&amp;#8217; Equity as a contra-equity account as &amp;#8220;Deferred Compensation.&amp;#8221;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, &amp;#8220;Equity Based Payments to Non-Employees.&amp;#8221; In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>

<!--FootNote Section Ref-->

  <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
  </link:footnoteLink>
</xbrli:xbrl>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>sglb-20160331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<schema targetNamespace="http://www.sigmalabsinc.com/20160331" elementFormDefault="qualified" xmlns:sglb="http://www.sigmalabsinc.com/20160331" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.sigmalabsinc.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>101 - Document - Document And Entity Information</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/BalanceSheets" id="BalanceSheets">
        <link:definition>102 - Statement - Balance Sheets</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>103 - Statement - Balance Sheets [Parenthetical]</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations" id="CondensedStatementsOfOperations">
        <link:definition>104 - Statement - Condensed Statements of Operations</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows" id="CondensedStatementsOfCashFlows">
        <link:definition>105 - Statement - Condensed Statements of Cash Flows</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities" id="SupplementalScheduleOfNoncashInvestingAndFinancingActivities">
        <link:definition>106 - Statement - Supplemental Schedule of Noncash Investing and Financing Activities</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>107 - Disclosure - Summary of Significant Accounting Policies</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>108 - Disclosure - Stockholders&#39; Equity</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/ContinuingOperations" id="ContinuingOperations">
        <link:definition>109 - Disclosure - Continuing Operations</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/LossPerShare" id="LossPerShare">
        <link:definition>110 - Disclosure - Loss Per Share</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/JointVenture" id="JointVenture">
        <link:definition>111 - Disclosure - Joint Venture</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>112 - Disclosure - Subsequent Events</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>113 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
        <link:definition>114 - Disclosure - Stockholders&#39; Equity (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>115 - Disclosure - Loss Per Share (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" id="SummaryOfSignificantAccountingPoliciesDetailsTextual">
        <link:definition>116 - Disclosure - Summary of Significant Accounting Policies (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
        <link:definition>117 - Disclosure - Stockholders&#39; Equity (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual" id="StockholdersEquityDetailsTextual">
        <link:definition>118 - Disclosure - Stockholders&#39; Equity (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/LossPerShareDetails" id="LossPerShareDetails">
        <link:definition>119 - Disclosure - Loss Per Share (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/JointVentureDetailsTextual" id="JointVentureDetailsTextual">
        <link:definition>120 - Disclosure - Joint Venture (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual" id="SubsequentEventsDetailsTextual">
        <link:definition>121 - Disclosure - Subsequent Events (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:linkbaseRef xlink:type="simple" xlink:href="sglb-20160331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="sglb-20160331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="sglb-20160331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="sglb-20160331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>

  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />

  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />

  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />

  <import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />

  <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />

  <import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd" />

  <element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_DocumentAndEntityInformationAbstract" />

  <element name="ContinuingOperationsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ContinuingOperationsDisclosureAbstract" />

  <element name="ContinuingOperationsDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ContinuingOperationsDisclosureTextBlock" />

  <element name="NatureOfBusinessPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_NatureOfBusinessPolicyTextBlock" />

  <element name="OrganizationExpenditurePolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_OrganizationExpenditurePolicyTextBlock" />

  <element name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="sglb_SummaryOfSignificantAccountingPoliciesTable" />

  <element name="ThirdPartyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="sglb_ThirdPartyAxis" />

  <element name="ThirdPartyDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ThirdPartyDomain" />

  <element name="OneConsultantsAndTwoProfessionalsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_OneConsultantsAndTwoProfessionalsMember" />

  <element name="ConsultantOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ConsultantOneMember" />

  <element name="TwoConsultantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_TwoConsultantsMember" />

  <element name="ConsultantTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ConsultantTwoMember" />

  <element name="EquityIncentivePlan2011Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_EquityIncentivePlan2011Member" />

  <element name="EquityIncentivePlan2013Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_EquityIncentivePlan2013Member" />

  <element name="WarrantsOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantsOneMember" />

  <element name="WarrantsTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantsTwoMember" />

  <element name="WarrantExpiryLifeOneYearMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantExpiryLifeOneYearMember" />

  <element name="WarrantExpiryLifeTwoYearMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantExpiryLifeTwoYearMember" />

  <element name="WarrantExpiryLifeNineMonthsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantExpiryLifeNineMonthsMember" />

  <element name="WarrantExpiryLifeFourteenMonthsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_WarrantExpiryLifeFourteenMonthsMember" />

  <element name="StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" />

  <element name="StockIssuedDuringPeriodValueIssuedForNoncashConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" />

  <element name="StockIssuedDuringPeriodShareBasedCompensationPerShareValue" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" />

  <element name="ClassOfWarrantOrRightsExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="sglb_ClassOfWarrantOrRightsExercisable" />

  <element name="ScheduleOfEarningsPerShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="sglb_ScheduleOfEarningsPerShareTable" />

  <element name="ScheduleOfEarningsPerShareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ScheduleOfEarningsPerShareLineItems" />

  <element name="BalanceSheetsParentheticalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_BalanceSheetsParentheticalAbstract" />

  <element name="ConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_ConsultantMember" />

  <element name="JointVentureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_JointVentureAbstract" />

  <element name="JointVentureDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_JointVentureDisclosureTextBlock" />

  <element name="FirstAnnualAnniversaryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_FirstAnnualAnniversaryMember" />

  <element name="SecondAnnualAnniversaryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_SecondAnnualAnniversaryMember" />

  <element name="EmployeeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_EmployeeMember" />

  <element name="CommonStockShareIssedToEmployeeOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_CommonStockShareIssedToEmployeeOneMember" />

  <element name="CommonStockShareIssedToEmployeeTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_CommonStockShareIssedToEmployeeTwoMember" />

  <element name="TwoThousandAndThirteenStockOptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_TwoThousandAndThirteenStockOptionPlanMember" />

  <element name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_SummaryOfSignificantAccountingPoliciesLineItems" />

  <element name="StockOptionsValuationAssumptionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="sglb_StockOptionsValuationAssumptionsTable" />

  <element name="StockOptionsValuationAssumptionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_StockOptionsValuationAssumptionsLineItems" />

  <element name="IncreaseDecreaseInDeferredCompensationperShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_IncreaseDecreaseInDeferredCompensationperShare" />

  <element name="CommonStockShareIssedToEmployeeNewMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_CommonStockShareIssedToEmployeeNewMember" />

  <element name="CosultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="sglb_CosultantMember" />

  <element name="CommonStockSharesAuthorisedPostReverseStockSplit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="sglb_CommonStockSharesAuthorisedPostReverseStockSplit" />
</schema>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>sglb-20160331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#ContinuingOperations" roleURI="http://www.sigmalabsinc.com/role/ContinuingOperations" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#BalanceSheets" roleURI="http://www.sigmalabsinc.com/role/BalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfOperations" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfCashFlows" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquity" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquity" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#JointVenture" roleURI="http://www.sigmalabsinc.com/role/JointVenture" />

  <calculationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_InventoryNet" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsNoncurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" use="optional" order="30" weight="1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_DeferredCompensationEquity" use="optional" order="30" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="40" weight="1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_GrossProfit" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_SalesRevenueServicesNet" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="loc_us-gaap_TechnologyServicesRevenue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesRevenueServicesNet" xlink:to="loc_us-gaap_TechnologyServicesRevenue" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_CostOfServices" use="optional" order="20" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="20" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SalariesAndWages" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InvestmentIncomeInterest" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" use="optional" order="20" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" use="optional" order="30" weight="-1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_NetIncomeLoss" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_AdjustmentForAmortization" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_Depreciation" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_StockOptionPlanExpense" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" order="50" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="60" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories" use="optional" order="70" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="80" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="90" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" order="100" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="10" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets" use="optional" order="20" weight="-1" />
  </calculationLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>sglb-20160331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#DocumentAndEntityInformation" roleURI="http://www.sigmalabsinc.com/role/DocumentAndEntityInformation" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SummaryOfSignificantAccountingPoliciesDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquityDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#LossPerShareDetails" roleURI="http://www.sigmalabsinc.com/role/LossPerShareDetails" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#BalanceSheets" roleURI="http://www.sigmalabsinc.com/role/BalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#BalanceSheetsParenthetical" roleURI="http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfOperations" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfCashFlows" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SupplementalScheduleOfNoncashInvestingAndFinancingActivities" roleURI="http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#JointVentureDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/JointVentureDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SubsequentEventsDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquityDetails" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetails" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_3" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentInformationTable_3" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_781" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_dei_LegalEntityAxis_781" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_782" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_781" xlink:to="loc_dei_EntityDomain_782" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_782_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_781" xlink:to="loc_dei_EntityDomain_782_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentType_5" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_6" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentFlag_6" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_7" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_8" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_10" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityRegistrantName_10" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_11" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_11" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_12" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_12" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_13" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFilerCategory_13" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_14" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_TradingSymbol_14" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15" use="optional" order="15" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_57" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" xlink:to="loc_us-gaap_PatentsMember_57" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_59" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_59" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60_default" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_64" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_AwardTypeAxis_64" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_65" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_65" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_66" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_66" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_67" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_67" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_68" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_68" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_71" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_71" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_72" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_InventoryRawMaterials_72" use="optional" order="17" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_710" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_76" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_76" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_77" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_StatementClassOfStockAxis_77" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_78" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_77" xlink:to="loc_us-gaap_ClassOfStockDomain_78" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_78_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_77" xlink:to="loc_us-gaap_ClassOfStockDomain_78_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_81" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_81" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_81" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_81" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_83" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" xlink:to="loc_us-gaap_PrivatePlacementMember_83" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_84" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_sglb_ThirdPartyAxis_84" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_85" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sglb_ThirdPartyAxis_84" xlink:to="loc_sglb_ThirdPartyDomain_85" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_85_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sglb_ThirdPartyAxis_84" xlink:to="loc_sglb_ThirdPartyDomain_85_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_OneConsultantsAndTwoProfessionalsMember" xlink:label="loc_sglb_OneConsultantsAndTwoProfessionalsMember_86" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_OneConsultantsAndTwoProfessionalsMember_86" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantOneMember" xlink:label="loc_sglb_ConsultantOneMember_87" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_ConsultantOneMember_87" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoConsultantsMember" xlink:label="loc_sglb_TwoConsultantsMember_88" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_TwoConsultantsMember_88" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantTwoMember" xlink:label="loc_sglb_ConsultantTwoMember_90" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_ConsultantTwoMember_90" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CosultantMember" xlink:label="loc_sglb_CosultantMember_786" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_CosultantMember_786" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_92" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" xlink:to="loc_us-gaap_RelatedPartyDomain_92" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_92_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" xlink:to="loc_us-gaap_RelatedPartyDomain_92_default" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember_94" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_92" xlink:to="loc_us-gaap_InvestorMember_94" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_95" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_AwardTypeAxis_95" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96_default" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2011Member" xlink:label="loc_sglb_EquityIncentivePlan2011Member_97" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_EquityIncentivePlan2011Member_97" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2013Member" xlink:label="loc_sglb_EquityIncentivePlan2013Member_98" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_EquityIncentivePlan2013Member_98" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_FirstAnnualAnniversaryMember" xlink:label="loc_sglb_FirstAnnualAnniversaryMember_412" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_FirstAnnualAnniversaryMember_412" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SecondAnnualAnniversaryMember" xlink:label="loc_sglb_SecondAnnualAnniversaryMember_413" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_SecondAnnualAnniversaryMember_413" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_105" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_TitleOfIndividualAxis_105" use="optional" order="28" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_105" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" use="optional" order="29" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_105" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106_default" use="optional" order="30" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_107" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_DirectorMember_107" use="optional" order="31" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_109" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_OfficerMember_109" use="optional" order="32" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="loc_us-gaap_VicePresidentMember_416" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_VicePresidentMember_416" use="optional" order="33" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EmployeeMember" xlink:label="loc_sglb_EmployeeMember_417" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_EmployeeMember_417" use="optional" order="34" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeOneMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeOneMember_636" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeOneMember_636" use="optional" order="35" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeTwoMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeTwoMember_637" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeTwoMember_637" use="optional" order="36" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeNewMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeNewMember_769" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeNewMember_769" use="optional" order="37" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_110" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_110" use="optional" order="38" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_111" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110" xlink:to="loc_us-gaap_EquityComponentDomain_111" use="optional" order="39" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_111_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110" xlink:to="loc_us-gaap_EquityComponentDomain_111_default" use="optional" order="40" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_112" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_us-gaap_WarrantMember_112" use="optional" order="41" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsOneMember" xlink:label="loc_sglb_WarrantsOneMember_113" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantsOneMember_113" use="optional" order="42" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsTwoMember" xlink:label="loc_sglb_WarrantsTwoMember_114" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantsTwoMember_114" use="optional" order="43" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeOneYearMember" xlink:label="loc_sglb_WarrantExpiryLifeOneYearMember_116" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeOneYearMember_116" use="optional" order="44" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeTwoYearMember" xlink:label="loc_sglb_WarrantExpiryLifeTwoYearMember_117" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeTwoYearMember_117" use="optional" order="45" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeNineMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeNineMonthsMember_118" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeNineMonthsMember_118" use="optional" order="46" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeFourteenMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeFourteenMonthsMember_119" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeFourteenMonthsMember_119" use="optional" order="47" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_406" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_406" use="optional" order="48" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" use="optional" order="49" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" use="optional" order="50" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708_default" use="optional" order="51" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_709" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" xlink:to="loc_us-gaap_EmployeeStockOptionMember_709" use="optional" order="52" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_707" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_RangeAxis_707" use="optional" order="53" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_711" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_707" xlink:to="loc_us-gaap_RangeMember_711" use="optional" order="54" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_711_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_707" xlink:to="loc_us-gaap_RangeMember_711_default" use="optional" order="55" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_712" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_711" xlink:to="loc_us-gaap_MinimumMember_712" use="optional" order="56" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_713" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_711" xlink:to="loc_us-gaap_MaximumMember_713" use="optional" order="57" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_121" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_121" use="optional" order="58" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_122" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_122" use="optional" order="59" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_123" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesIssued_123" use="optional" order="60" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_169" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_169" use="optional" order="61" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xlink:label="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations_124" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations_124" use="optional" order="62" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xlink:label="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration_125" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration_125" use="optional" order="63" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_126" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_126" use="optional" order="64" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_127" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_127" use="optional" order="65" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_128" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_128" use="optional" order="66" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_129" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_129" use="optional" order="67" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_130" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_130" use="optional" order="68" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_131" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_131" use="optional" order="69" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_133" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_133" use="optional" order="70" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_134" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_134" use="optional" order="71" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_135" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_135" use="optional" order="72" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_140" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_140" use="optional" order="73" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_141" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_141" use="optional" order="74" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_144" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_144" use="optional" order="75" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_145" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_145" use="optional" order="76" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xlink:label="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue_146" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue_146" use="optional" order="77" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_147" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_147" use="optional" order="78" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_150" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_150" use="optional" order="79" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_151" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_151" use="optional" order="80" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_152" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_152" use="optional" order="81" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_154" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_154" use="optional" order="82" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_155" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_155" use="optional" order="83" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_156" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_156" use="optional" order="84" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_157" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_157" use="optional" order="85" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_158" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_158" use="optional" order="86" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_159" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_159" use="optional" order="87" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ClassOfWarrantOrRightsExercisable" xlink:label="loc_sglb_ClassOfWarrantOrRightsExercisable_160" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_ClassOfWarrantOrRightsExercisable_160" use="optional" order="88" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_161" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_161" use="optional" order="89" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_162" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_162" use="optional" order="90" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_163" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_163" use="optional" order="91" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_164" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockValue_164" use="optional" order="92" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_167" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_167" use="optional" order="93" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_168" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_168" use="optional" order="94" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_407" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_407" use="optional" order="95" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_408" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_408" use="optional" order="96" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_409" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_409" use="optional" order="97" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_429" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_429" use="optional" order="98" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_702" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_702" use="optional" order="99" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_703" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_703" use="optional" order="100" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_704" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_704" use="optional" order="101" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_705" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_705" use="optional" order="102" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_706" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_706" use="optional" order="103" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_780" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_780" use="optional" order="104" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_783" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_783" use="optional" order="105" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_784" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_784" use="optional" order="106" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_800" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockOptionPlanExpense_800" use="optional" order="107" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareLineItems" xlink:label="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareTable" xlink:label="loc_sglb_ScheduleOfEarningsPerShareTable_190" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" xlink:to="loc_sglb_ScheduleOfEarningsPerShareTable_190" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_191" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_ScheduleOfEarningsPerShareTable_190" xlink:to="loc_us-gaap_StatementScenarioAxis_191" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_192" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_191" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_192" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_192_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_191" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_192_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_194" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_194" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_195" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_195" use="optional" order="6" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_201" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_198" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_StatementTable_198" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_199" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementScenarioAxis_199" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_200" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_199" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_200" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_200_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_199" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_200_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_202" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_AssetsAbstract_202" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_203" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_202" xlink:to="loc_us-gaap_AssetsCurrentAbstract_203" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_204" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_204" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_205" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_205" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_206" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_InventoryNet_206" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_207" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_207" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_208" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_AssetsCurrent_208" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_209" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_202" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_209" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_210" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_210" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_212" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_212" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_418" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_418" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_213" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_AssetsNoncurrent_213" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_214" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_Assets_214" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_216" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_216" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_217" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_AccountsPayableCurrent_217" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_218" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_218" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_219" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_LiabilitiesCurrent_219" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_220" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_Liabilities_220" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_221" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_StockholdersEquityAbstract_221" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_222" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_PreferredStockValue_222" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_223" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_CommonStockValue_223" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_224" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_224" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_225" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_DeferredCompensationEquity_225" use="optional" order="28" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_226" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_226" use="optional" order="29" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_227" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_StockholdersEquity_227" use="optional" order="30" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_228" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_228" use="optional" order="31" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_234" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_231" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_StatementTable_231" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_232" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_231" xlink:to="loc_us-gaap_StatementScenarioAxis_232" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_233" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_232" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_233" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_233_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_232" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_233_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_235" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_235" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_236" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_236" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_237" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesIssued_237" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_238" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_238" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_239" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_239" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_240" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_240" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_241" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesIssued_241" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_242" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_242" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_243" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_243" use="optional" order="13" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_249" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_246" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_StatementTable_246" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_247" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_246" xlink:to="loc_us-gaap_StatementScenarioAxis_247" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_248" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_247" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_248" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_248_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_247" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_248_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_250" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_RevenuesAbstract_250" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="loc_us-gaap_TechnologyServicesRevenue_251" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_250" xlink:to="loc_us-gaap_TechnologyServicesRevenue_251" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_252" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_250" xlink:to="loc_us-gaap_SalesRevenueServicesNet_252" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_253" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_CostOfServices_253" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_254" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_GrossProfit_254" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_255" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_OperatingExpensesAbstract_255" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_256" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_256" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_257" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_SalariesAndWages_257" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_258" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_258" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_259" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_259" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_260" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_OperatingExpenses_260" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_262" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" xlink:to="loc_us-gaap_InvestmentIncomeInterest_262" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_264" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_264" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_265" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_265" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_266" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_266" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_267" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_267" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_268" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_NetIncomeLoss_268" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_269" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_269" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_270" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_270" use="optional" order="24" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_276" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_273" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_StatementTable_273" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_274" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementScenarioAxis_274" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_275" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_274" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_275" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_275_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_274" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_275_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_278" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_NetIncomeLoss_278" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_280" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_280" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_282" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_AdjustmentForAmortization_282" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_283" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_Depreciation_283" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_785" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_StockOptionPlanExpense_785" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_284" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_ShareBasedCompensation_284" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_287" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_287" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_288" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_288" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_289" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_289" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_290" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_290" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_291" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_291" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_292" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_292" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_294" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_294" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_295" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_295" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_296" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_296" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_297" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_297" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_303" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_303" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_304" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_304" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_307" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" xlink:to="loc_us-gaap_InterestPaid_307" use="optional" order="28" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_308" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" xlink:to="loc_us-gaap_IncomeTaxesPaid_308" use="optional" order="29" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_356" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_311" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_StatementTable_311" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_312" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_StatementClassOfStockAxis_312" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_313" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_312" xlink:to="loc_us-gaap_ClassOfStockDomain_313" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_313_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_312" xlink:to="loc_us-gaap_ClassOfStockDomain_313_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_314" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_AwardTypeAxis_314" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_314" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_314" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_316" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" xlink:to="loc_us-gaap_StockCompensationPlanMember_316" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_317" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_sglb_ThirdPartyAxis_317" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_318" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sglb_ThirdPartyAxis_317" xlink:to="loc_sglb_ThirdPartyDomain_318" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_318_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sglb_ThirdPartyAxis_317" xlink:to="loc_sglb_ThirdPartyDomain_318_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantMember" xlink:label="loc_sglb_ConsultantMember_319" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_318" xlink:to="loc_sglb_ConsultantMember_319" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_320" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_TitleOfIndividualAxis_320" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_320" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_320" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354_default" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EmployeeMember" xlink:label="loc_sglb_EmployeeMember_422" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" xlink:to="loc_sglb_EmployeeMember_422" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_353" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_353" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_357" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_353" xlink:to="loc_us-gaap_EquityComponentDomain_357" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_357_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_353" xlink:to="loc_us-gaap_EquityComponentDomain_357_default" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_321" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_321" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_322" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_322" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_323" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_323" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_324" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_324" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_325" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_325" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_IncreaseDecreaseInDeferredCompensationperShare" xlink:label="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare_767" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare_767" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_802" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_StockOptionPlanExpense_802" use="optional" order="26" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/JointVentureDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_383" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_378" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_383" xlink:to="loc_us-gaap_StatementTable_378" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_379" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_378" xlink:to="loc_us-gaap_StatementClassOfStockAxis_379" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_380" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_379" xlink:to="loc_us-gaap_ClassOfStockDomain_380" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_380_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_379" xlink:to="loc_us-gaap_ClassOfStockDomain_380_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_381" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_378" xlink:to="loc_dei_LegalEntityAxis_381" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_384" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_381" xlink:to="loc_dei_EntityDomain_384" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_384_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_381" xlink:to="loc_dei_EntityDomain_384_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_385" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_384" xlink:to="loc_us-gaap_CorporateJointVentureMember_385" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_382" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_383" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_382" use="optional" order="9" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_796" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_683" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_SubsequentEventTable_683" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_684" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_PlanNameAxis_684" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_688" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_684" xlink:to="loc_us-gaap_PlanNameDomain_688" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_688_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_684" xlink:to="loc_us-gaap_PlanNameDomain_688_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoThousandAndThirteenStockOptionPlanMember" xlink:label="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember_689" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_688" xlink:to="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember_689" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_687" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_687" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_691" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_691" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_691_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_691_default" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_692" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_691" xlink:to="loc_us-gaap_SubsequentEventMember_692" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738_default" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_737" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_737" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_741" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_737" xlink:to="loc_us-gaap_EquityComponentDomain_741" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_741_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_737" xlink:to="loc_us-gaap_EquityComponentDomain_741_default" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_740" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_sglb_ThirdPartyAxis_740" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_791" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sglb_ThirdPartyAxis_740" xlink:to="loc_sglb_ThirdPartyDomain_791" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_791_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sglb_ThirdPartyAxis_740" xlink:to="loc_sglb_ThirdPartyDomain_791_default" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CosultantMember" xlink:label="loc_sglb_CosultantMember_792" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_ThirdPartyDomain_791" xlink:to="loc_sglb_CosultantMember_792" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_790" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_RangeAxis_790" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_797" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_790" xlink:to="loc_us-gaap_RangeMember_797" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_797_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_790" xlink:to="loc_us-gaap_RangeMember_797_default" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_798" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_797" xlink:to="loc_us-gaap_MinimumMember_798" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_799" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_797" xlink:to="loc_us-gaap_MaximumMember_799" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_787" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_787" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_788" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_788" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_789" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_789" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xlink:label="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit_793" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit_793" use="optional" order="28" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_794" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_794" use="optional" order="29" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_795" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_795" use="optional" order="30" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsLineItems" xlink:label="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsTable" xlink:label="loc_sglb_StockOptionsValuationAssumptionsTable_721" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_sglb_StockOptionsValuationAssumptionsTable_721" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_722" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable_721" xlink:to="loc_us-gaap_StatementClassOfStockAxis_722" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_724" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_722" xlink:to="loc_us-gaap_ClassOfStockDomain_724" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_724_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_722" xlink:to="loc_us-gaap_ClassOfStockDomain_724_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable_721" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_733" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" xlink:to="loc_us-gaap_EmployeeStockOptionMember_733" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_725" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_725" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_726" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_726" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_727" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_727" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_728" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_728" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_729" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_729" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_730" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_730" use="optional" order="14" />
  </definitionLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>sglb-20160331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />

  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_DocumentAndEntityInformationAbstract" xlink:label="loc_sglb_DocumentAndEntityInformationAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_DocumentAndEntityInformationAbstract" xlink:to="lab_sglb_DocumentAndEntityInformationAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ContinuingOperationsDisclosureAbstract" xlink:label="loc_sglb_ContinuingOperationsDisclosureAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ContinuingOperationsDisclosureAbstract" xml:lang="en-US">Continuing Operations Disclosure [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ContinuingOperationsDisclosureAbstract" xlink:to="lab_sglb_ContinuingOperationsDisclosureAbstract" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ContinuingOperationsDisclosureTextBlock" xlink:label="loc_sglb_ContinuingOperationsDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ContinuingOperationsDisclosureTextBlock" xml:lang="en-US">Continuing Operations Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_ContinuingOperationsDisclosureTextBlock" xml:lang="en-US">If there is a sustained losses in cash flows from operating activities in this financial year.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ContinuingOperationsDisclosureTextBlock" xlink:to="lab_sglb_ContinuingOperationsDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_NatureOfBusinessPolicyTextBlock" xlink:label="loc_sglb_NatureOfBusinessPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_NatureOfBusinessPolicyTextBlock" xml:lang="en-US">Nature Of Business [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_NatureOfBusinessPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for nature of business.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_NatureOfBusinessPolicyTextBlock" xlink:to="lab_sglb_NatureOfBusinessPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis Of Accounting, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value Of Financial Instruments, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xml:lang="en-US">Trade and Other Accounts Receivable, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_OrganizationExpenditurePolicyTextBlock" xlink:label="loc_sglb_OrganizationExpenditurePolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_OrganizationExpenditurePolicyTextBlock" xml:lang="en-US">Organization Expenditure [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_OrganizationExpenditurePolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for organization expenditure.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_OrganizationExpenditurePolicyTextBlock" xlink:to="lab_sglb_OrganizationExpenditurePolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xml:lang="en-US">Depreciation, Depletion, and Amortization [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xml:lang="en-US">Depreciation, Depletion, and Amortization [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use Of Estimates, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule Of Earnings Per Share, Basic and Diluted [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_SummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_sglb_SummaryOfSignificantAccountingPoliciesTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PatentsMember" xml:lang="en-US">Patents [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xml:lang="en-US">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Number Of Shares Exchanged For Each Share Of Acquired Entity (in shares)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance For Doubtful Accounts Receivable, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Finite-Lived Intangible Assets, Useful Life, Maximum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryRawMaterials" xml:lang="en-US">Inventory, Raw Materials, Gross</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders&#39; Equity Note [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Subsidiary, Sale of Stock [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock, Name of Transaction [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember" xml:lang="en-US">Private Placement [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ThirdPartyAxis" xml:lang="en-US">Third Party [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ThirdPartyAxis" xlink:to="lab_sglb_ThirdPartyAxis" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ThirdPartyDomain" xml:lang="en-US">Third Party [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ThirdPartyDomain" xlink:to="lab_sglb_ThirdPartyDomain" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_OneConsultantsAndTwoProfessionalsMember" xlink:label="loc_sglb_OneConsultantsAndTwoProfessionalsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_OneConsultantsAndTwoProfessionalsMember" xml:lang="en-US">One Consultants and Two Professionals [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_OneConsultantsAndTwoProfessionalsMember" xlink:to="lab_sglb_OneConsultantsAndTwoProfessionalsMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantOneMember" xlink:label="loc_sglb_ConsultantOneMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ConsultantOneMember" xml:lang="en-US">Consultant One [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ConsultantOneMember" xlink:to="lab_sglb_ConsultantOneMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoConsultantsMember" xlink:label="loc_sglb_TwoConsultantsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_TwoConsultantsMember" xml:lang="en-US">Two Consultants [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_TwoConsultantsMember" xlink:to="lab_sglb_TwoConsultantsMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantTwoMember" xlink:label="loc_sglb_ConsultantTwoMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ConsultantTwoMember" xml:lang="en-US">Consultant Two [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ConsultantTwoMember" xlink:to="lab_sglb_ConsultantTwoMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestorMember" xml:lang="en-US">Investor [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestorMember" xlink:to="lab_us-gaap_InvestorMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Equity Award [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2011Member" xlink:label="loc_sglb_EquityIncentivePlan2011Member" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_EquityIncentivePlan2011Member" xml:lang="en-US">Equity Incentive Plan 2011 [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_EquityIncentivePlan2011Member" xlink:to="lab_sglb_EquityIncentivePlan2011Member" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2013Member" xlink:label="loc_sglb_EquityIncentivePlan2013Member" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_EquityIncentivePlan2013Member" xml:lang="en-US">Equity Incentive Plan 2013 [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_EquityIncentivePlan2013Member" xlink:to="lab_sglb_EquityIncentivePlan2013Member" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualAxis" xlink:to="lab_us-gaap_TitleOfIndividualAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DirectorMember" xml:lang="en-US">Director [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectorMember" xlink:to="lab_us-gaap_DirectorMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OfficerMember" xml:lang="en-US">Officer [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficerMember" xlink:to="lab_us-gaap_OfficerMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsOneMember" xlink:label="loc_sglb_WarrantsOneMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantsOneMember" xml:lang="en-US">Warrants One [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantsOneMember" xlink:to="lab_sglb_WarrantsOneMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsTwoMember" xlink:label="loc_sglb_WarrantsTwoMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantsTwoMember" xml:lang="en-US">Warrants Two [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantsTwoMember" xlink:to="lab_sglb_WarrantsTwoMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeOneYearMember" xlink:label="loc_sglb_WarrantExpiryLifeOneYearMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantExpiryLifeOneYearMember" xml:lang="en-US">Warrant Expiry Life One Year [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantExpiryLifeOneYearMember" xlink:to="lab_sglb_WarrantExpiryLifeOneYearMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeTwoYearMember" xlink:label="loc_sglb_WarrantExpiryLifeTwoYearMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantExpiryLifeTwoYearMember" xml:lang="en-US">Warrant Expiry Life Two Year [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantExpiryLifeTwoYearMember" xlink:to="lab_sglb_WarrantExpiryLifeTwoYearMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeNineMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeNineMonthsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantExpiryLifeNineMonthsMember" xml:lang="en-US">Warrant Expiry Life Nine Months [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantExpiryLifeNineMonthsMember" xlink:to="lab_sglb_WarrantExpiryLifeNineMonthsMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeFourteenMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeFourteenMonthsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_WarrantExpiryLifeFourteenMonthsMember" xml:lang="en-US">Warrant Expiry Life Fourteen Months [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_WarrantExpiryLifeFourteenMonthsMember" xlink:to="lab_sglb_WarrantExpiryLifeFourteenMonthsMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xml:lang="en-US">Option Indexed to Issuer&#39;s Equity [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value (in dollars per share)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, share issued</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xlink:label="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xml:lang="en-US">Stock Issued During Period Shares Issued For Noncash Considerations</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xml:lang="en-US">Stock Issued During Period, Shares, Issued For Noncash Consideration (in shares)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xml:lang="en-US">Number of shares issued for noncash considerations for development stage entities.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xlink:to="lab_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xlink:label="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xml:lang="en-US">Stock Issued During Period Value Issued For Noncash Consideration</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xml:lang="en-US">Stock Issued During Period, Value, Issued For Noncash Considerations</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xml:lang="en-US">Value of shares issued for noncash consideration for development stage entities.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xlink:to="lab_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US">Shares vested</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par Or Stated Value Per Share</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value (in dollars per share)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds From Issuance Of Warrants</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Shares, Share-Based Compensation, Gross</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Shares Issued For Employee Equity Plan</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Value, Share-Based Compensation, Gross</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Gross</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US">Shares issued for prepaid stock compensation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xlink:label="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xml:lang="en-US">Stock Issued During Period Share Based Compensation Per Share Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xml:lang="en-US">Shares Issued For Employee Equity Plan Par Value (in dollars per share)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xml:lang="en-US">Represents the per share value of stock issued during period as share based compensation.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xlink:to="lab_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Costs incurred in association with warrant issuances</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Payments of Stock Issuance Costs</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Stock Offering Costs</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Shares issued for services at prices ranging from $0.094 to $0.136 (in shares)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Shares issued for services at prices ranging from $0.094 to $0.136</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ClassOfWarrantOrRightsExercisable" xlink:label="loc_sglb_ClassOfWarrantOrRightsExercisable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ClassOfWarrantOrRightsExercisable" xml:lang="en-US">Class Of Warrant Or Rights Exercisable</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_ClassOfWarrantOrRightsExercisable" xml:lang="en-US">Represents the total number of warrants exercisable as on the end of the reporting period.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ClassOfWarrantOrRightsExercisable" xlink:to="lab_sglb_ClassOfWarrantOrRightsExercisable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants and Rights Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares issued for services (in dollars per share)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, $0.001 par; 7,500,000 shares authorized; 6,232,778 issued and 6,210,278 outstanding at March 31, 2016 and 6,239,073 issued and 6,206,573 outstanding at December 31, 2015</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair Value Adjustment of Warrants</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Warrant Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareTable" xlink:label="loc_sglb_ScheduleOfEarningsPerShareTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ScheduleOfEarningsPerShareTable" xml:lang="en-US">Schedule of Earnings Per Share [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ScheduleOfEarningsPerShareTable" xlink:to="lab_sglb_ScheduleOfEarningsPerShareTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis" xlink:to="lab_us-gaap_StatementScenarioAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain" xml:lang="en-US">Scenario, Unspecified [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareLineItems" xlink:label="loc_sglb_ScheduleOfEarningsPerShareLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ScheduleOfEarningsPerShareLineItems" xml:lang="en-US">Schedule of Earnings Per Share [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems" xlink:to="lab_sglb_ScheduleOfEarningsPerShareLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Loss from continuing Operations available to Common stockholders (numerator)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic and Diluted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator) (in shares)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number of Shares Outstanding - Basic and Diluted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement Of Financial Position [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">CASH AT BEGINNING OF PERIOD</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">CASH AT END OF PERIOD</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, Net, Current, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, net</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Inventory, Net, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Inventory</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total Current Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xml:lang="en-US">Other Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and Equipment, net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Net Property and Equipment</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill), Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible Assets, net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Net Intangible Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xml:lang="en-US">Investment in Joint Venture</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">TOTAL ASSETS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#39; EQUITY</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Expenses</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">TOTAL LIABILITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders Equity Attributable To Parent [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders&#39; Equity</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid In Capital, Common Stock</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid-In Capital</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationEquity" xml:lang="en-US">Deferred Compensation Equity</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredCompensationEquity" xml:lang="en-US">Less Deferred Compensation 22,500 and 32,500 common shares, respectively</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationEquity" xlink:to="lab_us-gaap_DeferredCompensationEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Deficit)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders&#39; Equity Attributable To Parent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total Stockholders&#39; Equity</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#39; EQUITY</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_BalanceSheetsParentheticalAbstract" xlink:label="loc_sglb_BalanceSheetsParentheticalAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_BalanceSheetsParentheticalAbstract" xml:lang="en-US">Balance Sheets Parenthetical [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_BalanceSheetsParentheticalAbstract" xml:lang="en-US">Balance Sheets Parenthetical.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_BalanceSheetsParentheticalAbstract" xlink:to="lab_sglb_BalanceSheetsParentheticalAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Shares Authorized For Issuance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenues [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">INCOME</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="loc_us-gaap_TechnologyServicesRevenue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TechnologyServicesRevenue" xml:lang="en-US">Technology Services Revenue</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TechnologyServicesRevenue" xml:lang="en-US">Services</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyServicesRevenue" xlink:to="lab_us-gaap_TechnologyServicesRevenue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueServicesNet" xml:lang="en-US">Sales Revenue, Services, Net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_SalesRevenueServicesNet" xml:lang="en-US">Total Revenue</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueServicesNet" xlink:to="lab_us-gaap_SalesRevenueServicesNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfServices" xml:lang="en-US">Cost Of Services</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CostOfServices" xml:lang="en-US">COST OF SERVICE REVENUE</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfServices" xlink:to="lab_us-gaap_CostOfServices" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">GROSS PROFIT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">EXPENSES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">Other General and Administrative Expense</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">Other General and Administration</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalariesAndWages" xml:lang="en-US">Compensation</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SalariesAndWages" xml:lang="en-US">Payroll Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalariesAndWages" xlink:to="lab_us-gaap_SalariesAndWages" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Allocated Share-based Compensation Expense</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Stock-Based Compensation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Total Expenses</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Investment Income, Interest</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Interest Income</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total Other Income (Expense)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xml:lang="en-US">Current Income Tax Expense (Benefit)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xml:lang="en-US">Current Income Tax Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Income Tax Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable To Parent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted (In Dollars Per Share)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Loss per Common Share - Basic and Diluted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement Of Cash Flows [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">OPERATING ACTIVITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile Net Income (Loss) to Net Cash provided (used) by operations:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xml:lang="en-US">Share-Based Compensation [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xml:lang="en-US">Noncash Expenses:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentForAmortization" xml:lang="en-US">Amortization</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentForAmortization" xml:lang="en-US">Amortization</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Stock or Unit Option Plan Expense</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Stock Options Awarded</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Stock Option Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionPlanExpense" xlink:to="lab_us-gaap_StockOptionPlanExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) In Operating Capital [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Change in assets and liabilities:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) In Accounts Receivable</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">(Increase) Decrease in Accounts Receivable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based Compensation</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock Compensation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xml:lang="en-US">Increase (Decrease) in Inventories, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xml:lang="en-US">Decrease (Increase) in Inventory</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) In Prepaid Expense and Other Assets</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Decrease (Increase) in Prepaid Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Increase (Decrease) In Accounts Payable</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">(Decrease) Increase in Accounts Payable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">INVESTING ACTIVITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments To Acquire Property, Plant, and Equipment</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of Furniture and Equipment</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Payments To Acquire Intangible Assets</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Purchase of Intangible Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">FINANCING ACTIVITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">NET CASH (DECREASE) INCREASE FOR PERIOD</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Disclosure for Cash Flow Information Cash paid during the period for:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestPaid" xml:lang="en-US">Interest Paid</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InterestPaid" xml:lang="en-US">Interest</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income Taxes Paid</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income Taxes</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockCompensationPlanMember" xml:lang="en-US">Stock Compensation Plan [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockCompensationPlanMember" xml:lang="en-US">Equty Incentive Plan [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantMember" xlink:label="loc_sglb_ConsultantMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_ConsultantMember" xml:lang="en-US">Consultant [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_ConsultantMember" xlink:to="lab_sglb_ConsultantMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders Equity Note Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders&#39; Equity Note Disclosure [Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">OTHER INCOME (EXPENSE)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_JointVentureAbstract" xlink:label="loc_sglb_JointVentureAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_JointVentureAbstract" xml:lang="en-US">Joint Venture [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_JointVentureAbstract" xlink:to="lab_sglb_JointVentureAbstract" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_JointVentureDisclosureTextBlock" xlink:label="loc_sglb_JointVentureDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_JointVentureDisclosureTextBlock" xml:lang="en-US">Joint Venture Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_JointVentureDisclosureTextBlock" xml:lang="en-US">Disclosure of joint venture or partnership that is included in the enterprise&#39;s financial statements using the proportionate consolidation method of accounting.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_JointVentureDisclosureTextBlock" xlink:to="lab_sglb_JointVentureDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CorporateJointVentureMember" xml:lang="en-US">Corporate Joint Venture [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Increase (Decrease) In Accrued Liabilities</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Increase In Accrued Expenses</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total Current Liabilities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xml:lang="en-US">Deferred Compensation [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_FirstAnnualAnniversaryMember" xlink:label="loc_sglb_FirstAnnualAnniversaryMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_FirstAnnualAnniversaryMember" xml:lang="en-US">First Annual Anniversary [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_FirstAnnualAnniversaryMember" xlink:to="lab_sglb_FirstAnnualAnniversaryMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SecondAnnualAnniversaryMember" xlink:label="loc_sglb_SecondAnnualAnniversaryMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_SecondAnnualAnniversaryMember" xml:lang="en-US">Second Annual Anniversary [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_SecondAnnualAnniversaryMember" xlink:to="lab_sglb_SecondAnnualAnniversaryMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="loc_us-gaap_VicePresidentMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VicePresidentMember" xml:lang="en-US">Vice President [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VicePresidentMember" xlink:to="lab_us-gaap_VicePresidentMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EmployeeMember" xlink:label="loc_sglb_EmployeeMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_EmployeeMember" xml:lang="en-US">Employee [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_EmployeeMember" xlink:to="lab_sglb_EmployeeMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent" xml:lang="en-US">Assets, Noncurrent, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent" xml:lang="en-US">Total Other Assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeOneMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeOneMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_CommonStockShareIssedToEmployeeOneMember" xml:lang="en-US">Common stock share issed to Employee one [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_CommonStockShareIssedToEmployeeOneMember" xlink:to="lab_sglb_CommonStockShareIssedToEmployeeOneMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeTwoMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeTwoMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_CommonStockShareIssedToEmployeeTwoMember" xml:lang="en-US">Common stock share issed to Employee two [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_CommonStockShareIssedToEmployeeTwoMember" xlink:to="lab_sglb_CommonStockShareIssedToEmployeeTwoMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">NET CASH (USED) BY INVESTING ACTIVITIES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoThousandAndThirteenStockOptionPlanMember" xlink:label="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_TwoThousandAndThirteenStockOptionPlanMember" xml:lang="en-US">Two Thousand and Thirteen Stock Option Plan [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sglb_TwoThousandAndThirteenStockOptionPlanMember" xml:lang="en-US">2013 Stock Option Plan</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember" xlink:to="lab_sglb_TwoThousandAndThirteenStockOptionPlanMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_SummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_sglb_SummaryOfSignificantAccountingPoliciesLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Shares Issued</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Compensation Expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Exercise Price</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis" xlink:to="lab_us-gaap_RangeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xml:lang="en-US">Option Indexed to Issuer&#39;s Equity, Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee Stock Option [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember" xlink:to="lab_us-gaap_RangeMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember" xlink:to="lab_us-gaap_MinimumMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember" xlink:to="lab_us-gaap_MaximumMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsTable" xlink:label="loc_sglb_StockOptionsValuationAssumptionsTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_StockOptionsValuationAssumptionsTable" xml:lang="en-US">Stock Options Valuation Assumptions [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable" xlink:to="lab_sglb_StockOptionsValuationAssumptionsTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected term (in years)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Volatility, Minimum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Volatility, Maximum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Risk-free interest rate, Minimum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Risk-free interest rate, Maximum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsLineItems" xlink:label="loc_sglb_StockOptionsValuationAssumptionsLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_StockOptionsValuationAssumptionsLineItems" xml:lang="en-US">Stock Options Valuation Assumptions [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems" xlink:to="lab_sglb_StockOptionsValuationAssumptionsLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_IncreaseDecreaseInDeferredCompensationperShare" xlink:label="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_IncreaseDecreaseInDeferredCompensationperShare" xml:lang="en-US">Increase Decrease In Deferred Compensation,Per Share</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_IncreaseDecreaseInDeferredCompensationperShare" xml:lang="en-US">The amount of increase (decrease) per share during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare" xlink:to="lab_sglb_IncreaseDecreaseInDeferredCompensationperShare" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeNewMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeNewMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_CommonStockShareIssedToEmployeeNewMember" xml:lang="en-US">Common Stock Share Issed To Employee New [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_CommonStockShareIssedToEmployeeNewMember" xml:lang="en-US">Common Stock Share Issed To Employee New</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_CommonStockShareIssedToEmployeeNewMember" xlink:to="lab_sglb_CommonStockShareIssedToEmployeeNewMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityReverseStockSplit" xml:lang="en-US">Stockholders&#39; Equity, Reverse Stock Split</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityReverseStockSplit" xlink:to="lab_us-gaap_StockholdersEquityReverseStockSplit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CosultantMember" xlink:label="loc_sglb_CosultantMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_CosultantMember" xml:lang="en-US">Cosultant [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_CosultantMember" xlink:to="lab_sglb_CosultantMember" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xlink:label="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xml:lang="en-US">Common Stock Shares Authorised Post Reverse Stock Split</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xml:lang="en-US">The number of common stock shares authorised after giving effect to the reverse stock splits.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xlink:to="lab_sglb_CommonStockSharesAuthorisedPostReverseStockSplit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" />
  </labelLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>sglb-20160331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 12-May-2016 [01:34:35] {PM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#DocumentAndEntityInformation" roleURI="http://www.sigmalabsinc.com/role/DocumentAndEntityInformation" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquity" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquity" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#ContinuingOperations" roleURI="http://www.sigmalabsinc.com/role/ContinuingOperations" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#LossPerShare" roleURI="http://www.sigmalabsinc.com/role/LossPerShare" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#JointVenture" roleURI="http://www.sigmalabsinc.com/role/JointVenture" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#BalanceSheets" roleURI="http://www.sigmalabsinc.com/role/BalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SubsequentEvents" roleURI="http://www.sigmalabsinc.com/role/SubsequentEvents" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquityTables" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityTables" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#LossPerShareTables" roleURI="http://www.sigmalabsinc.com/role/LossPerShareTables" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SummaryOfSignificantAccountingPoliciesDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#BalanceSheetsParenthetical" roleURI="http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquityDetails" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetails" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#StockholdersEquityDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#LossPerShareDetails" roleURI="http://www.sigmalabsinc.com/role/LossPerShareDetails" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfOperations" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#JointVentureDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/JointVentureDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SubsequentEventsDetailsTextual" roleURI="http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#CondensedStatementsOfCashFlows" roleURI="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SupplementalScheduleOfNoncashInvestingAndFinancingActivities" roleURI="http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities" />

  <roleRef xlink:type="simple" xlink:href="sglb-20160331.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPolicies" />

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_DocumentAndEntityInformationAbstract" xlink:label="loc_sglb_DocumentAndEntityInformationAbstract_2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_3" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_DocumentAndEntityInformationAbstract_2" xlink:to="loc_dei_DocumentInformationTable_3" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_781" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_dei_LegalEntityAxis_781" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_782" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_781" xlink:to="loc_dei_EntityDomain_782" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_4" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_dei_DocumentInformationLineItems_4" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentType_5" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_6" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentFlag_6" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_7" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_8" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_10" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityRegistrantName_10" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_11" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_11" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_12" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_12" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_13" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFilerCategory_13" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_14" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_TradingSymbol_14" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_15" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_15" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquity">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_331" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_332" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_331" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_332" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/ContinuingOperations">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ContinuingOperationsDisclosureAbstract" xlink:label="loc_sglb_ContinuingOperationsDisclosureAbstract_19" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ContinuingOperationsDisclosureTextBlock" xlink:label="loc_sglb_ContinuingOperationsDisclosureTextBlock_20" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ContinuingOperationsDisclosureAbstract_19" xlink:to="loc_sglb_ContinuingOperationsDisclosureTextBlock_20" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_23" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_23" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/JointVenture">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_JointVentureAbstract" xlink:label="loc_sglb_JointVentureAbstract_374" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_JointVentureDisclosureTextBlock" xlink:label="loc_sglb_JointVentureDisclosureTextBlock_375" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_JointVentureAbstract_374" xlink:to="loc_sglb_JointVentureDisclosureTextBlock_375" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_197" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_198" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_197" xlink:to="loc_us-gaap_StatementTable_198" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_199" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementScenarioAxis_199" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_200" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_199" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_200" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_201" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementLineItems_201" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_202" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_AssetsAbstract_202" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_203" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_202" xlink:to="loc_us-gaap_AssetsCurrentAbstract_203" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_204" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_204" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_205" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_205" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_206" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_InventoryNet_206" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_207" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_207" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_208" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_203" xlink:to="loc_us-gaap_AssetsCurrent_208" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_209" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_202" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_209" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_210" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_210" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_212" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_212" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_418" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_418" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_213" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_209" xlink:to="loc_us-gaap_AssetsNoncurrent_213" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_214" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_Assets_214" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_201" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_216" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_216" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_217" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_AccountsPayableCurrent_217" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_218" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_218" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_219" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_216" xlink:to="loc_us-gaap_LiabilitiesCurrent_219" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_220" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_Liabilities_220" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_221" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_StockholdersEquityAbstract_221" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_222" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_PreferredStockValue_222" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_223" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_CommonStockValue_223" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_224" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_224" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_225" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_DeferredCompensationEquity_225" use="optional" order="28" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_226" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_226" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_227" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_221" xlink:to="loc_us-gaap_StockholdersEquity_227" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_228" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_215" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_228" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_26" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_25" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_26" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_28" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_NatureOfBusinessPolicyTextBlock" xlink:label="loc_sglb_NatureOfBusinessPolicyTextBlock_457" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_sglb_NatureOfBusinessPolicyTextBlock_457" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_29" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_29" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_30" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_30" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_32" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_32" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_33" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_33" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_34" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_34" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_35" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_35" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_36" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_36" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_37" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_37" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_38" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_38" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_39" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_39" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_40" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_40" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_OrganizationExpenditurePolicyTextBlock" xlink:label="loc_sglb_OrganizationExpenditurePolicyTextBlock_41" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_sglb_OrganizationExpenditurePolicyTextBlock_41" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_42" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_42" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_43" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_43" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_44" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_UseOfEstimates_44" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_45" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_45" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_47" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_47" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_48" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_28" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_48" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquityTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_717" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_718" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_717" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_718" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_50" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_51" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_50" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_51" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_53" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_53" xlink:to="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_57" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56" xlink:to="loc_us-gaap_PatentsMember_57" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_59" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_59" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_64" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_us-gaap_AwardTypeAxis_64" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesTable_54" xlink:to="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_65" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_65" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_66" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_66" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_67" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_67" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_68" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_68" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_71" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_71" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_72" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_SummaryOfSignificantAccountingPoliciesLineItems_699" xlink:to="loc_us-gaap_InventoryRawMaterials_72" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_BalanceSheetsParentheticalAbstract" xlink:label="loc_sglb_BalanceSheetsParentheticalAbstract_230" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_231" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_BalanceSheetsParentheticalAbstract_230" xlink:to="loc_us-gaap_StatementTable_231" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_232" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_231" xlink:to="loc_us-gaap_StatementScenarioAxis_232" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_233" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_232" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_233" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_234" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_231" xlink:to="loc_us-gaap_StatementLineItems_234" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_235" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_235" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_236" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_236" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_237" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesIssued_237" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_238" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_238" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_239" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_239" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_240" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_240" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_241" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesIssued_241" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_242" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_242" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_243" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_234" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_243" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_720" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsTable" xlink:label="loc_sglb_StockOptionsValuationAssumptionsTable_721" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_720" xlink:to="loc_sglb_StockOptionsValuationAssumptionsTable_721" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_722" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable_721" xlink:to="loc_us-gaap_StatementClassOfStockAxis_722" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_724" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_722" xlink:to="loc_us-gaap_ClassOfStockDomain_724" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable_721" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_723" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_733" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_732" xlink:to="loc_us-gaap_EmployeeStockOptionMember_733" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockOptionsValuationAssumptionsLineItems" xlink:label="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsTable_721" xlink:to="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_725" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_725" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_726" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_726" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_727" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_727" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_728" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_728" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_729" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_729" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_730" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_StockOptionsValuationAssumptionsLineItems_731" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_730" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_75" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_76" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_75" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_76" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_77" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_StatementClassOfStockAxis_77" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_78" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_77" xlink:to="loc_us-gaap_ClassOfStockDomain_78" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_81" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_81" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_81" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_83" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_82" xlink:to="loc_us-gaap_PrivatePlacementMember_83" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_84" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_sglb_ThirdPartyAxis_84" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_85" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyAxis_84" xlink:to="loc_sglb_ThirdPartyDomain_85" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_OneConsultantsAndTwoProfessionalsMember" xlink:label="loc_sglb_OneConsultantsAndTwoProfessionalsMember_86" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_OneConsultantsAndTwoProfessionalsMember_86" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantOneMember" xlink:label="loc_sglb_ConsultantOneMember_87" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_ConsultantOneMember_87" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoConsultantsMember" xlink:label="loc_sglb_TwoConsultantsMember_88" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_TwoConsultantsMember_88" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantTwoMember" xlink:label="loc_sglb_ConsultantTwoMember_90" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_ConsultantTwoMember_90" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CosultantMember" xlink:label="loc_sglb_CosultantMember_786" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_85" xlink:to="loc_sglb_CosultantMember_786" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_92" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_91" xlink:to="loc_us-gaap_RelatedPartyDomain_92" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember_94" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_92" xlink:to="loc_us-gaap_InvestorMember_94" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_95" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_AwardTypeAxis_95" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2011Member" xlink:label="loc_sglb_EquityIncentivePlan2011Member_97" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_EquityIncentivePlan2011Member_97" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EquityIncentivePlan2013Member" xlink:label="loc_sglb_EquityIncentivePlan2013Member_98" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_EquityIncentivePlan2013Member_98" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_FirstAnnualAnniversaryMember" xlink:label="loc_sglb_FirstAnnualAnniversaryMember_412" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_FirstAnnualAnniversaryMember_412" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_SecondAnnualAnniversaryMember" xlink:label="loc_sglb_SecondAnnualAnniversaryMember_413" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96" xlink:to="loc_sglb_SecondAnnualAnniversaryMember_413" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_105" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_TitleOfIndividualAxis_105" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_105" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_107" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_DirectorMember_107" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_109" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_OfficerMember_109" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="loc_us-gaap_VicePresidentMember_416" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_us-gaap_VicePresidentMember_416" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EmployeeMember" xlink:label="loc_sglb_EmployeeMember_417" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_EmployeeMember_417" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeOneMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeOneMember_636" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeOneMember_636" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeTwoMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeTwoMember_637" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeTwoMember_637" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockShareIssedToEmployeeNewMember" xlink:label="loc_sglb_CommonStockShareIssedToEmployeeNewMember_769" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_106" xlink:to="loc_sglb_CommonStockShareIssedToEmployeeNewMember_769" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_110" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_110" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_111" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110" xlink:to="loc_us-gaap_EquityComponentDomain_111" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_112" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_us-gaap_WarrantMember_112" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsOneMember" xlink:label="loc_sglb_WarrantsOneMember_113" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantsOneMember_113" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantsTwoMember" xlink:label="loc_sglb_WarrantsTwoMember_114" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantsTwoMember_114" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeOneYearMember" xlink:label="loc_sglb_WarrantExpiryLifeOneYearMember_116" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeOneYearMember_116" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeTwoYearMember" xlink:label="loc_sglb_WarrantExpiryLifeTwoYearMember_117" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeTwoYearMember_117" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeNineMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeNineMonthsMember_118" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeNineMonthsMember_118" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_WarrantExpiryLifeFourteenMonthsMember" xlink:label="loc_sglb_WarrantExpiryLifeFourteenMonthsMember_119" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_sglb_WarrantExpiryLifeFourteenMonthsMember_119" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_406" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_111" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_406" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_120" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_709" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_708" xlink:to="loc_us-gaap_EmployeeStockOptionMember_709" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_707" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_RangeAxis_707" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_711" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_707" xlink:to="loc_us-gaap_RangeMember_711" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_712" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_711" xlink:to="loc_us-gaap_MinimumMember_712" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_713" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_711" xlink:to="loc_us-gaap_MaximumMember_713" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_710" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_76" xlink:to="loc_us-gaap_ClassOfStockLineItems_710" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_121" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_121" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_122" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_122" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_123" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesIssued_123" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_169" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_169" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations" xlink:label="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations_124" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations_124" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration" xlink:label="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration_125" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration_125" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_126" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_126" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_127" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_127" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_128" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_128" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_129" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_129" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_130" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_130" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_131" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_131" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_133" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_133" use="optional" order="62" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_134" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_134" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_135" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_135" use="optional" order="64" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_140" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_140" use="optional" order="65" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_141" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_141" use="optional" order="66" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_144" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_144" use="optional" order="67" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_145" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_145" use="optional" order="68" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue" xlink:label="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue_146" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue_146" use="optional" order="69" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_147" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_147" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_150" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_150" use="optional" order="71" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_151" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_151" use="optional" order="72" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_152" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_152" use="optional" order="73" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_154" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_154" use="optional" order="74" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_155" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_155" use="optional" order="75" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_156" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_156" use="optional" order="76" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_157" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_157" use="optional" order="77" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_158" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_158" use="optional" order="78" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_159" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_159" use="optional" order="79" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ClassOfWarrantOrRightsExercisable" xlink:label="loc_sglb_ClassOfWarrantOrRightsExercisable_160" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_sglb_ClassOfWarrantOrRightsExercisable_160" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_161" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_161" use="optional" order="81" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_162" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_162" use="optional" order="82" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_163" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_163" use="optional" order="83" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_164" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_CommonStockValue_164" use="optional" order="84" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_167" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_167" use="optional" order="85" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_168" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_168" use="optional" order="86" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_407" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_407" use="optional" order="87" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_408" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_408" use="optional" order="88" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_409" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_409" use="optional" order="89" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_429" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_429" use="optional" order="90" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_702" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_702" use="optional" order="91" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_703" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_703" use="optional" order="92" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_704" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_704" use="optional" order="93" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_705" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_705" use="optional" order="94" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_706" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_706" use="optional" order="95" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_768" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_768" use="optional" order="96" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_780" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_780" use="optional" order="97" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_783" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_783" use="optional" order="98" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_784" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_784" use="optional" order="99" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_800" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_710" xlink:to="loc_us-gaap_StockOptionPlanExpense_800" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_189" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareTable" xlink:label="loc_sglb_ScheduleOfEarningsPerShareTable_190" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_189" xlink:to="loc_sglb_ScheduleOfEarningsPerShareTable_190" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_191" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ScheduleOfEarningsPerShareTable_190" xlink:to="loc_us-gaap_StatementScenarioAxis_191" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_192" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_191" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_192" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ScheduleOfEarningsPerShareLineItems" xlink:label="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ScheduleOfEarningsPerShareTable_190" xlink:to="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_194" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_194" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_195" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ScheduleOfEarningsPerShareLineItems_193" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_195" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_245" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_246" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_245" xlink:to="loc_us-gaap_StatementTable_246" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_247" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_246" xlink:to="loc_us-gaap_StatementScenarioAxis_247" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_248" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_247" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_248" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_249" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_246" xlink:to="loc_us-gaap_StatementLineItems_249" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_250" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_RevenuesAbstract_250" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="loc_us-gaap_TechnologyServicesRevenue_251" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_250" xlink:to="loc_us-gaap_TechnologyServicesRevenue_251" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_252" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_250" xlink:to="loc_us-gaap_SalesRevenueServicesNet_252" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_253" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_CostOfServices_253" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_254" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_GrossProfit_254" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_255" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_OperatingExpensesAbstract_255" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_256" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_256" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_257" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_SalariesAndWages_257" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_258" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_258" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_259" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_259" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_260" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_OperatingExpenses_260" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_255" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_262" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_261" xlink:to="loc_us-gaap_InvestmentIncomeInterest_262" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_264" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_264" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_265" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_265" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_266" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_266" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_267" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_267" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_268" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_NetIncomeLoss_268" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_269" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_269" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_270" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_249" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_270" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/JointVentureDetailsTextual">
    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_JointVentureAbstract" xlink:label="loc_sglb_JointVentureAbstract_377" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_378" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_JointVentureAbstract_377" xlink:to="loc_us-gaap_StatementTable_378" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_379" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_378" xlink:to="loc_us-gaap_StatementClassOfStockAxis_379" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_380" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_379" xlink:to="loc_us-gaap_ClassOfStockDomain_380" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_381" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_378" xlink:to="loc_dei_LegalEntityAxis_381" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_384" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_381" xlink:to="loc_dei_EntityDomain_384" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_385" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_384" xlink:to="loc_us-gaap_CorporateJointVentureMember_385" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_383" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_378" xlink:to="loc_us-gaap_StatementLineItems_383" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_382" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_383" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_382" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_682" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_683" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_682" xlink:to="loc_us-gaap_SubsequentEventTable_683" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_684" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_PlanNameAxis_684" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_688" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_684" xlink:to="loc_us-gaap_PlanNameDomain_688" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_TwoThousandAndThirteenStockOptionPlanMember" xlink:label="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember_689" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_688" xlink:to="loc_sglb_TwoThousandAndThirteenStockOptionPlanMember_689" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_687" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_687" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_691" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_691" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_692" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_691" xlink:to="loc_us-gaap_SubsequentEventMember_692" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_690" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_738" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_737" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_737" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_741" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_737" xlink:to="loc_us-gaap_EquityComponentDomain_741" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_740" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_sglb_ThirdPartyAxis_740" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_791" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyAxis_740" xlink:to="loc_sglb_ThirdPartyDomain_791" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CosultantMember" xlink:label="loc_sglb_CosultantMember_792" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_791" xlink:to="loc_sglb_CosultantMember_792" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_790" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_RangeAxis_790" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_797" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_790" xlink:to="loc_us-gaap_RangeMember_797" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_798" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_797" xlink:to="loc_us-gaap_MinimumMember_798" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_799" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_797" xlink:to="loc_us-gaap_MaximumMember_799" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_796" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_683" xlink:to="loc_us-gaap_SubsequentEventLineItems_796" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_787" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_787" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_788" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_788" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_789" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_789" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_CommonStockSharesAuthorisedPostReverseStockSplit" xlink:label="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit_793" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_sglb_CommonStockSharesAuthorisedPostReverseStockSplit_793" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_794" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_794" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_795" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_796" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_795" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_272" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_273" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_272" xlink:to="loc_us-gaap_StatementTable_273" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_274" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementScenarioAxis_274" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_275" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_274" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_275" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_276" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementLineItems_276" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_278" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_NetIncomeLoss_278" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_280" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_280" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_282" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_AdjustmentForAmortization_282" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_283" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_Depreciation_283" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_785" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_StockOptionPlanExpense_785" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_284" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_280" xlink:to="loc_us-gaap_ShareBasedCompensation_284" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_279" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_287" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_287" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_288" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_288" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_289" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_289" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_290" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_290" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_291" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_286" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_291" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_292" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_277" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_292" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_294" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_294" use="optional" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_295" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_295" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_296" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_293" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_296" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_297" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_297" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_303" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_303" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_304" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_304" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_305" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_305" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_276" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_307" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" xlink:to="loc_us-gaap_InterestPaid_307" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_308" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_306" xlink:to="loc_us-gaap_IncomeTaxesPaid_308" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_310" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_311" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_310" xlink:to="loc_us-gaap_StatementTable_311" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_312" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_StatementClassOfStockAxis_312" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_313" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_312" xlink:to="loc_us-gaap_ClassOfStockDomain_313" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_314" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_AwardTypeAxis_314" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_314" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_316" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_315" xlink:to="loc_us-gaap_StockCompensationPlanMember_316" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyAxis" xlink:label="loc_sglb_ThirdPartyAxis_317" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_sglb_ThirdPartyAxis_317" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ThirdPartyDomain" xlink:label="loc_sglb_ThirdPartyDomain_318" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyAxis_317" xlink:to="loc_sglb_ThirdPartyDomain_318" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_ConsultantMember" xlink:label="loc_sglb_ConsultantMember_319" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sglb_ThirdPartyDomain_318" xlink:to="loc_sglb_ConsultantMember_319" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_320" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_TitleOfIndividualAxis_320" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_320" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_EmployeeMember" xlink:label="loc_sglb_EmployeeMember_422" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_354" xlink:to="loc_sglb_EmployeeMember_422" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_353" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_353" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_357" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_353" xlink:to="loc_us-gaap_EquityComponentDomain_357" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_356" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311" xlink:to="loc_us-gaap_StatementLineItems_356" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_321" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_321" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_322" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_322" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_323" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_323" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_324" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_324" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_325" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_325" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="sglb-20160331.xsd#sglb_IncreaseDecreaseInDeferredCompensationperShare" xlink:label="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare_767" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_sglb_IncreaseDecreaseInDeferredCompensationperShare_767" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_802" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_356" xlink:to="loc_us-gaap_StockOptionPlanExpense_802" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_328" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_329" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_328" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_329" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6742679968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>May. 12, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SIGMA LABS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000788611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGLB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,237,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6743022992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 1,086,363<span></span>
</td>
<td class="nump">$ 1,539,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, net</a></td>
<td class="nump">381,309<span></span>
</td>
<td class="nump">280,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">94,186<span></span>
</td>
<td class="nump">20,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid Assets</a></td>
<td class="nump">38,862<span></span>
</td>
<td class="nump">55,484<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">1,600,720<span></span>
</td>
<td class="nump">1,895,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, net</a></td>
<td class="nump">697,316<span></span>
</td>
<td class="nump">714,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, net</a></td>
<td class="nump">197,630<span></span>
</td>
<td class="nump">167,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in Joint Venture</a></td>
<td class="nump">9,222<span></span>
</td>
<td class="nump">9,222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Other Assets</a></td>
<td class="nump">904,168<span></span>
</td>
<td class="nump">891,620<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">2,504,888<span></span>
</td>
<td class="nump">2,787,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">144,026<span></span>
</td>
<td class="nump">38,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Expenses</a></td>
<td class="nump">82,630<span></span>
</td>
<td class="nump">71,523<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">226,656<span></span>
</td>
<td class="nump">109,916<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">226,656<span></span>
</td>
<td class="nump">109,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, $0.001 par; 7,500,000 shares authorized; 6,232,778 issued and 6,210,278 outstanding at March 31, 2016 and 6,239,073 issued and 6,206,573 outstanding at December 31, 2015</a></td>
<td class="nump">6,233<span></span>
</td>
<td class="nump">6,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid-In Capital</a></td>
<td class="nump">10,579,536<span></span>
</td>
<td class="nump">10,636,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Less Deferred Compensation 22,500 and 32,500 common shares, respectively</a></td>
<td class="num">(272,750)<span></span>
</td>
<td class="num">(401,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Deficit)</a></td>
<td class="num">(8,034,787)<span></span>
</td>
<td class="num">(7,564,120)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">2,278,232<span></span>
</td>
<td class="nump">2,677,348<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 2,504,888<span></span>
</td>
<td class="nump">$ 2,787,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 12<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.10-17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 18<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 25<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 8<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6743070240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets [Parenthetical] - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, share issued</a></td>
<td class="nump">6,232,778<span></span>
</td>
<td class="nump">6,239,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,210,278<span></span>
</td>
<td class="nump">6,206,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance', window );">Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance</a></td>
<td class="nump">22,500<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6743018352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesRevenue', window );">Services</a></td>
<td class="nump">$ 358,455<span></span>
</td>
<td class="nump">$ 185,686<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Total Revenue</a></td>
<td class="nump">358,455<span></span>
</td>
<td class="nump">185,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfServices', window );">COST OF SERVICE REVENUE</a></td>
<td class="nump">107,581<span></span>
</td>
<td class="nump">24,867<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">250,874<span></span>
</td>
<td class="nump">160,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other General and Administration</a></td>
<td class="nump">395,488<span></span>
</td>
<td class="nump">267,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Payroll Expense</a></td>
<td class="nump">215,589<span></span>
</td>
<td class="nump">72,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-Based Compensation</a></td>
<td class="nump">71,551<span></span>
</td>
<td class="nump">122,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="nump">39,071<span></span>
</td>
<td class="nump">70,147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Expenses</a></td>
<td class="nump">721,699<span></span>
</td>
<td class="nump">533,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest Income</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (Expense)</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="num">(470,667)<span></span>
</td>
<td class="num">(371,881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (470,667)<span></span>
</td>
<td class="num">$ (371,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per Common Share - Basic and Diluted</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted Average Number of Shares Outstanding - Basic and Diluted</a></td>
<td class="nump">6,233,729<span></span>
</td>
<td class="nump">6,206,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to services rendered by an entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51673353&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 10<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of expenses not otherwise specified in the taxonomy for managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for salaries other than officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueServicesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueServicesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 76<br> -URI http://asc.fasb.org/extlink&amp;oid=51674016&amp;loc=d3e132428-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TechnologyServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6742821488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (470,667)<span></span>
</td>
<td class="num">$ (371,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Noncash Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">5,002<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">42,868<span></span>
</td>
<td class="nump">40,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock Options Awarded</a></td>
<td class="nump">53,540<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock Compensation</a></td>
<td class="nump">18,011<span></span>
</td>
<td class="nump">122,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) Decrease in Accounts Receivable</a></td>
<td class="num">(101,087)<span></span>
</td>
<td class="num">(46,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (Increase) in Inventory</a></td>
<td class="num">(74,057)<span></span>
</td>
<td class="num">(6,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease (Increase) in Prepaid Assets</a></td>
<td class="nump">16,622<span></span>
</td>
<td class="nump">8,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">(Decrease) Increase in Accounts Payable</a></td>
<td class="nump">105,633<span></span>
</td>
<td class="num">(212,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase In Accrued Expenses</a></td>
<td class="nump">11,107<span></span>
</td>
<td class="nump">1,510<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES</a></td>
<td class="num">(393,028)<span></span>
</td>
<td class="num">(463,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of Furniture and Equipment</a></td>
<td class="num">(25,430)<span></span>
</td>
<td class="num">(7,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of Intangible Assets</a></td>
<td class="num">(34,988)<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">NET CASH (USED) BY INVESTING ACTIVITIES</a></td>
<td class="num">(60,418)<span></span>
</td>
<td class="num">(8,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET CASH (DECREASE) INCREASE FOR PERIOD</a></td>
<td class="num">(453,446)<span></span>
</td>
<td class="num">(472,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT BEGINNING OF PERIOD</a></td>
<td class="nump">1,539,809<span></span>
</td>
<td class="nump">2,962,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT END OF PERIOD</a></td>
<td class="nump">1,086,363<span></span>
</td>
<td class="nump">2,489,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure for Cash Flow Information Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6729801552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Schedule of Noncash Investing and Financing Activities - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Increase (Decrease) in Deferred Compensation</a></td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_IncreaseDecreaseInDeferredCompensationperShare', window );">Increase Decrease In Deferred Compensation,Per Share</a></td>
<td class="nump">$ 12.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock or Unit Option Plan Expense</a></td>
<td class="nump">$ 53,540<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember', window );">Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">3,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 4.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Equty Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Increase (Decrease) in Deferred Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_IncreaseDecreaseInDeferredCompensationperShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) per share during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_IncreaseDecreaseInDeferredCompensationperShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6733412320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 1 &#150; Summary of Significant Accounting Policies</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Nature of Business &#150;</b> On <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">September 13, 2010</font> Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the shares of B6 Sigma, Inc. by exchanging <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6.67</font> shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &#8220;reverse purchase&#8221;, and accordingly the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &#8220;B6 Sigma&#8221; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &#8220;Company,&#8221; &#8220;Sigma,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimatley leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and processs control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, <font style="FONT-SIZE: 10pt">automotive manufacturing, and other markets such as firearms and recreational equipment</font>.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Basis of Presentation</strong> &#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2016 and 2015 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2015 audited financial statements and notes thereto included in the Company&#8217;s Form 10-K. The results of operations for the periods ended March 31, 2016 and 2015 are not necessarily indicative of the operating results for the full year.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <font style="BACKGROUND-COLOR: transparent">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Reclassification</b> &#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Property and Equipment &#150;</b> Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Fair Value of Financial Instruments</b> - The Company applies ASC 820, &#8220;Fair Value Measurements<i>.</i>&#8221;<i>&#160;</i> This guidance defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; BORDER-TOP-COLOR: #000000; WIDTH: 5%; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; WIDTH: 94%; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Income Taxes</b> <b>&#150;</b> The Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company adopted the provisions of ASC Topic No. 740, &#8220;Accounting for Income Taxes,&#8221; at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company has no tax positions at March 31, 2016 and December 31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the three months ended March 31, 2016, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at March 31, 2016 and 2015 or December 31, 2015. All tax years starting with 2010 are open for examination.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Loss Per Share &#150;</b> The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accounts Receivable and Allowance for Doubtful Accounts</b> - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at March 31, 2016 and December 31, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> respectively.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Long-Lived and Intangible Assets &#150;</b> Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the three months March 31, 2016 or the year ended December 31, 2015.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Recently Enacted Accounting Standards</b> &#150; The FASB established the Accounting Standards Codification (&#8220;Codification&#8221; or &#8220;ASC&#8221;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Rules and interpretive releases of the Securities and Exchange Commission (&#8220;SEC&#8221;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Recent Accounting Standards Updates (&#8220;ASU&#8221;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Cash Equivalents</b> - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Concentration of Credit Risk -</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Organization Expenditures</b> &#150; Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Stock Based Compensation</b> &#150; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#150; Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grants for compensation are included in the Statement of Stockholders&#8217; Equity as a contra-equity account as &#8220;Deferred Compensation.&#8221;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, &#8220;Equity Based Payments to Non-Employees.&#8221; In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Amortization</b> - Utility patents are amortized over a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17</font> year period. Patents which are pending are not amortized.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accounting Estimates</b> - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenue Recognition &#150;</b> The Company&#8217;s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Inventory</b> &#150; Inventories consist of raw materials used in the production of customized parts totaling $94,186 and nominal work-in-process components which will be sold to customers. Inventories are valued at the lower of cost or market, using the first-in, first-out (FIFO) method.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Research and Development</b> &#150; Research and development costs are expensed as they are incurred. Research and development costs for the three months ended March 31, 2016 and 2015 were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">39,071</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">70,147</font>, respectively.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6908877360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="COLOR: black; FONT-SIZE: 10pt">NOTE 2 &#150; Stockholders&#8217; Equity</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt">Common Stock</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &#8220;Certificate of Change&#8221;) filed with the Nevada Secretary of State.&#160;The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &#8220;Reverse Stock Split&#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#8220;Share Decrease&#8221;).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> &#160; <font style="COLOR: black; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). &#160;Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. &#160;All amounts shown for common stock included in these financial statement are presented post-Reverse Stock Split.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As of March 31, 2016, the Company had <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,500,000</font> shares of authorized common stock, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.001</font> par value per share.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">On May 23, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20,000</font> shares of the Company&#8217;s common stock to a consultant as noncash compensation for services to be rendered valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">45,400</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.27</font> per share. Of these shares, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">22,700</font>) vested immediately and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,607</font> (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">21,808</font>) vested during the year ended December 31, 2015. The remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 393</font> shares (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">892</font>) vested and were earned by the consultant during the three months ending March 31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In January 2014, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 437,500</font> shares of stock to an investor for a total purchase price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,500,000</font>. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 142,593</font> shares of the Company&#8217;s common stock, at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> per share. The warrant had a term of nine months from the date of issuance (January 10, 2014) and had a fair value of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,212,037</font>. In May 2014, the term of the warrant was extended by nine months to expire in July 2015 and had a fair market value in excess of the remaining fair market value of the original warrant of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,283,333</font>. A warrant was also issued as part of the offering to a consultant to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,875</font> shares of common stock at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font> per share, valued at approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">271,250</font>. That warrant had a term of two years from the date of issuance (January 10, 2014). Offering costs paid from the proceeds of the offering were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">199,089</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent">&#160;</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">The fair value of the warrant of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,212,037</font> was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of nine months, expected volatility of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 202</font>%, a risk-free interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.09</font>%, and an expected dividend yield of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0</font>%. The fair value of the warrant of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">271,250</font> was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 201</font>%, a risk-free interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.39</font>%, and an expected dividend yield of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0</font>%.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">The fair value of the new warrant related to the extension of the warrant expiration of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,283,333</font> (net) was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of 14 months, expected volatility of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 226</font>%, a risk-free interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.1</font>%, and an expected dividend yield of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0</font>%.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In June 2014, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 62,500</font> shares of stock to an investor for a total purchase price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font>. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20,370</font> shares of the Company&#8217;s common stock, at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> per share. The warrant had a term of one year from the date of issuance (June 4, 2014) and had a fair value of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">132,407</font>. A warrant was also issued as part of the offering to a consultant to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,125</font> shares of common stock at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font> per share, valued at approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36,250</font>. That warrant has a term of two years from the date of issuance (June 4, 2014). Offering costs paid from the proceeds of the offering were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">25,035</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <font style="COLOR: black; FONT-SIZE: 10pt"><font style="COLOR: black; FONT-SIZE: 10pt"><font style="COLOR: black; FONT-SIZE: 10pt"></font></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> The fair value of the warrant of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">132,407</font> was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of one year, expected volatility of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 163</font>%, a risk-free interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.1</font>%, and an expected dividend yield of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0</font>%. The fair value of the warrant of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36,250</font> was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 287</font>%, a risk-free interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.41</font>%, and an expected dividend yield of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0</font>%.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">During July 2014, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 60,000</font> shares of common stock to three employees valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12.90</font> per share or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">774,000</font>. Twenty-five percent of each employee&#8217;s shares vested immediately upon the grant date, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% of such shares vested upon the first annual anniversary of each employee&#8217;s start date, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% of such shares will vest on each of the second and third annual anniversary of each employee's start date, provided that such employee remains in the Company&#8217;s continuous employ through such vesting dates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In November 2014, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000</font> shares of stock to a director, subject to restrictions, pursuant to the Company's 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). The shares were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.40</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">141,000</font>. All shares vested during the year ended December 31, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In March 2015, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> shares of stock to a director. The Company also issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000</font> shares of stock to an officer, and an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,038</font> shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.30</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">191,000</font>. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 33,037</font> of the shares vested during the year ended December 31, 2015. Another&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 429</font> shares (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,275</font>) vested during the three months ending March 31, 2016 and the remaining&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,572</font> shares unvested at March 31, 2016 (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13,630</font>) are reflected as prepaid assets.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In August 2015, in conjuction with the hiring of Ron Fisher, the Company's Vice President of Business Development, the Company issued to Mr. Fisher <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,500</font> shares of common stock, subject to performance-based vesting restrictions. The shares, valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,750</font>, remain unvested at March 31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In November 2015, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 625</font> shares of common stock to an employee valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.50</font> per share, or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,063</font>, and issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,500</font> shares of common stock to an employee valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.15</font> per share, or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15,375</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">In February 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 625</font> shares of common stock to a new employee, valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.82</font> per share, or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,013</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> In March 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,080</font> shares of common stock to a consultant, valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.87</font> per share, or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15,000</font>.</div> &#160; <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As of&#160;March 31, 2016, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,232,778</font> shares of common stock issued and outstanding. As of December 31, 2015, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,239,073</font> shares of common stock issued and outstanding, reflecting <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22,500</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 32,500</font> shares, respectively, issued but unvested shares pursuant to the Company's 2011 Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and the 2013 Plan. As of March 31, 2016, an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,500</font> shares and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 167,132</font> shares of common stock were reserved for issuance under the 2011 Plan and the 2013 Plan, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt">Deferred Compensation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As described under the Common Stock heading above, during July 2014, the Company issued to three employees an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 60,000</font> shares of the Company&#8217;s common stock, subject to restrictions, pursuant to the 2013 Plan. Such shares were valued at the fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">774,000</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12.90</font> per share. This compensation is being expensed over the vesting period. As of March 31, 2016, the balance of unvested compensation cost expected to be recognized is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">258,000</font> (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">20,000</font> shares valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12.90</font>) and is recorded as a reduction of stockholders&#8217; equity. The unvested compensation is expected to be recognized over the weighted average period of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2</font> years (through July 2017).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As described under the Common Stock heading above, in November 2014, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000</font> shares of stock to a director, subject to restrictions, pursuant to the 2013 Plan. The shares were valued&#160;at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.40</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">141,000</font>. All shares vested during the year ended December 31, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As described under the Common Stock heading above, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> shares of stock to a director in March 2015. The Company also issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000</font> shares of stock to an officer, and an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,038</font> shares of stock to two consultants, subject to vesting restrictions. The shares were issued pursuant to the 2013 Plan. The shares were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.30</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">191,000</font>. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 33,037</font> of the shares vested during the year ended December 31, 2015. Another&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 429</font> shares (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,275</font>) vested during the three months ending March 31, 2016 and the remaining&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,572</font> shares unvested at March 31, 2016 (valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13,630</font>) are reflected as prepaid assets.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As described under the Common Stock heading above, in August 2015, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,500</font> shares of stock to an employee, subject to performance-based vesting restrictions, pursuant to the Company's 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). The shares were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.90</font> or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,750</font>. All shares remained unvested as of March 31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As of March 31, 2016, the balance of unvested compensation cost expected to be recognized is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">272,750</font> and is recorded as a reduction of stockholders&#8217; equity. The unvested compensation is expected to be recognized over the weighted average period of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2</font> years (through July, 2017).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt">Preferred Stock</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></b></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">The Company is authorized to issue <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000,000</font> shares of preferred stock, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.001</font> par value per share. No shares of preferred stock were issued and outstanding at March 31, 2016 or December 31, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt">Stock Options</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> During 2015, the Company granted a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 56,875</font> options to three employees with vesting periods ranging from one to four years beginning August 10, 2015. As of March 31, 2016, none of the option grants had vested, and only a nominal amount of compensation cost had been recognized during the year. The weighted average period over which total compensation cost of the options of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">306,796</font> will be recognized is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.81</font> years. The weighted average exercise price of the options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.94</font> and the weighted average fair value of the options on the dates of grant was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.91</font>. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> &#160;</div> <table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 82%"> <div>Expected term:</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font> years&#160;</font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td> <div>Volatility:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">184</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Dividend yield:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.00</font>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Risk-free interest rate:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2.24</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.32</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> &#160;</div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">During 2016, the Company granted a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,875</font> options to <font style="BACKGROUND-COLOR: transparent">three employees with vesting periods&#160;ranging from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> three</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> four</font>&#160;years beginning February 16, 2016. As of March 31, 2016, compensation cost of $53,540, including options granted during 2015 was recognized during the period, for options vesting. The weighted average period over which total compensation cost of the options of <font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">116,177</font></font> ($306,796 in 2015)&#160;will be recognized is <font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.91</font></font> years. The weighted average exercise price of the options <font style="BACKGROUND-COLOR: transparent">was <font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.75</font></font> and the weighted average fair value of the options on the dates of grant was <font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> $</font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.73</font></font>. The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</font></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt"></font>&#160;</div> <table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 82%"> <div>Expected term:</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font> years&#160;</font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td> <div>Volatility:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 176</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">184</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Dividend yield:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.00</font>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Risk-free interest rate:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2.24</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.32</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt"></font></b>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Warrants</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <b><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></b></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">As of March 31, 2016, the Company had one outstanding warrant remaining to purchase a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,125</font> shares of common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font> per share. Such warrant will expire on June 4, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">During the three months ending March 31, 2016, a warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,875</font> shares of common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font> per share expired.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt">During the year ending December 31, 2015, a warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20,370</font> shares of common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> per share, as well as a warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 142,593</font> shares of common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> per share, expired.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d),(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section C<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6733409712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Continuing Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ContinuingOperationsDisclosureAbstract', window );"><strong>Continuing Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ContinuingOperationsDisclosureTextBlock', window );">Continuing Operations Disclosure [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="COLOR: black; FONT-SIZE: 10pt">NOTE&#160;3&#160;- Continuing Operations</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="COLOR: black; FONT-SIZE: 10pt">The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has had increasing revenues in recent periods. In addition, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. The Company believes it has adequate working capital and cash to fund operations through 2016, and has entered into significant revenue contracts that are expected to generate cash flow in the near term.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ContinuingOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ContinuingOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ContinuingOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If there is a sustained losses in cash flows from operating activities in this financial year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ContinuingOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6616574976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>NOTE&#160;4 &#150; Loss Per Share</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2016 and 2015:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="21%" colspan="5"> <div>3&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"> <div>03-31-16</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"> <div>03-31-15</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Loss from continuing Operations available to Common stockholders (numerator)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(470,667)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(371,881)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,233,729</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,206,220</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6908902208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Venture<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_JointVentureAbstract', window );"><strong>Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_JointVentureDisclosureTextBlock', window );">Joint Venture Disclosure [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="COLOR: black; FONT-SIZE: 10pt">NOTE&#160;5 - Joint Venture</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></b></div> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="COLOR: black; FONT-SIZE: 10pt">As previously reported in our Form 8-K filed with the SEC on July 6, 2015, we entered into an Operating Agreement and Statement of Work with Arete Innovative Solutions LLC (&#8220;Arete&#8221;). The Operating Agreement and Statement of Work govern the operations of Arete-Sigma LLC (the "Joint Venture"), a joint venture formed by us and Arete for the purpose of pursuing business opportunities related to AM utilizing our EOS M290 or like machines, including enabling and implementing sales and manufacturing transactions. Under the Operating Agreement and Statement of Work, among other matters reported in our Form 8-K and set forth in the Operating Agreement and Statement of Work, (i) each of Sigma and Arete hold a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% ownership interest in the Joint Venture, and (ii) the Joint Venture is managed by William F. Herman, President of Arete, subject to certain limitations. Based on the Operating Agreement, the Company holds the non-controlling interest in the Joint Venture. Therefore, the Joint Venture has not been consolidated, but rather is accounted for on the equity method of recording investments. During the three months ended March 31, 2016, the joint venture had no activity. The Company is evaluating whether to continue the Joint Venture and is continuing to pursue business opportunities related to AM utilizing the Company's EOS M290 or like machines.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_JointVentureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_JointVentureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_JointVentureDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of joint venture or partnership that is included in the enterprise's financial statements using the proportionate consolidation method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_JointVentureDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6909365952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="COLOR: black; FONT-SIZE: 10pt"> NOTE&#160;6</font></b> <font style="COLOR: black; FONT-SIZE: 10pt"> <b>&#150; Subsequent Events</b></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are the following items to disclose:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> On April 17, 2016, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,529</font> shares of common stock to a consultant for services to be rendered valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.25</font> per share, or $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15,000</font>.</div> &#160; <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On April 28, 2016, at the Annual Meeting of Stockholders of the Company, the Company's stockholders approved an amendment to the 2013 Plan to increase the number of shares of the Company's common stock reserved for issuance under the 2013 Plan by 638,538 shares of our common stock to a total of 750,000 shares (on a post-Reverse Stock Split basis).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On April 28, 2016, the Company's Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company's common stock from 7,500,000 to 15,000,000 shares of common stock&#160;</div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6743515504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_NatureOfBusinessPolicyTextBlock', window );">Nature Of Business [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Nature of Business &#150;</b> On <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">September 13, 2010</font> Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the shares of B6 Sigma, Inc. by exchanging <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6.67</font> shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &#8220;reverse purchase&#8221;, and accordingly the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &#8220;B6 Sigma&#8221; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &#8220;Company,&#8221; &#8220;Sigma,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimatley leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and processs control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace and defense manufacturing, oil and gas and energy manufacturing, bio-medical manufacturing, <font style="FONT-SIZE: 10pt">automotive manufacturing, and other markets such as firearms and recreational equipment</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Basis of Presentation</strong> &#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2016 and 2015 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2015 audited financial statements and notes thereto included in the Company&#8217;s Form 10-K. The results of operations for the periods ended March 31, 2016 and 2015 are not necessarily indicative of the operating results for the full year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Reclassification</b> &#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Property and Equipment &#150;</b> Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Fair Value of Financial Instruments</b> - The Company applies ASC 820, &#8220;Fair Value Measurements<i>.</i>&#8221;<i>&#160;</i> This guidance defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; BORDER-TOP-COLOR: #000000; WIDTH: 5%; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; WIDTH: 94%; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="PADDING-LEFT: 0.2pt; PADDING-RIGHT: 37.3pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The carrying amounts reported in the balance sheets for the cash and cash equivalents prepaid stock compensation, receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Income Taxes</b> <b>&#150;</b> The Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company adopted the provisions of ASC Topic No. 740, &#8220;Accounting for Income Taxes,&#8221; at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company has no tax positions at March 31, 2016 and December 31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the three months ended March 31, 2016, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at March 31, 2016 and 2015 or December 31, 2015. All tax years starting with 2010 are open for examination.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Loss Per Share &#150;</b> The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade and Other Accounts Receivable, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Accounts Receivable and Allowance for Doubtful Accounts</b> - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at March 31, 2016 and December 31, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Long-Lived and Intangible Assets &#150;</b> Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the three months March 31, 2016 or the year ended December 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Recently Enacted Accounting Standards</b> &#150; The FASB established the Accounting Standards Codification (&#8220;Codification&#8221; or &#8220;ASC&#8221;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Rules and interpretive releases of the Securities and Exchange Commission (&#8220;SEC&#8221;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Recent Accounting Standards Updates (&#8220;ASU&#8221;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Cash Equivalents</b> - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Concentration of Credit Risk -</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_OrganizationExpenditurePolicyTextBlock', window );">Organization Expenditure [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Organization Expenditures</b> &#150; Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Stock Based Compensation</b> &#150; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#150; Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grants for compensation are included in the Statement of Stockholders&#8217; Equity as a contra-equity account as &#8220;Deferred Compensation.&#8221;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, &#8220;Equity Based Payments to Non-Employees.&#8221; In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock', window );">Depreciation, Depletion, and Amortization [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Amortization</b> - Utility patents are amortized over a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 17</font> year period. Patents which are pending are not amortized.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Accounting Estimates</b> - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Revenue Recognition &#150;</b> The Company&#8217;s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Inventory</b> &#150; Inventories consist of raw materials used in the production of customized parts totaling $94,186 and nominal work-in-process components which will be sold to customers. Inventories are valued at the lower of cost or market, using the first-in, first-out (FIFO) method.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Research and Development</b> &#150; Research and development costs are expensed as they are incurred. Research and development costs for the three months ended March 31, 2016 and 2015 were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">39,071</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">70,147</font>, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_NatureOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_NatureOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_OrganizationExpenditurePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for organization expenditure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_OrganizationExpenditurePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 203<br> -Paragraph 02-03<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 206<br> -Paragraph b<br> -Subparagraph i, ii<br> -Chapter 2<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 13<br> -Section B<br> -Paragraph Question 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6378556&amp;loc=d3e10133-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5212-111524<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3, 4<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6733492544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> &#160;</div> <table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 82%"> <div>Expected term:</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font> years&#160;</font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td> <div>Volatility:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">184</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Dividend yield:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.00</font>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Risk-free interest rate:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2.24</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.32</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif ">&#160;</div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <font style="COLOR: black; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-COLOR: transparent">The estimated fair value of the options was determined using the Black-Scholls pricing model using the following assumptions:</font></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in"> <font style="COLOR: black; FONT-SIZE: 10pt"></font>&#160;</div> <table style="WIDTH: 50%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 82%"> <div>Expected term:</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right; WIDTH: 15%"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font> years&#160;</font></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td> <div>Volatility:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 176</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">184</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Dividend yield:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.00</font>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left"> <div>Risk-free interest rate:</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: right"> <div><font style="FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2.24</font>-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.32</font>&#160;</font></div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6909455664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2016 and 2015:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="21%" colspan="5"> <div>3&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"> <div>03-31-16</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%" colspan="2"> <div>03-31-15</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Loss from continuing Operations available to Common stockholders (numerator)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(470,667)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(371,881)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,233,729</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,206,220</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6731808416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 13, 2010</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number Of Shares Exchanged For Each Share Of Acquired Entity (in shares)</a></td>
<td class="nump">6.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for Doubtful Accounts Receivable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Useful Life, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,071<span></span>
</td>
<td class="nump">$ 70,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Inventory, Raw Materials, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Useful Life, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6680455280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - Employee Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_StockOptionsValuationAssumptionsLineItems', window );"><strong>Stock Options Valuation Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, Minimum</a></td>
<td class="nump">176.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, Maximum</a></td>
<td class="nump">184.00%<span></span>
</td>
<td class="nump">184.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, Minimum</a></td>
<td class="nump">2.24%<span></span>
</td>
<td class="nump">2.24%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, Maximum</a></td>
<td class="nump">2.32%<span></span>
</td>
<td class="nump">2.32%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_StockOptionsValuationAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_StockOptionsValuationAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section D<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6826270320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2016</div></th>
<th class="th"><div>Aug. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Nov. 30, 2014</div></th>
<th class="th"><div>Jul. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>May. 31, 2014</div></th>
<th class="th"><div>Jan. 31, 2014</div></th>
<th class="th"><div>May. 23, 2013</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Feb. 28, 2016</div></th>
<th class="th"><div>Nov. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,232,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,239,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,210,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,206,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,283,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance', window );">Deferred Compensation Arrangement With Individual, Shares Authorized For Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &#8220;Reverse Stock Split&#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#8220;Share Decrease&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statement are presented post-Reverse Stock Split.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock Option Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,540<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 10 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 9 months 22 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantsOneMember', window );">Warrants One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ClassOfWarrantOrRightsExercisable', window );">Class Of Warrant Or Rights Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantsTwoMember', window );">Warrants Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeOneYearMember', window );">Warrant Expiry Life One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271,250<span></span>
</td>
<td class="nump">$ 132,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeTwoYearMember', window );">Warrant Expiry Life Two Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeNineMonthsMember', window );">Warrant Expiry Life Nine Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.09%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,212,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeFourteenMonthsMember', window );">Warrant Expiry Life Fourteen Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,283,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation, Share-based Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,275<span></span>
</td>
<td class="nump">$ 2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429<span></span>
</td>
<td class="nump">429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Shares Issued For Employee Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember', window );">Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember', window );">Vice President [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember', window );">Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 774,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeOneMember', window );">Common stock share issed to Employee one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeTwoMember', window );">Common stock share issed to Employee two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeNewMember', window );">Common Stock Share Issed To Employee New [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2011Member', window );">Equity Incentive Plan 2011 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance', window );">Deferred Compensation Arrangement With Individual, Shares Authorized For Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member', window );">Equity Incentive Plan 2013 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Shares Issued For Employee Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock Issued During Period, Value, Share-based Compensation, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
<td class="nump">$ 774,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue', window );">Shares Issued For Employee Equity Plan Par Value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.40<span></span>
</td>
<td class="nump">$ 12.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued', window );">Deferred Compensation Arrangement with Individual, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense', window );">Deferred Compensation Arrangement with Individual, Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice', window );">Deferred Compensation Arrangement with Individual, Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member', window );">Equity Incentive Plan 2013 [Member] | Deferred Compensation, Share-based Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member', window );">Equity Incentive Plan 2013 [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock Issued During Period, Value, Share-based Compensation, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue', window );">Shares Issued For Employee Equity Plan Par Value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member', window );">Equity Incentive Plan 2013 [Member] | Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_FirstAnnualAnniversaryMember', window );">First Annual Anniversary [Member] | Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sglb_SecondAnnualAnniversaryMember', window );">Second Annual Anniversary [Member] | Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantOneMember', window );">Consultant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations', window );">Stock Issued During Period, Shares, Issued For Noncash Consideration (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration', window );">Stock Issued During Period, Value, Issued For Noncash Considerations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantOneMember', window );">Consultant One [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantOneMember', window );">Consultant One [Member] | Warrant Expiry Life One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_TwoConsultantsMember', window );">Two Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantTwoMember', window );">Consultant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_ConsultantTwoMember', window );">Consultant Two [Member] | Equity Incentive Plan 2013 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_CosultantMember', window );">Cosultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ClassOfWarrantOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total number of warrants exercisable as on the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ClassOfWarrantOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per share value of stock issued during period as share based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_StockIssuedDuringPeriodShareBasedCompensationPerShareValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for noncash considerations for development stage entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_StockIssuedDuringPeriodSharesIssuedForNoncashConsiderations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued for noncash consideration for development stage entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_StockIssuedDuringPeriodValueIssuedForNoncashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The compensation expense recognized during the period pertaining to the deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20015-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share price that the individual must pay to acquire shares under the deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued pursuant to the terms of a deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6939902&amp;loc=d3e20148-110875<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards not vested. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section C<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeTwoYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeTwoYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeNineMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeNineMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeFourteenMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=sglb_WarrantExpiryLifeFourteenMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_VicePresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=sglb_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeNewMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=sglb_CommonStockShareIssedToEmployeeNewMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sglb_EquityIncentivePlan2013Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sglb_FirstAnnualAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sglb_FirstAnnualAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sglb_SecondAnnualAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sglb_SecondAnnualAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_ConsultantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_ConsultantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_TwoConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_TwoConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_ConsultantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_ConsultantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_CosultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_CosultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6909059792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ScheduleOfEarningsPerShareLineItems', window );"><strong>Schedule of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing Operations available to Common stockholders (numerator)</a></td>
<td class="num">$ (470,667)<span></span>
</td>
<td class="num">$ (371,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator) (in shares)</a></td>
<td class="nump">6,233,729<span></span>
</td>
<td class="nump">6,206,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ScheduleOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ScheduleOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51673353&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 10<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6909008976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Joint Venture (Details Textual)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6382943&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6826373776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 17, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Apr. 28, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_ThirdPartyAxis=sglb_CosultantMember', window );">Cosultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Cosultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">3,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sglb_TwoThousandAndThirteenStockOptionPlanMember', window );">2013 Stock Option Plan | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sglb_CommonStockSharesAuthorisedPostReverseStockSplit', window );">Common Stock Shares Authorised Post Reverse Stock Split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_CommonStockSharesAuthorisedPostReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of common stock shares authorised after giving effect to the reverse stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_CommonStockSharesAuthorisedPostReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sglb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sglb_ThirdPartyAxis=sglb_CosultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sglb_ThirdPartyAxis=sglb_CosultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sglb_TwoThousandAndThirteenStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sglb_TwoThousandAndThirteenStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>36
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%0&7&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G--
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M0\(J6'(OW1R#W>Q;)%D^S//QFA&670E860H,$XR73MS#G"^*)$T8]TZ?".G
M'','/XSVK5 WR$K84ACK9B'=;F4CE&C$4X@;1[;6JY_:B">M')>STF@I.U7X
MT(EP!_LR@S$Z4?86.K[X$SI1).,4@??"BH60PCT62?<N(60R>)-*5_[7-Z:Z
MXFQ:S+ZKBDV50PH[5>OF86E"#+CXM.HV-A.!+^:TRM:EHJ!#+KDJ@7496*++
MB2[_GXY=7W*#X=30)7U-.#N$L[/-.=*J F6A8C.'_0@Y6::7[*(%@ZD0T)"
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M+,-%AX^UH8>CD%D8_\;+KTC"#867D9?R".<NU)GFW3F^)F^NMH-_4$L#!!0
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M<7"9*10AX$VEI#>5@+>+[PP3TGF7AO*2VFU8^)I7!H1R!2Q72<L5O'VC>Q6
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MJW;9J6A?]/F[&GJ(NH0;733VT]N<FE:7EY"%5V8?_36O[/7<?\/Y$(8'L"&
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M:[M;8>[K_EC1/[3Z>#DE78]JZW]02P,$%     @ 6(FL2%#B:)2F P  J0\
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M\,]G321T+H1??6S2C4J)P_'\/M9'6O\'4$L#!!0    ( %B)K$@Y%->UHP$
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M>O]^ED1"ZT+XT\<F7:F4.!R.#V1YI=4G4$L#!!0    ( %B)K$A=33CRH0$
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MN/>S)@(ZZ\.?+M;Q2L7$XGA\(.LKK3\!4$L#!!0    ( %B)K$CF@!^5F0(
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M/$EQ!:6 PA]Z! J(/?E2J010^*./0 'A)Q3K4$#A3P (*@,R@."Z)AF@\.<
M @4D <'E3T!ME_XT0*"0/, =@(#R+N_D 02%Y %N @14>'DG#R H) ]P'R"@
MR,L[>0! 54@>X%9 0)U7* ^&L\X(<L5G40$ZN!L04.K5G4\=!&6/=2CN!Q24
M>I5[=1"H"-#!_8""4J]*OPX$!?QO%/<#"DJ]FOAU(&B*=)*;H:3G<NMF+Q6M
MQ&'0X_1Q/;W.=\]NO$L^X4V]9UO^B\EM.ZAH*;09C=Q4M!%"<^-%^F2J:V<F
MT.NFXQMMEY59RW$F&S=:["\CYG7.;?X#4$L#!!0    ( %B)K$B(N(-$GP$
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M]WZ61$!K??C#Q3I>J9A8'(X/9'FEU1=02P,$%     @ 6(FL2-@H;E8D @
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M[>@[57&Z$E36&R:HRA'$K7MP!$$%O]UA@GZJH%ZR!-QO!X<9^JF">C&4.^Y
MP=!/%54/M4'%4.ZY0Z8[6U0YR+UR< 1#N7$-.]>*Z-4<5M3O*E_5&:,HL:5U
M.,4 <;3;*H9P:J\8MZ]A_UK1)2LC*?2OD(%9Q0![Q3IV>2JJWS8/,"L86)5[
MUJ)CK9"5WF'F&@.K,-#>4I1J.)B[#+"]K&/Q6E'2ZK5=C&&<ML@$9D4#[$4K
MHLQ\J*BZ7(#NL-I =4$*S-X&%BV*B[AU^Z&BMK)>SN1#4(Q"E>N^D)@P6<T>
M6T4UCTJ[R0;,,P?8-->E@[8M.1 3*-.3:8Y5K &&%;5_$3#",*7UFKGU )GL
M.LS7PXJJ)A#E\V9N/,!VO"*OT"NJ7[G&K': O79%K%JN*ZK?*AV8C0ZPCZZ(
MF7M=43L[FJHO_DT!)'-%5>PS4QNX_KL"P&QMX!0;\*.*ZK<##\P !]@!U_&-
M'T 6.'UO3!ZP$:[H1HNQWO7WU@!SN8$KAR>1846)D\B^+X@PIF)'G#PW#"N*
MSPW[^F)$19:WKDU10)XW[48P,-,;(->;4[;"*-@8VGH-*G.T@=?L@%=4K_U@
M8-8W0-XWI_OF%3.U@>^_"P[,L@;(L^:,^/W36XI237',V@8^HU9T2<KXYX^H
M])ES#9 KK?.^"4KWK2I&*^1><T:U1F9V,PC]SY2 ><D F\EDW^6@HOIY38&Y
MSB!@O[98U PJJH?U$I@Y#;"G3-ZM'E34;KM"+NWO,<Z[I*Q]F$L-L+E,WMD>
M5%3:"4MG7&V@4W_I&9AA#0*FM.8X Y@7#<(14RKSD $VD<EC=U]1/=W P.QF
M$!4F\_N*ZI.5S)4&$5-?]7R8Y0SB$=1G?C) AC)GQ)+M8T7U7&$P0QD@LYB3
M9]2/%=5LN@>O[(VQG]C*9 =]1?6L7)C_#"(N?CM*[=CFJH5L=-]M94R-"@O*
MQXK:5H#V3)DDC-!184,9553L>6N,^%'C1(%(3"9=.Y((5Z*.;<S:!LBVYE2V
M-6"^-6B,:[TXRYQKD.QA9;RKJ'[?0@'F<0-L<I,GJ[N*$GWV^[IC$H&-;K(.
MWU64_FM4P+QI@,QI#E05-[.=03JBXF:&,DC8>=I1@:4COM4%S%0&V%7658"E
MW/L1,RHC4YF3]Z\&@/UBP3C5?3''&&3,47$1/JBH?H9[8(XP0)8P!ZJ%"_.$
MP1&F,&"N,$"VL,Z5*O*%65"^GH(9PP YPYRN"F*>+\A'G)4QUQ=D-.MV'<[D
M]EF9TY6(S!T&R![FZ"NX=GVU'2E9=W3%_&& #&(.=$^'\>\(BQ@PCQ@@DUAG
M=A5S3'8QFQ@4S"M=*XQ7Y0A>,7<7('M7YX%':<]]6K\E,!\8%,5^T["B8JW8
M=9TQ^F''6-=I1VD?'/DSG1&)F<8 N<8<J+9JF1\,&J]7OS%ES$)6+T??&%<+
MC()\(J489O$X;[WC;SJ9?]^\4W-Q\G7VXW6Y#7+WZ>[%G7_8]3L"R>?OX=U'
M$#X?PKN'[5LY?S=_=?$V_CX9C>??GU\7)U]FR^5L>KE^+>&WV6PY645NSE8W
M_C09/^[^>)E\6ZY_79<[\^V[.;=_+&=OE\V[1G<O/+WZ/U!+ P04    " !8
MB:Q(8/[4I><!  #:!   &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R-
M5$V/FS 0_2L6]Z[!$$@C@K1)5;6'2JL]M&>'#!]:&U/;A.V_KS\("1'2[@5[
MQN^]>6-LYZ.0;ZH!T.B=LT[M@T;K?H>Q*AO@5#V)'CJS4@G)J3:AK+'J)="S
M(W&&21BFF-.V"XK<Y5YDD8M!L[:#%XG4P#F5_P[ Q+@/HN":>&WK1ML$+G(\
M\\XMATZUHD,2JGWP'.V.&XMP@-\MC.INCJSWDQ!O-OAYW@>AM0 ,2FT5J!DN
M< 3&K) I_'?2O)6TQ/OY5?V[Z]:X/U$%1\'^M&?=&+-A@,Y0T8'I5S'^@*D%
MY[ 43+DO*@>E!;]2 L3INQ_;SHVC7]F&$VV=0"8"F0ESG75"/!'B&R%QG7IG
MKJ]O5-,BEV)$JJ?V9T<[ Y=6Q"@CTXQRH=LNG[T4,8ER?+%""\S!8XC#W!#8
MJ*^6(,L2!W)')VL%CO>(E'Q<(7YH(G;\>&KB$P+)@T#B!)))(%Z:['P;'I,Y
MS)<D"],T6\,=%[@XB[;;3^S9YL'09F$H637D,>FT:W&<D:^KAI:X,"4D?#"$
M[\X,!UF[NZ10*89.^_\R9^?K^DSLF7O('\PU]K?N)E/D/:WA%Y5UVRET$MJ<
M:'>8*R$T&(/ADW'8F(=F#AA4VDXS,Y?^[OE B_[ZDLS/6?$?4$L#!!0    (
M %B)K$C!;H8U?0$  #<#   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM
M;(53RV[",!#\%<L?@$-X52A$*E15>ZB$.+1GDVR(A9U-;8?0OZ_MA!004B_9
MAV=FQX\D+>JC*0$L.2M9F14MK:V7C)FL!,7-"&NHW$J!6G'K2GU@IM; \T!2
MDL51-&>*BXJF2>AM=9I@8Z6H8*N):93B^F<-$ML5'=-+8R<.I?4-EB9LX.5"
M064$5D1#L:+/X^5ZXA$!\"F@-5<Y\=[WB$=?O.<K&GD+("&S7H&[<((-2.F%
MW.#O7O-OI"=>YQ?UU[!;YW[/#6Q0?HG<ELYL1$D.!6^DW6'[!OT69EXP0VG"
MEV2-L:@N%$H4/W=15"&VW<ITT=,>$^*>$ ^$\308[P8%FR_<\C31V!)3<W]W
MXZ6#:R_BE(GS9D(9=M]U3^DDGB7LY(5N,.L.$P=,/""84W\X(KX;$0?ZM!\Q
M_U]@<B<PN1%8//1XBWFZ&\*N#J7F!_C@^B J0_9HW?F&HRT0+3BE:#2CI'2O
M>"@D%-:G"Y?K[F*[PF)]>:;#OY+^ E!+ P04    " !8B:Q(2M97Q0,#  #V
M#   &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6R=5]MNHS 4_!7$!P1L
M<XT(4D,;[3ZL5/5A]YDF3H(*.(N=IOOWZUNH<6DA[4,!9^;,.3X>;+(+Z5[H
M$6/FO#5U2U?ND;'3TO/H]HB;DB[(";?\ESWIFI+QQ^[@T5.'RYTD-;4'?3_R
MFK)JW3R38X]=GI$SJZL6/W8./3=-V?U;XYI<5BYPKP-/U>'(Q("79U[/VU4-
M;FE%6J?#^Y5[!Y8;& F(1/RN\(4:]XY(_IF0%_'P<[=R?9$#KO&6B1 EO[SB
M M>UB,25_^J@[YJ":-Y?HV]DN3S]YY+B@M1_JAT[\FQ]U]GA?7FNV1.Y_,"Z
MAE $W)*:RO_.]DP9::X4UVG*-W6M6GF]J%_"1-/&"5 38$_H=<8)2!/07$*@
M"<$[(?B2$&I".)<0:4)D$3PU67*J[TM6YEE'+@X]E6(!@B6'=R((C^SP^:7R
M4790C;[F"*:9]RH"#3!KA8$2 T$TABE,#.@1'L]@- TX3&,-#3I"_JB$B8%C
MB'L3$8U"'H9"8 RS&0B%T\4@:TZ1Y".M :<#!%: 0 8(U&3Z5E-:5:O"1$HD
M\E$R+1-:,J$I _Q1&85))29<H&F1R!*)#!&$T)A($1FUQ*$O_L9PFZ]PGR84
M6PG%9D)@QK0E5H#DUO:F5H!TNKU%:K;73V;4"7S;VOYT?PL-4@T.%DD\0^C#
M.P080C".QX44*%;9A+-:!Z"M! >K*9@1PC8GN-F=P+8G"*;7] ,(OK-8@>U1
M$ ZT9KR-@.U $-U<L>T9$,^I.#8J!JKB.27;_@+)0"R:$<)V&$AO+1G:[H'^
MM$O7&J1M&AK[Y^="MGL@F+;I6H.N-IVS*T';/!!.VW2M03?9%-H>@VC0P1GO
M%&A[# 8W=]"V#AQ:)QE=M!IDVG2&E&TQ:.YR, 7C4N;V%:$D_+!G>\;9K<'=
M01ZSJ;,EYY:I TD_VA_E[Z X^UGC!5C>JP/Y>Y@\.Y4'_*OL#E5+G6?"^,E2
M'BKWA##,$_07?"Z._".D?ZCQGHG;F-]WZEBN'A@Y7;\R^D^=_#]02P,$%
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MBFV?(!:G'=N>[<\E1N)T13@J[V>G8N_YB])NRGEZ&OIU[!M%$8"4OK6C94F
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ME=^Q($,)* TPNK/#BKA1#6J2\Y,EZ2ER!&WV[YA7WL:/*M&[AXU%" S9(Q>
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M)\N8_-W<V\>_&*\ZM_8(>+F1VUYKMCO8YO!NAST5?ZMYS\O#[/>.F+;IKMW
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M;G1?5'EP97-=+GAM;%!+ 0(4 Q0    ( %B)K$A(=07NQ0   "L"   +
M          "  ;D!  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( %B)K$@]8 6J
M/@$   P.   :              "  :<"  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( %B)K$C:L+K82P(  #@'   0
M  "  1T$  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 6(FL2&-/L=H_
M 0  :0,  !$              ( !E@8  &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ 6(FL2)E<G",0!@  G"<  !,              ( !! @  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !8B:Q(O9F^3U\"  " "P
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M970R+GAM;%!+ 0(4 Q0    ( %B)K$@8 4QZ,@(  -<'   8
M  "  2X:  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !8
MB:Q(F$&$4D8#  "V#0  &               @ &6'   >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ 6(FL2%#B:)2F P  J0\  !@
M         ( !$B   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( %B)K$CF+:-BH@(  ,X)   8              "  >XC  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !8B:Q(GQX#9:$!  "Q P
M&               @ '&)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ 6(FL2!+W.K*B 0  L ,  !@              ( !G2@  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( %B)K$@Y%->UHP$
M +$#   8              "  74J  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " !8B:Q(=_.^NJ$!  "Q P  &0              @ %.
M+   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %B)K$A=
M33CRH0$  +$#   9              "  28N  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ 6(FL2%V&^X^B 0  L0,  !D
M     ( !_B\  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M" !8B:Q(YH ?E9D"  #S"@  &0              @ '7,0  >&PO=V]R:W-H
M965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( %B)K$B(N(-$GP$  +$#   9
M              "  :<T  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L!
M A0#%     @ 6(FL2!F_L2.C 0  L0,  !D              ( !?38  'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !8B:Q(V"AN5B0"
M  !G!P  &0              @ %7.   >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;%!+ 0(4 Q0    ( %B)K$A OM%;%0(  /H&   9              "
M ;(Z  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 6(FL
M2"_^(4QG#   _%0  !D              ( !_CP  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " !8B:Q(8/[4I><!  #:!   &0
M        @ &<20  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( %B)K$C!;H8U?0$  #<#   9              "  ;I+  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 6(FL2$K65\4# P  ]@P
M !D              ( !;DT  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " !8B:Q(/RYXL?P<   KA   %               @ &H4
J>&PO<VAA<F5D4W1R:6YG<RYX;6Q02P4&     !X '@ $"   UFT

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.4.0.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>89</ContextCount>
  <ElementCount>156</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>35</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>101 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>102 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>103 - Statement - Balance Sheets [Parenthetical]</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets [Parenthetical]</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>104 - Statement - Condensed Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/CondensedStatementsOfOperations</Role>
      <ShortName>Condensed Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>105 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/CondensedStatementsOfCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>106 - Statement - Supplemental Schedule of Noncash Investing and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SupplementalScheduleOfNoncashInvestingAndFinancingActivities</Role>
      <ShortName>Supplemental Schedule of Noncash Investing and Financing Activities</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>107 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>108 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>109 - Disclosure - Continuing Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/ContinuingOperations</Role>
      <ShortName>Continuing Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>110 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>111 - Disclosure - Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/JointVenture</Role>
      <ShortName>Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>112 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>113 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>114 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/StockholdersEquity</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>115 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/LossPerShare</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>116 - Disclosure - Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>117 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/StockholdersEquityTables</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>118 - Disclosure - Stockholders' Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/StockholdersEquityDetailsTextual</Role>
      <ShortName>Stockholders' Equity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/StockholdersEquityTables</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>119 - Disclosure - Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/LossPerShareDetails</Role>
      <ShortName>Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/LossPerShareTables</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>120 - Disclosure - Joint Venture (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/JointVentureDetailsTextual</Role>
      <ShortName>Joint Venture (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/JointVenture</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sglb-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>121 - Disclosure - Subsequent Events (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabsinc.com/role/SubsequentEventsDetailsTextual</Role>
      <ShortName>Subsequent Events (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabsinc.com/role/SubsequentEvents</ParentRole>
      <Position>21</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>sglb-20160331.xml</File>
    <File>sglb-20160331.xsd</File>
    <File>sglb-20160331_cal.xml</File>
    <File>sglb-20160331_def.xml</File>
    <File>sglb-20160331_lab.xml</File>
    <File>sglb-20160331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>42
<FILENAME>0001144204-16-101325-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-16-101325-xbrl.zip
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M9AZ,LB'&\J58T^BVNZJ B*?: (P<Q.3+J&:]66\5 R/;.[%^='*%X=>MZXI
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MTN@4NS%F+^<@YP(P$SM! ;>GAC4[1XS>-"JM7K&+1%X:,\5X1.8O9%A0H'.
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M%G9%IDG(N7^ZL/V_ BD \.7(M^9)ONU(OK6TJD;[I8D-.Q1Q]JV[_+9P[\V
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M#G[GRN+V*2>)5^2(X?IX4("Z0CNHQ&\,V! (7IN97I LJW!<S78=')!]M?S
MYP?-E[&*^2D]:4W@TB?4BI*-4.C(VU=:7&;Q,S=V0TH^&N#-[Q.@CQGELX'J
M [0$>U+1&')]1FERL&>RWF#**!].% +S"EU@R=CEP;2M?V/=!SRAOX-2_E?(
M4H5!O%0(3BN\#I3)AH^.:[L3:VF-,)7I^NY4=O;')"GE*][L"(N#,9TJH%,
M;(*- 5H\)IBO0=:U]E=H8I-D:N3O40H>PC+SW"%R4U&J K^CQHZYJ"C\X(!0
M0A)./.4DCRPFN20QA*S AJD"V*%*7#4EYZ 2& $0QY!-%QC8;*[9S!R)"@]*
M4,:*<L!O"KPDCO#8#ZT9W3)!:+(H6N1E8<BTJ9897[!QCYG->/7)=("8,D=/
M)K'EY-)R<:8BS05Y[-KBPB-. LHN8U',(VZG-@#\_"GYD2P?G[D!(PZ&")Q2
MBC*P-Q3YA%-9A68RSZ5NBB+K>XSI(TF 07)8G/@F)J=;K.>>S--O#2RW"@H9
M2$T[_2A3RTEI+V88N%.7"@I37Y,&(DK6O#\Q>N=C9RX\<""]3)11^(K',-]/
M$":3Z0J+2<)EJ5NGFH4%$P7("V30;NV4#YAMBWP+"^^0.^&.TQOQ[*IYRO52
MH?+0S6!9]0^Q5CC#3"J/<_%$AK\C5%$ZLJ(2EG)1M2Z"\TOMO@;X& +14L '
M2?*2*_HTR!3T:>11=VR"?E[\\;[Z/]1.@JNUEH-_@Y%XO2&O T3EPQS]$8H\
M!.T-OS*+'V#L1(=V$&@3L!H/Y^;R(/[@>\UAR%=05F&A&\<9W>TB].D8'3/7
M%UTMN-K!,Z5CE2?J',%;;P!O3-;OT0MT7QC^$-74\KX9^+,CROYB9$_-$:MI
MYZ)&TG)0,3(C5CYVW< !/B8K3"C7@Z_6GDL<D/::N:?13F9L'>T6;TQ!.MX0
M6X2PD316N(2!&:P9YAK' *.2B"R2S )W:@5D/:@"Q \G$^93+PR4J_$'F3!2
M90;U'L$W_PB=(<]EEC7<"\VZ-!,8=[!L.*X)<MD%1@'/@HZPI)"SU*?USGN?
M5_SJ]>J_^$JR=S^]GUD5G H%>(RJ2R7U6;1A9%(AAX\N%)(FB9Q3SC(.@?"Q
M:]FQL^P4]*NO&7N))CX'ZY2Z8T,;]"3R*49\?I!F\9)_F%/*,$%2)S= 5=PU
MN(+C>]$DPD=!PL+CE"I: OBBK)@LMYB1<EXECI;(<\J;]=BI^= 5D!V3HTR*
MY<)=JIC9?M+$NY$Z2HQ1E+*8 =US6=,H:QNX.LDW),"I^8>+CAV'/:.N3[8B
MPVX-G'3)+F%? R9NT0NI98]F6T_<US=;/K7H D7E+^$,:'? 2-;9YI#+"%$V
MF D4VEI.9+%0QCE:LCCLH^E->-D-XRGHJ)Y;//4/!.0%@P.#B9)T7*C"9A8&
MB;OC0'LSL7E[%1M?18T%GD0]5WPM77JQ^-2DI+OT!78VMDJ*W)!J12M51/)^
M!/Q>U9"[_TQI7P\M;QA.T0DT9,*A(GQQ"#VI,BBAYMK(A?<8OU#7Y\T91;,Q
MZ8.<8?!C?CKX1WWPK_ NQ%_E78A7$6>_=H!LB0"4X)9637H49C,;#8+^_;G6
M->H5U;.IC/N)F:C@1F-9<56K%>L%Y &-'J>VQ1+%XT"BD]#BVB[WVOC*;8X5
M/"+H1?$?T4SAYZ!JH_-)$]TTT$UN@6H&NMV<SKZJ@ ,"E*LAIS'8PC?PB//Z
MRB?24<Z9%PZW^+TXO/Q,$BR<L7#PZ7#QRG-_)U7FNW-D)BYW%!<Z?KAY>+CY
MA+-]U:CM2G35X\?+JX?$W^4->/62[H.,!GFXN<T"X.[ZYW^H$&QR?V3ZXI+
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MPA!9J?(9[:1>(2M2XZ6D-;T3C1\ZO#NC<=G$0XN;U_&F_AB:(0I#IGCAAH,
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MG@3)P0"W>T%R1[>- C.\=$P* 2E^WGLT\TQOE @+)"M=KOKW'Y3\+L[TLH8
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M&T677T KUML=O6&4B(!8;\J71A^6V!@_DY"_=GA<Z6?/]7/<D>H!RM?]^%^
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MV$YN8)I88!7]\W_]?'?SR^<+6,.8_K=P>M]K@)R'Z_/^1SD?D$;@3L6+OPE
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MXY4M0'18/08TA A5:"]X]-QP$L]10\:X;.#IS&94NY:Q?<I)0K76E</U\:
M=85V4(G?&+ A$+PV,[T O^1_1'0YKF:[#@[(OEI^X/.#ABNQ1I;IS1=KT@Y
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M!ZDA0$Z=?,3.>Z7>Y>>7/>A*7,!O',5?4$L#!!0    ( %B)K$C-M]MNG0D
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M$^H[M.M;0A3LR'_=:)5 *.J^'/Z+MML_QRY_#GIX_[7QQ(G_ U!+ P04
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M6(DE0>R71]%UG'R+(\]-Q_SNOP D**(?L5.=%DW"@"40*:#-8S=P$8Z[B]Q
M),SG=:F -1E6-PB +3XOVRF_NF 1=JWY,_)Q^2C).9^GG#]NIIP7CK/T!W\Y
MUU]_S50R:YOH#A1+X+RP_GM<QE2!C#%[[]!T@O0F*KZT:S=(\J]M8'R<5;L$
M!1,(U[$TUC!U(./-FDOJ+ID?Q=>UQ>45 2R!N*#:W.N 0ABTYL]:E[F!4:[7
M (#OHYU0!QS"K#4GV?+PC27/@<?$5][ ]NDYGW'R.2A]B#,W+/_](DZS;W'V
M=Y;=,R\>18K/VEB?SN#0XCWMC<>/87T@0\Y>DI,IN//5,$[FO^+E9)N2[0H"
M9/31>VQ#2<B(M>>_+)0V#QN]3>Z#T3A;[O29!W9G%K#TP@U#YG]^6Z: % 4U
MGF1NVC*HJY?^T"Y0(\_-V?.;BD!=O;+$"U)VE\"WL_SC$HEL=FK4'JBF3QZZ
M#K BP\!:B-==$GN,^>DU:(7[G]RH++QTBRRK"&#[Y)JK PIAD.[MTMBMCTL[
M_!R03@I+_3Y(?[M.&+N),@:&7G8/=H'*3V*R;V=PU,<M\I;T@@Q%N][@KF!?
MO4Z9QZW2F-^/$0;9VS8'H[AW4'L?-\5;TPPR(.VYCF6G:6*M_)+$J?P6DF9-
M@H+ZN-5I!Q<9#_;>19><OG4Z'%0M@GKZN#]JA189#!U>["T9JQ7!%G[.7/8F
MP0?R%@%RGTX5.T&+$&SOHJFFR][BI8$T2V9YVN5M-F;)P]B-Y@=:2P=2X04P
ML2FI*P-0T-NCQ>WI!QFBUIS+C4]6E?#/1Z.$C6!G!F8#?,MIX.5?ZE(K)DZ_
M6POE#(Y[:^Y95!@RJJTYH+6"G.8>^J:;JTH[H(I>VF;U,8KI/K7F2EY<3C"'
MO7"<\5,4J0=14@V ]C'D70T)X<[>NX=:\:;-OU6D(5#&N[.&$9 (X];\Q:4P
M\0MW&F1N6(A_SU*0.P=P/<MF^:VR^>C5BZ+7:PM4TD>[MR%.A'I[_EG9\/W&
M7O(_-?[(EPT ^#[9ODW (<Q2<W06F\7FQ*[7!^B]-#'UL2&TVO-7-G[2;6X_
M_)(?7"XB;__&^%$T\\^?6>*.V-J)=1L?1G=2  U]#)+=NH:0@6HMXE88$:&9
MB:>H"H#[&&6K!POAL8'+%'M@021&.A]1_"X5S/6MK.@,3OKDJZD#"F'%FI=P
M$8!R'OF%Q'I?EJP: .VCMT0-">'.GB^L9!OF$[A&^@%:!R#VT2VBP".F[,R:
M/ZMMNM/&R<,6\AJ1'D&]?8RW-:H-9+!9<\"57 O84316% #UT8DFAH'P8LU-
MM@I]\O\Q2S,^QK3B8J7U &H?+6@-3 A][RL4\9(_V\5@ZV$A$+'<-ZC\75K)
MW>@%&8IV\]>;P!;Z!I0!:=WWYAQ1>$]Y>\--I0ED@-'U$F) \__PY/RE4U1Y
M*4)'W8 B_Z5F,%0%R%BRYLAKO/<N(RQ,<\#IP5_=D7*M[+H_4&T?788&=8$,
M,U+O@I2 \G=15Z^D;EXZ<1TG&F?3777A'/7REH=NX2/CQYI'M $ZY26.C=MT
MAOM]],JUQ(L,"6N.UEIPRH6X)1&EG4TE@J9!87WTPW4#6SQ.!OO6W+NU8.F>
MD3=O%+341R]>6\#8L+#_V$G7-X>4'@J1&>Y;Z1]TW\?XNRWJ!AN7_<OOUPDM
MR?]XZ69LZ6+;FFM)*0GPT<LP0AM:PD:MW5#3<1SZR]>5[AE 2(MGD[Y/PR"3
MC31U;6=XVJ?PD]K(,$;[Y\96)CFM7P^:S]M&IZ-6 @$[?=S+VU06-I3[YS"O
MJ0P"@Q<8Z*-UL5WU8 /4GA=^M2V]"UT-#X6X@G.ZW]LU$@&#437W9 /&O15(
MZ.VW.?B?UG^[AIV]9BSR5[[!-?0O+R\?TV T<4'K:1!Y'[UXLI?#_Q*GZ2*0
M[9)E;A"F'_[<Q346RX</K]PD"J+1LI>E]K"@78VJSJ!)4$9M41]DL<6*:B"B
MR6'KAF%UL-93W_JXU<>$C%YH$(3ULT]>'&4P&J_"?(X#M;,1_V'U]S"&^>[G
M#S"Y,7MS$Y@?7*KO'HM<F$05CXL*RX,Z3(8?:STTJD\;-DVAP,0\VW,AS 7\
M-4JGS N> N8K7VY&ZP!"HZ<=VB^22O2/$":')";-G@7=-6FTGC'MECW5 Z?6
MK.:;"/8+C&\5^)VB%S"_!]$,IIG;Z>+9IL_L*4Y84>[!?67IU6N6N"!W '#?
M\D6'OP<$-4'%(-]H<0^D9!P8[!6T;=&@:+-,;TTYR'N&UK*'UEV(:T'QI?09
M,*4"[SSR+X-P)K\?J%F#H!N+1P]=#)PVN)$[XK=OM7R&7T7\"(6QK*:]TO'^
M46;-X(6= WM'A$MI,.M&7!!&@,E@1Z$]HU*@8DM;DOL/FV6U.3$9"*9EL\B(
MJF>EH$%=[\1*.3#K^FIMI9S5W^<>X ZP=V*E ,)^6"G-V"-KI9RG*>P&SA]3
MV.9Z,L-BO2!@(A#X6&^)$R$@MF$O1+R8)0D_U= E9:,\("-P3BG2MHP7(0CI
MWME"QJZ;CF%[S__AITW/;LC/F<ZS"S=)WF#_KTSCU:D/R F<VTE($;-8 QMR
M::FUC\[SXAG(>L\\!G+#KNH;R^;(9=^>I!K@)!!L5YM#-23DC@U[/K9G$"U.
MWD!.J5-L50QP$(@MJTU-%0(2A6_QY=6I&_CS(UN8"?+C]S6<$H8T:@-J KFH
MM8G31H:=;Y/8B^CN00 *@>S.^A-?%0-"AS4/5"$B=S[7W!U6JP!  GEM=3>(
M& Z$*&O.C+LDGK(D>^,!+!E\[WPW-.5&BGR-DE5S#@8$HGGD-&"SGPH50I\U
MM\9-E+G1*("]SQPORZY>O7#&_?N_Q+'_$JR<KL*MAKHZ "=@/#>A4Q\=0JO%
MTUB>(9+'!=Y$YT]/01BX&4N_SQ[3P _<)& I0(J]_+<P4/\:@UI_0/&9_/ZN
M5NTZ1P,RJV7=@= :-C)"+/M>5FJHL;#"D"?C<:G'HQ@)0HTUOTLAI9(0$)Z
MYZ2)4[*0'%&[-<?(E\!]Y,\\!ODG7,U?T=B"ZC8!"B#@,*E'73UL"+G67"<E
MZ?7]S7@E $G K5*/$B6M0HP(D=8<+PNGW9W[QCUV^H[+]0H CH![1:5\N=]2
MA @YZK;G5O&\9,;\*E Y8^(Z )' !K(Q:3)0"&_6_"^U"!."(N!S:<84A@:A
MR)KGI22G'C?.P0$!OTK'BU8!"N&&4%:XQG9#IHL# I?8=\&<"B-"I#5'RETR
MO_Y%Z^)J06F 1<#[I5([>I@CAH.P9,V9T>9N\8,# LZ,9OR(L2#DV'-G^'Y0
M"'/G!OY--']8KB2\;"^HK R@2;A!FA"HBPZAE-2ME@5J"95X)0!)PAW2A$(5
M*H0Z:XZ0>Y[ '3%_D1@"=LEL,@M=?L,X:-V37E>CK@R@"3A&FE&IBPZAU.XK
MU&MH:VTR 10!5T@SRC T2/"X-3>(:NO<PJ<,@&DY1;JPZB1($6H'EC/,[ESN
M*1BS+/! K#ZFFQU:?-2U6;K9P:%)J[AVNAE7(#9-5>7^(]ULD65R<&C20FZ3
M;I83I:"T"N5]IYL=&C676Z:;Y?I'")-#>M_I9H>'?4@W:\H>V72S=0<:;!%N
MDQQY\2:WQ@.9>@V #DC8SW66Q#K(B*6MK8N^^:2$-IN;%0$K"=.Y.8MB1,2R
MVD0B*Y_,P"L!1A+6<UO6RFB(9:R)Q-5[&%I1$] 2,)W;<U>!1"QOK>3/;K &
M:M0&U 3"#>H1J0V+6.9;2>X:2Y^DEG-P1" LH3%Y8CC4TMLJ BN7/*0&P",0
MBM"2K3(4:IEO%6'UECI9-0!*(@:A%6<5/-0RX?KTU-_!$8F@ASH#HEOL\CR\
M;9XB7,10*4KYAFZNCO3V:75%8R^/$HXLGH4V/$HX,FE[USY*.,+O71+(_<=1
MPM*#>&32&&]UE'"$!AQ+H+SOHX0CH]9WVZ,$KO_:SN@C_(3ZW9#6BZ.$ANR1
M/4K@KV=%,Z9S=]UF4>?@F*B!C2]S8@S$#@(>F#>.XC >O<W?:TSG8DO(0>L
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MT(A+#5S4;J2KX*RS>7$.3@AX,)HM=V(LU*Z#^Q9'\4+2XCVPQ16^ZKVFLBY
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MDN?X"J,[?MKC<G/;+M?U_P-02P,$%     @ 6(FL2"K"$IL*.@  5S@# !4
M  !S9VQB+3(P,38P,S,Q7VQA8BYX;6SE?>MSXT:2Y_>+N/^AUKZ8Z(Z@^N&V
M/=N>F=V@)*J'N]VB3J+;X^B8<$!$4<08!#@ J,=<W/]^]0!  /4&@:I2WQ>W
M+%46,K-^F?7*ROSS?SYN8W /LSQ*D[]\\_;5FV\ 3%9I&"5W?_GFY^7%R;]_
M _[S/_[G__CSOYV<@ \P@5E0P!#</H'SH B66;#Z/:_HP=M7;U^]!_B'[TX^
M!4\GW[UY^R/X\N;M3^^^_^G=#W\'_^?JT_\%LYLE. $/#P^O0M1#07IXM4JW
MX.0$?R>.DM]O@QP"Q%B2_^6;35'L?GK]&K=_O,WB5VEV]_J[-V_>O:X:?D-;
M_O281ZW6#^^JMF]?_^W3QYO5!FZ#DRC)BR!9':AP-SRZM^_?OW]-_HJ:YM%/
M.:'_F*Z"@JA*R1<0ML#_=U(U.\&_.D$*>_?VU6,>?H-T ,"?LS2&UW -" ,_
M%4\[^)=O\FB[BS'CY'>;#*[Y7,19]AK3OT[@'1XL_(7W^ MO?\1?^+;\]<?@
M%L;? -SRY^NY4*#WK;Y*HM>(2UM\7L$L2L-9TH_A+K5]SF^*("N.X+U);Y/[
M95H$<2^^FY0V.;Z$_?1\H+.J7^0T83_]-BB'YKA@N356*J/-&/__1\1#BSOX
M6, DA&'%'Z:6^%72.?''Q$7B;M-5J\,8.^<T:\N;W\6W9")Z\XYZV&_Q;WX[
M3U?[+4R*:8*<0Q$53_-DG69;XMRGMSF>EHJJ(\(^Z?XW ]I*^DK^%JL9S--]
MMH)&LE.MMGD*;DUX0G,>HL13.TQ.?K[YYC\J,H#H "4$#4KPI:+]^Y_I]SM"
M3;/V$ 39JN(0_:B0JFSQ>I6B"7E7G+0$7&?IUECG)2NIL6*:@Z6#JE(F(D\.
M5Z_NTOO7(8R07&^_QS]@Q'U_\N9M.:M_BWY5<])@8!G<'NRS 3-Y<VO(4G M
M!%,+0:2U0_CHJ+Y"C+[>QP+)1^3B8PK4Z6.4"[#!M+(*"9;'+A)(B\J??,&-
M' - H-;FN$MU.K9/6*)N%7Z -G%B^R5W0GO'?_?#P)MZY!DUJ\2Q1G:*/A?B
M3U[$P9U@:#MMK(YME[_NX-9_![B!V]'EZK(YO!)%CFVY]0;S'"W-%2;<:>O$
MEKO\"HV:-D1./,1'/9[8-U?;/$.7J'IL1%Q$^2J(?X5!=H%^(YK"A:V=H(+E
M68@+VA3@MH T]@,9 JWSL"%5N1UT4'CJXZ/5WB%"VGRK,%*Z$.]0PM&^&"="
MU8^%%+H&O89W$=Z=)L5EL!5-+/RF5O$AX+8+C7(O<&@'<$.WH) INHD'M9;'
MA<(9PF(6Q/,DA(__#9^D6&#:.@ #RZ\ #65#0%H"U-0'/ BTS0)"JNJQ$'&V
MS[+6%"9?>8J;6\6%A.LN-,JFK66&'VM0E>J;"-'3^[ANXR**87:&/GJ79G*G
MT6GIP&5T>14X#-(,5.U\\!9<);.^0J+AL4"PS )\BW_SM+U-&>67,G3:6!WX
M+G_=(2__#F@#MV/-U65SE"6*''EMD&ZW:7)3I*O?;S8!&J/%OL 1#I@;^4)!
M2NABU2"71+2$(%2 D$T )00-2A]\A,X8<987V@-TQ#7H68J^E>Q1EXL=#NV)
MTB0_1Y-6G.;[#*HN0G6I[5Z%:LO$+#UJ0G"@! =2?VY#S8:M=1_:9\Q& ]@2
M/A:GJ+O?^R&L0>X3Q)I2F6,,4P-"+D#9T:*%Y?D&^?CP(L[7H-A )$J4@P#D
M>^2TH@2& %'FR#E'"5@%^0:LX_0A!QC8(*5?0#I!T(ONHR*B[8H-ZF(=)4&R
MBM!>X FMHU]Y;7D,G@U,3P!FT^7#.LAOB6C[_.0N"'9X#?'#:Q@7>?4;;*4_
M-!83Y:]_FP59@GC+KV!&)AR)]U>36+-'#>Z9I4/9%)]/TB6#%YY==QPJ3)D-
M@CL<R9R\!HUS),E\'0]*XSOP>YC=IG4(H#M!7%J%T-4:0LJ>7=SL;W/XSSV:
M>&?WZ#^YAG\5DUBW"@GW72P=F@+:UBOWJAJ&+H[TQL =C'3<JX3&.9!D7HF#
M)&^\Z]ARN+0)I7/5!)0]JYBN5ND>+Z_OKM(X6J$-A(9[E1%9MPNI!$QT5MT8
M5*V]<K+JX>@B2G<LCCB+N P*M,]:K$_W.=J0YCGYT)/R#$))9O?L02U%%RR4
M BS6H*(!7R@5\.2PP5RFQHE)N@;!P1QV5+!UFH&$RHW^?EOVZ_KT0!.!K5,#
M(_C9<[BG01[EBW7';)_4-F7:@75'K"U9%Y.$$)O9@70"2D.S9W":RY<CI4R/
MD]+F7&2&U.Z\U >F]JSP*HO2C$:H7<-5'.1YM([H$^5I^(]]7F#7>P[S51;M
M> ZXH2;SKJQ;9@]IN^CMTOEKH%X(:]-.^V*Y:['' =FF[>)[C^+I"HT9>9[X
MSWVT(['KVG.H?A<.;%5;NBYL*U($5TP, OPVM2+WV6!]D=BNU9JAF+76/A"V
M9Z47091]#N(]6H%?5#>1\P3M3,FNIER-2TQ4D]ZZ?>K*U84JI@.$$*]T:U+0
MH/771 <0.AU,:)M6:H3BKHGV@+ ]^YPGJW0+E\&C_JPI)K%NA1+NF; *TA2@
MMO[:ER5Q;%J."E]=8]$#E[O;>'TS45(ZOYE7HXR]UO;7>-Q(Y_(.7].DC(!H
MS[)PS#=$*]8%CG8KSX=RM..$T3W.%Z)<&6K26[<R7;EX ?N0;%T(974^F(,#
MK=_P-!K0+DA[C*8]J'Y(T_ ABF/$WSPIT*!%B*5IGL-"XQ*L3R?606LD81>Y
M%3$![X$<4'I_9PROA+9IJ>9X[IIK7S#;L]E+^-"X=,C2!/VX@HT=E[[EFG=E
MW7Y[2,M<<\,'T(R+:'7BKQ'[)[E-2^Z+\JX]'P=Q>U9]%N0;Y'/P/_BD\SZ(
M#RSJF+(FO77[U96+>0^#GX+@&8C\T"#UUV ]$-6FA1HAMFN6/>!JT1:Q G .
M!WP+>!WEOY]E,(P*_)/, F54]NU.*@/G]=FA-<"-)H 2E/_CK<VY%=.JO:E1
MR5B9+B2/")Y<9'=!$OV+?&+VN(,)^L!>YSC1B-IN**6V3%V -0E!@]*WN,K>
M NJ$5Z9-)<!#[ZZ#+,V0VHJU[ -3BR\_\.'G:9##\"S=(N9RPN>"!+&0?2QV
M M$]Q%?IZHOI7KW9?RW22V;F_07NY81T YK]3 #MJ3P#*?LB01BYMW/AD"JY
M'5<E5M^P]+<.YG7+L:9ASR><PUT&5Q%A$/T<PY+'Z3;-BM*3Z>\N>_5FW2?T
MDYF9XAJ]3$#=SX0 O]F5?Q[ 6P78M/<CD-^U]Z-A;\_>?\[A8CW+BV@;%)"7
M.U;4T+J5,IQV\8<:X!"RNHF_NT\M4=*C1+%I.7P,=8U"!B![>+^&]S#9PVNX
M2N^2R&PVTZ"U;A4Z\K!A_(0&-(C\M15G MJT(&U4=HW*$)(VPRCQ.^XT,[A5
M%),X"*,4<L_&'99-_4:8:CS8L$.=P;#IMW.(1,:'_^<(\W%*8OK)F4JN#HW2
MHG;@NW5D8IT;I2++Z@8=* G]QJ'!.+*^SG 0+9ZDK38PW,=X@=.)+<3//5>8
MXRC>XU*+.'9+*\-*WQ[MGZCUEITY0BI[(JMX3B@JZ8_"GO98%H/S9[$R@B[2
MH75A]0SM.+M@SM&&,(HC[JQN]MMMD#TMUC<16FWA1Z!)P>89$15A-._"[NV5
MF71L2B)"C6VW00^XB65<EW#L.YBMNYW>(VGQK6&$]@3P8W0/F:#$TZ=/P3_2
M[ P_9Q84ANS5B_UWAT8R,@_Q"/4)(6>#5G%9>M(%('TXKSQYQ+@R;_#Z#JH7
MZ#TPB&OGG*?;()*EHC#NR2<4"V0U0_*DA6/<$?A"N_(;SK*!-H"T>I0MIFD(
M"ARS]@EN;V$F 6VGG?V$"QT^F1P#]._@"VWA 8ZXFF7R XC5:C'959E[:[KZ
MYS[*R;F=8A(64MA/9R7DG<GL5&6':S3U9@Y5# &3MDE'_VX!A'_,H'HVU*#U
M E1=>73@-0$5F4?SF_9@Z8!.,E(6LZ,^!%FX1%]1>*U.._LY4#M\,FE/\=])
MN7%O_!)7M4QR4[%>[2:.CL(([X$S'(Q?/'V"Q28-\=5!7D!XMM_NXX#$-<$,
M1S@%=W#QD, LWT2[Z;J V32.EUF0Y+A*1YK(@#3"MYPDJAY:7[S$T/0;8)$!
M^A5 /P.J[TS X4O@\"E0?PN0CP'T-=#\G/OTV!:UE_;77F"@/=M)N4>Q5UXR
M[Q&-U>DJB\J#]I<08;W(YWF^A^$BP__BD[[+/=Y6+-:TPAK]J]E2K-<'?%BO
M]=.,WJ*N-,6J<T#)L9%6W4\ _0"^+Z&?&,E=(0XTDN&.I9Y2R$4E))@]KC:H
M <15T9'+"E:;LMH*21M,UHHA*&L;OH@2D!.RE^Z]T;"VI;%R/MJP+"ZOXSA]
M") :T9B>I_O;8KV/V10@94U@V?+;K!_[RW-#.9GE>T5/P%_UP$\44_;B=A$S
MG,#KXP2VNJ/I@V9FQ],?RC[<6/R<0\3PQVC-NQ@V(_?H;J(EE=&%Q 106H")
M'>?P'$&\O"4?OGQYC+;[K7M;-$&H_OV*")Z>A ?V#0ST+22P5S#@,BT"0;5S
M6Q8VE%#NS4<+9D9QB\[CLZ^#AT\!6A-'02P[@!.T=Q>9W>%;$I:-6H*ZZ01\
MR-+<@],8Z0 (H['%VK=X[HM+R&_2.$0[8;JINDP+G>J^*D+[)[(J29@#P@;!
M'[Y]]_Y/U<D$IO.J8)K>(#$G=P8CY"*ZFO!W^D0B.41AEEI4#J.D>3+(HG])
M>QR)5L:@N0Z>-!@5<?RN8DAL.C/D3O%\3%@I&5/<:DIH'+@P,?],&B,"H!I2
MOMQX*H> ]5):^K>8^*O!AS+\@M?8?IHO'L<JO'@34"'6-Y/)2J%L%[?E-T'M
M 56.1DSC\/::Y5]\CSH!N+6'/D<U&N([3>E06,33@0T<T[I8-RY,E3Y(A]@^
MPG0D8J#6A->$1C:C_VV0>N2W],>,@9_A@%FM&'F/IN.K.*#I<=5QS0("%]4?
M^9RSU=1(0U"W]"GF6:I^3BE#I>Z/>!^WW$19>!5DQ9-@8N.VLOO*C>&1*3N!
M&P#2POET)=%JZRV:3*6#C*=P1A&T<S6FPGFB-:K.)P2I=@4CV]?-B_*O)O L
M3?)]7 1)D4^3</F07F7I&N8YFE."6/Q Q8S<<@96;:F8%*P)! U2<O> B$&+
MV@/'WV?PVCE)^XS<$4 [? Q]60XJ;E.[ .)SRTD(7;8"&#>>H$*BZ18"E&H^
M9LIX2!OHD@\WOZWEJ8//+S-]($_0] Z>C+A,V^UI1*GJ02P<?4;7PAM-75EX
MDUN)A>.Q]V2\)9H66+A S38C,V*TXZ!+F&9,]^E3\R^*@S"33AS$;!A(R,8Z
MD":>[#?Z#QH;]-!OQ-P 4WE@QFOL%&C"C4X'4,ZW.FIURZ#C]FR+/EA),^69
M5K>AD["8%J>\>!C<P(.93*Y=7NB+2+6N2R5,LPR_O2!5P4Z?#FVN@B?\._)*
M\_!4,PEQ?G>MA"7C?,Z38@M':XTI6TQC<.AC7G\\WIB8T:LP,"1@CM@?5"]O
M&E4.4*.W\IV"@LCNGD$E@0"1[7(7 )-XX'_UQZ2UIS 8D,&Q\JX/5M[YA)5W
MYEAYYS=6WAECA3L@%NNK1P6^1)TG870?A?L@5FPZ!>WMUT\7\,V<4>%V^/+[
MT-*;#:54]TSI<[7B':+FEZC8D"T*WLYNHMTRI<]KE8LZXY[<(TTI*W?W638&
M15J]//9G4=9S.)40-1E+B]6<H@RN=#:PW8;V:S!U.64K"-(&'DR*<NTRQ8 D
MJK6'A,5Z':V@&@B==M9QT.63N::E?_<(!5S-=D$@4:N#6'>Z/,,[Q33!>T/=
M>'<^G;N8=X$<@A7VH9TWRR*M$1&&OZN'PQZV.KPH%T."]M:Q).);A2&/EC12
MU7?!HZ%W>Z#Y)< '5.J0T4X[ZR#I\MD%1_EWCR8EKF:[6)"H]8@3G++77!GM
MPVEH]Z2&QZE@:'.?XGR$&FZ=P2C4.\ (*Z,]. W=C+ LTJ,>88_B/(0:YH[P
M$3$>\A&>/>ZB[ GG]4 @^A4&XNV#%I63L1?+(/+BE()D;B%6CXD\ X9B8'@H
MT1J5(2&#4-D#,ATJQY#IRJ #&>Q&O(8,=V#DD)&,RI"0N8S07)4FQ481.*I!
MZ!@X'$ETL(/) *7S%CZB09(C2#Y"0X+H @UM 6'2"TA\8L=@$DBD ZB*U'=0
MR09-#BSUB%D\9-WAX_]Y$L)'&"Y3DD2T2J1"_ZLX:=/MP/ZQK*YDS'DM(00E
M);X2HK0D>TY>I<_QY3S.; "90]X>HV<Q246ZW:8)>4),<]Q.]\4FS:)_23-4
M2ZGLIZV0RL#&\./6U=/P,F'R@<)M4KQ>HN14%)K$&00*4:RFY%"CB\G-H0LM
M)S9R%62+C!RUAY^#> ^K2J-ZMB*F=FDS$IGDMH,(<;)U2@H([:$8K3=V9"Y>
M:4\[)-X]$0JG2 _3. ZR'.R0@,32/,B6;@!,B9GIH=+AE*0LF""D<#\5"7/V
M\Z:A25G"P!O;T9.A.?^ 2"*!TZE'7AI "T(.;6"Q+_(B2,(HN3,QA!:9>VMH
M2Z%G$@T:S^Q"2YKVXBQ5">/41#@@4]J)$&''5%3'W5,#/-]GN&XVS*(T;!KF
M19I=(BF#?(-?M48AS )1M;#CN[1<<?THZ;G)::O2.+0_0#NL]C[EWW"QC+)3
MT.[5C=E9U45W!A9K0UTOYVC%A.EJCR-YR/?L:.90)JET5'0:)P5%DE(-JU8G
MY$]A([=\3@J>X=#^(H+Y*\=GB0.XD-8)XV#^8WBW2!;M4A8,G:).AUZX1"W)
M#1PBW<*J/(!_[G!@/4RH(M2^<*R9X1@'V$L7=.#UO=_S='[ZCD+']9EZ"<O/
MLF\ESU[+5Z^WW5>O]*@^_XSK48;MTF^23=<XGW/S+'MXK3%N!__AA'0"FA\"
MC2_AO/;-=N77Z%MNM".D'T1NBGS26I%'W9JT%A4)3N6*/"T56;9K*1(<RD;2
M3U8; J\J0HYIS-SW\J-:\G-S@O.$.ON+(,J(PW\[NB/D??*9.D.N]L9WB #9
M;[62PY^FR[FOP2GJ*S0'I*JT!P?18QOB.$Y,984V4XG#-<PR&)H&*:@(':06
M5TC"IA@O"3R-5CA"(']C%O3PQN90UP>;*]OI$;R@VX%C6S*XXV=L"D<Q+/R,
M8AA R&<3RV &5;GY^1;1,-ONXO0)PAN8W4<KR$_+=9DF=,E")N.<5&AM_OTL
MS8O+M/@5%M=PE=XEBMEOQ&_:?XX[HOZ8)[WEMT#Y,2!:GT] _46Z#D?K[];Z
M'7\0EX $3[  AV]Z47SWV6B4?%1+K^Y=V.AFSCS;MF/C7X&C+#<S:5;^"K>3
M'6789N3K<:DB36MZ!?8\T]0K_-KQMN7='K[$:K#T%7L+*=:MN1 -H%LOQ5D^
M$UIDU]'=IJC/:>%JGY%[N[,@CF%X^E0_DJ<-99<_1_?LJLCG$;H05@2MWIIA
M4\.-6S<S=<^ =HW/-.M7]A6%XZN;YZ@;JQ&#P]B1H![K,$;DV*O,'F&VBG)X
ME2%W6O^QYE6VZ.C9GQ\>1$-N ]NH>@.DNT8;OUV%?25X>YYSE'%H.0@SR[!Y
MZ)JN( SS"Z03'!\3)$WVI(>M<D('AZP*2=AS1TH , 6H2'"$047D^D"UKT#K
MED"I2B"[)Z<Z>&-/3/7!YE%%#5'!@OJ><HIDV=*;S.LH__TB@W">%!"!JK@.
M"ME=AX5O^U=K8P!]\@,:- .33CB!2<VH!=#X_@1@#@!F 50\ ,R$!Z$-3G1\
M5-#((#KVJG+*4+[!N(S*L([AF7K;V>,.KO"-6XKSG<=1\633WXJ^_KP]KE"G
M%GUNQ0,X,/&U.5U#-8_B=LW4_&S]KMQ+C.IY=5R$S;3KD@=E?+D_9&DNS\C>
MMTL'R=I[2]_G4:?X;HGTZMB5#:@+YD5O?<U6YM3"19<\<"E'@I]-?C\$\IT;
M/_%8@]J^ND=?3%]#]AXO&)^CX8^I"5[0S9B:0'L<JWI@GF_N,K@+HC(.$JP:
M?7CK!76]@*83-',!(V7M8#Y=A602[CA^[>@>O7B@KB>[:<H.WJ._.F+9Y6.?
M$52AM: A,=R?C<.;CU;'T8DZC/5Q#9%#RTFUHF(##Q*6P=WX!3L!3^D!0PJ>
M'05/D)>-Z2S0=(:>OE@W\!W:V3I,',<S.(JKBJKF14:PF"\0,++E)DC*]UQU
M\!8-J!CC0,Z<A^=S+-=#OR.<&M7E@&LV .$#>0'D_NKWGS4O5731!)S"NRA)
ML!<X#6)\R>?!NL<VU@<[5CH.Z,_@\;=2P.G=70;O@@+?7R#'FD<KXC9KN57N
MQ1%3S^<!^1 CX,X!U<R!FKMJ UHSZ,'%@5<#<U0.#^&X+!OC@G5?OH>7;0^>
MQ:OXP3S48._F!W9/?IQ"UHF=RH<!?<\>.?UX=>+(D[-_IC1\XE1UY._9HH[,
M^$E'#J)DM2?/B-&N.LCS=!51]_00%1OP4 :L1F7TF >A<+T0;7*.IH"SQ2!3
MZH#RQ;IF%X\!&399B*F4S'Z J5P*)AJS;$[>3-1&22(R"8GCX%(S8:@ B_4:
M$H<B$<!J,*D&KIA04FU0.9_;Z'GB ).;L"-?9C>QI$=D1?9^?C.0FKDJRLO&
M("C +B,_X;4?5@>)_OY?;UZ]>?\]+E:%?GK[[D?/\N3U KS11;HWDU\C"?U9
ML(N*(*8,7D,\AH3%BWVQSV#EBB3VW:,OEW44M.65%U<HNZD22E4=$3N@7=53
MJWMH]QYN2?&"/F/MR>QU"1_(GWK/6HT._)JMFI+UF:40/6WAP4+*; B-_+!@
M_)S#DYYJ]$=GE]X7<#)R]3@@4$'3AW,!J8A'+Y>\-4D^;$U.!=P;I.I"*Q?=
M:)5'E!_(J[\JZ><O$+^@A>$4@2JX@ZV'ML?<'P_)A7\WR(/JN,\53JZ;)IAR
MTDP37'$#2G8Z;\\]L%W["#>^-1X+WHXS6FB6GE.2^I&G0E&T39R-05F'SGEV
M!9WR;4:C=$0P*/=#>0GRX#86QGQJ$-H-[=21A ^C0]H#G&"VS-?1('09E=A'
MJD[P84&2L"5U%J.'*CD)//2"8P[1)(6;PR3$K?"/&=RE67&(3'0=?:@-UE:0
MH2%2[7GQ*HG#- DI3WH>7$YFW7LKI.B"LTZ-@UI4MN:5R]89E:Z[UA\2RWN-
M\BR8+%8TTHA+:-RLXP7\2\//)V4>)D^2@_>0@[=[]S5_E!)FW.6Y&F//( B3
M'TMJH1*9\(O/)WQ2J;LQR^\PX=>'DF3^!F*/A]"A*]-HP=/)+:3H%9NXJ<L[
M1-'CHO8582NRS>7S4&/.\<GSF[>XYL6?P!\G/[QY,WGSY@U;:N9/X,?)=^^^
MF_SQC_]>S8QX[8A^^?;-Y#OTRT:Q=GS(_0E9UP:\>SL!>+M;M7WW?O+FC^\Z
M';SY<?(#^F6G@W.X@L0KE'W\X-X#B# LN3EU^DSJD-<C_,<^+["'T$JMJ*"S
M;HTJ.;H ;V:-J2G4:0AMK45-Q:F.17!*EB3W8";4PE77* Q Y=%54)^4.>?1
M?11"M EUD-&K_6W_KGT&T*>+-%,5"U]K+B^%BFOQGR(8>U [QIK96DFQ);;9
M8_)+K#8PW,=PL9X%&=Y(Y=4.?RF[4%"26<X4H92"\08E!9[N*YI&OH<OA.[O
MKA_PZPU.^Y6^R<C8C&Y"J,4POUG!),BB=/H8R:.9N.T=1"_Q^6;Q1/\,ON &
M#H&CI7 V#D>I;8M0*7GX.<F1XXO6$7)]Z3:(F&NWIK1B&ON0D? O@LT$-%J#
M+[2]#RA2C06#)+V!&&7&^A@E<(YPS/,K^J2^S%Q-:4QG+TP+"+&_4Q@S6IK3
MF&"H[/FG>;)*M_!CFI,T_V=I4D3)'G&XV,&,K//R4[A.,TC;+8-'B)9P11:D
M61@AVW@BS%\BW2%*I$?$WUV5MUKBX4;]JG4?.:X.N^9">P$O\/=>TD#:PR?!
MX9O@EGP4E.W)9_'NKO%A:E7D5J+Q[3JKNQ=U2.TJ%W^'ZG3%U6EP'T0Q"5LI
M4E">*9-\6ILT#F&6@Q?)?HM;I]E8*<5(4(U?6IM?GBT^S1 D%S<W+\'I[&)Q
M/0/E+Y?3O\UNW,_]%OQ<=_5@S<E9C!MJ1Z2V;MD:@2>G01ZMI@G:Y,=[><:?
MOAW:CS7J*SESL-V-HR[O@1?5/7 S)FD"2(?DTJCLTJTW'EX-0:F&0Y3@JG2K
MC#; /J>))F+LI0^9#<L<ACANL$R"^2*$2;I%5H3]L/H5KIU;RM$AE/(@!$YT
M,60UU.TH1\($P0W@11R<'BW6%PBBR2H*XJLT)_5OI[<YF@%6LK6S'KF[LR6Y
M5.S#N)(,.\":$%24X$M%Z\/Y@<' "0^EM$?- 2!%I^2BANY )CP)K^'D_-!;
MKETA/OPXV):=/LD:NT.$](3I@ HO#I/4ZA;"P_F!T33/89%KS%/=AM:AP7#:
MA05MH)QB;*VMU?S>W,R6'NRE^1#H0E8V_K;A>H9SU"6%-FJ9]H[ R_+-Q_ $
ME"T] [.:_XIOVMX7; OPPH>X%"P6@XV#?(,V-_@?G&_T/HCQ.[QI<19DV1/:
M_2@CD/7H[8<E:\K%( L1D$TO^:%!.L&1MA5U%<3LP4GW,8*.Q#E]?(D6'UDQ
M&O?3F[^"Z1*<SC[,+R_GEQ_ X@)<S:[GB_-1A9HEX=@BS2[/5<)8C>0V<1!,
M>+>Y=[ XR:]6Z1ZQ<PU7$+&&-E"7L"C=LFRNEY+9G_+E4C S?]D<'-KC)$)%
MO1;PPJD-(50""_?6HX,Q9GV@#3";%_[WZ.MI]H18D=[0-YLYN%)O<<G>@9=_
M+A'O =!U.7:/9!X"V+M+T?!;3&!-"_.5+T#0Y$.RYK?6W!( :U';3V>M)1.3
MU;HL45B2D54MK>'0V?XY3F]]E'"^[  -8,>DN3;%G*-S$-WS#]?G'NKSCG%=
MOU:HC8ICPB#P^IQ#ZWS#+7)Q'(SA(1Z/Q!&>N=R+H'UH[-EIGI84S7G)%YB+
MP<-'O HY-M= Z0YFQ1.N85J@"07OO7?X'DB^>I>3.5CU2*5@5P2T^824;BW(
M<J<F\6?%WU.JKCC"W:V=Z<M0"O1;P)?$O;'K& N[9-.U%)M;] *G2;Z-8>F.
M8#%[7,5[',/T(4W#ARAF1K2UO],A=["EUY**W3A79/5F!V/P14T+*N*7(R\&
M=6+\AA-R/+>@?:#12Q0\.(PX[GV#B4VQAR&F!F7W.(\FELCGR72]CN(H*&!^
ML[_-HS *L@CFT[(L&\1) O\KC9+B,VJ^ER<*.[)?)P>&Q^B!=UY7]D=*VZ&9
M;AK>DT)B10H.'YB YB<FX/"1"2$BWP'5A[Q8MXRG*JRIEL ^V/T ]L$['1W(
M.&SOHY6[9F=[9,F.V),S'M[ASF(Y_0C\"LR2[VU=P>]C%-PB.RDB8A$WC3=S
MM#JNQK&.?A?6(6P@'?/D\$!:;ZC0WLJ7HY]C))M/3^<?Y\OY[ 9,+\_!S7)Q
M]M]_77P\GUW?_.';=^__!&;_^^?Y\E?WAF,*SJYI]4.F$^/3#X64$;DT,'50
M8:.Q?Y&11I)4S#>(O+(6S4!)72C9#QFZ"IYP7(9^L%"7P%F8$,.Y,):F;.G)
M+7%O_MT#7PX:4?2/##%6 9_M8<A:HASS(AH7L!?RST$.;@MX\X!S\!M+4883
M>.#XE1CBF( .@)PLA/16/FZ7.JJUC?.-L9Q7NCMN; /<0Y@# ,EBQ6GY5-/M
ML5<;8J.-8K-QM?^=%D46W>X+DFQGF:)%@%>K^-[RE1M?0N+>',RWNOYM;J]0
M7Q#-*J%6H05N:Q=QH!R>.:&1M)7-B@OZP9Y])&A67GA+RBZ(2B]<I@EL%DU(
M?2K5)<$<)RA4#CB+>X P) DG@O@JB,)Y4I:X;Y1ND&T&-(CM[PIT)&(6UC41
MP%1@GH"2;@*:=4(<;Q4&$.WD()I[F]%''[.-,(2>/8LZ+VV[F1F=SHH22Y(1
M6;<@J01,3OS*F[=J#L@6,_WY?T_Y3^!=4$#E6TTC,3["/ =\6;[[#I<#(A/.
M._IC*QW9!*#_X SVT3V,/5B_J?'7M25=\-FSH6M8!%$"PRHW[G2UVF_W,1YU
MQ&RTBF2;'AUBZS:E)1%;.Y<2'7(@OVC0@9)PK QVFI/24)+)I;%I0?KHZUJ2
M*?1<'A\8'1MX<5Q@L(T6G!6X/!?3DH>^##(['#B:?8.4#EI"2$M5#L2M1JZ&
MXWEU>^RB?]SBP=$Y-\;AB, =#P-VM -U/#E]UQ6".9)_YI$Y?2-R!JO@4?J4
MFPV$^*H73SP;6$2K()8<V6M3VJW?H26+P*D"2@5:9.,?UX<I6G2A#Y)]C#6Y
M7CDN1*(/NE8=$E/$N3K#;Q9JUS[*;Q,Y/M'O2* \%B_S=OMWL*\M2$X%*0_R
M(XD@[L[I>;B2']>+0>76-AI9S0T-I$7IA96T9=$UE87J.LBEO>B*U#8:CV^X
MA*C3,1\AY-R>TS<JF/X2%9LY8O ^"O=!3+F>UG>1%VF&/0">.@U/]?M]PHL[
M@)[:T;LQ:%8IQKV#0_>U@1^^ - G0/4-M\;N5%,/:DVME9IR?3MQC-7IW&4<
M;W*VB^_5N=TU8KR$%(Z*WO%X%Q2L:R3A]ZBFAV((^#6]%/JW>75V#Y,]U$G'
MSS9U<"W&<,M>%=$FWL3Y:?!,"]VYA[((#.R]E0P)]L"[A*M-DL;IW=,-S.ZC
M%<Q+SB0HEM!8A[.,?^;8M6X+JL:@;.T6WR9"5"W<0UT)G2[F-7%C\8HVB&L>
M*I;D.;V$%/8O:X6\,XC!+2N@3VKHDQ0^3J]GM26@=[124[5Z<2B'#7-[J(,9
MBR4JTKQ8K"M&)%CO-K1?=*++*?,P%S4@-3NE/M&6%U>SN[A9XEH$-[/KS_.S
M&;B>?9Y=_NS!HH4/":;Z@ 0/]N#[(4OS_"I+U]*(M%8KZ\!M\]B% ?DKH']V
MZ7\57%XO;F[ U?7B8KYTCU#.J'?A*1QR>]@LBTHG=]5K48TMH83&.FYE_#,I
M9JNV]=-8;[:+)F+,_G8UN[SQX5&D$CQ=P&LBQR+\<=;A#S!!;,73))R&VRB)
M,$LX4+MD4F8)6N3VC4)/*GX*YI*N3%W7I*S,QK&IC"%<FGA@30989 S+&(A6
MMZPTM5T2_A+<2=?O;%,7F]0NM^P:_G!MX/@UL9K9J^ )]1C+;=?R5I0+!\X>
M5((%BX\?8](Y#,E%T&F0=][ *"<)W0[L/X+4E8QY+5@1TIO$DUM,VGG;Y<-4
MT5M $H1P<LJ(Y=YZS-#(/(CL 46'>Q&3/8@/>P^M/8?+_;,.Q_3DTI_D04)4
M*#<7[G-KTVO?>5) -*2JLGE\$H<9L1GN)1F<:=L)J%K[DJI:0P;ZIU("]WA7
MH4><5%H&'7OHOTR3M+)$RI%ZB22AL8Y_&?],T8)&VQ) N,($:3[6BULM1V\B
M!'7X='^L)X--<U#"J6L/FEBR>'M%4]=17I;!8\G.*=JMRV\$5(3V;[=4DHC2
MT):P0B1U+<H7)97CA^D#BN3>5O20QER2&<#,?N2UN=DH*9W%2>NCK [J]==R
M!A7*O>UHXDT42NR9]5S"TIX_IKEL&]UI9W^QU>&37Q6*KDEPDY<>YFPPEL%E
MH;&!F+6Z N1AF5GUB8%LS^JJC"Y7,*L.V*+5- G/HWA?2)^D*BFM6Z9:%N9>
MNLK2@TCHP? $$"IRVU;2@1?S!)RG<1QDC89.3<)<4HPQ@/88==8_3 9.6&G=
M&X\F)+OF9(1'FPF*R@<4B_59D&\NXO1!)V!%3N8@:9%4"O8RHGH LU@#3  (
MA5?/870&ADU1HSLJ5M=-F)>K++V/0AB>/OV<X[5=?;0\Q1G\:$+Z-$&_V*/?
ME7],$QTH#O4!%RNU833#6W$05%==@]LG\ +W#J+D)3A<H!R^@-.M5M\ AX]X
M$\TUFJX65[/KZ7)^^0%,SY;SSY[DQA_6:#@KN\$MQF;JY'_LRY*/R_0:8HU&
M,6RM5I>IIGP:[F6<SSE(SSR*UMBLQ_5G\%:R_A!@MYWHSVTG=5HYJ;G 27GC
MC1PHLTA!)E$F^G/M]7>50E_LT4=?8N>?UM;[DWOG-J8!L_FJQ[9>BTMU;H2)
MSF)=06A_N:Z2A%FPDZ H-GK(&X]@+-$E0B(VUBJRP@.[U,,7L^<P )>+1<)%
MFDVW:59$_^(FIN/Z)8;&X73-\L],$XT_NSSU&99G-S.2 "WB:44*%9MW>SNT
M/(A4$&\W<W!KU^*2O<TZ_-DED(]FT^XM&SOR[)6::-@M9T)?[# +5TB=Z@@F
M$8&;C.@\SKDQSB#-P,])5 !* 3")'[';AG+0ECF8/@19.%HJ3"V#[,6Y/Q?A
M<NAS\XPK<&\U,58&T>KN'-)_&SNCLO:/7JXL[4Y<I,_2EY"348L0X3H:]*>7
MN(C5X?2B[,*;C<I1TIYM<$(W$"4@R'.<BAE?S,6'_-X>;&+,\<I)+-8+K"YM
MLBIP?0U7,+K'@1Q&UL@C]\ .N5)I6F!=LOQ [+8L5D_Q7E1T+T%%B>U/6SRW
MMB?&I=KJ5*!T??!F?.#FS4&;\("-?77H=-6GS3Q9]?GUJE".&;U#-'_F%_PB
M)D%?DQ=K5]!Y,*.TY="92I"O;1"-5.?]V)E$+E8];S3FDH98'M1.U *<>L80
MHLVEZ5QE<!=$81757&[GIDE(G@=-R3K:R*;T.O3 V#0EUUS0E;W5,?MXZT%?
M6-&>?+/)GM(+C+627B:K6XLUP;G:E,U![L/VZRIXZKWWJFD]L%Q6'M-=5TGI
M<OG81ZR6-)S=EE0L/[9:'0SJ[[.X 'PN<:(2DSNVXV<6%\J+-1@L'G2D]:_A
MVZ"!M3-;@K/IS5]QFLO/\_/9.5+-S>S\)3C]%7R-T:$BSS"DG3AW&S2%PXCA
MY<8?\,6-F&O&T)W4'WC^X>7'ZVI^^7EV\UP<2$^CT70D1UF,Q1I_P5,9+CI=
M_7,?91#)@9@KGO!E;(%V(+AJ[0XWD3@-DT[L5_XSD9"3_+".[B[)044_(<$.
MQ:2NR4PZ<;LQ/TY8Q-0&[P'2-;C89TE4[#.H(YU-8S8'+%,IL"=:'1KE/"G0
M0$5HOZ(\0=.@=6^"''ET+.] YL4I6"^Q&C:F*8Y3ZQ(A3VE4<M@Y7S%?1$F0
MK$9<,1M_P)<5L[EF#%?,]0>>_XKY>%U=S"^GEV?/9,7<TV@T5\Q'68S%;&R(
M=;1(P/_@A<)]$&._=P6S* V[QXT2MV'6C?U,;692,J%SV/SQRI'\T.AA F@?
M@'.D[O*<[4AYZU.U%^>SL^O9]&;V$LPOZ4_@8G$-KF;7\\6Y>\ON@UXFWUMO
MZ%H,8MKO=C%)#A'$57*(>;).LZWV,T+='NR'.6G+QH0.-2@/F4! @]B;&7<@
M(<^C?!6G.=[(XA+5?)GI.V)\X1SN,[P"*380I^?!?@JU\B#.UQ#.3,!5'RS;
MO&*F&8>OT!!(;Y.;S1Q<'+>X%.:!QG]W'?6NQ:E[6/,&GKW"%8VZ[7KIR^ 1
MYDJ,=EHZJH_>Y%50%YTT\0*M)@S[ %HN&/@5VP5(L/P0L1EFBT\Y/\'M+<PD
M,)92N7F2*)1!'1]-7R5^H12NUS5&LJ#U=?&$]TIHZL8%U#0$L?[43PXN[GL_
M'63IF$A^%]]BX/_XYET)>_R;W\[2)-_'19 40J +VEF#MHA/ME18U<2#89<J
MMQIH#<VZ#%ZL8BPUW[;H=N!!&*- ,LVP_SJWME\/2\P&4!W^IQX]BU-S=)=$
MZVB%;QUI5"+:>UZE<;2*8+Z$C\4I^OCOLEE:LP/[$[:N9,S<?2 $!TI0D8(O
MF!@0:M?SN#L1K<[P1AAE)OL> +6\--ZD<0BS'!]D%D^7:0$/)T9:)JC?AYME
MLZ9\W$5T20LH,<#4S0,UCXQQ($G_\.V[]W_J+Z[UI;<)>+D+<7/D>E '3.=2
M7DWK3UTP>=X\<7TP;\[J^TBV6/YU=HWOR!:?9D@D6I+>AV(1NJC3+AO6_W1=
ML+W]KS1*BL\PP>%Y$EN0M+6[S17PVT4$:0;*=EXDIU=JN[7G5:MZH#'76Z'H
MD;E#@M[LW :%W<5'F*[VY,Z,=T;07Z2&$.D:_(,(>%\*F&9@%V1%@N;D3;0#
MQ28H0)2C_?DJWH<D?HK<34)\)[++HAR2%4L.UC1V)HA!7A5%R,$^K^\RLW2'
MLS:F"?HC0*C/T1H\I&>C6UALTA"S$M1+]%<>V9S&DL8<ZA9+^I"EU2>BY$.E
MU<5#.<17,,-GN\&=+%;(H _[97X,Y..<;N.%-B4&!^H)J.G!H0/W:P/CL62J
MXO0;2%.TYG#UZBZ]?QW"" /U>_P#QN?W#7RB7_TV0\9>/)VGVR#BG8&R3:RA
MB\,= Q[R9_"%-G"X2A!ILAI\N1HM!BZF&9H$T 30])3*FT IE?VP1*D,[.5)
MV1ITUI;.;U(,QH2)OM,=$,<I(K(]##\>DB4:W;'PR#VX8>%*I9\K M."!K%W
MZ2(,A&M(5.7T=V]-)CC4RA0A!:$]^VJP4-9:EE@3K[%UV^%RS%1!/#2:@+*9
M!RD7M'BG->^K6MY*H[9I!6*T=#&O@HK]8MW-:]E#EL#J<9ERL6+6C;,RWII2
M"LM?-^DGH)G,LGXUZ4>PTQ@">[1ZZX-:4?UO<\BZS@@[S3*<'QOS=_K$L$SR
MZ)=)]3^@AD4^3^@3D0^9O*3X*%_S)!?ML3K3360+&A_"KR\Y/H)6.IA4A0\F
M@'Z1I-\CW\2_05]U;V8CPD^SO--PV'L&1DO^\YDF+Z%RO!W#6KF?>3YFRM?2
M"/9)_@'EETK3?,8V*4'78,:HA)9E*[Q5RW KD^$ZNMN0!Y;JJX*1ON?&+D?0
MV^@&2K\Y\>K>8E00<JUV7 0><8]^$65Y,4V2?1"C_T9H'Y,'V9/\F8"<QNX-
MNH)_)KT$;@YH>] @\& 3I3T<K5M>_;$X B0WN')N:(@2!9%=F*@D8-P@:>\Q
M4+2&I(44@_&PMQSX'*W@%1KM*(22QTG2UM:G8C[/703A5J!NY@%L-%3>G;J4
M^C["I\RVNSA]@N(+5VXKNUZ#X9&Y<R\;>#"\$J6VW(!,HQ8+-),<:+@*MO+^
MAFUJOQPSRRU3T9@TF8!#(P]N;C3XIO<VZDH:-CV4"!Q,&68I,HYZ+[O=I@EY
M$$"6YG/TH7"95J:S2!1>2Y_>]OM:;;G8T!%,"G+RECS'Q"#"U*!(0>T%T\0;
M3V@ZA)W7NGW&;SS +1_2HP#7H/<*<$VY>@&N>$B?">"8(30!G&#\G"<-U<SI
M+9G<C^W8ER2A^IH8+YV^!PN.X;53YQ&LBW)\C3GU12N<(<W#9J[!VQS^<X]6
M9#/\CF.I*(K%;^X@BR"7:S:;7M4,D';@"VGIP<9>IG8V 9Y*YQ:SNR/]7@9;
M.'V,I(G<6\WLYVQO<\GD,<>)B/#?P1?<P@,X\-3*9"D7ZM2=MT#?4R!!2.'<
M9QQX5[H-W-8;K"C&0.4]N -@WX$('^Z(&CIS(L)'/ TWXOP=CUR](E?2]TV/
M8&>,MC[+3;K/ WQU$2XW459 2'=*-,1(FK[/O N[^V,SZ9BS.[3[K<A)<O&J
M T!3_M$N?$CV-X"P"!KO6+D<;_I[H+.U[^\-3:?3L]+/2FA\F**%WE<P27OC
MB95CH3%1NWUSV6%(G7>5W]XUBL1Q \SNT/GII);J%< 9.IYDO]T&V=-B+<V'
M]C%*X+R 6]Y6H%\WEF-.C*5DT41Z (LU4&;)P_T TI'KD_">H]L.5CEF:-T^
MTVI$]OT2%9MY$D;W4;@/8G*RG\_S? ]E&=./Z-.+!URZ\NL];FJ&G3Z@[L"A
MO_*E5PYHE^X][-%HT'D+U0,*GMI#LU'Y9GHHL^!V[;=U\+4Q@)&T6I8]/S-;
MD2#E*)-1PL13RYD]PFP5Y? JBU:#V4RG4[^MI:N! >RDZA*0/I^9A7 1<91M
M2.!@,5E8&0!Q [-[Q ;_ =1E2JY#(7TPD9-+\.;?S]*\N$R+7V%Q#5<I6D[^
M"X:-(Q;938.E[]M/4F9)K\)XV?+#0/3<B 12TJ_3]T1Y9R)#'P9/L "'3T]:
MIX,>A#%:!2^36<T^<I_!4U[NJ^1?('Y<A91P#[/@#I(_G@<%O BB[',0[Y7/
M"VUR\GP>!/?6M=TW_15'H&2)-@&8*8"Y H0M]][$$>;'30A@"'A['N8:BZ,(
M0VBTL6Z53?ZZ]D+^YDUH :/)+J($:K0WUA29:.4+'W'0+3E!J4H :%UWZ79@
M'27:DC')Z.D-:TF)0ZXI;9E=F?8P\>UZS&P@NSCL,XH.=D*'Y9?R\DQ"XV['
MP>%?O$MH7O?[<Y.F' OA8EP^$!93W\9!GB_6A!_9-9NBO?UTMP*^F<<CN!U.
MX4X1Y,?EF);RF>RV:LU;7A4IW4ZKE9N5D="UE&LC;Z8LCD:YZR.W[N)3E$3;
M_58Y\IUVUL>^RV=W],N_>S25<#7;18!$K18Q$#SJ8:#=SCX&.GPR&*!_]PD#
M/,TR&!"KU>*YVVH#PWT,T7S$W>,WSP;Q]IV>#:"%]);^CCPST:HB./"'[)^:
M#:TIYE"L_ !9Y(@/OEI'XA-0?PHTOE6^8 )^E?,;!6K,:=:(.#LF/D[GL\*H
M.#UBR[%PFA+Q:]>7A%+X.H]Z,QFS=JR;^8!Y&I? YFD^)4<GBS6W&_GQZNA?
M]CO"H9<N^06E3D@WS>L2-!4<OD1>D^/B?'EYHH>F%$&F<4_.E"V!\OAPO",0
M^0Q2LM:W- UGA<.H5@4,ES#;*M,DC_31YY.<54>#(UR''NXUFQ/I!%2?!OC;
MCBM8VU1I+7>!&H 740*>8)#E'E3?'=\V!TM7:VB8SR!:1";1YS1&W<1H=KT.
M"EB>T(P1*-*#B><3(])'PR[\X8$7@)F9@)(=EQ7+G"K]T$ZABV<1(M/;T >+
MCCG2RK\N9TJ/.AT[TXJ)K]*9UAKVPYE2=KYV9RI4>LN9RG3QM3G3MJ&[<*8\
M*W^FSO0ZRG^_R""<)PCQ,"\<K$NE+#QO1RK7KD4WBAD!F!-0L?*5+DG--(Y;
MGZRQ6J)*+9E:+<_6H6H8^ZCN5-O2OR9G:G==*F7A*W2F+M:D8F<ZZI+4Y S4
MC<[%[O2K7)]JF+M]=]IW;=HSJ."C,MV.?@=^!1=\E*78T0DP^.A#^'"_032*
M-!",H,57#N2^FIA,\[:ZF;&AO*H67Z4JG^L,^1'[[RB&U-#8X0+>A%D/CROF
MB<=(H#K"X<^350810^>0_CM/>!_=P8S,4R*O;]J+7==O+&,7\E4'H.H!(9T/
MY\D5S.@:<Z1589BN]A@TY&NC";S<0!!L<2(U;+A1)?Z+L.SP)4#$9<&5<)_A
M)',%(LG@+LU(RKD=>;F+GU#CWZ>W<71'S1W3%[1^!:Q>< 5W:%5#+ $\;-#2
M!O\MR!+4:M7T% ]1'(-;"'9!5/>\WA?[#+YR/.'V,Z+6K'N,!8U74^@2/AQ5
M4ZA![U5-H:9<@II"=,U'B &A!LM&32'4P=C9DK4LW8*<?I=,8A!J4C)) $^+
MQU&8LTT:A_4CXFN(2Z[21Z WNSB2%3W4HK9_"*0E$W>+55*1!^3U^_&2N@(J
MIG>_5C08..9,P'343.&8P]6KN_3^=0@CC,3O\0\8@-\W (A^]=MYZ6#FR3K-
MML3-R+;W:A)K4-/@GLGU5C8'C?:>[-EUQZ("DME /(.S=6H%\R0O,B)43BJ-
M+C=!4AU#D/Q353X8DH%JU+Q+1S+T?,[=C]7\"*?PE"70X*DL/%L@KAJ/U&C:
MMT:.IJ\B#],@IC#8*?2 =O#UN2$/',]7[&J\<B[__S@4URYDP(.-?!\7@:1Z
M"+^9[6.*+I?L+KULX4$N IEB.]MNB58'/*W*I_MBDV81QER:%SI[YY[]N#V]
MTI!3?;J3@T,O '>CO[-V<Y;50VI\;IWL,>;PN?6*J0Z>@^"@@V!=H'9WT3T^
ML(;K-5P5.(D=/<BFFBE)\==RUX?,?<$O/1 S0[ZS$E"R<PDUB>M"4-+0 J86
ME!=G$KKCH"@)U1D$) &5"/W^=_3_Z/_0#WBE1D3\?U!+ P04    " !8B:Q(
MO9C'UCDK  "GRP( %0   '-G;&(M,C Q-C S,S%?<')E+GAM;.U];5/CR)+N
M]XVX_X';^[F[,88&)F9VPPW-!+LT$,#,W!,W-A1"+FR=D24?2>9E-O:_;Y;\
M@FQ7UHM<=F6ISY<>!JI*]>23]9:5F?7SO[^.DKUGEA=QEO[RH?-I_\,>2Z.L
M'Z>#7S[\]G#Q\>3#WK__V__YEY__[\>/>[^RE.5AR?I[CV][YV$9/N1A]&<Q
MK[_7^=3Y=+K'?SCX^#U\^WBPW_FR]__W.S]U#W_J'OW7WG_??O^?O6_W#WL?
M]UY>7C[UH86R:N%3E(WV/G[DWTGB],_'L&![T+&T^.7#L"S'/WW^S,N_/N;)
MIRP??#[8W^]^GA?\,"WYTVL1+Y5^Z<[+=C[_O^]7]]&0C<*/<5J481J]U^+-
MB.IU3D]//U=_A:)%_%-1U;_*HK"L1*7LUQY:@O_?QWFQC_Q7'T%@W<ZGUZ+_
M 62PM_=SGB7LCCWM51WXJ7P;LU\^%/%HG/".5[\;YNP)?C=('BLQ[W>G]?_U
M/(LF(Y:6O;3_+2WC\NTR?<KR4=7K#WN\W=_N+I>Z7\2#49B$CT6<1IR(S[S0
M9WD[GZ&;&W;TOLRB/X=9T@?E^?:/"7S!I'NBVA8Z=98!UG0"VG\SYJH.8 N3
M;HGK6^C85584MRR_'X8Y,^G0<CT+'?F/+$[+WT$Q)F8=6:YGH2-?X1LPD.^'
MC)5&'*U4M*'*D\>"_6,"X+X]PS]&O5FO:Z5#HU&8O]T\W<>#-'Z*HQ &<A1E
M$ZZ=@]LLB:.8%?/_FG77K.6M3!0/X6-BV&VT#<MCT[QKHMH[4X%S5H9Q4CRP
MUW(2)O858;5]V^/^%H26ED-6PO>-NB]K92LZ.Y/$9DJ[:&2;76RB#,JV+ ^S
M!M(45K>S9>BSM&#]>]C-,KYE*FZ>&N\>Y$U97K^;$RYK90L+ZB;3E+RE;2G
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M$G/J!M^8=FULMAPY*:B#+O&K8B!A[C*?LM=1V'+I++,R3 A0R6/M#??CZU5
M-"1,7:9;<@R)+5]/"B/V-L_&+"_?;I-P&AP.N\\Q/Y#*5V99M># K:.]'HG8
MK*W"9<M7E +YET!*.HAAKSF3%2N_O4;)A/O@_9IE_9<X$?F6FE0'H9$PM#11
M!GU\MKQ22Y8[5PF>5:7*&G.9]IZ>XB0.2U;P##AQ/P[SF!4@C"RJ?@L#I'Y3
M*K.C;M1N<-@AM$,P5:*-@=ORA*4PY:R*T& [ 4.-D&7/3 O$6!!BC>U[5':+
M2C(!-@G[7!.S^[3O"&7&YC?WE%W%X2-,1CQ7%DP[ZR["&AM^W29 ="2,<F:T
MFZ%#%,-+\UP-N?YM#%X)!$3"=&=&J%(IA"@1-?#2N#<W2=^&;]P>K6^87ZX
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M$I<J9WUY[>#XQ"^_1V-LB![\()<KRL&T_"! M<G:ZCY@HPX!HWX>\UV*"QD
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M>IBQN 8 \<3P;S#.K#CI8.:'H+-K0NN ;$@$9YB1JX"#^63X.%PK)Z-?60J
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M,2YX;6Q02P$"% ,4    " !8B:Q(S;?;;IT)  "06@  $0
M@ '3<0  <V=L8BTR,#$V,#,S,2YX<V102P$"% ,4    " !8B:Q([Y6EU74'
M  #.70  %0              @ &?>P  <V=L8BTR,#$V,#,S,5]C86PN>&UL
M4$L! A0#%     @ 6(FL2-;>/VKL)@  LVD" !4              ( !1X,
M '-G;&(M,C Q-C S,S%?9&5F+GAM;%!+ 0(4 Q0    ( %B)K$@JPA*;"CH
M %<X P 5              "  6:J  !S9VQB+3(P,38P,S,Q7VQA8BYX;6Q0
M2P$"% ,4    " !8B:Q(O9C'UCDK  "GRP( %0              @ &CY
K<V=L8BTR,#$V,#,S,5]P<F4N>&UL4$L%!@     &  8 B@$   \0 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
